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Preface
Obsessive-compulsive disorder (OCD) represents really unique category in psychopatholo‐
gy since it is characterized by signs that are similar, but not identical to other psychopatho‐
logical syndromes. Thus, OCD is usually accompanied by unpleasant affects such as
sadness, anxiety, and fear that cause the patients the feelings of suffering and are Ego-dyston‐
ic. On the other hand, the structure of obsessions itself is rather similar to delusions and so-
called thought automatisms, but unlike the latter, the insight in OCD patients is preserved,
and patients themselves really understand the morbid nature of their suffering.
In his excellent book on the history of psychopathological symptoms, a famous modern psy‐
chiatrist German Berrios (2002) regards the long way of formation of terms “Obsessions and
compulsions” in their modern sense. Thus, he points out that during the 19th century, ob‐
sessions were considered as signs of affective or, alternatively, as pathology of thinking. Ob‐
viously, such inconsistency in appraisal of obsessions may be explained by overlap between
affective, delusional symptoms and obsessions themselves.
Noteworthy, OCD shares with depression and anxiety not only common psychopathologi‐
cal features, but neurochemical mechanism too. From historical point of view, the observa‐
tion of Fernando-Cordoba and Lopez-Ibor Alino (1967) about Clomipramine efficacy in the
treatment of OCD patients was the first one. This finding has triggered a great number of
studies of the drug treatment of OCD, with emphasis on selective serotonin reuptake inhibi‐
tors (SSRI) use. Obtained results have shown the efficacy of SSRI but, unfortunately, not in
all cases, and a certain number of OCD cases remain resistant to SSRI treatment.
Principally, response rate on SSRI in OCD patients achieves only 50-80%, and total obsession
and compulsion score can’t be reduced more than 40-50% compared with baseline level (Ho‐
hagen, 2000). In this context, other biochemical mechanisms of OCD origin have been sug‐
gested. It concerns the glutamate metabolism dysregulation in terms of increased
glutamatergic activity in CNS (Pittenger C., Bloch M.H., Williams K., 2011). The probable
efficacy of glutamate-modulating agents in the OCD treatment should be proved in blind
placebo-controlled studies.
Many years ago a famous Russian psychiatrist Mark Y. Sereysky (1958) considered OCD
syndrome in patients with schizophrenia as buffer one. By this he implied both poor re‐
sponse of OCD syndrome to treatment and lack of any further progression and evolvement
to delusional and hallucinatory syndromes. The mechanisms of such properties remain un‐
known until present days. Nevertheless, such buffer mechanisms can explain the definite
and peculiar psychopathological structure, stability and persistence of OCD symptoms.
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gy since it is characterized by signs that are similar, but not identical to other psychopatho‐
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sadness, anxiety, and fear that cause the patients the feelings of suffering and are Ego-dyston‐
ic. On the other hand, the structure of obsessions itself is rather similar to delusions and so-
called thought automatisms, but unlike the latter, the insight in OCD patients is preserved,
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chiatrist German Berrios (2002) regards the long way of formation of terms “Obsessions and
compulsions” in their modern sense. Thus, he points out that during the 19th century, ob‐
sessions were considered as signs of affective or, alternatively, as pathology of thinking. Ob‐
viously, such inconsistency in appraisal of obsessions may be explained by overlap between
affective, delusional symptoms and obsessions themselves.
Noteworthy, OCD shares with depression and anxiety not only common psychopathologi‐
cal features, but neurochemical mechanism too. From historical point of view, the observa‐
tion of Fernando-Cordoba and Lopez-Ibor Alino (1967) about Clomipramine efficacy in the
treatment of OCD patients was the first one. This finding has triggered a great number of
studies of the drug treatment of OCD, with emphasis on selective serotonin reuptake inhibi‐
tors (SSRI) use. Obtained results have shown the efficacy of SSRI but, unfortunately, not in
all cases, and a certain number of OCD cases remain resistant to SSRI treatment.
Principally, response rate on SSRI in OCD patients achieves only 50-80%, and total obsession
and compulsion score can’t be reduced more than 40-50% compared with baseline level (Ho‐
hagen, 2000). In this context, other biochemical mechanisms of OCD origin have been sug‐
gested. It concerns the glutamate metabolism dysregulation in terms of increased
glutamatergic activity in CNS (Pittenger C., Bloch M.H., Williams K., 2011). The probable
efficacy of glutamate-modulating agents in the OCD treatment should be proved in blind
placebo-controlled studies.
Many years ago a famous Russian psychiatrist Mark Y. Sereysky (1958) considered OCD
syndrome in patients with schizophrenia as buffer one. By this he implied both poor re‐
sponse of OCD syndrome to treatment and lack of any further progression and evolvement
to delusional and hallucinatory syndromes. The mechanisms of such properties remain un‐
known until present days. Nevertheless, such buffer mechanisms can explain the definite
and peculiar psychopathological structure, stability and persistence of OCD symptoms.
It should be stressed that pathogenic mechanisms relating OCD with serotonin dysregula‐
tion in CNS couldn’t explain the unique OCD symptoms which can be simply distinguished
from symptoms of affective and anxiety syndromes on psychopathological level. Obviously,
further investigations in this context are needed in order to shed light on the OCD patho‐
genesis. Perhaps, the data connecting OCD pathogenesis with Cortico-Basal Ganglia Circuit
Dysfunction would properly explain the OCD mechanisms in the nearest future (Graybiel
A.M., Rauch S.L., 2000).
The existing data on cognitive dysfunction in OCD patients, including tests on memory,
planning, decision making, executive control, attention and vigilance as a whole confirm the
above mentioned tests for the role of endophenotypic markers of OCD (Chamberlain S.R.,
Blackwell A.D., Fineberg N.A. et al., 2005).
Moreover, the so-called psychotherapeutic approach to the OCD treatment has been elabo‐
rated several decades ago, and promising results in this domain have been achieved. Such
approach really can broaden our therapeutic success in the OCD treatment.
OCD cause a serious distress, and patients suffering from it usually lose their social adjust‐
ment. In numerous studies it has been shown that patients with OCD experience significant
disruption in social and family relationships, impaired work performance, and decreased
quality of life (Turner S.M. et al., 2004). In this context the role of social support and cogni‐
tive behavioral therapy can’t be exaggerated and such approach must be widely used for
OCD patients.
The present collective monograph contains several chapters concerning the different dimen‐
sions of OCD, i.e. unresolved problems of pathogenic mechanisms, origin, treatment and
social support work. The principally novel data with emphasis on broad range of yet unre‐
solved OCD problems are presented. The book is intended for medical specialists, mainly
for psychiatrists and psychotherapists. In addition, the book may also interest psychologists
and social workers. Besides, the data on pathogenesis may be of practical use for physiolo‐
gists, biochemists, pharmacologists.
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1. Introduction
Obsessive–compulsive disorder (OCD) is a mental disorder characterized by absurd, recurrent
and uncontrollable thoughts (obsessions) that produce anxiety, which are followed by
repetitive behaviors (compulsions) aimed at reducing anxiety. OCD may be looked upon as a
condition in which the affected person frequently experiences irresistible urges to perform
repetitive rituals (compulsions). OCD may be defined as the irruption in the mind of uncon‐
trollable, egodystonic and recurrent thoughts, impulses or images. In OCD, repetitive rituals
serve to counteract the anxiety precipitated by obsessions. The OCD patients realize the
irrational nature of thoughts and rituals but feel helpless and hopeless about controlling them.
Obsessive-Compulsive disorder can impair all areas of brain functioning and produce
devastating effects on patients and their families. Classic psychoanalysis, as pioneered by
Freud, interpreted obsessive-compulsive disorder as unconscious conflicts, which were
defensive and punitive (Rapoport et al., 1993). In modern psychoanalysis, obsessive-compul‐
sive disorder is described as a portrayal of ambivalence, with confusion of thoughts and actions
that are paradoxically manifested by rigidity and abnormal behaviors. Dynamic psychiatry
interprets obsessive-compulsive symptoms as a reflection of feelings and thoughts that
provoke aggressive or sexual actions that might produce shame, weakness, or loss of pride
(Baer, 1993). The thoughts and behaviors associated with OCD are viewed as senseless, and
egodystonic and they stand contradictory to the individual’s motives, goals, identity, and self-
perception thereby creating significant subjective distress. The excessive nature of the com‐
pulsion, however, creates its own distress and it appears that the individual may be caught up
in a kind of negative reinforcement loop (David et al., 2004) The obsessive-compulsive
spectrum disorders are Tourette’s disorder, Body dysmorphic disorder, Hypochondriasis,
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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Pathological jealousy, Trichotillomania, Skin picking, Nail biting, Compulsive buying,
Kleptomania, Pathological gambling, Nonparaphilic sexual disorders, Obsessive compulsive
personality disorder.
OCD is a psychiatric affliction with a lifetime prevalence of 1–3% (Rasmussen and Eisen, 1992;
Sasson et al., 1997). According to the Diagnostic and Statistical Manual of Mental Disorders
(4th ed; DSM IV), the essential features of OCD are recurrent obsessions and/or compulsions
(e.g., doubting, checking, washing) that are time consuming (i.e., they take more than 1 h a
day) or cause marked distress or significant impairment. To date, the most effective treatments
for OCD are pharmacological treatment, using serotonin reuptake inhibitors (SRIs, e.g.,
Masand and Gupta, 1999; Piccinelli et al., 1995; Pigott and Seay, 1999; Stein et al., 1995; Zohar
et al., 1992), and behavioral treatment, using the response exposure and prevention technique
(e.g., Simpson et al., 2004). Yet, around 30% of the patients are refractory to pharmaco- and
behavioral therapy (Eddy et al., 2004). Some of these treatment-resistant patients are treated
by lesions to structures and pathways within basal gangliathalamo- cortical circuits (Lopes et
al., 2004) as well as by high frequency stimulation (HFS) of the ventral striatum region
(Aouizerate et al., 2004, 2005; Greenberg et al., 2006, 2008; Rauch et al., 2006; Sturm et al., 2003)
the subthalamic nucleus (Mallet et al., 2008), and the thalamic reticular nucleus and the inferior
thalamic peduncles (Jimenez et al., 2007; Jimenez-Ponce et al., 2009). Several neural systems
have been implicated in the pathophysiology of OCD: The results of neuroimaging studies in
OCD patients have implicated most consistently the orbitofrontal cortex, the cingulated cortex
and the basal ganglia, and more recently also regions within the parietal lobe, in the patho‐
physiology of obsessions and compulsions (for review see Menzies et al., 2008; Rotge et al.,
2009; Saxena et al., 1998; Stein, 2000). Dysregulation of the serotonergic (5-HT) system has been
suggested primarily on the basis of the effectiveness of SRI’s and selective serotonin reuptake
inhibitors (SSRI’s) in alleviating obsessions and compulsions in patients (Zohar and Insel,
1987; Zohar et al., 1992), and has received further support from neurobiological, pharmaco‐
logical and more recently genetic data (for review see Murphy et al., 2001; Ozaki et al., 2003;
Sasson and Zohar, 1996; Stein, 2000, but see Baumgarten and Grozdanovic, 1998). Abnormal‐
ities of the dopaminergic system have also been implicated in the pathophysiology of OCD,
based on surplus therapeutic benefits obtained with co-administration of SSRI’s and dopamine
blockers (McDougle et al., 1990, 1994; Sasson andZohar, 1996) as well as on clinical observa‐
tions of obsessions and compulsions in basal ganglia-related disorders, such as Tourette’s
syndrome (Frankel et al., 1986; Grad et al., 1987; Pitman et al., 1987). More recently, an
increasing body of evidence points also to the involvement of the glutamatergic system in OCD
(for review, see Pittenger et al., 2006), including association of certain polymorphisms in the
NMDA receptor gene with susceptibility to OCD N. Albelda, D. Joel / Neuroscience and
Biobehavioral Reviews 36 (2012) 47–63 49 (Arnold et al., 2004); elevated glutamate levels in the
cerebro-spinal fluid of drug-naïve patients (Chakrabarty et al., 2005); correlations between
symptom severity and the level of several glutamatergic metabolites (Starck et al., 2008);
improvement of symptoms following treatment with d-cycloserine (DCS), a partial NMDA
agonist (blinded controlled trials, Kushner et al., 2007; Wilhelm et al., 2008), riluzole, a
glutamatergic antagonist (open-label trials, Coric et al., 2005; Grant et al., 2007), and meman‐
tine, a non-competitive NMDA antagonist (an open-label trial, Aboujaoude et al., 2009). There
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is also some evidence suggesting the involvement of nitric oxide (NO) in OCD. Atmaca et al.
(2005) found that OCD patients have higher NO levels in their plasma compared to healthy
subjects and that these levels are positively correlated with the severity of OC symptoms. The
possibility that high NO levels are related to OC symptoms is supported by the fact that SSRI’s,
anti-dopaminergic drugs and the NMDA antagonist memantine, all used to treat OCD
patients, inhibit the synthesis of NO (Almeida et al., 2006; Park and West, 2009; Zhang et al.,
2010). Reports that life events related to the female hormonal cycle may trigger or exacerbate
OCD in women patients (Abramowitz et al., 2003; Labad et al., 2005; Maina et al., 1999) suggest
that ovarian hormones play a modulatory role in OCD (Uguz et al., 2007). Indeed, gonado‐
tropine-releasing hormone (GnRH) agonists were reported to ameliorate OC symptoms in
OCD patients (Casas et al., 1986; Eriksson, 2000). The understanding and treatment of diseases
such as OCD must rely heavily on appropriate animal models that closely mimic their
behavioral and if possible their neural manifestations. This is especially true for OCD as its
neuropathological mechanisms are still largely unknown, and many patients are either
treatment-resistant or experience only partial alleviation of symptoms. Before reviewing
animal models of OCD that are currently in use, we discuss the criteria for the validation and
evaluation of animal models.
2. Clinical features
The OCD is clinically manifested by a wide range of symptoms. The most common types of
obsessions are related to contamination, pathological doubts, somatic dysfunctions, need for
symmetry, aggression and hyper sexual drive. The classical forms of compulsions include
checking, washing, counting, need to ask, precision and hoarding. In OCD, senseless, repetitive
rituals (such as counting, washing etc.) serve to counteract the anxiety precipitated by
obsessive thoughts e.g. Symmetry and exactness preoccupations. Fears of contamination and
illness produce washing and cleaning compulsions (Leckman et al., 1997). Some symptoms
get stable over a time period i.e. sexual/religious obsessions. The symptoms that is more likely
to change are aggressive and contamination obsessions. Changes usually occur within rather
than between individual symptom dimensions (Mataix-Cols et al., 2002). Patients with OCD
may report only one or, more typically, multiple symptoms that cut across dimensions (Stein
et al., 1997).
Many children with obsessive-compulsive disorder (OCD) suffer from an almost pathological
doubting, which can vary from a mild form to an incapacitating form of extreme severity, in
which the child is uncertain about its own understandings. Other high frequency symptoms
are checking, fear of harming others, obsessions relating to death or sex produce compulsions
serving to avoid a horrible event. Indecisiveness is frequently found in children with OCD and
ranges from difficulty in making minor decisions. Following Group A Beta–Hemolytic
Streptococcal (GABHS) infections, it was noted that OCD symptoms along with choreic
movements in sydenham chorea became worse, and this was mediated by antineuronal
antibodies that adversely affected basal ganglia cells. It was later hypothesized that this
abnormal reaction to GABHS might play a part in the etiology of OCD.1 This subgroup of OCD
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patients has been termed PANDAS (for Pediatric Autoimmune Neuropsychiatric disorders
Associated with Streptococcal Infection). Asbahr, Ramos, Negrao and Gentil presented four
cases of children with PANDAS. They suggested that OCD may occur after repeated strepto‐
coccal infection as all four cases developed OCD only after the second infection. MRI tests
showed that children with PANDAS have enlarged basal ganglia. The frontal-lobe function
compared in 21 children and adolescents with OCD who were approximately 12 years of age
and in matched healthy subjects, investigators found no cognitive impairment on the basis of
performance on frontal tests and concluded that OCD symptoms may not interfere with
cognitive abilities at early stages in the illness. The study with 42 children and adolescents
(mean age, 14 years) and 35 normal subjects and concluded that subjects with OCD have
impaired executive functions and nonverbal memory. Andres administered a neuropsycho‐
logical battery to 35 OCD patients without psychiatric comorbidity aged between 7 and 18
years and 35 healthy controls and found that children and adolescents with OCD had impair‐
ments in visual memory, visual organization.2
The performances of 21 obsessive-compulsive children compared with 21 healthy controls on
neuropsychological tests, including the Stroop test, Wisconsin Card Sorting Test, Verbal
Fluency test, California Verbal Learning Test, Grooved Pegboard Test suggested there were
no differences in neuropsychological performance between obsessive-compulsive children
and the healthy controls. Therefore, it was concluded that obsessive-compulsive children do
not show clinically significant cognitive impairment during the early stages of the illness, but
a deficiency may become significant over time. The doubting and checking are found fre‐
quently in OCD patients which associated with memory dysfunction of OCD patients. The
children with tic disorder frequently show OCD symptoms. The negative emotions such as
anxiety have an adverse effect on memory function. The most striking feature of the symptoms
presented by obsessive-compulsive children is the severity of the psychopathology in the
absence of formal thought disorder. Thus, Obsessive-Compulsive disorder can impair all areas
of brain functioning and produce devastating effects on patients and their families. Therefore,
there is necessity to aware about the OCD in children and different treatments for it’s man‐
agement.
Sr. Obsessions Compulsions
1.
Concern with cleanliness (dirts, germs,
contamination)
Excessive and ritualized bathing, washing and
cleaning
2. Concern with exactness (symmetry and order) Ritualized arranging and rearranging
3. Concern with household tools (dishes, spoons, soap)
Checking, rechecking and keeping inventory
with detailed description of tools, objects, and
appliances
4. Concern about body secretions (saliva, urine, stool) Rituals to remove body secretions
5. Sexual obsessions (aggressive sexual actions) Ritualized and rigid sexual relationship
Table 1. List of typical obsessive thoughts compelling repetitive actions
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3. Causes
• Serotonin is involved in regulating anxiety
• Abnormality in the neurotransmitter serotonin
• In order to send chemical messages serotonin must bind to the receptor sites located on the
neighboring nerve cells
• OCD suffers may have blocked or damaged receptor sites preventing serotonin from
functioning to full potential
• Possible genetic mutation
• Some people suffering have mutation in the human serotonin transporter gene
Figure 1. OCD patients have lower serotonin levels than control subjects.
4. Epidemiology
The frequency of compulsions in 8-year-old German children, to be 4.6% (moderate severity)
and 2.8% (severe symptomatology). Later, the prevalence of compulsive checking in the same
population (13 years old) was 3.4%, all of moderate severity. 2.3% reported compulsion for
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cleanliness and 4.0% experienced obsessive thoughts. OCD in the child psychiatric population
found as 0.2-1.2%. In an epidemiological study of 5000 high-school students, Flament found
that 0.35% fulfilled the criteria of OCD, as defined by DSM-III (American Psychiatric Associ‐
ation, 1980). They calculated a lifetime prevalence of 0.4%. In their Isle of Wight-study, 2000
children examined at the age of 11 and found no children who fulfilled the criteria for OCD.
They found eight children whom they diagnosed with "mixed emotional disorder" (with
obsessive-compulsive features).
5. Genetics and family lifestyle
Family lifestyle could be regarded as a possible precipitating factor, for developing obsessive-
compulsive symptoms in predisposed children. Family functioning was described in 20
Danish children with OCD and later assessed adaptability and cohesion of the family. In
studies of children and adolescents most surveys show that OCD patients are generally from
white, middle- or upper-class, intact families. Certain myths have prevailed regarding families
with OCD children. The families are often said to show a cultural behaviour that emphasises
cleanliness and perfection. 9% of mothers and 25% of fathers to OCD children had OCD
themselves. 19% of 21 OCD children had one parent with OCD and as many as 52% had parents
with obsessive-compulsive symptoms, without meeting the criteria for OCD, when parents
were interviewed with standard clinical psychiatric assessments. 52% of children with OCD
have a positive family history of OCD amongst first-degree relatives and that risk to relatives
is related to the age of onset of the OCD proband: the younger the onset of OCD in proband,
the higher risk of OCD or Tourette's syndrome in relatives. 24% of referred OCD children had
a first degree relative with OCD.
6. Biological aspects
An electrophysiological investigation in obsessional states informed the presence of altered
neural inhibition in connection with obsessive symptoms. The EEGs of a group of OCD patients
compared with a control group of patients with other neurotic disorders, indicated abnormal
findings in two thirds of the OCD patients, which was not significantly higher than in the
control group. An orbitofrontal-subcortical hyperactivity in children and adolescent OCD
patients may be the result of abnormal neuroanatomical development of these structures. A
report suggested OCD develop by head injuries in four cases. The OCD patients have a
particularly higher range of neurological diseases in childhood.
7. Neurological soft-signs and neuropsychological findings
Soft-signs are non-localized deviant performances in a motor or sensory test, without other
signs or presence of focal neurological disorder. Soft-signs in child psychiatric patients have
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been well studied and implications of soft-signs have been thouroughly analysed in a general
population of pre-school and school-children. 44 out of 54 childhood OCD patients, at the age
from 6 to 20 years, had neurological abnormalities. Of these 44 patients 18 had choreiform
movements, 13 had non-specific neurodevelopmental signs only, eight had left hemisyn‐
drome, and five had miscellaneous abnormalities. Most studies conducted on OCD children
have resulted an overweigth of soft-signs, compared to normal control-groups. The children
with early OCD onset, have more soft-signs than children with a later onset. The neurological
soft-signs found in 18.6% of 61 OCD-children and adolescents compared to 14.4% in a control
group consisting of non-psychotic and non-retarded children and adolescents with psychiatric
disorders other than OCD. In studies of children, a pattern of association between OCD and
selected neurological disorders has been long recognized. A prominently left frontal dysfunc‐
tion in OCD patients indicated that cerebral cause had responsible for the obsessive-compul‐
sive symptoms.
8. Pathophysiology
The brain regions impaired in OCD includes dorsolateral prefrontal cortex (DLPC), anterior
cingulate cortex (ACC), basal ganglia, orbito-frontal cortex (OFC), striatum, amygdala,
thalamus and brainstem.
8.1. Dorsolateral prefrontal cortex (DLPC)
It is the most important cortex part for cognitive functions in human beings. The involvement
of the DLPC in working memory was initially demonstrated in primate studies. The DLPC
also plays a role in adaptation to changes in the environment. DLPC plays a crucial role in
focusing attention on specific stimuli and in decision-making (Miller, 1999). Lesions of DLPC
disturb the subject’s ability to process temporal information and impair the successful
performance of goal-directed behaviors. Functional neuroimaging data have shown dimin‐
ished activity in the DLPC of patients suffering with psychiatric disorders such as major
depression and OCD, which may account for the difficulty in overcoming compulsive
behaviors (Saxena et al., 1998).
8.2. Anterior cingulate cortex (ACC)
Neuroimaging studies indicated that the ACC is involved in a variety of cognitive processes
such as attention, motivation, reward, error detection, working memory, problem solving and
action–plan (Bush et al., 2000). There are two major regions within ACC viz. a dorsal region,
known as the cognitive region, and a ventral or affective region. The cognitive region is a part
of attentional netwok and is closely connected with the DLPC, premotor, and parietal cortices
whereas, the affective region is linked to the amygdala, nucleus accumbens, hypothalamus,
anterior insula, hippocampus and OFC and sends projections to the neuro-vegetative, viscero-
motor and endocrine systems. Excessive activation of ACC has been reported in patients
presenting psychiatric disturbances such as phobias, OCD and mood disorders. Moreover,
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electrophysiological studies in man have demonstrated its particular role in error detection
processes.
8.3. Basal ganglia-thalamo-cortical circuits
Basically, the role of the basal ganglia is to integrate the various inputs arriving from the cortex
and to use this information for selecting certain motor and/or cognitive programs. The point
of entry of information to the basal ganglia is through striatum, which receives converging
information from the limbic and associative cortices. It then sends projections to the output
structures, i.e. the globus pallidus pars internalis (Gpi) and the substantia nigra pars reticulata
(SNr), through two pathways: one direct and the other indirect. The indirect pathway succes‐
sively involves the globus pallidus pars externalis (Gpe) and the subthalamic nucleus (STN).
In addition, the cortex sends direct inputs to the STN and the connections between the Gpe
and Gpi.These two pathways seem to play opposite roles in controlling cortical activity.
Activation of the direct loop facilitates the triggering of programs at the cortical level through
a double inhibition. On the other hand, the indirect loop blocks the activation of thalamic relay
by increasing the activity of the Gpi, a GABA-ergic inhibitory structure. Dopamine of nigral
origin seems to facilitate the direct pathway through D1 receptors and plays an inhibitory role
on the indirect pathway through D2 receptors. The pathological activation of segregated closed
loop circuits involving cortex-basal ganglia–thalamus–cortex pathways would produce
reverberating activity and result in a persistent discharge of the innate programs characteristic
of OCD. The clinical manifestations of neuronal disorders of the basal ganglia can be viewed
as a disruption of information processing at the cortical level due to the loss of the focusing
action of subcortical inputs.
8.4. Orbito-frontal cortex (OFC)
The OFC is a large brain region, which encompasses both rostral and ventromedial areas.
Because, it receives multimodal inputs from the temporal association cortex, amygdala and
hypothalamus as well as limbic components of the basal ganglia, it has been viewed as the
highest integration center for emotional processing (Krawezyk, 2002). By analogy with the
Dorsolateral prefrontal cortex (DLPC), which is the prefrontal area for parietal lobe, the OFC
can be regarded as the prefrontal area for the temporal lobe. The OFC seems to play a role in
situations involving incentives/bonus/rewards and in conditions, where the subject has to
make rapid alterations in behavior to accommodate the environmental changes. Several lines
of evidence suggested that OFC played a crucial role in the decision-making process based on
rewards. Patients with orbitofrontal damage experience great difficulties in decision-making.
They also tend to take risks, whether profitable or not (Miller, 1985). Experimental lesions of
OFC in monkeys have shown impairment in reward–related learning tasks and irrespective
of the nature of the sensory context. These monkeys also exhibited an absence of emotional
reaction to environmental stimuli. OFC neurons become particularly active, when the animal
is placed in a situation where, it expects and receives a reward. Interestingly, face selective
neurons have been reported in OFC, which may be relevant in the detection of facial expression
which is a critical point in social decision. These neurons may be involved in the association
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between a positive reward value and a particular facial expression. The OFC seems to play a
predominant role in motivational aspects of decision-making. Among the more posterior
cortical areas, the left inferior parietal cortex and parieto-occipital junction are involved in
cognitive tasks related to visual imagery. The underactivity of these regions could probably
explain the spatial memory deficits and visual memory deficits observed in OCD patients. The
repetitive rituals (compulsions) and aggressive behavior, which is predominant in OCD
patients is probably due to serotonin depletion.
8.5. Striatum
The striatum is known to be formed by two types of information-processing modules: the
striasomes and the matrisomes. The striasomes receive information from the limbic structures
such as amygdala, OFC & ACC (Eblen and Graybiel, 1995). In turn, they send projections to
the dopaminergic neurons of the substantia nigra. These anatomical findings suggest that the
striasomes could also play a role in the emotional modulation of cortical information. The
matrisomes receive information from the lateral parts of the premotor and prefrontal cortices,
which are involved in the anticipation behavior and planning (Flaherty and Graybiel, 1994).
The cholinergic inter-neurons of the striatum, viz. tonically active neurons (TANS), may be
playing a particular role in integrating the information flowing through the striasomes and
matrisomes. These neurons could constitute a neural system that is involved in the processing
of several aspects of information, such as the detection of unpredicted events or the context of
stimulus discrimination (Ravel et al., 2001).
The limbic part of the striatum (ventral striatum) under the control of the dopaminergic
afferents might be involved in reward–driven learning processes. On the other hand, the dorsal
striatum seems to be involved in the procedural learning of behavioral routines that are
performed almost without conscious effort. In particular, in the context of procedural learning,
the disruption of the “readiness” and “release” functions ascribed to the striatum might
support some aspects of OCD pathophysiology. However, the striatum could also play a part
in other processes potentially disrupted in OCD, such as emotional modulation of information
and representation of the expected consequences of action. On the other hand, the performance
of repetitive behaviors in OCD patients might have a positive effect on the reduction of anxiety,
a process that can be assimilated to some form of reward.
8.6. Amygdala
In the past decade, much research has been focused on the neural substrates that are involved
in the expressions of fear and anxiety. The amygdala and its various outputs might play a
major role in mediating the clinical signs and symptoms of fear and anxiety (Le Doux, 2000).
Schematically, the amygdala is comprised of several nuclei, such as the lateral nucleus,
basolateral nucleus and central nucleus. However, recent evidence supports the fundamental
idea that the amygdala is not only involved in negative emotions such as fear and anxiety but
also in reward and motivational processes through reciprocal connections to the nucleus
accumbens and the OFC. Thus, the amygdala appears to play an important role in the
expressions of emotion and motivation, probably through its connections with the OFC, ACC
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and ventral striatum. A dysfunction of this structure, as suggested by some neuroimaging
studies in OCD patients, might mediate the non-specific anxiety experienced relative to
obsessive thoughts.
8.7. Thalamus
The diencephalic position of the thalamus in the brain explains why it receives large cortical
inputs. It participates in emotional expression through the AN (anterior nucleus of the
thalamus), which is connected to the MB (mammillary bodies) and, in turn, sends projections
to the ACC. The putative role of the VA (ventral anterior nucleus of the thalamus) in cognitive
functions involving attention and working memory is based on the link with DLPC. Discrete
parts of the MD (medial dorsal nucleus of the thalamus) seem to be important in both emotional
and cognitive processing through their preferential anatomical connections with the OFC and
DLPC. Thalamic dysfunction has been associated with deficits in executive functions like
planning, goal directed behavior, attention, and working memory (Lacerda et al., 2003).
8.8. Brainstem inputs
The mesocorticolimbic dopaminergic system emanates from the ventral mesencephalon,
which encompasses the Ventral tegmental area (VTA), and projects to the nucleus accumbens
with other limbic ventral striatal regions and cortical areas, especially the OFC, DLPC, ACC.
The effects of the lesions, receptor blocking agents, electrical stimulation and self-administra‐
tion of drugs of abuse suggest the effective contribution of the mesocorticolimbic system in
the attentional, emotional and motivational processes. Dopamine contributes to the organiza‐
tion and regulation of goal-directed behavior. The serotonin-producing neurons are mainly
located in the brainstem raphe nuclei. The description of the anatomy and development of the
brainstem raphe nuclei has shown that they form the largest and most complex neurochemical
efferent system in the human brain. General theories have attributed a broad range of behav‐
ioral functions to serotonin, which is considered as a general inhibitor of motor behavior. In
contrast, reduced serotonin function has been shown to increase exploration, locomotor
activity, aggression and sexual behaviors in animals and human beings (Lucki, 1998). The
repetitive rituals (compulsions) and aggressive behavior, which is predominant in OCD
patients is probably due to serotonin depletion.
• PET Scans show people with OCD have different brain activity from others
• Another theory: miscommunication between the orbital frontal cortex, the caudate nucleus
and the thalamus
• Caudate nucleus doesn’t function properly and causes thalamus to become hyperactive and
sends never-ending worry signals between OFC and thalamus OFC responds by increasing
anxiety
The Group A Beta–Hemolytic Streptococcal (GABHS) infections produce anti-neuronal
antibodies that adversely affect basal ganglia cells, which might lead to the development of
OCD (Swedo et al., 1998). The susceptibility marker that may predispose some individuals to
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develop OCD has been well identified. D8/17 ((the antigen present on the surface of peripheral
blood mononuclear cells) positive individuals develop OCD as a consequence of their
autoimmune response to Group A beta-hemolytic streptococcal infection, a response that is
believed to yield antibodies which cross react with basal–ganglia antigens and produce tissue
damage. The orbitofrontal cortex that had been demonstrated to be overactive in OCD is a
region mediating the active expression of emotional response to significant biological stimuli
as well as the inhibition of behavioral response.
9. Treatment of OCD
9.1. Pharmacological treatments
The serotonin reuptake inhibitors (SRIs) are consistently effective in patients of Obsessive-
compulsive  disorder.  The  anti-obsessional  effects  of  potent  SRIs  produce  progressive
desensitization of the presynaptic autoreceptors present on 5HT neurons and their nerve
terminals,  thereby increasing synaptic  5HT release in the orbitofrontal  cortex.  Clomipra‐
mine was the first to show beneficial effects on OCD symptoms. The newer generation of
antidepressant  drugs  viz.  fluvoxamine,  fluoxetine,  paroxetine,  sertraline  and  citalopram
have also been found useful in management of OCD. The mean daily dosage is 50–200 mg
for  sertraline,  20–80  mg  for  fluoxetine,  40–60  mg  for  paroxetine  and  150–300  mg  for
Figure 2. High energy use in the brain of a typical person with OCD
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fluvoxamine. The atypical antipsychotics such as risperidone act as new therapeutic options
for  refractory  OCD.  Marble  burying  behavior  of  mice  has  been  used  to  model  anxiety
disorder including obsessive–compulsive disorder (OCD) due to the excessive nature of the
behavior and due to the pharmacological effects of clinical standards. Gaikwad et al., 2007
suggested that LHRH agonist such as leuprolide may be clinically effective in OCD, resulted
dose  dependently  attenuated marble-burying  behavior  in  mice  has  been  used to  model
anxiety disorders viz. obsessive–compulsive disorder. Acute administration of the neuroste‐
roid allopregnanolone (i.c.v.) or its precursor, progesterone, decreased marble burying in
male  mice,  but  administration  of  the  5-reductase  inhibitor  finasteride,  an  allopregnano‐
lone indirect antagonist, did not affect marble burying (Umathe et al., 2009). In addition,
acute  administration  of  the  5-HT2a/2c  antagonist  ritanserin  abolished  the  leuprolide-
induced decrease in marble-burying of male mice without having any effect on locomo‐
tion. Ritanserin treatment on its own had no effect on marble-burying or on locomotion
(Gaikwad et al., 2010). These results suggest that the anti-compulsive effects of GnRH may
depend upon serotonergic  activity,  and specifically,  that  the  effects  of  leuprolide  in  the
marble-burying model are mediated through 5-HT2A/2C receptors (Gaikwad et al., 2010).
9.2. Neurosurgical treatments
Neurosurgical treatments have been used for the management of chronic, severely distressing
forms of OCD where conventional treatments are ineffective. In the United States and Canada,
anterior cingulotomy was the most widely used neurosurgical procedure applied in the
treatment of anxiety refractory OCD. Two surgical techniques have been used: radiofrequency
thermolesion or thermocapsulotomy and the newer radiosurgical or gamma knife capsuloto‐
my techniques. It has been shown that 50–70% of patients with OCD respond favorably to this
type of operation at the end of the follow-up period ranging from 1 to 9 years. The Bilateral
thermolesions are produced by radiofrequency in the anterior cingulate cortex (ACC) (Broad‐
man areas 24 and 32). It has found that 25% of patients with OCD were slightly improved,
31.3% were markedly improved, 12.5% were functionally normal on medication or psycho‐
therapy maintenance and 12.5% were essentially well without any treatment at the mean
follow-up of 9 years. The Y-BOCS used for assessment of OCD symptom severity, resulted a
moderate-to-marked improvement (defined as a 50% or greater reduction in Y-BOCS scores)
in 57% of cases at the mean 13-year follow-up. Approximately 50–70% of patients with OCD
showed good outcome by surgery, indicated no or mild residual symptoms at the follow-up
ranging from 16 months to 8 years. The recent report suggested that good outcome was
observed in only 33% of cases within 1 year of surgery. In the United Kingdom limbic
leucotomy was developed, a technique based on making bilateral lesions of the cingulotomy,
in addition to those of the original subcaudate tractotomy.
9.3. Psychological treatments
Psychological treatments based on cognition-behavioral therapy (CBT) are effective in the
treatment of OCD, alone or in combination with SRIs. The current procedures are in vivo
(real-life) exposure with self-imposed response prevention (EX/RP) which showed benefi‐
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cial effects of this behavioral approach in two patients with severely disabling OCD. The
reduction in OCD symptom severity was found after 3–7 weeks of EX/RP treatment while
no change occurred during the control condition. The goal of CBT treatment is to learn to
respond appropriately to intrusive thoughts and urges of  OCD in new and much more
adaptive ways and to reattribute the belief about “false brain messages” as intimately due
to  a  biomedical  disease  state.  The  therapeutic  effects  showed the  functional  changes  in
interactions between the limbic cortex (including the orbital cortex and anterior cingulate
gyrus) and the basal ganglia that are extremely important in redirecting information flow
toward  the  integration  of  new  behaviorally  significant  environmental  events  during
learning.  This  function  may  be  central  in  the  acquisition  of  more  adapted  patterns  of
behavioral responses during the course of CBT.
10. Conclusion
OCD is an anxiety disorder featuring intrusive and troubling thoughts, which are perceived
as the products of one’s own mind unlike schizophrenia. The Patient affected by OCD feels
compelled to carry out certain stereotyped behaviors, although he recognizes that his behavior
is at times irrational. Entire brain functioning is disturbed in patients suffering from OCD,
thereby producing devastating effects at the work-place as well as at homes of the patients.
OCD is a complicated disorder. Selective serotonin reuptake inhibitors (SSRIs) and to some
extent tricyclic antidepressants form the main stay in the symptomatic treatment of OCD. Most
of the OCD cases are incurable. Therefore, there is a great challenge to discover new drug
treatment for the management of OCD.
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1. Introduction
Empirically-supported treatments for obsessive-compulsive disorder (OCD) emphasize the
behavioral principles of exposure and response prevention [1]. However, theory and data
suggest that cognitive components play a substantial role in the etiology and maintenance of
OCD. This chapter will review cognitive theories and models of OCD, and cognitive processes
in OCD including thought-action-fusion, inferential confusion, reality monitoring, cognitive
inhibition, and memory and attentional biases. A comprehensive treatment that draws on both
the cognitive literature reviewed herein plus exposure and response prevention is proposed.
2. General cognitive theories of OCD
The seminal cognitive theory by Rachman describes a diathesis-stress model in which an
individual’s history of being reared in an environment where strong values are placed upon
the person’s thoughts increases vulnerability to OCD [2]. Current levels of stress and negative
affect increase the likelihood of obsessions which tend to be elicited by cues in the external
environment [3]. Learning history then increases the likelihood of the obsessions being
appraised as significant or meaningful. The appraisal of the obsessions as significant represents
a cognitive bias because without a cognitive vulnerability towards OCD, credibility would not
be given to the thoughts that become obsessions. These processes are more likely to occur in
individuals with pre-existing trait anxiety. For example, an anxious person may read a story
in a newspaper about an electrical house fire and then obsess over the possibility of accidentally
setting an electrical fire.
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It is the above combination of factors that lays the groundwork for obsessions, coupled with
other specific cognitive processes and biases which are about to be discussed. Overestimating
the probability of the occurrence of negative events can occur if one believes that one is
responsible in a situation. For example, a person may believe that “a child is more likely to
have an accident if I am babysitting than if someone else is babysitting.” Relatedly, Rachman
discusses the cognitive process of Thought-Action Fusion (TAF) [2]. TAF is a cognitive
distortion representing a moral component and an event probability component. A moral
reasoning error is made when an individual has a thought about an action and then appraises
that thought as being equivalent or almost equivalent to actually having engaged in the action
itself. In TAF, the probability of an event occurring can be perceived as increasing simply by
having a thought about the event. Both the moral reasoning and event probability components
fuse thoughts and actions. TAF is increased by the overestimation of attributions of responsi‐
bility to the self for events, which represents a cognitive distortion. It should be noted that
although TAF is a component of Rachman’s cognitive theory, it is described in other literature
as a separate theory [4].
Salkovskis (1985) proposed a second cognitive theory of OCD [5]. As Salkovskis points out,
the components of this theory have substantial overlap with Rachman’s previously described
theory. According to this theory, obsessions can be cued via stimuli in the environment. Cuing
of obsessions is aversive to the individual and therefore avoidance measures are taken. The
person may or may not recognize the obsessional thought to be irrational. If the thought does
not have negative ramifications for the person, this cognitive chain of events will end. If
negative ramifications are present, automatic thoughts, similar to Beck’s conceptualization of
automatic thoughts will occur [6]. Automatic thoughts are more likely to occur if the current
mood state is negative. These thoughts interact with a set of assumptions, including but not
limited to, thought equals action, increased sense of responsibility for events, beliefs about the
need to control thoughts, and self blame for events. These negative thoughts then influence
mood which leads to attempts to reduce distress by engaging in compulsions. Negative
reinforcement occurs when the distress is reduced lending credibility to the negative automatic
thoughts. Co-occurring depressed mood can also play a role via several mechanisms. The first
mechanism increases the dysfunctional beliefs via increasing the stimuli that may cue an
intrusive thought that could become an obsession. This can then create a transactional process
by which mood increases negative automatic thoughts and in turn, these thoughts then can
increase negative mood.
Rachman proposed a specific cognitive theory of the compulsive checking subtype of OCD [7].
According to this theory, individuals with this subtype of OCD have an increased belief in
self-responsibility for maintaining the safety of self and others. The increased sense of
responsibility comes from an unrealistic appraisal of the probability of harm. Repeated
checking serves the function of increasing certainty that any possible threat will be alleviated.
Given that certainty is improbable, checking continues. Repeated checking results in memories
of repeated events becoming fuzzy, and therefore confidence in memory as to whether
checking has or has not occurred is decreased. That is, checking behavior temporarily reduces
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the anxiety via engaging in the compulsive behavior itself or via negatively reinforcing
cognitions.
3. Specific cognitive processes in OCD
Thought-action fusion and OCD. Thought-action fusion is a component of OCD in the two
previously discussed theories [2,5]. Researchers have developed assessment measures of TAF
which have resulted in empirical findings supporting TAF as a process in OCD. Most com‐
monly, TAF is measured using the Thought-Action-Fusion questionnaire, a 19-item question‐
naire composed of moral TAF, likelihood-self TAF, and likelihood-other TAF scales [8].
Accordingly, the two factors of moral and likelihood TAF accounted for 71% of the variance.
Internal consistency ranged from.88 to.96, and the TAF converged as expected with the
Maudsley Obessive Compulsive Inventory. As expected, an OCD sample exhibited higher
TAF scores on all three scales than did two pathology-absent adult comparison samples. TAF
is not specific to patients with OCD but rather occurs with other anxiety disorders [9].
Researchers have examined whether TAF is more common to depression than to OCD due to
high negative affect being characteristic of depression [10]. Drawing on Rachman’s model,
Abramowitz and colleagues theorized that negative affect mediates the relationship between
TAF and OCD [2]. Their results supported this view. Interestingly, this study also found that
the likelihood component but not the moral component of TAF is present in individuals with
OCD. Researchers have further specified the relationship between these variables [11]. They
examined the relation between TAF, schizotypal traits (magical thinking), OCD symptoms,
general anxiety, and depression. Schizotypal traits were deemed important to include because
nearly half of people with OCD have schizotypal personality characteristics. Among those
characteristics are magical thinking, which the authors note may be associated with cognitive
biases and therefore increased vulnerability to OCD. Schizotypical traits were associated with
likelihood TAF such that the relation between TAF and OCD disappeared when schizotypal
traits were controlled. No significant relation was found between OCD and moral TAF. In a
third investigation, other investigators examined TAF, self-doubt regarding the belief that the
compulsion will fix the problem, and cognitive control when obsession related beliefs emerge
in youth with OCD, youth with another anxiety disorder, and a psychopathology-absent
comparison group [12]. They found that higher likelihood TAF occurs in youth with OCD
compared to youth without psychopathology, with no significant differences between the
OCD and other-anxiety disorder groups, but self-doubt does not differ between the OCD and
control group. Moral TAF was not measured in this study.
In sum, people with OCD tend to make cognitive errors in their thinking with regard to the
fusion of thoughts and actions. This tends to occur in the following two ways: 1). Having a
thought can be viewed as being as “bad” as having completed the action (moral TAF) and 2).
thinking about the events increases the perception that the event will occur (likelihood TAF).
The evidence appears to be slightly stronger for likelihood TAF than for moral TAF, but moral
TAF was not measured in all studies examining this construct. Some evidence suggests that
TAF is not specific to OCD but instead also occurs in anxiety disorders in general.
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Inferential Confusion and OCD. A concept related to TAF is “inferential confusion” or the process
of confusing imagined events and actually occurring events. According to this view people
with OCD mistake the imagined negative event for a real event, such that the imagined event
becomes more realistic creating the belief that the event has an increased probability of
occurrence [13]. Devaluation of information taken in by the senses (e.g., the tendency to believe
something despite the available evidence to the naked eye) and inferential reasoning errors
combine to make conditions ripe for the confusion of real and imagined events [14]. A
“crossover point” can be identified in these individuals in which obsessions begin and can be
identified [13]. Compulsions result from the obsessions as attempts to modify the probability
of the event occurrence. Engaging in compulsions gives credibility to the imagined event. A
specific type of inferential confusion can occur in which thinking a particular thought makes
it likely that a person will act on that thought. Therefore, similar to TAF, a thought is equivalent
to a personal action.
Support for inferential confusion theory comes from a follow-up study in which participants
with OCD were given questionnaires measuring inferential confusion and obsessional
thinking [15]. Analyses showed strong overlap between inferential confusion and common
obsessions such as contamination and harm, and compulsions, such as washing. Even when
other variables were controlled (e.g., overestimation of threat and general anxiety), the
relationship between inferential confusion and obsessions/compulsions remained. Additional
data show that when inferential confusion improves (as measured by a specific paper and
pencil questionnaire of inferential confusion), OCD symptoms improve [16].
In a nonclinical sample, schizotypal symptoms (delusional thinking, perceptual disturbances,
living in an inner world) and inferential confusion predicted obsessive compulsive behavior,
with the majority of the predictive validity coming from the perceptual disturbances subscale
of the schizotypal measure (22% of the variance) [17]. Inferential confusion explained 5% of
the variance. The authors note that people with OCD typically do not have perceptual
disturbances, but perceptual disturbances can be considered to be a product of inferential
confusion.
Reality monitoring and intrusive imagery in OCD. Reality monitoring errors occur when people
confuse real and imagined events [18]. It has been suggested that poorer reality monitoring
ability in OCD individuals due to intrusive imagery present in OCD [19]. That is, with the
occurrence of repeated involuntary images, those images seem real which leads participants
to confuse them with reality. Indeed there is a large body of literature now showing that
imagination leads people to believe in events that never occurred (see [20] for a review).
Therefore, other researchers examined reality monitoring ability for actions in an inpatient
group with OCD and a yoked nonanxious control group [21]. In this study, participants were
given sequences of 6 actions and instructed to either perform an action or imagine performing
an action. Action sequences were either anxiety provoking or neutral. There were no significant
differences in ability to identify imagined versus performed actions between the groups.
Results did not differ as a function of whether the action sequences were anxiety-provoking
or neutral. However, people with OCD had less confidence in their reality monitoring ability.
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Relatedly, deficits in reality monitoring ability have been shown to occur in people with
subclinical OCD symptoms (specifically checking behaviors) compared to people without
OCD symptoms [22]. To document this effect, all participants were read a list of actions. They
were then asked to perform an action, observe an action being performed on a videotape, or
write down a never performed action that was read to them by an experimenter. Following
this task, participants were then asked to generate a written list of all actions they could recall,
and then reality monitor by indicating whether they had performed, observed, or written each
action they had recalled. People with OCD symptoms recalled fewer of the performed, written,
and observed actions. In addition, they miscategorized (made more reality monitoring errors)
whether they performed an action, wrote down the action, or observed the action being
performed.
Additional data suggest that intrusive imagery related to the experience of adverse life events
is a component of OCD at least in some patients. In an inpatient OCD sample, 81% of 34 patients
reported intrusive images directly from or related to adverse life events [23]. Interestingly,
none of the patients met co-morbid criteria for PTSD. OCD patients with intrusive images had
higher levels of general anxiety and more OCD symptoms than OCD patients who did not
have images. However, the number of patients without images was small (n=7). Consistent
with Rachman’s previously discussed theory, patients who reported imagery felt greater
responsibility for events than those who did not report images, although the origins of this
increased responsibility are unclear.
Other reports of intrusive images in OCD have been found in the literature [24]. Therefore,
Rachman correlated a single item measuring intrusive images with mental contamination
(feeling dirty inside) [24]. This item correlated approximately.54 with other measures of OCD.
Based on analyses from another archival dataset, Rachman reported that mental imagery items
correlated.34-.445 with other measures of OCD [24]. Therefore, it has been suggested that
imagery rescripting of distressing events might be an intervention appropriate for these
individuals, but also point out that it is unknown whether this would decrease OCD symptoms
given the lack of current empirical data for this intervention for OCD [23].
In sum, the evidence suggests that imagery can be an important in the treatment of people
with OCD who experience intrusive images from negative life events. More broadly, imagery
plays a role in the development OCD. Imagery acts as a mechanism by which obsessions come
to seem more realistic thereby increasing the perception of the likelihood of occurrence.
However, specific tests of reality monitoring ability do not always show differences in the
performance of people with and without OCD. Methodological issues, including the timing
of memory tests (i.e., lack of a substantial delay between exposure to the stimuli and memory
test), may have influenced the results of existing studies. Therefore, further research is needed.
4. Memory biases in OCD
Negative memory biases have been theorized to play a role in psychological disorders,
particularly anxiety. According to Beck, negative schemata formed in childhood render an
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Inferential Confusion and OCD. A concept related to TAF is “inferential confusion” or the process
of confusing imagined events and actually occurring events. According to this view people
with OCD mistake the imagined negative event for a real event, such that the imagined event
becomes more realistic creating the belief that the event has an increased probability of
occurrence [13]. Devaluation of information taken in by the senses (e.g., the tendency to believe
something despite the available evidence to the naked eye) and inferential reasoning errors
combine to make conditions ripe for the confusion of real and imagined events [14]. A
“crossover point” can be identified in these individuals in which obsessions begin and can be
identified [13]. Compulsions result from the obsessions as attempts to modify the probability
of the event occurrence. Engaging in compulsions gives credibility to the imagined event. A
specific type of inferential confusion can occur in which thinking a particular thought makes
it likely that a person will act on that thought. Therefore, similar to TAF, a thought is equivalent
to a personal action.
Support for inferential confusion theory comes from a follow-up study in which participants
with OCD were given questionnaires measuring inferential confusion and obsessional
thinking [15]. Analyses showed strong overlap between inferential confusion and common
obsessions such as contamination and harm, and compulsions, such as washing. Even when
other variables were controlled (e.g., overestimation of threat and general anxiety), the
relationship between inferential confusion and obsessions/compulsions remained. Additional
data show that when inferential confusion improves (as measured by a specific paper and
pencil questionnaire of inferential confusion), OCD symptoms improve [16].
In a nonclinical sample, schizotypal symptoms (delusional thinking, perceptual disturbances,
living in an inner world) and inferential confusion predicted obsessive compulsive behavior,
with the majority of the predictive validity coming from the perceptual disturbances subscale
of the schizotypal measure (22% of the variance) [17]. Inferential confusion explained 5% of
the variance. The authors note that people with OCD typically do not have perceptual
disturbances, but perceptual disturbances can be considered to be a product of inferential
confusion.
Reality monitoring and intrusive imagery in OCD. Reality monitoring errors occur when people
confuse real and imagined events [18]. It has been suggested that poorer reality monitoring
ability in OCD individuals due to intrusive imagery present in OCD [19]. That is, with the
occurrence of repeated involuntary images, those images seem real which leads participants
to confuse them with reality. Indeed there is a large body of literature now showing that
imagination leads people to believe in events that never occurred (see [20] for a review).
Therefore, other researchers examined reality monitoring ability for actions in an inpatient
group with OCD and a yoked nonanxious control group [21]. In this study, participants were
given sequences of 6 actions and instructed to either perform an action or imagine performing
an action. Action sequences were either anxiety provoking or neutral. There were no significant
differences in ability to identify imagined versus performed actions between the groups.
Results did not differ as a function of whether the action sequences were anxiety-provoking
or neutral. However, people with OCD had less confidence in their reality monitoring ability.
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Relatedly, deficits in reality monitoring ability have been shown to occur in people with
subclinical OCD symptoms (specifically checking behaviors) compared to people without
OCD symptoms [22]. To document this effect, all participants were read a list of actions. They
were then asked to perform an action, observe an action being performed on a videotape, or
write down a never performed action that was read to them by an experimenter. Following
this task, participants were then asked to generate a written list of all actions they could recall,
and then reality monitor by indicating whether they had performed, observed, or written each
action they had recalled. People with OCD symptoms recalled fewer of the performed, written,
and observed actions. In addition, they miscategorized (made more reality monitoring errors)
whether they performed an action, wrote down the action, or observed the action being
performed.
Additional data suggest that intrusive imagery related to the experience of adverse life events
is a component of OCD at least in some patients. In an inpatient OCD sample, 81% of 34 patients
reported intrusive images directly from or related to adverse life events [23]. Interestingly,
none of the patients met co-morbid criteria for PTSD. OCD patients with intrusive images had
higher levels of general anxiety and more OCD symptoms than OCD patients who did not
have images. However, the number of patients without images was small (n=7). Consistent
with Rachman’s previously discussed theory, patients who reported imagery felt greater
responsibility for events than those who did not report images, although the origins of this
increased responsibility are unclear.
Other reports of intrusive images in OCD have been found in the literature [24]. Therefore,
Rachman correlated a single item measuring intrusive images with mental contamination
(feeling dirty inside) [24]. This item correlated approximately.54 with other measures of OCD.
Based on analyses from another archival dataset, Rachman reported that mental imagery items
correlated.34-.445 with other measures of OCD [24]. Therefore, it has been suggested that
imagery rescripting of distressing events might be an intervention appropriate for these
individuals, but also point out that it is unknown whether this would decrease OCD symptoms
given the lack of current empirical data for this intervention for OCD [23].
In sum, the evidence suggests that imagery can be an important in the treatment of people
with OCD who experience intrusive images from negative life events. More broadly, imagery
plays a role in the development OCD. Imagery acts as a mechanism by which obsessions come
to seem more realistic thereby increasing the perception of the likelihood of occurrence.
However, specific tests of reality monitoring ability do not always show differences in the
performance of people with and without OCD. Methodological issues, including the timing
of memory tests (i.e., lack of a substantial delay between exposure to the stimuli and memory
test), may have influenced the results of existing studies. Therefore, further research is needed.
4. Memory biases in OCD
Negative memory biases have been theorized to play a role in psychological disorders,
particularly anxiety. According to Beck, negative schemata formed in childhood render an
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individual susceptible to drawing attention towards threatening stimuli which is theorized to
positively impact memory for these stimuli [6]. These schemata are activated when ambiguous
or anxiety-provoking stimuli are encountered and predispose a person towards an anxious
interpretation of events. A more specific model of how anxiety influences the allocation of
attention and memory has been developed [25]. Specifically, when a stimulus is encountered
in the environment, it is mapped onto existing schemata and a decision is made as to the threat
level of the stimulus. When stimuli are appraised as threatening, they receive further cognitive
resources allocated towards them. That is, attention is drawn towards those stimuli, particu‐
larly in people high in trait anxiety. The opposite cognitive allocation or drawing attention
away from the stimulus occurs in people low in trait anxiety which serves the function of not
allocating unnecessary cognitive resources in the case of stimuli that do not warrant attention.
Williams and colleagues discuss how the allocation of attention is a first step towards impact‐
ing or improving memory for those threatening stimuli [25].
Despite these theories, the rationale for studies examining memory biases in OCD focuses on
studying phenomenon that have been observed in clinical settings rather than theory-based
predictions. For example, because it has been noted that people with OCD express doubt
regarding whether they have performed a particular behavior (e.g., checked whether they
turned the stove off) which might lead to repeating the compulsion. One study compared
people with the contamination subtype of OCD to both anxious controls to an undergraduate
sample (n=10 per group in the OCD and anxious control conditions) [26]. In this study,
participants watched an experimenter touch objects with a “dirty” tissue (i.e., contaminate) or
touch objects with a “clean” tissue (i.e., not contaminate). Memory was tested immediately
following the task. People with OCD remembered “dirty” objects better. This pattern of
findings did not hold for both the anxious control group or the undergraduate comparison
sample. It should be noted that items were scored only for correct recall in this study. Analyses
did not include errors in recall.
Other researchers replicated the above study [26] using a sample that included different control
groups and included an analysis of recall errors [27]. The study included 16 OCD washers, 16
OCD checkers, 16 controls with anxiety (specific phobia), 16 in a no-pathology comparison
group. Participants entered a room with 50 items which they then observed the experimenter
touch with a tissue (prevents contamination) or bare hand (brings into contact with contami‐
nation). Participants were asked to recall the items 50 minutes later by first generating a written
list of all items they recalled. For the recalled items only, they were then asked to recall whether
the experimenter touched each item with tissue or bare hands. No significant group differences
emerged in total number of items recalled in free recall. There was a difference in recall of
whether the object was touched by the experimenter with tissue vs. hand. OCD washers
showed superior accurate recall as to whether the objects were touched by bare hands. The
anxious control group showed superior recall for objects touched by a tissue. These results
suggest superior memory in OCD washers for “contaminated” items.
Another study examined whether differences in recall existed between an OCD sample and
control sample as a function of the anxiety provoking properties of the to-be-remembered
experienced versus imagined actions [21]. Participants had a booklet with 6 actions listed. They
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were asked to perform those actions. They were then taken to a room and were asked to either
imagine or perform a set of 20 actions. They were then asked to state whether only the last
item was imagined or performed. Following this they were asked for a series of ratings of
vividness, confidence, desire for vividness, and satisfaction with memories. Results showed
no significant difference in reality monitoring performance across anxiety provoking and
nonanxiety provoking stimuli, but a significant difference in desire for vividness emerged and
was greater in the OCD group. No significant differences were found on the other 3 ratings.
However, the sample size in this study was small and may not have been sufficient to detect
significance (N=19; 12 OCD, 7 controls).
McNally and colleagues examined directed forgetting in OCD patients and controls [28].
Participants were presented with words of a negative, positive, or neutral valence followed by
instructions directing them to remember or forget the just-presented stimuli. OCD patients
had a more difficult time forgetting negative words than did comparison participants.
However, it should be noted that a small portion of the words seemed to be directly related to
specific types of OCD (contamination) and it is unclear whether the results would hold if these
items were removed. It would be important to compare an OCD relevant negative list to
another non-OCD related negative list to determine whether the above findings hold.
Another study examined memory as a function of experimenter induced sense of responsibility
[29]. The authors note that people with OCD report a strong sense of responsibility for
outcomes including correctness of their checking or lack of checking behavior. For example,
one might think, “If I didn’t look at the stove carefully to see whether it was off, it might still
be on and the house may catch on fire.” Following a baseline check in their homes to induce
anxiety, the researchers had participants with OCD (all handwashers N=11) complete their
typical checking behaviors (e.g., check to make sure the stove is off) in their homes under
conditions of low and high responsibility. In the high responsibility condition, participants
were told that they were responsible for completing the check without assistance and were
responsible for the accuracy of the check. They were asked to sign a contract to this effect
agreeing to these terms. In the low responsibility condition, participants signed a contract that
attributed the responsibility of the check to the research assistant. Participants completed a
memory interview immediately after the checks and provided confidence ratings for their
responses to the interview questions. The memory interview included memory for specific
aspects of the check that might have been perceived as threatening (“ What was the final state
of the thermostat?” (Radomsky et al., 2001, p. 817) [29] as well as nonthreatening aspects of
the check (“Did I (the experimenter) cough during the check?) (Radomsky et al., 2001, p. 817)
[29]. In the next phase of the study, all participants returned to the lab a week later and watched
videos of both checks and then completed the same memory interview and confidence ratings.
This delayed phase represented a no responsibility phase. Results showed no overall differ‐
ences in the amount remembered across the conditions, but under conditions of high respon‐
sibility, OCD handwashers recalled more threatening information than irrelevant information.
This result did not hold under conditions of low responsibility. When the people who were
originally in the high responsibility group were tested under conditions of no responsibility
one week later, they no longer showed superior recall of threatening information. However,
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individual susceptible to drawing attention towards threatening stimuli which is theorized to
positively impact memory for these stimuli [6]. These schemata are activated when ambiguous
or anxiety-provoking stimuli are encountered and predispose a person towards an anxious
interpretation of events. A more specific model of how anxiety influences the allocation of
attention and memory has been developed [25]. Specifically, when a stimulus is encountered
in the environment, it is mapped onto existing schemata and a decision is made as to the threat
level of the stimulus. When stimuli are appraised as threatening, they receive further cognitive
resources allocated towards them. That is, attention is drawn towards those stimuli, particu‐
larly in people high in trait anxiety. The opposite cognitive allocation or drawing attention
away from the stimulus occurs in people low in trait anxiety which serves the function of not
allocating unnecessary cognitive resources in the case of stimuli that do not warrant attention.
Williams and colleagues discuss how the allocation of attention is a first step towards impact‐
ing or improving memory for those threatening stimuli [25].
Despite these theories, the rationale for studies examining memory biases in OCD focuses on
studying phenomenon that have been observed in clinical settings rather than theory-based
predictions. For example, because it has been noted that people with OCD express doubt
regarding whether they have performed a particular behavior (e.g., checked whether they
turned the stove off) which might lead to repeating the compulsion. One study compared
people with the contamination subtype of OCD to both anxious controls to an undergraduate
sample (n=10 per group in the OCD and anxious control conditions) [26]. In this study,
participants watched an experimenter touch objects with a “dirty” tissue (i.e., contaminate) or
touch objects with a “clean” tissue (i.e., not contaminate). Memory was tested immediately
following the task. People with OCD remembered “dirty” objects better. This pattern of
findings did not hold for both the anxious control group or the undergraduate comparison
sample. It should be noted that items were scored only for correct recall in this study. Analyses
did not include errors in recall.
Other researchers replicated the above study [26] using a sample that included different control
groups and included an analysis of recall errors [27]. The study included 16 OCD washers, 16
OCD checkers, 16 controls with anxiety (specific phobia), 16 in a no-pathology comparison
group. Participants entered a room with 50 items which they then observed the experimenter
touch with a tissue (prevents contamination) or bare hand (brings into contact with contami‐
nation). Participants were asked to recall the items 50 minutes later by first generating a written
list of all items they recalled. For the recalled items only, they were then asked to recall whether
the experimenter touched each item with tissue or bare hands. No significant group differences
emerged in total number of items recalled in free recall. There was a difference in recall of
whether the object was touched by the experimenter with tissue vs. hand. OCD washers
showed superior accurate recall as to whether the objects were touched by bare hands. The
anxious control group showed superior recall for objects touched by a tissue. These results
suggest superior memory in OCD washers for “contaminated” items.
Another study examined whether differences in recall existed between an OCD sample and
control sample as a function of the anxiety provoking properties of the to-be-remembered
experienced versus imagined actions [21]. Participants had a booklet with 6 actions listed. They
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were asked to perform those actions. They were then taken to a room and were asked to either
imagine or perform a set of 20 actions. They were then asked to state whether only the last
item was imagined or performed. Following this they were asked for a series of ratings of
vividness, confidence, desire for vividness, and satisfaction with memories. Results showed
no significant difference in reality monitoring performance across anxiety provoking and
nonanxiety provoking stimuli, but a significant difference in desire for vividness emerged and
was greater in the OCD group. No significant differences were found on the other 3 ratings.
However, the sample size in this study was small and may not have been sufficient to detect
significance (N=19; 12 OCD, 7 controls).
McNally and colleagues examined directed forgetting in OCD patients and controls [28].
Participants were presented with words of a negative, positive, or neutral valence followed by
instructions directing them to remember or forget the just-presented stimuli. OCD patients
had a more difficult time forgetting negative words than did comparison participants.
However, it should be noted that a small portion of the words seemed to be directly related to
specific types of OCD (contamination) and it is unclear whether the results would hold if these
items were removed. It would be important to compare an OCD relevant negative list to
another non-OCD related negative list to determine whether the above findings hold.
Another study examined memory as a function of experimenter induced sense of responsibility
[29]. The authors note that people with OCD report a strong sense of responsibility for
outcomes including correctness of their checking or lack of checking behavior. For example,
one might think, “If I didn’t look at the stove carefully to see whether it was off, it might still
be on and the house may catch on fire.” Following a baseline check in their homes to induce
anxiety, the researchers had participants with OCD (all handwashers N=11) complete their
typical checking behaviors (e.g., check to make sure the stove is off) in their homes under
conditions of low and high responsibility. In the high responsibility condition, participants
were told that they were responsible for completing the check without assistance and were
responsible for the accuracy of the check. They were asked to sign a contract to this effect
agreeing to these terms. In the low responsibility condition, participants signed a contract that
attributed the responsibility of the check to the research assistant. Participants completed a
memory interview immediately after the checks and provided confidence ratings for their
responses to the interview questions. The memory interview included memory for specific
aspects of the check that might have been perceived as threatening (“ What was the final state
of the thermostat?” (Radomsky et al., 2001, p. 817) [29] as well as nonthreatening aspects of
the check (“Did I (the experimenter) cough during the check?) (Radomsky et al., 2001, p. 817)
[29]. In the next phase of the study, all participants returned to the lab a week later and watched
videos of both checks and then completed the same memory interview and confidence ratings.
This delayed phase represented a no responsibility phase. Results showed no overall differ‐
ences in the amount remembered across the conditions, but under conditions of high respon‐
sibility, OCD handwashers recalled more threatening information than irrelevant information.
This result did not hold under conditions of low responsibility. When the people who were
originally in the high responsibility group were tested under conditions of no responsibility
one week later, they no longer showed superior recall of threatening information. However,
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this result is confounded by methodological issues. That is, threatening actions were some‐
times performed by the participant whereas nonthreatening actions were sometimes per‐
formed by the experimenter. There is now a large body of literature showing superior memory
for participation versus observation [30].
One study measured explicit memory with a recognition task for previously heard or never
heard sentences and confidence [31]. Implicit memory was assessed via participants’ ratings
of the volume of the previously heard or never heard sentences. There was no tendency for
OCD participants to rate previously heard sentences as louder thereby demonstrating a lack
of a superior implicit memory bias. As expected, OCD participants did not show an explicit
memory bias; that is they did not exhibit superior recognition performance compared to
control participants nor did they correctly reject never-presented sentences at higher rates than
control participants. Instead, OCD patients rated all sentences as louder than matched
nontreatment seeking controls suggesting what the authors referred to as a “perceptual
deficit,” or difficulty accurately perceiving the stimuli, rather than memory deficit, although
the ramifications of this finding are unclear. Failure to find an explicit memory bias appeared
to be due to high accuracy rates in both groups. Perhaps a longer test delay would have been
beneficial in this study.
In sum, the data on memory biases in OCD show that the majority of studies fail to find
evidence for such as bias. Numerous methodological issues in the above described studies
exist, thereby precluding firm conclusions from being drawn. Small sample size is clearly one
limitation in some studies examining this topic. It is also possible that delay of test was not
long enough in some of the above studies for differences to emerge. In some studies, partici‐
pants were informed prior to encoding that memory would be tested, thereby raising the
possibility that rehearsal strategies were used following experimenter notification that a
memory test would occur. Other methodological issues include failure to score incorrect recall
and confounds regarding the effects of participation.
5. Attentional bias in OCD — Theory and research
According to theory, individuals are more vulnerable to emotional disorders when the level
of emotion exceeds an individual’s capacity to control that emotion [32]. Individuals with
anxiety disorders are more likely to display selective attention to threatening stimuli and
experience more difficulty disengaging once attention to threatening stimuli is activated. It is
also the case that the threshold for appraising a stimulus as threatening is lower in people with
anxiety disorders. Accordingly, attention towards threat is a combination of current level of
state anxiety, level of threat appraisal, and ability to modulate attention. Mathews and
MacLeod suggest that attentional bias plays a role in the development of anxiety disorders [32].
Although many studies show that people with anxiety disorders display an attentional bias,
these data do not show that attentional bias causes anxiety disorders. Indirect support for the
hypothesis that attention plays a causal role in anxiety comes from studies that demonstrate
that creating cognitive bias impacts emotional state. It is important to acknowledge that to date
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there has not been a study conducted in which an attentional bias towards anxiety is created
with the resulting outcome showing that anxiety increases. However, research does show that
training away from an attentional bias reduces anxiety [33]. Attentional bias is important in
anxiety disorders because attending to threatening information leads to behavioral avoidance
of the anxiety provoking and does not allow for exposure to the feared stimuli which would
reduce the anxiety in the long term [34].
Several studies have examined whether attentional bias exists in patients with OCD. An early
study presented patients with OCD and panic disorder, with OCD threat related words, panic
threat related words, general threat related words, and neutral words within a stroop test [35].
There were no significant differences between OCD and panic patients with respect to correct
responses on the stroop task. Response latencies also did not differ between panic and OCD
participants. Note that longer latencies indicate greater interference or attentional bias. An
earlier study presented within the same paper showed no significant differences between the
panic and normal comparison groups. Taken together, these results argue against an atten‐
tional bias in OCD.
Using a new methodology that involved reaction time to investigate attentional bias, research‐
ers compared people with OCD (predominantly checking behavior) to normal controls and
found no significant differences in reaction time to checking related, paranoid theme related,
or neutral words [36]. Another study found that an attentional bias was not present in people
with OCD compared to normal controls when words were used in a stroop task, but attentional
bias was present when pictures were used [37]. In contrast, a series of two studies using the
dot-probe task demonstrated that people with OCD exhibited a contamination attentional bias
and a general threat attentional bias [38]. However, the general threat attentional bias was
equivalent to a high trait anxiety group thereby demonstrating that attentional bias is not
specific to OCD. Neither the contamination attentional bias nor the general threat attentional
bias was present in a normal control population.
Some evidence for attentional bias in people with an OCD washing compulsion as indicated
by longer latencies to name words in a stroop task has been found, although all findings were
not supportive of attentional bias [39]. The authors interpreted these results to suggest that the
activation of fear in contamination OC washers occurs and interferes with general information
processing ability. Some evidence was found for general threat bias in OC nonwashers.
Similarly, behavioral treatment of OCD, presumably exposure and response prevention,
reduces fear sensitivity as measured by behavioral and physiological measures taken during
a cognitive task [40].
Studies have investigated whether attentional bias could be modified in college students with
subclinical OCD symptoms [33]. Specifically, the modification intervention focused on
drawing participants’ attention away from threatening words using a computerized task that
displayed threat and neutral words at equal frequencies, but always drew participants’
attention to the neutral words by replacing the neutral word with a probe. The modification
intervention was administered after establishing that each participant exhibited an attentional
bias. The modification intervention group was compared to a control group in which the probe
replaced threatening or neutral words at equal frequencies. A behavioral avoidance task using
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this result is confounded by methodological issues. That is, threatening actions were some‐
times performed by the participant whereas nonthreatening actions were sometimes per‐
formed by the experimenter. There is now a large body of literature showing superior memory
for participation versus observation [30].
One study measured explicit memory with a recognition task for previously heard or never
heard sentences and confidence [31]. Implicit memory was assessed via participants’ ratings
of the volume of the previously heard or never heard sentences. There was no tendency for
OCD participants to rate previously heard sentences as louder thereby demonstrating a lack
of a superior implicit memory bias. As expected, OCD participants did not show an explicit
memory bias; that is they did not exhibit superior recognition performance compared to
control participants nor did they correctly reject never-presented sentences at higher rates than
control participants. Instead, OCD patients rated all sentences as louder than matched
nontreatment seeking controls suggesting what the authors referred to as a “perceptual
deficit,” or difficulty accurately perceiving the stimuli, rather than memory deficit, although
the ramifications of this finding are unclear. Failure to find an explicit memory bias appeared
to be due to high accuracy rates in both groups. Perhaps a longer test delay would have been
beneficial in this study.
In sum, the data on memory biases in OCD show that the majority of studies fail to find
evidence for such as bias. Numerous methodological issues in the above described studies
exist, thereby precluding firm conclusions from being drawn. Small sample size is clearly one
limitation in some studies examining this topic. It is also possible that delay of test was not
long enough in some of the above studies for differences to emerge. In some studies, partici‐
pants were informed prior to encoding that memory would be tested, thereby raising the
possibility that rehearsal strategies were used following experimenter notification that a
memory test would occur. Other methodological issues include failure to score incorrect recall
and confounds regarding the effects of participation.
5. Attentional bias in OCD — Theory and research
According to theory, individuals are more vulnerable to emotional disorders when the level
of emotion exceeds an individual’s capacity to control that emotion [32]. Individuals with
anxiety disorders are more likely to display selective attention to threatening stimuli and
experience more difficulty disengaging once attention to threatening stimuli is activated. It is
also the case that the threshold for appraising a stimulus as threatening is lower in people with
anxiety disorders. Accordingly, attention towards threat is a combination of current level of
state anxiety, level of threat appraisal, and ability to modulate attention. Mathews and
MacLeod suggest that attentional bias plays a role in the development of anxiety disorders [32].
Although many studies show that people with anxiety disorders display an attentional bias,
these data do not show that attentional bias causes anxiety disorders. Indirect support for the
hypothesis that attention plays a causal role in anxiety comes from studies that demonstrate
that creating cognitive bias impacts emotional state. It is important to acknowledge that to date
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there has not been a study conducted in which an attentional bias towards anxiety is created
with the resulting outcome showing that anxiety increases. However, research does show that
training away from an attentional bias reduces anxiety [33]. Attentional bias is important in
anxiety disorders because attending to threatening information leads to behavioral avoidance
of the anxiety provoking and does not allow for exposure to the feared stimuli which would
reduce the anxiety in the long term [34].
Several studies have examined whether attentional bias exists in patients with OCD. An early
study presented patients with OCD and panic disorder, with OCD threat related words, panic
threat related words, general threat related words, and neutral words within a stroop test [35].
There were no significant differences between OCD and panic patients with respect to correct
responses on the stroop task. Response latencies also did not differ between panic and OCD
participants. Note that longer latencies indicate greater interference or attentional bias. An
earlier study presented within the same paper showed no significant differences between the
panic and normal comparison groups. Taken together, these results argue against an atten‐
tional bias in OCD.
Using a new methodology that involved reaction time to investigate attentional bias, research‐
ers compared people with OCD (predominantly checking behavior) to normal controls and
found no significant differences in reaction time to checking related, paranoid theme related,
or neutral words [36]. Another study found that an attentional bias was not present in people
with OCD compared to normal controls when words were used in a stroop task, but attentional
bias was present when pictures were used [37]. In contrast, a series of two studies using the
dot-probe task demonstrated that people with OCD exhibited a contamination attentional bias
and a general threat attentional bias [38]. However, the general threat attentional bias was
equivalent to a high trait anxiety group thereby demonstrating that attentional bias is not
specific to OCD. Neither the contamination attentional bias nor the general threat attentional
bias was present in a normal control population.
Some evidence for attentional bias in people with an OCD washing compulsion as indicated
by longer latencies to name words in a stroop task has been found, although all findings were
not supportive of attentional bias [39]. The authors interpreted these results to suggest that the
activation of fear in contamination OC washers occurs and interferes with general information
processing ability. Some evidence was found for general threat bias in OC nonwashers.
Similarly, behavioral treatment of OCD, presumably exposure and response prevention,
reduces fear sensitivity as measured by behavioral and physiological measures taken during
a cognitive task [40].
Studies have investigated whether attentional bias could be modified in college students with
subclinical OCD symptoms [33]. Specifically, the modification intervention focused on
drawing participants’ attention away from threatening words using a computerized task that
displayed threat and neutral words at equal frequencies, but always drew participants’
attention to the neutral words by replacing the neutral word with a probe. The modification
intervention was administered after establishing that each participant exhibited an attentional
bias. The modification intervention group was compared to a control group in which the probe
replaced threatening or neutral words at equal frequencies. A behavioral avoidance task using
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items that participants were led to believe were contaminated served as the outcome measure.
Participants who received attentional bias modification training engaged in less behavioral
avoidance. They also showed less attentional bias during repeated trials of the attentional bias
task administered immediately after bias modification training. An earlier study confirmed
the presence of attentional bias in OCD but the bias was limited to the earlier portions of the
task [41]. Bias was remediated via habituation in the later portions of the task.
Additional data show that people with OCD exhibit an attentional bias toward threatening
information in general as opposed to only OCD related items [42].These data further show that
this bias is not due to other aspects of the stimuli that could account for the results, namely
emotional arousal [43].
Relatedly, cognitive theories of OCD emphasize cognitive inhibition deficits in OCD, deficits
in the allocation of attention via the inhibition of unwanted thoughts [44]. Experimental tests
of cognitive inhibition show that people with OCD experience greater difficulty in ignoring
previously presented stimuli when instructed to do so relative to people with anxiety disorders
other than OCD [45]. Cognitive inhibition becomes further impaired as the complexity of the
cognitive task increases [46].
In sum, a substantial amount of evidence exists for attentional bias in OCD. Importantly,
attentional bias is not specific to OCD, but rather is present in anxiety disorders in general [47].
Nevertheless, existing studies show that when attentional bias is present in people with OCD,
it can be modified, which can reduce behavioral avoidance of distressing stimuli. These data
imply that clients should be assessed for attentional bias so that if present, this can be a focus
of treatment.
6. Conclusion
6.1. Do the extant data fit the etiological models of OCD?
An examination of the data discussed herein reveals varying levels of support for the compo‐
nents of cognitive models of OCD described at the beginning of this chapter. Consistent
support exists for inferential confusion which combines errors in reasoning with devaluation
of information taken in by the senses and confusion between real and imagined events. The
available data show both higher levels of inferential confusion in people with OCD and
reduced inferential confusion following OCD treatment [15[16]. With regard to the role that
the tendency to confuse real and imagined events plays in OCD (i.e., reality monitoring), the
data are weaker [21,22]. However, it should be noted that reality monitoring ability is the only
component of inferential confusion being examined in these studies. However, in inferential
confusion processes, reasoning errors and the tendency to discount information taken in by
the senses are factors that contribute to the tendency to make reality monitoring errors [14].
Nevertheless, a small amount of data do support the notion that imagery plays a role in the
development or maintenance of OCD in people with OCD plus trauma histories [22,24].
However, further research should be conducted in this area. In addition, there is consistent
support for the likelihood component of thought-action fusion [8,10,11]. That is, people with
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OCD are more apt to believe that having a thought increases the likelihood that the event
contained in the thought is going to occur than people without OCD. Less support exists for
the belief that having a thought that contains a moral transgression is the equivalent to having
completed that transgression (moral component of TAF) [11]. With regard to memory biases
in OCD, the data as a whole do not support the existence of memory biases in OCD [27].
However, it is the case that methodological issues in extant studies preclude firm conclusions
from being drawn. Moreover, there are numerous studies showing support for the existence
of an attentional bias in OCD [36,37,49,41,42]. Also, the data support attentional bias training
in reducing OCD symptoms [33]. It should be noted that attentional bias is not a component
of the theoretical models specific to OCD described herein, but the data support incorporating
attentional bias into models of OCD.
It should be noted that research in this area is in its infancy. Although some but not other
components of these models have been tested, extant research has not gone beyond asking the
question of whether group differences exist between people with a diagnosis of OCD and
various comparison or control groups. Longitudinal studies are needed to test these models
holistically. In addition, other components of the models have not been examined. For
example, there are no published data on family factors that lend themselves towards vulner‐
ability to creating obsessions. In addition, cognitive appraisals of specific thoughts in people
with OCD have not been studied. Moreover, data on the relations between life stress and OCD
need to be collected. That is, stress levels in the year preceding the onset of OCD symptoms
and overall history of life stress in people with OCD warrant study.
6.2. Treatment implications of cognitive processes and biases in OCD
The theories and data described throughout this chapter indicate that there is substantial room
for cognitive components to make a significant contribution to OCD case conceptualization
and treatment. Rachman’s theory implies that psychoeducation about OCD should begin with
presentation of the idea that obsessions are cued by stimuli in the environment [2]. Given that
the environment is ripe with cues, clients can expect and should be prepared to expect that the
obsessive thought will be cued. If clients are more distressed by obsessions than they are by
compulsions, cognitive bias training modification could be employed at this point in the
treatment. Modification training would be expected to decrease the obsessions because clients
should be less likely to attend to and interpret environmental cues as being related to their
obsessions. This would prevent the obsessions from being cued. If cued, clients can be taught
that it is the actions that they now take when the obsession is present that are key. Clients
should be taught to first, identify when the obsession has come to mind. It is at this point that
the client needs to employ mechanisms to cope with the obsession, including cognitive
restructuring. The therapist is advised to administer a measure of thought-action fusion such
as the Thought-Action Fusion scale [8]. If scores are elevated in the clinical range, the clinician
can introduce the idea of thought-action fusion and review each statement endorsed on the
TAF as indicating that thoughts equal actions. In order to ward off inferential confusion, clients
can be taught inferential reasoning skills that would be expected to reduce the tendency to
make reasoning errors. In addition, clients can be taught reality monitoring skills to help
remind themselves that a thought is not equal to an action. That is, clients can be taught to ask
themselves, “Did I think X thought or did I perform X action?” [adapted from 48]. The therapist
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items that participants were led to believe were contaminated served as the outcome measure.
Participants who received attentional bias modification training engaged in less behavioral
avoidance. They also showed less attentional bias during repeated trials of the attentional bias
task administered immediately after bias modification training. An earlier study confirmed
the presence of attentional bias in OCD but the bias was limited to the earlier portions of the
task [41]. Bias was remediated via habituation in the later portions of the task.
Additional data show that people with OCD exhibit an attentional bias toward threatening
information in general as opposed to only OCD related items [42].These data further show that
this bias is not due to other aspects of the stimuli that could account for the results, namely
emotional arousal [43].
Relatedly, cognitive theories of OCD emphasize cognitive inhibition deficits in OCD, deficits
in the allocation of attention via the inhibition of unwanted thoughts [44]. Experimental tests
of cognitive inhibition show that people with OCD experience greater difficulty in ignoring
previously presented stimuli when instructed to do so relative to people with anxiety disorders
other than OCD [45]. Cognitive inhibition becomes further impaired as the complexity of the
cognitive task increases [46].
In sum, a substantial amount of evidence exists for attentional bias in OCD. Importantly,
attentional bias is not specific to OCD, but rather is present in anxiety disorders in general [47].
Nevertheless, existing studies show that when attentional bias is present in people with OCD,
it can be modified, which can reduce behavioral avoidance of distressing stimuli. These data
imply that clients should be assessed for attentional bias so that if present, this can be a focus
of treatment.
6. Conclusion
6.1. Do the extant data fit the etiological models of OCD?
An examination of the data discussed herein reveals varying levels of support for the compo‐
nents of cognitive models of OCD described at the beginning of this chapter. Consistent
support exists for inferential confusion which combines errors in reasoning with devaluation
of information taken in by the senses and confusion between real and imagined events. The
available data show both higher levels of inferential confusion in people with OCD and
reduced inferential confusion following OCD treatment [15[16]. With regard to the role that
the tendency to confuse real and imagined events plays in OCD (i.e., reality monitoring), the
data are weaker [21,22]. However, it should be noted that reality monitoring ability is the only
component of inferential confusion being examined in these studies. However, in inferential
confusion processes, reasoning errors and the tendency to discount information taken in by
the senses are factors that contribute to the tendency to make reality monitoring errors [14].
Nevertheless, a small amount of data do support the notion that imagery plays a role in the
development or maintenance of OCD in people with OCD plus trauma histories [22,24].
However, further research should be conducted in this area. In addition, there is consistent
support for the likelihood component of thought-action fusion [8,10,11]. That is, people with
Obsessive-Compulsive Disorder - The Old and the New Problems28
OCD are more apt to believe that having a thought increases the likelihood that the event
contained in the thought is going to occur than people without OCD. Less support exists for
the belief that having a thought that contains a moral transgression is the equivalent to having
completed that transgression (moral component of TAF) [11]. With regard to memory biases
in OCD, the data as a whole do not support the existence of memory biases in OCD [27].
However, it is the case that methodological issues in extant studies preclude firm conclusions
from being drawn. Moreover, there are numerous studies showing support for the existence
of an attentional bias in OCD [36,37,49,41,42]. Also, the data support attentional bias training
in reducing OCD symptoms [33]. It should be noted that attentional bias is not a component
of the theoretical models specific to OCD described herein, but the data support incorporating
attentional bias into models of OCD.
It should be noted that research in this area is in its infancy. Although some but not other
components of these models have been tested, extant research has not gone beyond asking the
question of whether group differences exist between people with a diagnosis of OCD and
various comparison or control groups. Longitudinal studies are needed to test these models
holistically. In addition, other components of the models have not been examined. For
example, there are no published data on family factors that lend themselves towards vulner‐
ability to creating obsessions. In addition, cognitive appraisals of specific thoughts in people
with OCD have not been studied. Moreover, data on the relations between life stress and OCD
need to be collected. That is, stress levels in the year preceding the onset of OCD symptoms
and overall history of life stress in people with OCD warrant study.
6.2. Treatment implications of cognitive processes and biases in OCD
The theories and data described throughout this chapter indicate that there is substantial room
for cognitive components to make a significant contribution to OCD case conceptualization
and treatment. Rachman’s theory implies that psychoeducation about OCD should begin with
presentation of the idea that obsessions are cued by stimuli in the environment [2]. Given that
the environment is ripe with cues, clients can expect and should be prepared to expect that the
obsessive thought will be cued. If clients are more distressed by obsessions than they are by
compulsions, cognitive bias training modification could be employed at this point in the
treatment. Modification training would be expected to decrease the obsessions because clients
should be less likely to attend to and interpret environmental cues as being related to their
obsessions. This would prevent the obsessions from being cued. If cued, clients can be taught
that it is the actions that they now take when the obsession is present that are key. Clients
should be taught to first, identify when the obsession has come to mind. It is at this point that
the client needs to employ mechanisms to cope with the obsession, including cognitive
restructuring. The therapist is advised to administer a measure of thought-action fusion such
as the Thought-Action Fusion scale [8]. If scores are elevated in the clinical range, the clinician
can introduce the idea of thought-action fusion and review each statement endorsed on the
TAF as indicating that thoughts equal actions. In order to ward off inferential confusion, clients
can be taught inferential reasoning skills that would be expected to reduce the tendency to
make reasoning errors. In addition, clients can be taught reality monitoring skills to help
remind themselves that a thought is not equal to an action. That is, clients can be taught to ask
themselves, “Did I think X thought or did I perform X action?” [adapted from 48]. The therapist
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can then work with the client to restructure cognitions regarding the probability of events and
responsibility for events. Given that the client has likely had a similar thought many times and
not acted on it, what is the evidence that they will do so now? With regard to compulsions,
clients should be taught about memory norms. First, repeated routine events tend not to be
recalled [49]. Therefore, the fact that one cannot remember if one has turned off the stove is
normal given the large number of checks performed; therefore, one’s memory does not need
to be confirmed. Skills from other therapies can be borrowed, such as distress tolerance skills
from Dialetical Behavior Therapy [50]. That is, it is OK to feel distress in response to an
obsession; one does not need to act on the distress by engaging in compulsions. Distress
tolerance skills should be used as opposed to thought suppression skills because research
shows that thought suppression can increase rather than decrease unwanted thoughts [51].
Similarly, behavioral activation can be employed so that the client engages in other activities
besides rumination. Clients should receive psychoeducation about the normative progression
of OCD symptoms. That is, they should expect that new compulsions may occur [52]. They
can expect that the OCD will be worse in times of stress and can coincide with negative affect
[2]. Consistent with behavioral theory, clients should be taught exposure and response
prevention skills; family members that have become part of the OCD rituals should be
participants in the therapy [53]. As in many empirically-supported treatments, relapse
prevention skills should be taught and clinicians should be sure their clients are able to
generalize these skills in order to deal with multiple obsessions and compulsions.
Although inclusion of cognitive components either in addition to exposure and response
prevention or as a stand-alone treatment has not been found to add to the effectiveness of OCD
treatment, existing treatment outcome studies have not included many of the components
discussed in this section [54,55,56] [57]. Therefore, a more comprehensive treatment as
proposed may yield more promising results.
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can then work with the client to restructure cognitions regarding the probability of events and
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clients should be taught about memory norms. First, repeated routine events tend not to be
recalled [49]. Therefore, the fact that one cannot remember if one has turned off the stove is
normal given the large number of checks performed; therefore, one’s memory does not need
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obsession; one does not need to act on the distress by engaging in compulsions. Distress
tolerance skills should be used as opposed to thought suppression skills because research
shows that thought suppression can increase rather than decrease unwanted thoughts [51].
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besides rumination. Clients should receive psychoeducation about the normative progression
of OCD symptoms. That is, they should expect that new compulsions may occur [52]. They
can expect that the OCD will be worse in times of stress and can coincide with negative affect
[2]. Consistent with behavioral theory, clients should be taught exposure and response
prevention skills; family members that have become part of the OCD rituals should be
participants in the therapy [53]. As in many empirically-supported treatments, relapse
prevention skills should be taught and clinicians should be sure their clients are able to
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1. Introduction
A young adult presents to a psychiatrist and describes the need to “unwind” himself around
pieces of furniture if he has passed them in a clockwise direction. When he is weighed, he
expresses the concern that pieces of rubber will come off the office scale and that will be
considered stealing. He hesitates before he sits down on a chair in the office because he is
afraid that he will catch the emotional problems of the person who sat in the chair before
him. Are these psychotic delusions or obsessions and compulsions?
A delusion is a fixed, false, unshakable belief. An obsession is a worried thought or image
that  is  experienced as disturbing.  The distinction is  important  to make as the treatment
paths for obsessive compulsive disorder (OCD) and schizophrenia (SCZ) diverge.
The aim of this chapter is to review electromagnetic measures that may be used to help
with diagnostic clarification and may predict treatment response in these two psychiatric
disorders.  At  present,  electroencephalograms  (EEGs)  or  other  neurophysiological  meas‐
ures  are  not  routinely  ordered  for  psychiatric  patients.  They  have  not  yet  become  the
standard  of  care.  The  Food  and  Drug  Administration  (FDA)  recently  approved  the
Neuropsychiatric EEG-Based Assessment Aid (NEBA) System to assist in the diagnosis of
attention deficit hyperactivity disorder (ADHD) based on the ratio of theta to beta frequency
bandwidths.  Electrophysiological  tests  to  aid  in  the  diagnosis  and  management  of  pa‐
tients with OCD and SCZ may develop in the near future.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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2. Similarities and differences between OCD and SCZ: Epidemiology and
clinical signs
2.1. Epidemiology
The prevalence of both OCD and SCZ is high, with estimates across the globe ranging from
1-2% of the population [1-4]. There is significant morbidity associated with both of these
conditions [5]. Symptoms of these diseases may impact the individual’s family, and ability
to work and contribute to society.  The quality of  life  of  patients  with OCD is  impaired
primarily during the symptomatic state but less so when patients are treated or in remission
[6, 7]. Close to 76% of patients with SCZ are unable to engage in basic social roles, even
when psychotic  symptoms are  in  remission;  few marry,  and less  than  one  third  are  in
regular employment [8].  Nine to thirteen percent of patients with schizophrenia commit
suicide [9].
The prevalence of obsessive compulsive symptoms in patients with SCZ ranges from 7.8%
[10]  to  25% [11].  Whereas  less  than 2% of  patients  with  OCD develop psychotic  symp‐
toms [12].  The age of  onset  of  OCD is  bimodal with peaks both in children and young
adults [13];  the typical age of onset of SCZ is in the third decade of life with childhood
onset being extremely rare [14].
2.2. Clinical characteristics
The  clinical  presentation  of  OCD  and  SCZ  is  currently  what  is  used  to  diagnose  and
distinguish these conditions.  OCD is  characterized by the presence of  obsessions and/or
compulsions [15].  Obsessions are unwanted thoughts or images that recur.  Compulsions
are  repetitive  behaviors  or  mental  acts  that  an  individual  feels  driven  to  perform.  Pa‐
tients with OCD often describe either a sense of incompleteness if a ritual is not done just
right or a sense that something bad will happen if they don’t perform the ritual. SCZ, on
the other hand, is characterized by positive and negative symptoms [15]. Positive symp‐
toms refer  to  additional  symptoms that  are  not  present  in  a  healthy individual  such as
hallucinations, delusions, and thought disorder. Negative symptoms refer to deficits, such
as, lack of facial expressions and emotional variability, decreased energy and diminished
verbal  output.  Cognitive dysfunction [16]  and disorganized behavior  may be present  as
well and include disorganized speech, bizarre behavior and poor attention [17].
While OCD and SCZ are described as distinct psychiatric disorders [18], some authors argue
that a “schizo-obsessive disorder” exists as well [19-21]. Indeed, a subset of individuals with
SCZ present with obsessive compulsive symptoms and a subset of patients with OCD lack
insight. Some have concluded from this overlap, that there is a spectrum of disorders that
ranges from: [1] OCD, [2] OCD with poor insight, [3] OCD with schizotypal personality
disorder, [4] schizophrenia with obsessive compulsive symptoms, [5] SCZ with OCD and [6]
SCZ [22].
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3. Electromagnetic measures of neural activity
3.1. Transcranial magnetic stimulation (TMS)
TMS is a versatile tool in the hands of a neurophysiologist as it can be used to measure and
modulate cortical excitation and inhibition. The TMS unit consists of a strong (1 to 2 Tesla)
electromagnetic generator and a handheld magnet or adjustable coil. When stimulating, the
coil is positioned manually over the scalp. Some systems also include a means by which the
investigator may navigate and visualize the location of stimulations by co-registering the head
position with a 3-dimensional reconstruction of the subject’s own MRI. The magnet can be set
to deliver single or repetitive pulses generating focal electrical currents.
With the magnet held over the contralateral primary motor cortex, a single magnetic pulse
excites the underlying brain tissue and leads to an evoked potential and movement in the
corresponding muscle. The amplitude of the motor evoked potential (MEP) and the motor
threshold (or level at which 50% of the stimuli lead to movement) reflects the degree of
excitability of the brain, spinal cord neurons and muscles in that individual. A period of
inhibition, typically lasting for a few hundred milliseconds, follows the MEP. This cortical
silent period (CSP) is obtained by asking the subject to maintain muscle contraction while a
single suprathreshold TMS pulse is applied to the motor cortex [23-25].
Neuroplasticity is a feature of the nervous system that helps the brain learn, develop or
reorganize in response to intrinsic or environmental stimuli. In broad terms, though such
reorganization can be associated with the development of a healthy skill or recovery after
a functional loss such as a stroke, maladaptive changes may lead to problematic patterns
of  thoughts  and  behaviors.  The  underlying  mechanism  behind  the  strengthening  or
weakening of neuronal connections is supported by in vivo and in vitro animal experimen‐
tation and is thought to be based upon long term potentiation (LTP) or long-term depres‐
sion respectively (LTD) [26, 27]. More recently, several TMS protocols have been developed
to study the inhibition and facilitation of MEPs which may reflect the underlying influen‐
ces  of  inhibitory  and  excitatory  cortico-cortial  and  subcortico-cortical  circuits  which
modulate cortical excitability.
Paired-pulse TMS is a method of applying stimuli below the MEP threshold to change the
size of subsequent MEP. A single “conditioning” pulse is followed by a “test” pulse. The
interstimulus interval (ISI) affects the size of the resultant MEP. In short interval intracort‐
ical  inhibition (SICI)  protocols,  a  subthreshold stimulus is  followed by a suprathreshold
stimulus. Interstimulus intervals of 1-5ms lead to suppression of the MEP. With long interval
intracortical inhibition (LICI) both pulses are suprathreshold, and the interstimulus interval
is 50-200ms. MEPs can be facilitated when a subthreshold pulse is given 10-25ms before a
suprathreshold pulse. Research suggests that intracortical inhibition and facilitation reflect
the influences of  inhibitory and excitatory cortio-cortical  and subcortical–cortical  circuits
modulating  activity  in  motor  cortex  output  neurons  without  the  involvement  of  spinal
neurons [28-30].
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More durable changes to cortical excitability which persist past the stimulation period can be
induced utilizing various repetitive TMS (rTMS) protocols. Already in wide use for the
treatment of depression, 1 Hz rTMS can also be used experimentally to temporarily disrupt
cortical activity and thus establish structure-function relationships when used in tandem with
behavioral experiments and functional imaging. Higher frequency rTMS (5 to 20 Hz) tends to
increase cortical excitability. Although 1-Hz rTMS (applied at 90% of resting motor threshold)
to the contralateral motor cortex for 10 minutes results in approximately 10 minutes of MEP
size depression following stimulation, recent protocols that utilize more complicated patterns
of stimulation can result in effects that last longer than 30 minutes. Theta-burst stimulation,
for example, consists of ultra-rapid trains of three TMS pulses (50 Hz) with variable interval
between bursts for a total stimulation time of 40 to 190 seconds. Remarkably, this brief
stimulation can result in relatively long-lasting changes in MEP size resembling a human
model of LTP and LTD of synaptic efficiency [31].
TMS has an important role in research regarding the nervous system and its role in the
treatment of various psychiatric conditions is expanding (for review, see 32). It has been shown
to be useful in reducing auditory hallucinations [33, 34] and improving negative symptoma‐
tology in SCZ [35]. The jury is still out on whether rTMS will prove useful for improving
symptoms in OCD; the three studies to date do not support significant benefit of rTMS [36].
TMS studies in OCD. Just as there are few treatment studies utilizing TMS in OCD, so too, few
investigator have employed TMS to examine cortical excitability in OCD. The first study we
found in the literature, reported decreased SICI in 12 patients with OCD compared with 12
healthy comparison subjects (HCS) [37]. This group expanded upon their findings using both
single-pulse TMS and paired-pulse TMS in 9 medicated and 7 unmedicated patients with OCD
compared with 11 HCS [38]. They found a lower motor threshold both when the OCD subject
was stimulated at rest or during an active state. They also found diminished SICI in the OCD
subjects, with even lower intracortical inhibition in subjects with comorbid OCD and a tic
disorder. There were no significant differences between subjects with OCD and HCS with
regard to MEP amplitude, intracortical facilitation or length of the silent period. In a larger
sample, Richter, de Jesus [39] compared 34 patients with OCD (23 medicated and 11 unmedi‐
cated) with 34 HCS. In contrast to the previous study, no difference was found in resting motor
threshold between the OCD and HCS, although the resting motor threshold was significantly
lower in the OCD subjects on medication. The CSP was shorter in patients with OCD compared
with HCS. No differences were found in SICI between the OCD and HCS, but patients with
OCD had greater intracortical facilitation. No correlations were found between illness severity
and TMS parameters in either the medicated or unmedicated patients. The discrepancies
between these studies may reflect the presence of unmedicated subjects or may be attributed
to different TMS stimulus parameters. However given the paucity of studies of TMS in subjects
with OCD there is a need to continue research to further our understanding of the possible
excitation inhibition imbalance in this disorder.
To explore the mechanism of action of rTMS in subjects with OCD, recently Pedapati, DiFran‐
scesco [40] examined the effects of 30 minutes of 1 Hz repetitive TMS (rTMS) of the dorsolateral
prefrontal cortex. We compared sham (subthreshold) TMS with rTMS on the blood oxygena‐
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tion level-dependent (BOLD) signal during symptom provocation and found increased BOLD
activity in the right inferior frontal gyrus, right insular cortex, and the left thalamus in the sham
subjects suggesting that rTMS may have inhibited the desensitization process experienced by
the subjects during provocative image exposure (Figure 1).
Figure 1. Differences in brain activation for subject-specifc OCD symptom-provocative task comparing 1 Hz rTMS with
sham rTMS. Top: Select axial slices show an interaction between the intervention (real or sham rTMS) and time (pre- or
post-rTMS). Hot colors indicate (sham/after > sham/before) > (TMS/after > TMS/before) contrasts. Colors indicate acti‐
vations that passed an uncorrected threshold of p < 0.005. Neurological convention used. Bottom: Results of regional
analysis for a region of interest covering the right insula. A difference index comparing activation before and after
rTMS is shown for the real and sham rTMS subject groups. The group difference is significant at p<0.05. Black bars
indicate the standard error.
TMS studies in SCZ. There is a somewhat larger body of literature examining the effects of TMS
in SCZ that is less divergent in its findings than the OCD literature. Abnormalities in cortical
inhibition in patients with SCZ have been reported by a number of authors [41-43]. Eichham‐
mer, Wiegand [44] found that treatment naïve patients with SCZ had significantly lower
resting motor threshold relative to healthy subjects. Liu, Fitzgerald [45] found that patients
with SCZ who were treated with clozapine had longer CSP compared with other patients with
SCZ, while Wobrock, Schneider-Axmann [46] found prolonged CSP in patients with new onset
SCZ who had limited exposure to medication. Daskalakis, Christensen [47] found deficits in
use-dependent plasticity in subjects with SCZ which is measured after subjects have been
trained to move in the opposite direction of the movement that is induced by TMS.
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More durable changes to cortical excitability which persist past the stimulation period can be
induced utilizing various repetitive TMS (rTMS) protocols. Already in wide use for the
treatment of depression, 1 Hz rTMS can also be used experimentally to temporarily disrupt
cortical activity and thus establish structure-function relationships when used in tandem with
behavioral experiments and functional imaging. Higher frequency rTMS (5 to 20 Hz) tends to
increase cortical excitability. Although 1-Hz rTMS (applied at 90% of resting motor threshold)
to the contralateral motor cortex for 10 minutes results in approximately 10 minutes of MEP
size depression following stimulation, recent protocols that utilize more complicated patterns
of stimulation can result in effects that last longer than 30 minutes. Theta-burst stimulation,
for example, consists of ultra-rapid trains of three TMS pulses (50 Hz) with variable interval
between bursts for a total stimulation time of 40 to 190 seconds. Remarkably, this brief
stimulation can result in relatively long-lasting changes in MEP size resembling a human
model of LTP and LTD of synaptic efficiency [31].
TMS has an important role in research regarding the nervous system and its role in the
treatment of various psychiatric conditions is expanding (for review, see 32). It has been shown
to be useful in reducing auditory hallucinations [33, 34] and improving negative symptoma‐
tology in SCZ [35]. The jury is still out on whether rTMS will prove useful for improving
symptoms in OCD; the three studies to date do not support significant benefit of rTMS [36].
TMS studies in OCD. Just as there are few treatment studies utilizing TMS in OCD, so too, few
investigator have employed TMS to examine cortical excitability in OCD. The first study we
found in the literature, reported decreased SICI in 12 patients with OCD compared with 12
healthy comparison subjects (HCS) [37]. This group expanded upon their findings using both
single-pulse TMS and paired-pulse TMS in 9 medicated and 7 unmedicated patients with OCD
compared with 11 HCS [38]. They found a lower motor threshold both when the OCD subject
was stimulated at rest or during an active state. They also found diminished SICI in the OCD
subjects, with even lower intracortical inhibition in subjects with comorbid OCD and a tic
disorder. There were no significant differences between subjects with OCD and HCS with
regard to MEP amplitude, intracortical facilitation or length of the silent period. In a larger
sample, Richter, de Jesus [39] compared 34 patients with OCD (23 medicated and 11 unmedi‐
cated) with 34 HCS. In contrast to the previous study, no difference was found in resting motor
threshold between the OCD and HCS, although the resting motor threshold was significantly
lower in the OCD subjects on medication. The CSP was shorter in patients with OCD compared
with HCS. No differences were found in SICI between the OCD and HCS, but patients with
OCD had greater intracortical facilitation. No correlations were found between illness severity
and TMS parameters in either the medicated or unmedicated patients. The discrepancies
between these studies may reflect the presence of unmedicated subjects or may be attributed
to different TMS stimulus parameters. However given the paucity of studies of TMS in subjects
with OCD there is a need to continue research to further our understanding of the possible
excitation inhibition imbalance in this disorder.
To explore the mechanism of action of rTMS in subjects with OCD, recently Pedapati, DiFran‐
scesco [40] examined the effects of 30 minutes of 1 Hz repetitive TMS (rTMS) of the dorsolateral
prefrontal cortex. We compared sham (subthreshold) TMS with rTMS on the blood oxygena‐
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tion level-dependent (BOLD) signal during symptom provocation and found increased BOLD
activity in the right inferior frontal gyrus, right insular cortex, and the left thalamus in the sham
subjects suggesting that rTMS may have inhibited the desensitization process experienced by
the subjects during provocative image exposure (Figure 1).
Figure 1. Differences in brain activation for subject-specifc OCD symptom-provocative task comparing 1 Hz rTMS with
sham rTMS. Top: Select axial slices show an interaction between the intervention (real or sham rTMS) and time (pre- or
post-rTMS). Hot colors indicate (sham/after > sham/before) > (TMS/after > TMS/before) contrasts. Colors indicate acti‐
vations that passed an uncorrected threshold of p < 0.005. Neurological convention used. Bottom: Results of regional
analysis for a region of interest covering the right insula. A difference index comparing activation before and after
rTMS is shown for the real and sham rTMS subject groups. The group difference is significant at p<0.05. Black bars
indicate the standard error.
TMS studies in SCZ. There is a somewhat larger body of literature examining the effects of TMS
in SCZ that is less divergent in its findings than the OCD literature. Abnormalities in cortical
inhibition in patients with SCZ have been reported by a number of authors [41-43]. Eichham‐
mer, Wiegand [44] found that treatment naïve patients with SCZ had significantly lower
resting motor threshold relative to healthy subjects. Liu, Fitzgerald [45] found that patients
with SCZ who were treated with clozapine had longer CSP compared with other patients with
SCZ, while Wobrock, Schneider-Axmann [46] found prolonged CSP in patients with new onset
SCZ who had limited exposure to medication. Daskalakis, Christensen [47] found deficits in
use-dependent plasticity in subjects with SCZ which is measured after subjects have been
trained to move in the opposite direction of the movement that is induced by TMS.
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Reduced SICI has been recorded in first-episode SCZ and has been found to correlate with
positive symptom severity [46, 48]. Some medications have been found to affect TMS measures
of cortical inhibition. For instance, Fitzgerald, Brown [49] found that olanzapine and risperi‐
done confer different effects on the resting motor threshold and cortical inhibition. It may take
time or a dose effect to notice medication changes as Daskalakis, Christensen [50] have pointed
out that single doses of haloperidol and olanzapine did not alter cortical inhibition in healthy
subjects.
In summary, relative to HCS, patients with OCD were found, by at least some investigators,
to have lower motor threshold, shorter CSP, decreased SICI, and greater intracortical facilita‐
tion. Patients with SCZ were also found to have lower motor threshold and decreased SICI,
but prolonged CSP and abnormalities in use-dependent plasticity. Thus the only measure to
date which may distinguish between these conditions to date, using TMS, is the length of the
cortical silent period. For the development of a useful diagnostic measure, head-to-head
studies are needed for direct comparison between these and other psychiatric conditions. No
studies to our knowledge have used TMS measures to predict treatment outcome, although,
as discussed above, TMS measures can detect changes that result from treatment with
antipsychotics.
3.2. Electroencephalography (EEG) and magnetoencephalography (MEG)
The neural origins of brain function in psychiatric patients can also be effectively studied with
non-invasive neurophysiological techniques such as electroencephalography (EEG) and
magnetoencephalography (MEG) [51-53]. Handy (2009) notes that for a time investigators
began to consider EEG to be a tool of the past, but functional magnetic resonance imaging
helped revive an interest in combining the complimentary anatomical and electrophysiological
approaches and there is now an upsurge of interest in EEG and MEG. Both EEG and MEG can
be recorded in patients at rest with eyes open or closed (spontaneous EEG or MEG) as well as
during cognitive or behavioral tasks. Signal analysis techniques allow for quantitative
interpretation of both EEG and MEG waveforms – qEEG/qMEG, respectively. Such analysis
can be helpful not only in the diagnosis of psychiatric conditions [54], but also in predicting
treatment outcome [55]. Moreover, recent development in functional connectivity analysis,
permit investigators to study the activity in disparate brain regions in psychiatric patients at
rest with MEG or EEG. This approach has been referred to as the study of “resting state
functional connectivity” or the “default mode network.” [56]. Indeed, since there is evidence
to suggest that the core feature of disorders like OCD and SCZ are a result of altered functional
connections between different brain regions [57, 58] this approach is likely to prove to be very
valuable.
EEG and MEG add, to the already rich functional imaging literature, the ability to record neural
activity with high temporal resolution. EEG uses surface scalp electrodes to monitor cortical
electrical potentials. Electrodes distributed across the scalp together with mathematical
analyses can estimate the location of the generator of the neural activity within several
centimeters. Measurements with MEG permit 3-D localization of current sources studied on a
time scale of less than 1 ms [59]. MEG uses magnetometers to record the magnetic fields
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produced by extracellular electrical currents. The most common magnetemotors in use are
referred to as superconducting quantum interference devices or SQUIDS. Subjects are seated
or supine during recordings with a helmet containing the SQUIDS placed over their heads.
Cortical activity is on the order of 10 femtotesla (fT) and the alpha rhythm runs on the order
of1000 fT. These magnetic fields are much smaller than the background noise, which is on the
order of 108 fT, thus various strategies are employed to remove the noise, including magneti‐
cally shielding the recording room. With three fiducial markers (typically at points on the nose
and ears), MEG data can be aligned with the subject’s own anatomical magnetic resonance
image (MRI). MEG and MRI data can further be transformed to Tailarach space to assist in
group comparisons.
One of the principal differences between MEG and EEG is thought to be that MEG mainly
records activity from tangentially oriented sources leading to better recordings from sulci
where the pyramidal cell dendrites are lined up parallel with the cortex, while EEG can detect
sources with both radial and tangential components resulting from intracellular currents [51,
60, 61]. If one uses a perfect sphere to model the brain, there would be no magnetic field
detected from an entirely radially oriented current dipole. However, the human brain has a
more complex shape and most current dipoles have both radial and tangential components.
Therefore, a nearly radial source in the brain may generate a magnetic field that can be detected
by MEG [62]. In both mathematical modeling studies and in animal experiments, the strength
of the sources has been found to differ based on the location and orientation [63-65]. Sensitivity
to tangential sources makes MEG highly relevant for studies of auditory processing. For
example, MEG can be particularly sensitive to studying auditory hallucinations in SCZ or
auditory sensory information processing in OCD, as temporal brain regions are thought to be
involved in pathophysiology of both of these disorders [66-68]. A further difference between
EEG and MEG recordings is that magnetic fields are less distorted than electric fields by the
skull and scalp, leading to better spatial resolution for MEG. Thus, although EEG is sensitive
to activity both at the tops of the gyri and in the sulci, activity that is recorded with MEG can
be localized better.
Since frontal regions play a prominent role in the pathophysiology of both OCD and SCZ, one
might wonder how effective MEG is at detecting neuronal activity in the orbitofrontal cortex
(OFC), for instance. Hillebrand et al. [69] addressed this issue with detailed computations of
MRI modeled brain gyral surfaces, realistic strength cortical sources, and realistic background
noise. As a result of the study, the authors found limitations for MEG sensitivity only for the
most posterior aspect of the OFC. A careful study comparing MEG and fMRI localization of
responses to emotionally laden pictures showed co-localization of MEG and fMRI activation
of orbitofrontal cortex within 7-9 mm [70]. More recently, others [71, 72] have confirmed MEG
sensitivity to source activity in the OFC.
In quantitative electroencephalography (QEEG), multichannel recordings, usually from the
standard 19 electrode positions, are obtained while the subject has his or her eyes-closed and
is in a relaxed, awake state. One to two minutes of artifact-free data is analyzed using the Fast
Fourier Transform to quantify the power at each frequency of the EEG averaged across the
recording time. This is referred to as the power spectrum. There is very good test-retest
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Reduced SICI has been recorded in first-episode SCZ and has been found to correlate with
positive symptom severity [46, 48]. Some medications have been found to affect TMS measures
of cortical inhibition. For instance, Fitzgerald, Brown [49] found that olanzapine and risperi‐
done confer different effects on the resting motor threshold and cortical inhibition. It may take
time or a dose effect to notice medication changes as Daskalakis, Christensen [50] have pointed
out that single doses of haloperidol and olanzapine did not alter cortical inhibition in healthy
subjects.
In summary, relative to HCS, patients with OCD were found, by at least some investigators,
to have lower motor threshold, shorter CSP, decreased SICI, and greater intracortical facilita‐
tion. Patients with SCZ were also found to have lower motor threshold and decreased SICI,
but prolonged CSP and abnormalities in use-dependent plasticity. Thus the only measure to
date which may distinguish between these conditions to date, using TMS, is the length of the
cortical silent period. For the development of a useful diagnostic measure, head-to-head
studies are needed for direct comparison between these and other psychiatric conditions. No
studies to our knowledge have used TMS measures to predict treatment outcome, although,
as discussed above, TMS measures can detect changes that result from treatment with
antipsychotics.
3.2. Electroencephalography (EEG) and magnetoencephalography (MEG)
The neural origins of brain function in psychiatric patients can also be effectively studied with
non-invasive neurophysiological techniques such as electroencephalography (EEG) and
magnetoencephalography (MEG) [51-53]. Handy (2009) notes that for a time investigators
began to consider EEG to be a tool of the past, but functional magnetic resonance imaging
helped revive an interest in combining the complimentary anatomical and electrophysiological
approaches and there is now an upsurge of interest in EEG and MEG. Both EEG and MEG can
be recorded in patients at rest with eyes open or closed (spontaneous EEG or MEG) as well as
during cognitive or behavioral tasks. Signal analysis techniques allow for quantitative
interpretation of both EEG and MEG waveforms – qEEG/qMEG, respectively. Such analysis
can be helpful not only in the diagnosis of psychiatric conditions [54], but also in predicting
treatment outcome [55]. Moreover, recent development in functional connectivity analysis,
permit investigators to study the activity in disparate brain regions in psychiatric patients at
rest with MEG or EEG. This approach has been referred to as the study of “resting state
functional connectivity” or the “default mode network.” [56]. Indeed, since there is evidence
to suggest that the core feature of disorders like OCD and SCZ are a result of altered functional
connections between different brain regions [57, 58] this approach is likely to prove to be very
valuable.
EEG and MEG add, to the already rich functional imaging literature, the ability to record neural
activity with high temporal resolution. EEG uses surface scalp electrodes to monitor cortical
electrical potentials. Electrodes distributed across the scalp together with mathematical
analyses can estimate the location of the generator of the neural activity within several
centimeters. Measurements with MEG permit 3-D localization of current sources studied on a
time scale of less than 1 ms [59]. MEG uses magnetometers to record the magnetic fields
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produced by extracellular electrical currents. The most common magnetemotors in use are
referred to as superconducting quantum interference devices or SQUIDS. Subjects are seated
or supine during recordings with a helmet containing the SQUIDS placed over their heads.
Cortical activity is on the order of 10 femtotesla (fT) and the alpha rhythm runs on the order
of1000 fT. These magnetic fields are much smaller than the background noise, which is on the
order of 108 fT, thus various strategies are employed to remove the noise, including magneti‐
cally shielding the recording room. With three fiducial markers (typically at points on the nose
and ears), MEG data can be aligned with the subject’s own anatomical magnetic resonance
image (MRI). MEG and MRI data can further be transformed to Tailarach space to assist in
group comparisons.
One of the principal differences between MEG and EEG is thought to be that MEG mainly
records activity from tangentially oriented sources leading to better recordings from sulci
where the pyramidal cell dendrites are lined up parallel with the cortex, while EEG can detect
sources with both radial and tangential components resulting from intracellular currents [51,
60, 61]. If one uses a perfect sphere to model the brain, there would be no magnetic field
detected from an entirely radially oriented current dipole. However, the human brain has a
more complex shape and most current dipoles have both radial and tangential components.
Therefore, a nearly radial source in the brain may generate a magnetic field that can be detected
by MEG [62]. In both mathematical modeling studies and in animal experiments, the strength
of the sources has been found to differ based on the location and orientation [63-65]. Sensitivity
to tangential sources makes MEG highly relevant for studies of auditory processing. For
example, MEG can be particularly sensitive to studying auditory hallucinations in SCZ or
auditory sensory information processing in OCD, as temporal brain regions are thought to be
involved in pathophysiology of both of these disorders [66-68]. A further difference between
EEG and MEG recordings is that magnetic fields are less distorted than electric fields by the
skull and scalp, leading to better spatial resolution for MEG. Thus, although EEG is sensitive
to activity both at the tops of the gyri and in the sulci, activity that is recorded with MEG can
be localized better.
Since frontal regions play a prominent role in the pathophysiology of both OCD and SCZ, one
might wonder how effective MEG is at detecting neuronal activity in the orbitofrontal cortex
(OFC), for instance. Hillebrand et al. [69] addressed this issue with detailed computations of
MRI modeled brain gyral surfaces, realistic strength cortical sources, and realistic background
noise. As a result of the study, the authors found limitations for MEG sensitivity only for the
most posterior aspect of the OFC. A careful study comparing MEG and fMRI localization of
responses to emotionally laden pictures showed co-localization of MEG and fMRI activation
of orbitofrontal cortex within 7-9 mm [70]. More recently, others [71, 72] have confirmed MEG
sensitivity to source activity in the OFC.
In quantitative electroencephalography (QEEG), multichannel recordings, usually from the
standard 19 electrode positions, are obtained while the subject has his or her eyes-closed and
is in a relaxed, awake state. One to two minutes of artifact-free data is analyzed using the Fast
Fourier Transform to quantify the power at each frequency of the EEG averaged across the
recording time. This is referred to as the power spectrum. There is very good test-retest
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reliability of power spectra computed in this manner. Power spectra are typically examined
in the range of 1 to 20 Hz frequency band. This frequency range is further divided into
frequency bands and assigned names from the Greek alphabet: delta (δ, 1.5—3.5 Hz), theta (θ,
3.5—7.5 Hz), alpha (α, 7.5—12.5 Hz), and beta (β, 12.5—20 Hz). Results of the analyses describe
absolute power in each frequency band, the relative power or percentage of total power in
each channel, coherence which measures synchronization between two channels, or symmetry
which is the ratio of power in each band between a symmetrical pair of electrodes [73].
EEG/MEG in OCD. The first known EEG study regarding patients with OCD patients reported
seizure like patterns with slow waves of 2–4 Hz [74]. Similarly, nonspecific theta activity was
found in the EEG of patients with OCD [75]. To date, the δ, θ, α and β frequency bandwidths
have been examined in patients with OCD in the awake, resting state and during the per‐
formance of cognitive tasks. Table 1 illustrates the large variability in findings between
different investigators. Both increased α and β [76-79], as well as, decreased α and β have been
found in patients with OCD [80-85]. There are also reports of lateralized left [86] and right
hemispheric differences in patients with OCD [87, 88]. What the majority of the studies have
in common is a deviation from the healthy comparison group in frontal and frontotemporal
regions [78, 79, 81, 83, 84, 87, 89].
Method Population Results for OCD patients (pts)
Authors,
year
Resting EEG
intracortical exact low
resolution
electromagnetic
tomography software
30 drug-free pts with
OCD and 30 HCS
↓ lagged non-linear coherencee β2 frequency between
frontal brain areas but not within the default mode
network.
High vigilance stages had yielded ↓ frontal phase
synchronisation for β and θ
Olbrich,
Olbrich [90]
Resting EEG with
standardized low-
resolution
electromagnetic
tomography software
50 OCD (8 drug-free;
42 on SSRIs), 50 HCS
↑ δ in the cingulate gyrus, did not correlate with
symptom severity or illness duration. δ power in the right
orbitofrontal cortex positively correlated with age of
OCD onset
Koprivova,
Horacek [91]
Resting EEG with low-
resolution
electromagnetic
tomography and
coherence analysis
37 drug naïve pts
with OCD and 37 HCS
↑ δ in the insula
↑ β in frontal, parietal and limbic regions.
Decreased interhemisphereic coherence
Reduced coupling between δ and β
Velikova et
al. [79]
Quantitative EEG
20 adults (10 M, 10 F)
with OCD and 19 HC
↑ in θ coherence in the fronto-occipital region
Desarkar et
al. [92]
Resting EEG with variable
resolution
electromagnetic
20 adults with OCD
treated with
paroxetine
↑ α in the striatum, orbito-frontal and temporo-frontal
regions pre-treatment. This abnormality decreased
following successful treatment with paroxetine.
Bolwig et al.
[76]
Obsessive-Compulsive Disorder - The Old and the New Problems44
Method Population Results for OCD patients (pts)
Authors,
year
tomography
Quantitative EEG
18 unmedicated
adults with OCD and
18 HC
Lower average background frequency in frontal regions.
↑ δ - and ↓ α / β power.
Pogarell et
al. [81]
Multilead QEEG while
subjects performed
executive function tasks
32 drug-free pts with
OCD and 32 HC
↓ α power
Bucci et al.
[80]
Rey-Osterrieth Complex
Figure Test
23 pts with OCD
Score correlated with the α power with regression
coefficients that had different directions by hemisphere
Shin et al.
[93]
neurometric QEEG
20 nondepressed pts
with OCD all treated
with paroxetine
↑ α at baseline in medication responders.
Hansen et al.
[77]
19-channel QEEG
recorded at rest in supine
subjects
32 drug-free patients
(8 males) with OCD
and 31 HCS (9 males)
↓ absolute β power and an ↑ relative θ power in
frontotemporal regions
There were also differences by OCD subtype
Karadag et
al. [84]
QEEG during resting
state and during
hyperventilation
22 unmedicated
nondepressed pts
with OCD and 20 HC
At rest: ↑ δ & θ; ↓ α in left frontotemporal regions
During hyperventilation: ↓ β in left frontal regions
Tot et al.
[82]
self-paced movement of
the right thumb; 29-
channel EEG
10 untreated OCD
patients and 10 HC
Delayed onset of mu event-related desynchronization
with movement preparation and less postmovement β
synchronization
Leocani et al.
[94]
QEEG during live and
imaginal exposure to
feared contaminants
6 pts with OCD
significant change in the anterior-to-posterior scalp
distribution of α power during live exposure
Simpson et
al. [96]
rest and during a
temporal lobe activating
procedure, i.e., olfactory
stimulation
37 drug-free patients
with OCD and 30 HCS
At rest: ↑ delta-1 and ↓ α -2 power.
During olfactory stimulation: HCS had a power increase
in β, whereas OCD patients showed no change (right) or
slight decrease (left)
Locatelli et
al. [83]
EEG spectral analysis
50 pts with OCD, 50
pts with anxious
neurosis, 25 HC
↑ mean α power in occipital regions.
↓ frontal β activity found in both patient groups
Serra et al.
[85]
QEEG
27 adult patients with
OCD in a drug-free
state at baseline
Found 2 groups: Cluster 1 - ↑ relative power θ in the
frontal and frontotemporal regions; 80% of these
patients did not respond to medication.
Cluster 2 - ↑relative power α, 82.4% of these patients
were treatment responders.
Prichep et al.
[78]
Table 1. Summary of EEG findings in OCD
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reliability of power spectra computed in this manner. Power spectra are typically examined
in the range of 1 to 20 Hz frequency band. This frequency range is further divided into
frequency bands and assigned names from the Greek alphabet: delta (δ, 1.5—3.5 Hz), theta (θ,
3.5—7.5 Hz), alpha (α, 7.5—12.5 Hz), and beta (β, 12.5—20 Hz). Results of the analyses describe
absolute power in each frequency band, the relative power or percentage of total power in
each channel, coherence which measures synchronization between two channels, or symmetry
which is the ratio of power in each band between a symmetrical pair of electrodes [73].
EEG/MEG in OCD. The first known EEG study regarding patients with OCD patients reported
seizure like patterns with slow waves of 2–4 Hz [74]. Similarly, nonspecific theta activity was
found in the EEG of patients with OCD [75]. To date, the δ, θ, α and β frequency bandwidths
have been examined in patients with OCD in the awake, resting state and during the per‐
formance of cognitive tasks. Table 1 illustrates the large variability in findings between
different investigators. Both increased α and β [76-79], as well as, decreased α and β have been
found in patients with OCD [80-85]. There are also reports of lateralized left [86] and right
hemispheric differences in patients with OCD [87, 88]. What the majority of the studies have
in common is a deviation from the healthy comparison group in frontal and frontotemporal
regions [78, 79, 81, 83, 84, 87, 89].
Method Population Results for OCD patients (pts)
Authors,
year
Resting EEG
intracortical exact low
resolution
electromagnetic
tomography software
30 drug-free pts with
OCD and 30 HCS
↓ lagged non-linear coherencee β2 frequency between
frontal brain areas but not within the default mode
network.
High vigilance stages had yielded ↓ frontal phase
synchronisation for β and θ
Olbrich,
Olbrich [90]
Resting EEG with
standardized low-
resolution
electromagnetic
tomography software
50 OCD (8 drug-free;
42 on SSRIs), 50 HCS
↑ δ in the cingulate gyrus, did not correlate with
symptom severity or illness duration. δ power in the right
orbitofrontal cortex positively correlated with age of
OCD onset
Koprivova,
Horacek [91]
Resting EEG with low-
resolution
electromagnetic
tomography and
coherence analysis
37 drug naïve pts
with OCD and 37 HCS
↑ δ in the insula
↑ β in frontal, parietal and limbic regions.
Decreased interhemisphereic coherence
Reduced coupling between δ and β
Velikova et
al. [79]
Quantitative EEG
20 adults (10 M, 10 F)
with OCD and 19 HC
↑ in θ coherence in the fronto-occipital region
Desarkar et
al. [92]
Resting EEG with variable
resolution
electromagnetic
20 adults with OCD
treated with
paroxetine
↑ α in the striatum, orbito-frontal and temporo-frontal
regions pre-treatment. This abnormality decreased
following successful treatment with paroxetine.
Bolwig et al.
[76]
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Method Population Results for OCD patients (pts)
Authors,
year
tomography
Quantitative EEG
18 unmedicated
adults with OCD and
18 HC
Lower average background frequency in frontal regions.
↑ δ - and ↓ α / β power.
Pogarell et
al. [81]
Multilead QEEG while
subjects performed
executive function tasks
32 drug-free pts with
OCD and 32 HC
↓ α power
Bucci et al.
[80]
Rey-Osterrieth Complex
Figure Test
23 pts with OCD
Score correlated with the α power with regression
coefficients that had different directions by hemisphere
Shin et al.
[93]
neurometric QEEG
20 nondepressed pts
with OCD all treated
with paroxetine
↑ α at baseline in medication responders.
Hansen et al.
[77]
19-channel QEEG
recorded at rest in supine
subjects
32 drug-free patients
(8 males) with OCD
and 31 HCS (9 males)
↓ absolute β power and an ↑ relative θ power in
frontotemporal regions
There were also differences by OCD subtype
Karadag et
al. [84]
QEEG during resting
state and during
hyperventilation
22 unmedicated
nondepressed pts
with OCD and 20 HC
At rest: ↑ δ & θ; ↓ α in left frontotemporal regions
During hyperventilation: ↓ β in left frontal regions
Tot et al.
[82]
self-paced movement of
the right thumb; 29-
channel EEG
10 untreated OCD
patients and 10 HC
Delayed onset of mu event-related desynchronization
with movement preparation and less postmovement β
synchronization
Leocani et al.
[94]
QEEG during live and
imaginal exposure to
feared contaminants
6 pts with OCD
significant change in the anterior-to-posterior scalp
distribution of α power during live exposure
Simpson et
al. [96]
rest and during a
temporal lobe activating
procedure, i.e., olfactory
stimulation
37 drug-free patients
with OCD and 30 HCS
At rest: ↑ delta-1 and ↓ α -2 power.
During olfactory stimulation: HCS had a power increase
in β, whereas OCD patients showed no change (right) or
slight decrease (left)
Locatelli et
al. [83]
EEG spectral analysis
50 pts with OCD, 50
pts with anxious
neurosis, 25 HC
↑ mean α power in occipital regions.
↓ frontal β activity found in both patient groups
Serra et al.
[85]
QEEG
27 adult patients with
OCD in a drug-free
state at baseline
Found 2 groups: Cluster 1 - ↑ relative power θ in the
frontal and frontotemporal regions; 80% of these
patients did not respond to medication.
Cluster 2 - ↑relative power α, 82.4% of these patients
were treatment responders.
Prichep et al.
[78]
Table 1. Summary of EEG findings in OCD
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Spontaneous MEG in OCD. In the first documented MEG study with OCD subjects, the findings
of Amo, Quesney [71] are reminiscent of the early EEG studies in OCD (for example, 74) with
fronto-temporal paroxysmal rhythmic activity with low-amplitude spikes and intermittent
isolated spikes and sharp waves. Amo, Quesney [71] expanded their findings with the addition
of two selective serotonin specific reuptake inhibitor-naïve subjects [97] and they found similar
paroxysmal activity in fronto-temporal regions. Maihofner, Sperling [98] observed the
spontaneous MEG activity in 10 subjects with OCD and 10 healthy subjects. These authors
parsed the frequency bandwidths examined into “slow” (2-6 Hz) and “fast” (12.5-30 Hz). They
found dipole maxima concentrated in the left superior temporal gyrus with no difference in
the number of dipoles between subject groups for slow MEG activity. However, the OCD
group had a clustering of slow MEG activity over the left dorsolateral prefrontal cortex.
Figure 2. Example of MEG data in an Adolescent with OCD following the presentation of Symptom Provocative Im‐
ages. Event-related beta synchronization (warm colors) and de-synchronization (cool colors) are shown in frontal corti‐
cal regions, thalamus and caudate in an adolescent subject with OCD who was presented with contamination related
stimuli. Left to right, Axial, parasagittal views (Left=Right), and graph of time course of activity following stimulus pre‐
sentation. The red circle in the graph indicates the time at which the peak activity occurs within the green cross-hairs
in the corresponding MRI.
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Task-related MEG in OCD.To explore the network and compensatory mechanisms, Ciesielski,
Hamalainen [99] examined the MEG pattern of activation during a working memory task in
subjects with OCD. They found that during the encoding phase, there was enhanced activity
in OCD subjects in the anterior insula and decreased activity in the posterior inferior parietal
cortex. During the retention phase, activity was lower in the occipital, parietal, superior
temporal sulcus and dorsolateral prefrontal cortex. During the retrieval phase there was a
significant increase in activation from the right anterior insula extending toward the orbital
region and the right superior temporal sulcus. There was reduced activity in the left parietal
cortex. Ciesielski et al. [100] examined event-related synchronization (ERS) and desynchroni‐
zation (ERD) in the alpha band associated with a working memory task in subjects with OCD
and healthy subjects. In subjects with OCD, these authors found lower baseline alpha and a
task phase-specific ERD.
In a small sample of adolescents with OCD, we have begun to look at the power of oscillations
at rest and during a symptom provocative task [101, 102]. The majority of images for the visual
task were the neutral and contamination sets of images previously used by Gilbert, Akkal [103]
The spatiotemporal structure of beta band event-related changes were analyzed with synthetic
aperture magnetometry together with a Stockwell transform to provide power as a function
of time for each voxel. Results from one individual are illustrated in Figure 2 demonstrating
the ability of MEG to show the precise timing of activity of elements within the circuit.
With regards to functional connectivity analysis of electromagnetic data, to our knowledge,
only one study in OCD has been conducted to date [90]. When recording resting state EEG,
these authors demonstrated altered functional connectivity within the frontal brain region
(decreased non-linear coherence within the beta-2 frequency band) in OCD group compared
with HCS.
Overall, although the electrophysiological literature is sparse, both EEG and MEG data support
other functional imaging modalities (Beucke et al. 2013; [104] in their implication of elements
of a frontocortical, striatal, thalamic circuit with involvement of limbic regions, in line with
current neural model of OCD [105].
Spontaneous EEG/MEG in SCZ. A large number of studies have demonstrated that EEG
abnormalities occur more frequently in patients with SCZ than in healthy subjects. As early as
1936, Lemere [106] wrote "... the apathy and affective deficiency of the schizophrenic was the
feature of the illness most clearly related to an absent or 'poor' alpha rhythm." Berger, too, in
1937 [107], noted alpha and beta frequency abnormalities in a patient with schizophrenia. Early
reports also suggested that there were statistically significant resting EEG differences between
healthy individuals and patients with SCZ [108-116]. Abnormalities include general slowing,
dysrhythmia, nonspecific diffuse patterns, atypical sharp waves and epileptiform discharges.
A discussion in the literature ensued regarding the relationship between schizophrenia and
epilepsy. In support of this connection were the slow waves and spikes that were recorded
during catatonic episodes [112, 117, 118]. Still in all, a number of early studies failed to find
any EEG abnormalities in patients with SCZ, e.g., Colony and Willis [119] did not find EEG
differences between their 1000 patients with SCZ and HCS. Abnormal EEG activity was
thought of by some to be the result of a premorbid head injury or the consequence of treatment
The Utility of Electromagnetic Activity Measures in Obsessive Compulsive Disorder and Schizophrenia
http://dx.doi.org/10.5772/57247
47
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isolated spikes and sharp waves. Amo, Quesney [71] expanded their findings with the addition
of two selective serotonin specific reuptake inhibitor-naïve subjects [97] and they found similar
paroxysmal activity in fronto-temporal regions. Maihofner, Sperling [98] observed the
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found dipole maxima concentrated in the left superior temporal gyrus with no difference in
the number of dipoles between subject groups for slow MEG activity. However, the OCD
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Figure 2. Example of MEG data in an Adolescent with OCD following the presentation of Symptom Provocative Im‐
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Task-related MEG in OCD.To explore the network and compensatory mechanisms, Ciesielski,
Hamalainen [99] examined the MEG pattern of activation during a working memory task in
subjects with OCD. They found that during the encoding phase, there was enhanced activity
in OCD subjects in the anterior insula and decreased activity in the posterior inferior parietal
cortex. During the retention phase, activity was lower in the occipital, parietal, superior
temporal sulcus and dorsolateral prefrontal cortex. During the retrieval phase there was a
significant increase in activation from the right anterior insula extending toward the orbital
region and the right superior temporal sulcus. There was reduced activity in the left parietal
cortex. Ciesielski et al. [100] examined event-related synchronization (ERS) and desynchroni‐
zation (ERD) in the alpha band associated with a working memory task in subjects with OCD
and healthy subjects. In subjects with OCD, these authors found lower baseline alpha and a
task phase-specific ERD.
In a small sample of adolescents with OCD, we have begun to look at the power of oscillations
at rest and during a symptom provocative task [101, 102]. The majority of images for the visual
task were the neutral and contamination sets of images previously used by Gilbert, Akkal [103]
The spatiotemporal structure of beta band event-related changes were analyzed with synthetic
aperture magnetometry together with a Stockwell transform to provide power as a function
of time for each voxel. Results from one individual are illustrated in Figure 2 demonstrating
the ability of MEG to show the precise timing of activity of elements within the circuit.
With regards to functional connectivity analysis of electromagnetic data, to our knowledge,
only one study in OCD has been conducted to date [90]. When recording resting state EEG,
these authors demonstrated altered functional connectivity within the frontal brain region
(decreased non-linear coherence within the beta-2 frequency band) in OCD group compared
with HCS.
Overall, although the electrophysiological literature is sparse, both EEG and MEG data support
other functional imaging modalities (Beucke et al. 2013; [104] in their implication of elements
of a frontocortical, striatal, thalamic circuit with involvement of limbic regions, in line with
current neural model of OCD [105].
Spontaneous EEG/MEG in SCZ. A large number of studies have demonstrated that EEG
abnormalities occur more frequently in patients with SCZ than in healthy subjects. As early as
1936, Lemere [106] wrote "... the apathy and affective deficiency of the schizophrenic was the
feature of the illness most clearly related to an absent or 'poor' alpha rhythm." Berger, too, in
1937 [107], noted alpha and beta frequency abnormalities in a patient with schizophrenia. Early
reports also suggested that there were statistically significant resting EEG differences between
healthy individuals and patients with SCZ [108-116]. Abnormalities include general slowing,
dysrhythmia, nonspecific diffuse patterns, atypical sharp waves and epileptiform discharges.
A discussion in the literature ensued regarding the relationship between schizophrenia and
epilepsy. In support of this connection were the slow waves and spikes that were recorded
during catatonic episodes [112, 117, 118]. Still in all, a number of early studies failed to find
any EEG abnormalities in patients with SCZ, e.g., Colony and Willis [119] did not find EEG
differences between their 1000 patients with SCZ and HCS. Abnormal EEG activity was
thought of by some to be the result of a premorbid head injury or the consequence of treatment
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with electric, insulin or chemical shock [120-122]. Sponheim et al. [123, 124] looked for
correlations to explain the variance in central EEG slow wave prevalence. Patterns found
include a relationship that favored winter birth over diagnosis. Patients with more negative
symptoms and larger ventricles had an increased likelihood of slow wave abnormalities. In a
landmark study, Shagass et al. [125] compared the EEGs of patients with SCZ with patients
with other psychiatric conditions and HCS. They reported a sensitivity of 50% and specificity
of 90% when patients with SCZ were compared to patients with Major Depression. Their work
was replicated by Gerez and Tello [126] who used a battery of 10 neurophysiological assess‐
ments and found 78% sensitivity and 85% specificity in classifying subjects. However,
Sponheim et al. [127] were unable to differentiate patients with SCZ from patients with
affective disorders using low frequency and alpha band EEG power, but they succeeded in
using these measures to differentiate SCZ from healthy subjects.
The intrinsic EEG of SCZ show augmented theta/delta and reduced alpha power (for example,
128, 129, 130). These abnormalities correlate with psychotic symptoms [131, 132], candidate
risk genotypes [129] and perithalamic ventricular volume [123]. Stimulus elicited low fre‐
quency (delta-alpha) phase locking and single trial power is also consistently reduced in SCZ
[133, 134], an effect that is highly heritable [135]. Importantly, thalamic aberrations have been
theorized to be relevant both for SCZ neuropathology and the expression of psychotic
symptoms [136, 137]. Klimesch, Sauseng [138] suggest that the heritability and consistency
across paradigms with regard to alpha/theta/delta oscillations should be a considered an EEG
marker of thalamocortical disconnectivity in SCZ.
Siekmeier and Stufflebeam [139] reviewed the resting state MEG literature for patients with
SCZ from 1993 to 2009 and found that there was overwhelming support (11/12 studies) for
increased theta (4-8 Hz) and delta (1-4 Hz) band oscillations in the temporal lobes of patients.
Of the studies that correlated oscillations with symptoms, there was a positive correlation (in
8/10 studies) between temporal lobe theta activity and positive symptoms.
As Boutros, Arfken [140] point out in their meta analysis that included 15 studies of sponta‐
neous EEG comparing subjects with SCZ to healthy subjects or non-schizophrenic psychotic
patients, a large number of statistically significant differences have been found. However, they
go on to note, no systematic effort using a large multicenter population has been made to
standardize an assessment battery. Further research in this area is warranted.
Task-related EEG in SCZ. In addition to resting state analyses, EEG oscillations can be examined
during specific phases of cognitive tasks. For example, Dias, Bickel [141] compared the
responses of patients with SCZ and HCS during the “AX” continuous performance task. In
this task, subjects are asked to attend to a sequence of individually presented letters and must
respond whenever they view a letter “A” followed by a letter “X,” and ignore all other
sequences. They found task-related event-related desynchronization that was reduced in the
beta band in the parieto-occipital cortex for sensory encoding in and reduced beta ERD in the
motor cortex during response preparation in patients with SCZ.
Gamma EEG oscillations in humans can be stimulated by a task, induced by a stimulus, or
evoked by repetitive inputs. In almost all cases, the amplitude of gamma is reduced in SCZ
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[142]. Gamma oscillations are thought to support the cognitive processes (e.g., attention,
memory, and learning) that are disrupted in SCZ, and these oscillations are thought to facilitate
communication between brain regions involved in SCZ. This has given rise to the hypothesis
that abnormalities in gamma oscillations may be one of the principal underlying problem in
patients with SCZ [143]. In support of this notion, many studies have found that patients with
SCZ to have decreased power or synchrony of gamma oscillations during responses to sensory
stimulation or cognitive tasks [144-149]. In some cases, these abnormalities correlate with the
severity of cognitive dysfunction or other symptoms [145, 148]. Despite the decreased power
or synchrony of gamma oscillations evoked by sensory stimuli or cognitive tasks, surprisingly,
auditory hallucinations are apparently linked with increased power or synchrony of beta and
gamma oscillations [150-152].
Functional connectivity studies in SCZ. As highlighted above by the opposing valence of the
changes in gamma oscillations in SCZ dependent on the task or setting, examination of a single
frequency range in a single brain region may yield insufficient information to be a reliable
biomarker of disease state. Bassett has suggested that functional connectivity disturbances
would make excellent diagnostic biomarkers for the disease [153]. The examination of
oscillations across brain regions using network theoretical tools borrowed from the social
sciences indeed provides support for “dysconnectivity” in patients with SCZ [153-165]. Allen,
Liu [166] demonstrated that cross-frequency interactions are abnormal and increased or
decreased in various regions in SCZ, with the strength of these interactions correlating with
genetic risk factors for the disease. Hinkley, Vinogradov [58] too performed resting-state
functional connectivity analysis of MEG data (alpha frequency band) with eyes closed in SCZ
patients and compared it with HCS. In SCZ patients, left prefrontal cortex as well as right
superior temporal cortex had decreased connectivity; at the same time functional connectivity
in left extrastriate cortex and in the right inferior prefrontal cortex were increased. Importantly,
these latter changes in the right inferior prefrontal cortex correlated with cognitive deficits in
SCZ patients. Important results were demonstrated by Higashima, Takeda [167], who by using
functional connectivity analysis approach of resting state EEG data, showed that there is a
functional disconnection between left and right frontal lobes in schizophrenia patients and
with normalization following antipsychotic treatment.
Most recently, Siebenhuhner, Weiss [154] examined the functional connectivity in 14 patients
with SCZ and 14 HCS using MEG during a working memory N-back task. Their analysis was
based on a multiresolution approach [159] which posits that neurophysiological alterations in
SCZ manifest as a complex hierarchy of signatures across univariate (individual sensor time
series or entropy), bivariate (co-variability between time series or functional connectivity), and
multivariate (patterns of co-variability across sensors or network topology) statistical meas‐
urements. In addition, they examined functional networks constructed from the interactions
between frequency bands. They found an extensive pattern of altered network structure and
network dynamics in patients with SCZ with disease-associated changes in brain function at
each level of analysis. Patients with SCZ had lower time series entropy and increased strength
of co-variability between time series. These findings were suggestive of decreased information
content of MEG signals and, perhaps surprisingly, hyperconnectivity between brain regions.
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theorized to be relevant both for SCZ neuropathology and the expression of psychotic
symptoms [136, 137]. Klimesch, Sauseng [138] suggest that the heritability and consistency
across paradigms with regard to alpha/theta/delta oscillations should be a considered an EEG
marker of thalamocortical disconnectivity in SCZ.
Siekmeier and Stufflebeam [139] reviewed the resting state MEG literature for patients with
SCZ from 1993 to 2009 and found that there was overwhelming support (11/12 studies) for
increased theta (4-8 Hz) and delta (1-4 Hz) band oscillations in the temporal lobes of patients.
Of the studies that correlated oscillations with symptoms, there was a positive correlation (in
8/10 studies) between temporal lobe theta activity and positive symptoms.
As Boutros, Arfken [140] point out in their meta analysis that included 15 studies of sponta‐
neous EEG comparing subjects with SCZ to healthy subjects or non-schizophrenic psychotic
patients, a large number of statistically significant differences have been found. However, they
go on to note, no systematic effort using a large multicenter population has been made to
standardize an assessment battery. Further research in this area is warranted.
Task-related EEG in SCZ. In addition to resting state analyses, EEG oscillations can be examined
during specific phases of cognitive tasks. For example, Dias, Bickel [141] compared the
responses of patients with SCZ and HCS during the “AX” continuous performance task. In
this task, subjects are asked to attend to a sequence of individually presented letters and must
respond whenever they view a letter “A” followed by a letter “X,” and ignore all other
sequences. They found task-related event-related desynchronization that was reduced in the
beta band in the parieto-occipital cortex for sensory encoding in and reduced beta ERD in the
motor cortex during response preparation in patients with SCZ.
Gamma EEG oscillations in humans can be stimulated by a task, induced by a stimulus, or
evoked by repetitive inputs. In almost all cases, the amplitude of gamma is reduced in SCZ
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that abnormalities in gamma oscillations may be one of the principal underlying problem in
patients with SCZ [143]. In support of this notion, many studies have found that patients with
SCZ to have decreased power or synchrony of gamma oscillations during responses to sensory
stimulation or cognitive tasks [144-149]. In some cases, these abnormalities correlate with the
severity of cognitive dysfunction or other symptoms [145, 148]. Despite the decreased power
or synchrony of gamma oscillations evoked by sensory stimuli or cognitive tasks, surprisingly,
auditory hallucinations are apparently linked with increased power or synchrony of beta and
gamma oscillations [150-152].
Functional connectivity studies in SCZ. As highlighted above by the opposing valence of the
changes in gamma oscillations in SCZ dependent on the task or setting, examination of a single
frequency range in a single brain region may yield insufficient information to be a reliable
biomarker of disease state. Bassett has suggested that functional connectivity disturbances
would make excellent diagnostic biomarkers for the disease [153]. The examination of
oscillations across brain regions using network theoretical tools borrowed from the social
sciences indeed provides support for “dysconnectivity” in patients with SCZ [153-165]. Allen,
Liu [166] demonstrated that cross-frequency interactions are abnormal and increased or
decreased in various regions in SCZ, with the strength of these interactions correlating with
genetic risk factors for the disease. Hinkley, Vinogradov [58] too performed resting-state
functional connectivity analysis of MEG data (alpha frequency band) with eyes closed in SCZ
patients and compared it with HCS. In SCZ patients, left prefrontal cortex as well as right
superior temporal cortex had decreased connectivity; at the same time functional connectivity
in left extrastriate cortex and in the right inferior prefrontal cortex were increased. Importantly,
these latter changes in the right inferior prefrontal cortex correlated with cognitive deficits in
SCZ patients. Important results were demonstrated by Higashima, Takeda [167], who by using
functional connectivity analysis approach of resting state EEG data, showed that there is a
functional disconnection between left and right frontal lobes in schizophrenia patients and
with normalization following antipsychotic treatment.
Most recently, Siebenhuhner, Weiss [154] examined the functional connectivity in 14 patients
with SCZ and 14 HCS using MEG during a working memory N-back task. Their analysis was
based on a multiresolution approach [159] which posits that neurophysiological alterations in
SCZ manifest as a complex hierarchy of signatures across univariate (individual sensor time
series or entropy), bivariate (co-variability between time series or functional connectivity), and
multivariate (patterns of co-variability across sensors or network topology) statistical meas‐
urements. In addition, they examined functional networks constructed from the interactions
between frequency bands. They found an extensive pattern of altered network structure and
network dynamics in patients with SCZ with disease-associated changes in brain function at
each level of analysis. Patients with SCZ had lower time series entropy and increased strength
of co-variability between time series. These findings were suggestive of decreased information
content of MEG signals and, perhaps surprisingly, hyperconnectivity between brain regions.
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They also found that patients with SCZ had deviant topological organization in binary sensor
networks and that network properties of cross-frequency associations between time series in
the beta and gamma bands differed between groups.
Overall, there is a strong potential of functional connectivity analysis to contribute to diagnosis
and treatment in SCZ since the essential feature of this disorder is thought to be one of
functional disconnection between brain regions.
In our review of the literature, we did not find any comparative studies that examined groups
of subjects with OCD and directly compared them with subjects with SCZ using spontaneous
EEG or MEG recordings or functional connectivity analyses. This work would be valuable to
aid in the development of diagnostic tests that differentiate between these conditions.
3.3. Information processing studied with event related potentials and fields (ERPs/ERFs)
Signal averaging helps extract event-related potentials (ERPs, recorded with EEG) and event-
related fields (ERFs, recorded with MEG), brain responses specifically related to the external
or internal stimuli, from background spontaneous brain activity. ERPs/ERFs studies contrib‐
uted significantly to understanding neural basis of both OCD and SCZ, and specifically the
neural origins of cognitive dysfunction of these disorders [168]. Moreover, some of ERPs are
proposed to be used as biomarkers of each of these specific disorders [169, 170]. For a summary
of information about ERP studies in OCD – see Table 2). The main ERP/ERF responses studied
in OCD and SCZ to date are related to early sensory processing, attention and performance
monitoring.
Information processing at the brain stem level. In OCD, it has been possible to demonstrate changes
in processing of auditory information stream already at the level of brain stem [85, 171]. For
instance, Nolfe et al. [171] by recording brain stem auditory evoked potentials (BAEPs) showed
that the interpeak latency of wave I-V was delayed, as well as amplitude of wave III was
reduced in OCD patients when compared with HCS.
At the same time, BAEPs results observed in SCZ are variable [172, 173], with some of them
including modified BAEPs among patients with positive symptoms [173]. More recently,
Kallstrand, Nehlstedt [174] has demonstrated significant interhemispheric differences in wave
II of BAEPs in SCZ patients when compares with HCS, which may imply that lateralized
abnormalities exist already on the initial level of auditory information processing in the brain.
Overall, information processing alterations at the brain stem level seem to be better docu‐
mented and more consistent in OCD patients rather than in patients with SCZ. Comparative
studies are needed to evaluate differences on the initial stages of auditory information
processing in the brain in these two patient groups.
Sustained neuronal entrainment to repetitive stimulation. A remarkable opportunity to study how
brain activity is synchronized with the external events is provided by steady-state evoked
responses (SSR) (for review, see 175]. SSRs can be evoked by the trains of repetitive auditory
(ASSR) [176], visual (VSSR) [177] or multi-sensory (audio-visual) [178] stimuli. At certain
frequencies, these stimuli entrain electromagnetic brain activity in such a way that an evoked
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EEG/MEG response is produced with its frequency components remaining constant in
amplitude and phase during the whole duration of sensory processing of presented stimuli.
Unlike conventional ERPs/ERFs, which are analyzed primarily in the time domain (by
calculating amplitude, latency, evaluating brain topography or estimating source localization
at each particular time point), SSRs are evaluated in the frequency domain. The use of such
responses may provide important insight into how internal brain activity and external
information are synchronized in OCD. However, no ASSR studies in OCD have been con‐
ducted to date.
The situation is different for SCZ. A number of authors demonstrated deficits in ASSR
generation in patients with SCZ as compared to HCS (for review, see 179]. The main findings
related to ASSR abnormality in SCZ are: [1] a reduction of spectral power to 40-Hz clicks, in
particular in the gamma-frequency band [180, 181]; [2] diminished inter-trial phase-locking
[182]; and [3] delayed phase synchrony [181] when compared with HCS. However, some data
points to the fact that under certain circumstances ASSRs may be augmented in SCZ [183] and
might be resting state related [184].These findings imply an impaired mechanism of neuronal
entrainment and possible alteration of synchronization/desynchronization mechanisms of
electromagnetic brain activity in SCZ patients, especially in gamma-frequency band.
3.4. Early sensory processing
Sensory processing is altered in both OCD and SCZ patients. In OCD, it is can often be observed
clinically as sensory intolerances or as a neurological soft sign [185]. A case series provide
examples of pediatric patients with OCD who were significantly impaired by a chief complaint
of a sensory intolerances to external environmental triggers, e.g. the sensation of oil on the
skin, the smell of fish, salad dressing or cheese, and the tension of shoelaces and underwear
[185-187]. In SCZ, on the other hand, the most frequent complaints of sensory changes are
responses to internal visual or auditory experiences [188, 189]. Involvement of primary
auditory areas in auditory hallucinations has been demonstrated in a number of studies with
SCZ patients [190-192].
Early sensory information processing studied ERPs/ERFs in OCD. Sensory intolerances can be
investigated on the neurophysiological level by studying early information processing with
auditory, visual, or tactile stimuli. Indeed, a number of ERP studies demonstrated that
processing of primary sensory information is altered in OCD patients. In our ERF study,
Korostenskaja, Harris [193] demonstrated increased early auditory evoked fields M100 and
M150 in the right hemisphere when compared to the right hemisphere in OCD subjects,
whereas in no significant asymmetry was found in HCS. This interhemispheric asymmetry
deserves detailed attention. This finding of increased auditory evoked response amplitudes
over the right hemisphere is supported by other studies. In this way, Oades, Zerbin [194] found
that OCD patients had higher N1 response amplitude in the right hemisphere, which was not
the case in HCS. Morault et al. [195] showed that in response to verbal auditory stimuli
presented in an “odd-ball” paradigm, patients with OCD had auditory evoked responses that
are more positive in the left hemisphere while healthy subjects have more positive responses
in the right hemisphere, however the opposite tendency was found for words when compared
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They also found that patients with SCZ had deviant topological organization in binary sensor
networks and that network properties of cross-frequency associations between time series in
the beta and gamma bands differed between groups.
Overall, there is a strong potential of functional connectivity analysis to contribute to diagnosis
and treatment in SCZ since the essential feature of this disorder is thought to be one of
functional disconnection between brain regions.
In our review of the literature, we did not find any comparative studies that examined groups
of subjects with OCD and directly compared them with subjects with SCZ using spontaneous
EEG or MEG recordings or functional connectivity analyses. This work would be valuable to
aid in the development of diagnostic tests that differentiate between these conditions.
3.3. Information processing studied with event related potentials and fields (ERPs/ERFs)
Signal averaging helps extract event-related potentials (ERPs, recorded with EEG) and event-
related fields (ERFs, recorded with MEG), brain responses specifically related to the external
or internal stimuli, from background spontaneous brain activity. ERPs/ERFs studies contrib‐
uted significantly to understanding neural basis of both OCD and SCZ, and specifically the
neural origins of cognitive dysfunction of these disorders [168]. Moreover, some of ERPs are
proposed to be used as biomarkers of each of these specific disorders [169, 170]. For a summary
of information about ERP studies in OCD – see Table 2). The main ERP/ERF responses studied
in OCD and SCZ to date are related to early sensory processing, attention and performance
monitoring.
Information processing at the brain stem level. In OCD, it has been possible to demonstrate changes
in processing of auditory information stream already at the level of brain stem [85, 171]. For
instance, Nolfe et al. [171] by recording brain stem auditory evoked potentials (BAEPs) showed
that the interpeak latency of wave I-V was delayed, as well as amplitude of wave III was
reduced in OCD patients when compared with HCS.
At the same time, BAEPs results observed in SCZ are variable [172, 173], with some of them
including modified BAEPs among patients with positive symptoms [173]. More recently,
Kallstrand, Nehlstedt [174] has demonstrated significant interhemispheric differences in wave
II of BAEPs in SCZ patients when compares with HCS, which may imply that lateralized
abnormalities exist already on the initial level of auditory information processing in the brain.
Overall, information processing alterations at the brain stem level seem to be better docu‐
mented and more consistent in OCD patients rather than in patients with SCZ. Comparative
studies are needed to evaluate differences on the initial stages of auditory information
processing in the brain in these two patient groups.
Sustained neuronal entrainment to repetitive stimulation. A remarkable opportunity to study how
brain activity is synchronized with the external events is provided by steady-state evoked
responses (SSR) (for review, see 175]. SSRs can be evoked by the trains of repetitive auditory
(ASSR) [176], visual (VSSR) [177] or multi-sensory (audio-visual) [178] stimuli. At certain
frequencies, these stimuli entrain electromagnetic brain activity in such a way that an evoked
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EEG/MEG response is produced with its frequency components remaining constant in
amplitude and phase during the whole duration of sensory processing of presented stimuli.
Unlike conventional ERPs/ERFs, which are analyzed primarily in the time domain (by
calculating amplitude, latency, evaluating brain topography or estimating source localization
at each particular time point), SSRs are evaluated in the frequency domain. The use of such
responses may provide important insight into how internal brain activity and external
information are synchronized in OCD. However, no ASSR studies in OCD have been con‐
ducted to date.
The situation is different for SCZ. A number of authors demonstrated deficits in ASSR
generation in patients with SCZ as compared to HCS (for review, see 179]. The main findings
related to ASSR abnormality in SCZ are: [1] a reduction of spectral power to 40-Hz clicks, in
particular in the gamma-frequency band [180, 181]; [2] diminished inter-trial phase-locking
[182]; and [3] delayed phase synchrony [181] when compared with HCS. However, some data
points to the fact that under certain circumstances ASSRs may be augmented in SCZ [183] and
might be resting state related [184].These findings imply an impaired mechanism of neuronal
entrainment and possible alteration of synchronization/desynchronization mechanisms of
electromagnetic brain activity in SCZ patients, especially in gamma-frequency band.
3.4. Early sensory processing
Sensory processing is altered in both OCD and SCZ patients. In OCD, it is can often be observed
clinically as sensory intolerances or as a neurological soft sign [185]. A case series provide
examples of pediatric patients with OCD who were significantly impaired by a chief complaint
of a sensory intolerances to external environmental triggers, e.g. the sensation of oil on the
skin, the smell of fish, salad dressing or cheese, and the tension of shoelaces and underwear
[185-187]. In SCZ, on the other hand, the most frequent complaints of sensory changes are
responses to internal visual or auditory experiences [188, 189]. Involvement of primary
auditory areas in auditory hallucinations has been demonstrated in a number of studies with
SCZ patients [190-192].
Early sensory information processing studied ERPs/ERFs in OCD. Sensory intolerances can be
investigated on the neurophysiological level by studying early information processing with
auditory, visual, or tactile stimuli. Indeed, a number of ERP studies demonstrated that
processing of primary sensory information is altered in OCD patients. In our ERF study,
Korostenskaja, Harris [193] demonstrated increased early auditory evoked fields M100 and
M150 in the right hemisphere when compared to the right hemisphere in OCD subjects,
whereas in no significant asymmetry was found in HCS. This interhemispheric asymmetry
deserves detailed attention. This finding of increased auditory evoked response amplitudes
over the right hemisphere is supported by other studies. In this way, Oades, Zerbin [194] found
that OCD patients had higher N1 response amplitude in the right hemisphere, which was not
the case in HCS. Morault et al. [195] showed that in response to verbal auditory stimuli
presented in an “odd-ball” paradigm, patients with OCD had auditory evoked responses that
are more positive in the left hemisphere while healthy subjects have more positive responses
in the right hemisphere, however the opposite tendency was found for words when compared
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with HCS [196]. In addition, mismatch negativity (MMN) responses shifted to the right in
subjects with OCD in a study by Oades et al. [194]. Gonçalves et al. [197] hypothesized that
patients with OCD have an inter-hemispheric functional imbalance that is responsible for their
symptoms and improves with treatment. Specifically, Serra et al. [85] suggested that patients
with OCD have insufficient fronto-caudal regulation of the left hemisphere.
There is a large literature of support for interhemispheric asymmetry, supposedly reflecting
interhemispheric dysfunction, in patients with OCD. Early evidence of such dysfunction in
OCD subjects comes from neuropsychological performance results, implicating the dominant
(left) hemisphere in the pathophysiology of OCD [86].
Anatomically, both gray matter and white matter interhemispheric differences have been
found. There is reduced cortical folding in the left anterior cingulate cortex in subjects with
OCD [198]. Using diffusion spectrum imaging, subjects with OCD were shown to have
decreased left-lateralized asymmetry of the anterior segment of the cingulum bundles
compared with HCS [199]. In pediatric patients with OCD, increased gray matter in the left
putamen and right lateral orbitofrontal cortex correlate with OCD symptom severity [200].
Electrophysiologically, left hyperactivity in the frontal region is supported by alpha frequency
bandwidth power increase [93]. Quantitative EEG analysis shows higher frequencies of slow-
wave bands and lower frequencies of alpha activity predominantly in left frontotemporal
regions in patients with OCD [82]. A left predominance of posterior frontal mid-temporal
theta-2 was reported by [201].
Interhemispheric neurochemical differences have been found as well. Patients with OCD have
higher binding ratios for the dopamine transporter in the left caudate and left putamen
compared with healthy subjects and a higher D2 receptor binding potential in the left caudate
[202, 203]. Interestingly, the P2 EEG response, which is considered to be an analogue of the
M150 magnetic response has been proposed to reflect DA and NA activities [204]. M150 may
reflect early stimulus evaluation and correspond to information inhibition processing in
cortical and subcortical structures [205-207]. Importantly, deficits in inhibitory control were
reported by a large number of studies on subjects with OCD [208, 209].
The data points to forward toward dissociation of early sensory processing deficits in auditory
and visual modalities. Thus, early (before 200 ms) processing alterations in OCD patients are
observed in the auditory, but not the visual, modality. For example, Savage, Weilburg [210]
found shorter latencies for N1 and P2 responses of the auditory evoked potential to binaural
clicks in adult OCD population. Importantly, the authors did not observe similar changes in
the visual modality, suggesting particular involvement of auditory system in the pathophysi‐
ology of OCD. Moreover, the study by Ciesielski et al. [211] demonstrated that processing
visual stimuli is altered in OCD subjects, only for the later but not the early stages of processing.
In this way, the early visual component (P130) did not differ between HCS and OCD patients,
but a later N220 component was reduced in amplitude and had shorter latency during the
cognitive task consisting of presented two different picture stimuli in OCD subjects. However,
one can expect changes already on the early stages of auditory processing in those OCD
subjects, whose sensory intolerances are related to visual stimuli. More studies are needed to
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understand diverging results of processing auditory and visual information streams in OCD
patients, including those with different types of sensory intolerances.
Early sensory information processing studied with ERPs/ERFs in SCZ. Although several studies
reported early sensory auditory processing deficits in SCZ patients, which can start as early
as after 15ms after the stimulus onset [212], the deficit at the early stages of visual information
processing is more prominent and specific to this particular disorder.
Hypoactivation of the magnocellular pathway in patients with SCZ and schizoaffective
disorder is a well documented phenomenon [213, 214]. Patients with SCZ have deficits at the
early stages of visual information processing, starting with reduction of P1 amplitude to red
light in VEPs [215] and following by reduced P1 during memory encoding and retrieval phases
[216]. Notably, only a reduction in visual P1 amplitude but not in the later N1 and P2 compo‐
nents was found in SCZ patients in a study by Koychev et al. [217], although the study by Oribe
et al. [218] demonstrated deficits on the late stages on visual information processing in SCZ
patients as well.
Abnormalities in the latency and/or amplitude of auditory evoked responses may represent
biomarkers of disease state in SCZ patients. Some investigators have shown that P2 component
abnormalities represent physiological markers for a positive-symptom subtype [219, 220].
Likewise, Roth et al. [221] demonstrated a negative correlation between P2 latency to frequency
tones and the delusion/hallucination score, and Laurent et al. [222] showed a negative
correlation between P2 latency and the PANSS positive syndrome score, whereas Shenton et
al. [223] found that reduced P2 amplitudes correlated significantly with a negative-symptom
subtype.
In regards to functional asymmetry in SCZ, it found to be abnormal (for review, see 224, 225).
Patients with SCZ failure to demonstrate functional asymmetry for language function.
Although the main alterations in asymmetrical responses are observed at later stages of
information processing, first changes can be detected as early as 150 ms [226]. Functional
asymmetry in SCZ has been proposed to be utilized as a possible biomarker of SCZ disorder
[227].
OCD and SCZ studies investigating early sensory information processing with ERPs/ERFs. No
comparative studies investigating early stages of sensory processing in OCD and SCZ patients
have been conducted to date. However, from the existing literature the following tendencies
emerge: [1] Early auditory information processing is altered more OCD than in SCZ. This might
be related to sensory intolerances that predominate in patients with OCD, more so than in
patients with in SCZ; In OCD, such changes in auditory information processing can start
already at the level of brain stem; [2] Early visual information processing is deficient in SCZ,
but not in OCD; this tendency changes during the late stages of the processing, during which
both OCD and SCZ show deficits. Comparative studies are needed for developing biomarkers
distinguishing OCD and SCZ based on early visual and auditory ERP responses. Functional
asymmetry can be a potential biomarker for these two psychiatric conditions.
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with HCS [196]. In addition, mismatch negativity (MMN) responses shifted to the right in
subjects with OCD in a study by Oades et al. [194]. Gonçalves et al. [197] hypothesized that
patients with OCD have an inter-hemispheric functional imbalance that is responsible for their
symptoms and improves with treatment. Specifically, Serra et al. [85] suggested that patients
with OCD have insufficient fronto-caudal regulation of the left hemisphere.
There is a large literature of support for interhemispheric asymmetry, supposedly reflecting
interhemispheric dysfunction, in patients with OCD. Early evidence of such dysfunction in
OCD subjects comes from neuropsychological performance results, implicating the dominant
(left) hemisphere in the pathophysiology of OCD [86].
Anatomically, both gray matter and white matter interhemispheric differences have been
found. There is reduced cortical folding in the left anterior cingulate cortex in subjects with
OCD [198]. Using diffusion spectrum imaging, subjects with OCD were shown to have
decreased left-lateralized asymmetry of the anterior segment of the cingulum bundles
compared with HCS [199]. In pediatric patients with OCD, increased gray matter in the left
putamen and right lateral orbitofrontal cortex correlate with OCD symptom severity [200].
Electrophysiologically, left hyperactivity in the frontal region is supported by alpha frequency
bandwidth power increase [93]. Quantitative EEG analysis shows higher frequencies of slow-
wave bands and lower frequencies of alpha activity predominantly in left frontotemporal
regions in patients with OCD [82]. A left predominance of posterior frontal mid-temporal
theta-2 was reported by [201].
Interhemispheric neurochemical differences have been found as well. Patients with OCD have
higher binding ratios for the dopamine transporter in the left caudate and left putamen
compared with healthy subjects and a higher D2 receptor binding potential in the left caudate
[202, 203]. Interestingly, the P2 EEG response, which is considered to be an analogue of the
M150 magnetic response has been proposed to reflect DA and NA activities [204]. M150 may
reflect early stimulus evaluation and correspond to information inhibition processing in
cortical and subcortical structures [205-207]. Importantly, deficits in inhibitory control were
reported by a large number of studies on subjects with OCD [208, 209].
The data points to forward toward dissociation of early sensory processing deficits in auditory
and visual modalities. Thus, early (before 200 ms) processing alterations in OCD patients are
observed in the auditory, but not the visual, modality. For example, Savage, Weilburg [210]
found shorter latencies for N1 and P2 responses of the auditory evoked potential to binaural
clicks in adult OCD population. Importantly, the authors did not observe similar changes in
the visual modality, suggesting particular involvement of auditory system in the pathophysi‐
ology of OCD. Moreover, the study by Ciesielski et al. [211] demonstrated that processing
visual stimuli is altered in OCD subjects, only for the later but not the early stages of processing.
In this way, the early visual component (P130) did not differ between HCS and OCD patients,
but a later N220 component was reduced in amplitude and had shorter latency during the
cognitive task consisting of presented two different picture stimuli in OCD subjects. However,
one can expect changes already on the early stages of auditory processing in those OCD
subjects, whose sensory intolerances are related to visual stimuli. More studies are needed to
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understand diverging results of processing auditory and visual information streams in OCD
patients, including those with different types of sensory intolerances.
Early sensory information processing studied with ERPs/ERFs in SCZ. Although several studies
reported early sensory auditory processing deficits in SCZ patients, which can start as early
as after 15ms after the stimulus onset [212], the deficit at the early stages of visual information
processing is more prominent and specific to this particular disorder.
Hypoactivation of the magnocellular pathway in patients with SCZ and schizoaffective
disorder is a well documented phenomenon [213, 214]. Patients with SCZ have deficits at the
early stages of visual information processing, starting with reduction of P1 amplitude to red
light in VEPs [215] and following by reduced P1 during memory encoding and retrieval phases
[216]. Notably, only a reduction in visual P1 amplitude but not in the later N1 and P2 compo‐
nents was found in SCZ patients in a study by Koychev et al. [217], although the study by Oribe
et al. [218] demonstrated deficits on the late stages on visual information processing in SCZ
patients as well.
Abnormalities in the latency and/or amplitude of auditory evoked responses may represent
biomarkers of disease state in SCZ patients. Some investigators have shown that P2 component
abnormalities represent physiological markers for a positive-symptom subtype [219, 220].
Likewise, Roth et al. [221] demonstrated a negative correlation between P2 latency to frequency
tones and the delusion/hallucination score, and Laurent et al. [222] showed a negative
correlation between P2 latency and the PANSS positive syndrome score, whereas Shenton et
al. [223] found that reduced P2 amplitudes correlated significantly with a negative-symptom
subtype.
In regards to functional asymmetry in SCZ, it found to be abnormal (for review, see 224, 225).
Patients with SCZ failure to demonstrate functional asymmetry for language function.
Although the main alterations in asymmetrical responses are observed at later stages of
information processing, first changes can be detected as early as 150 ms [226]. Functional
asymmetry in SCZ has been proposed to be utilized as a possible biomarker of SCZ disorder
[227].
OCD and SCZ studies investigating early sensory information processing with ERPs/ERFs. No
comparative studies investigating early stages of sensory processing in OCD and SCZ patients
have been conducted to date. However, from the existing literature the following tendencies
emerge: [1] Early auditory information processing is altered more OCD than in SCZ. This might
be related to sensory intolerances that predominate in patients with OCD, more so than in
patients with in SCZ; In OCD, such changes in auditory information processing can start
already at the level of brain stem; [2] Early visual information processing is deficient in SCZ,
but not in OCD; this tendency changes during the late stages of the processing, during which
both OCD and SCZ show deficits. Comparative studies are needed for developing biomarkers
distinguishing OCD and SCZ based on early visual and auditory ERP responses. Functional
asymmetry can be a potential biomarker for these two psychiatric conditions.
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3.5. Change detection processing
The auditory MMN, which can also be detected magnetically (MMNm), was first reported by
Näätänen et al. [228] (see also, [229]). It is a negative ERP component elicited by any change
in the repetitive auditory stimulus presentation (such as changes in frequency, duration,
intensity, location) The MMN peaks at about 100-200 ms from change onset (for review, see
[230]). It is suggested that the MMN represents a sensory memory trace formation process
related to the evaluation of presented stimuli. The MMN could provide information about the
amount of neuronal resources participating in automatic (involuntary) change-detection
processes [231].
The change detection mechanism studied with MMN/MMNm in OCD. There are very few studies,
to date, that investigate the change-detection mechanism in OCD patients. Most studies do not
demonstrate significant differences between OCD patients relatively to HCS. For example,
Towey et al. [232] did not find any alterations in MMN responses in OCD patients when
compared with HCS. Nevertheless, they demonstrated differences between OCD patients and
HCS in the later ERP components. It must be mentioned, though, that MMN in the above
mentioned study was not elicited in the passive listening condition – without active partici‐
pation, which is the most established approach to record this evoked response. Rather, the
study participants were asked to pay active attention to deviant stimuli. Therefore, the study
was addressing active rather than passive change-detection processes. More relevant infor‐
mation was obtained in a comparative MMN study between OCD and SCZ groups. This will
be discussed below.
Perhaps it is unlikely for there to be abnormalities in the MMN in patients with OCD given its
proposed neurochemical basis. The neurochemical dysfunction in OCD is thought by many
to involve, deficits in serotonin (5-HT). Some studies confirm 5-HT involvement in MMN
generation [233, 234]. However, it seems that NMDA-related changes have more influence on
MMN generation than the serotonergic influences [235]. Therefore, one may not expect strong
pronounced deficits in MMN generation in OCD patients.
Change detection mechanism studied with MMN/MMNm in SCZ. Unlike studies of MMN in OCD,
the literature on MMN research in SCZ is very extensive. Both MMN and MMNm have proved
to be particularly valuable in SCZ research (for review, see [236], [237]). The first report
concerning MMN deficiency in SCZ was made by Shelley et al. [238]. Patients with SCZ show
abnormal MMN and MMNm responses (for review, see [236], [239]) and the most significant
finding is the reduction of the MMN amplitude [239, 240]. This is also shown in the magnetic
MMN counterpart [241]. Important interhemispheric differences were also demonstrated in
MMN response amplitude. Patients with SCZ seem to have lower MMN responses over the
left hemisphere when compared with HCS [241, 242]. This corresponds well with MRI studies
showing that SCZ patients have structural brain abnormalities with reduced grey matter
density in the left posterior superior temporal gyrus, the medial temporal lobe structures [243],
the left inferior parietal lobule, the cingulate gyrus, the left middle frontal gyrus, the left
hippocampal gyrus and the right superior frontal cortex [244]. Moreover, the MMN amplitude
in patients with SCZ correlates with the volume of primary auditory cortex (Heschl gyrus)
[245]. In addition, several studies reported correlations between negative symptoms and the
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MMN amplitude [240, 246]. More recently, studies of MMN in schizophrenia, utilize a
functional connectivity analysis approach [247]. These authors demonstrated that cortical
functional connectivity is impaired during “odd-ball” task eliciting MMN response. Imaginary
coherence indexes measured from EEG activity in gamma frequency band between different
brain regions correlated with hallucinatory behavior and clinical positive and negative
symptom scores.
It is important to mention a relation between MMN generation and dysfunctional neurotrans‐
mission in SCZ. Glutamate NMDA receptors, which are thought to be implicated in patho‐
physiology of SCZ, are crucially involved in MMN generation [248, 249]. Another
neurotransmitter system implicated in pathophysiology of SCZ was demonstrated to have
significant inhibitory GABA influences on MMN generation as well [250, 251].
Comparative OCD and SCZ studies investigating change detection mechanism with MMN/MMNm.
In their comparative study, Oades et al. [194] contrasted MMN findings between paranoid-
hallucinatory and non-paranoid schizophrenia patients with OCD and HCS. Main differences
were found in MMN scalp distribution. In this way, MMN amplitudes were higher on the right
in OCD patients, whereas in a group of paranoid SCZ patients they were distributed bilaterally
and in the group of non-paranoid SCZ patients they have shifted posteriorly. Right-hemi‐
spheric MMN amplitude asymmetry in OCD group is consistent with our previous findings
of increased amplitudes of both M100 and M150 components over the right hemisphere in
OCD patients [193]. In their study Oades et al. [252] found MMN reduced at frontal and
increased at temporal sites of the brain in patients with SCZ in both passive and active attention
conditions. Usually expected increase of MMN amplitude with switch to the active condition
was observed only in OCD and HCS groups, but not in the SCZ group. Overall, both studies
on neurochemical regulation of MMN and comparative studies between MMN responses in
OCD and SCZ suggest the possibility of using the MMN as a marker to differentiate these
disorders.
3.6. Attention
A specially designed “distraction” paradigm utilizes novel (distractive) stimuli to elicit P3a
response [253, 254], which is considered to reflect reorienting of involuntary attention towards
the novel (distracting) event. The P3a in EEG recordings is a positive response, peaking around
250-350 ms after stimulus onset [255]. It follows the processes reflected by it preceding MMN
response [254]. The frontal lobes seem to be necessary for P3a generation, as P3a amplitude
was significantly diminished in the presence of distracting stimuli in patients with frontal lobe
lesions [256]. Similar to MMN, the P3a response can be recorded with MEG (P3am) [257, 258]
The P300 (or P3) first described by Sutton et al. [259] is a positive potential occurring at an
approximate latency of 300 ms and is evoked by the presentation of a deviant target (rare)
stimulus embedded among irrelevant (frequent) stimuli, while the subject is actively reacting
(pressing a button or mentally counting) to the target stimuli [260]. Classical P300 response
requires positive response to the infrequent stimulus of an “odd-ball” task, has a parietal scalp
maximum, and sometimes is referred to as P3b [261]. P300 is usually interpreted as an
electrophysiological correlate of active attention processes and working memory [262]. The
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3.5. Change detection processing
The auditory MMN, which can also be detected magnetically (MMNm), was first reported by
Näätänen et al. [228] (see also, [229]). It is a negative ERP component elicited by any change
in the repetitive auditory stimulus presentation (such as changes in frequency, duration,
intensity, location) The MMN peaks at about 100-200 ms from change onset (for review, see
[230]). It is suggested that the MMN represents a sensory memory trace formation process
related to the evaluation of presented stimuli. The MMN could provide information about the
amount of neuronal resources participating in automatic (involuntary) change-detection
processes [231].
The change detection mechanism studied with MMN/MMNm in OCD. There are very few studies,
to date, that investigate the change-detection mechanism in OCD patients. Most studies do not
demonstrate significant differences between OCD patients relatively to HCS. For example,
Towey et al. [232] did not find any alterations in MMN responses in OCD patients when
compared with HCS. Nevertheless, they demonstrated differences between OCD patients and
HCS in the later ERP components. It must be mentioned, though, that MMN in the above
mentioned study was not elicited in the passive listening condition – without active partici‐
pation, which is the most established approach to record this evoked response. Rather, the
study participants were asked to pay active attention to deviant stimuli. Therefore, the study
was addressing active rather than passive change-detection processes. More relevant infor‐
mation was obtained in a comparative MMN study between OCD and SCZ groups. This will
be discussed below.
Perhaps it is unlikely for there to be abnormalities in the MMN in patients with OCD given its
proposed neurochemical basis. The neurochemical dysfunction in OCD is thought by many
to involve, deficits in serotonin (5-HT). Some studies confirm 5-HT involvement in MMN
generation [233, 234]. However, it seems that NMDA-related changes have more influence on
MMN generation than the serotonergic influences [235]. Therefore, one may not expect strong
pronounced deficits in MMN generation in OCD patients.
Change detection mechanism studied with MMN/MMNm in SCZ. Unlike studies of MMN in OCD,
the literature on MMN research in SCZ is very extensive. Both MMN and MMNm have proved
to be particularly valuable in SCZ research (for review, see [236], [237]). The first report
concerning MMN deficiency in SCZ was made by Shelley et al. [238]. Patients with SCZ show
abnormal MMN and MMNm responses (for review, see [236], [239]) and the most significant
finding is the reduction of the MMN amplitude [239, 240]. This is also shown in the magnetic
MMN counterpart [241]. Important interhemispheric differences were also demonstrated in
MMN response amplitude. Patients with SCZ seem to have lower MMN responses over the
left hemisphere when compared with HCS [241, 242]. This corresponds well with MRI studies
showing that SCZ patients have structural brain abnormalities with reduced grey matter
density in the left posterior superior temporal gyrus, the medial temporal lobe structures [243],
the left inferior parietal lobule, the cingulate gyrus, the left middle frontal gyrus, the left
hippocampal gyrus and the right superior frontal cortex [244]. Moreover, the MMN amplitude
in patients with SCZ correlates with the volume of primary auditory cortex (Heschl gyrus)
[245]. In addition, several studies reported correlations between negative symptoms and the
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MMN amplitude [240, 246]. More recently, studies of MMN in schizophrenia, utilize a
functional connectivity analysis approach [247]. These authors demonstrated that cortical
functional connectivity is impaired during “odd-ball” task eliciting MMN response. Imaginary
coherence indexes measured from EEG activity in gamma frequency band between different
brain regions correlated with hallucinatory behavior and clinical positive and negative
symptom scores.
It is important to mention a relation between MMN generation and dysfunctional neurotrans‐
mission in SCZ. Glutamate NMDA receptors, which are thought to be implicated in patho‐
physiology of SCZ, are crucially involved in MMN generation [248, 249]. Another
neurotransmitter system implicated in pathophysiology of SCZ was demonstrated to have
significant inhibitory GABA influences on MMN generation as well [250, 251].
Comparative OCD and SCZ studies investigating change detection mechanism with MMN/MMNm.
In their comparative study, Oades et al. [194] contrasted MMN findings between paranoid-
hallucinatory and non-paranoid schizophrenia patients with OCD and HCS. Main differences
were found in MMN scalp distribution. In this way, MMN amplitudes were higher on the right
in OCD patients, whereas in a group of paranoid SCZ patients they were distributed bilaterally
and in the group of non-paranoid SCZ patients they have shifted posteriorly. Right-hemi‐
spheric MMN amplitude asymmetry in OCD group is consistent with our previous findings
of increased amplitudes of both M100 and M150 components over the right hemisphere in
OCD patients [193]. In their study Oades et al. [252] found MMN reduced at frontal and
increased at temporal sites of the brain in patients with SCZ in both passive and active attention
conditions. Usually expected increase of MMN amplitude with switch to the active condition
was observed only in OCD and HCS groups, but not in the SCZ group. Overall, both studies
on neurochemical regulation of MMN and comparative studies between MMN responses in
OCD and SCZ suggest the possibility of using the MMN as a marker to differentiate these
disorders.
3.6. Attention
A specially designed “distraction” paradigm utilizes novel (distractive) stimuli to elicit P3a
response [253, 254], which is considered to reflect reorienting of involuntary attention towards
the novel (distracting) event. The P3a in EEG recordings is a positive response, peaking around
250-350 ms after stimulus onset [255]. It follows the processes reflected by it preceding MMN
response [254]. The frontal lobes seem to be necessary for P3a generation, as P3a amplitude
was significantly diminished in the presence of distracting stimuli in patients with frontal lobe
lesions [256]. Similar to MMN, the P3a response can be recorded with MEG (P3am) [257, 258]
The P300 (or P3) first described by Sutton et al. [259] is a positive potential occurring at an
approximate latency of 300 ms and is evoked by the presentation of a deviant target (rare)
stimulus embedded among irrelevant (frequent) stimuli, while the subject is actively reacting
(pressing a button or mentally counting) to the target stimuli [260]. Classical P300 response
requires positive response to the infrequent stimulus of an “odd-ball” task, has a parietal scalp
maximum, and sometimes is referred to as P3b [261]. P300 is usually interpreted as an
electrophysiological correlate of active attention processes and working memory [262]. The
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latency of P300 could correspond to the speed of cognitive processing or to that of stimulus
classification [263]. It is notable that the P300 latency is negatively correlated with mental
function in normal subjects, such that shorter latencies are related to superior cognitive
performance [264].
Attention studied with P300 in OCD. There are few studies regarding novelty detection reflected
in P3a response in patients with OCD. The only study we were able to find to date showed
increased in novelty P3a amplitude in OCD patients compared with HCS [265]. It was
interpreted by authors as “indicator of an enhanced cortical orienting response implicating
stronger involuntary shifts of attention.” Interestingly, the emotional context (neutral or
negative) of stimulus presentation did not have any influence on P3a generation. It is worth
mentioning here two other studies by Gohle, Juckel [266] and Mavrogiorgou, Juckel [267], who
separated P3a and P3b subcomponents from P300 response elicited during classical “odd-ball”
paradigm with one standard and one deviant stimuli in OCD patients. Study design did not
utilize novel distracting stimuli here to elicit novelty P3a response.
Reports about alteration in P300 response in OCD patients are variable. Reduced P300
amplitude was demonstrated by Beech, Ciesielski [268] as well as by Towey, Tenke [232] in
response to attended target stimuli. At the same time an increase in P300 amplitude was
reported by other research groups [266, 267]. Interestingly, Towey, Tenke [232] observed
differences in P300 amplitudes between two conditions – attended and unattended stimuli.
P300 amplitude for unattended non-target stimuli was increased; at the same time it was
decreased in response to attended targets. These authors speculated that these findings may
imply abnormal allocation of attentional resources from relevant information (decreased P300
amplitude to the attended target stimulus) to irrelevant details (increased P300 amplitude to
unattended non-target stimuli). Interestingly, the degree of P300 increase was shown to
separate future treatment responders from non-responders [195]. Unlike the variable findings
regarding P300 amplitude in OCD, the findings of changes in P300 latency are very consistent
among the research groups. All studies show reduced P300 component latency in the OCD
group when compared to HCS [195, 211, 267-270] (see also Table 2). This is very important
finding demonstrating cortical hyperarousal associated with active attention processes and
faster cognitive processes in OCD patients.
Attention studied with P300 in SCZ. Similar to MMN response, most of the published studies
demonstrate decrease in P3a amplitude in SCZ patients when compared with HCS [271-273].
Reduction in P3a amplitude is strongly associated with clinical symptomatology, such as
negative SCZ symptoms [272]. P3a reduction in SCZ is a well established phenomena and has
also been confirmed in nonhuman primate model [274]. Together with MMN response, P3a
changes are excellent proposals for biomarkers of SCZ [275, 276].
Patients with SCZ also show reduction of P300 amplitude, particularly in an auditory task
[277-279]. Roth and Cannon [280] were the first to report reduced P300 amplitude in SCZ. Since
that time, the reduction of P300 amplitude has been demonstrated in various experimental
paradigms in acute, remitted, medicated and medication-free patients [277, 281-284]. Patients
with SCZ also exhibit a delayed P300 latency [285, 286]. These effects are robust and inde‐
pendent of medication, gender, or clinical state at the time of testing. A positive correlation
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between the duration of schizophrenia illness and P300 latency was demonstrated [287]. A
parietal P300 amplitude reduction in SCZhas been linkedto poorer performance on neuropsy‐
chological tests of memory, whereas frontal P300 amplitude reduction has been linked to
impaired selective attention [288]. Notably, the relationship between neural P300 generator
and clinical symptomatology was observed. In this way, Kim, Shim [289] demonstrated that
the decreased P300 source activation in the middle temporal gyrus, posterior cingulate,
precuneus, and superior occipital gyrus negatively correlated with negative symptom scores.
Comparative OCD and SCZ studies investigating attention processes with P300. Several comparative
studies were conducted. Kim, Kang [290] compared P300 responses elicited by an auditory
“odd-ball” paradigm in OCD, SCZ and a group of HCS; these authors also correlated neuro‐
physiological results with neuropsychological scores. In this study, the P300 amplitude was
smaller in both OCD and SCZ groups when compared with HCS. However, the differences in
correlation between deficits in P300 generation and cognitive performance scores were
observed in OCD and SCZ. Whereas P300-related cognitive deficits in OCD patients were
localized and mostly related to controlled attention and self-guided behavior, the P300-
associated cognitive deficits in SCZ were generalized, implying wide-range impairment. A
more recent study by Pallanti, Castellini [291] explored not only differences in P300 responses
between OCD and SCZ groups, but it also looked at SCZ patients exhibiting OCD behavior
(Schizo-OCD patients). This group of patients demonstrated a distinct pattern of P300respons‐
es: Unlike OCD patients there was no differences in P300 responses between non-target and
target conditions; unlike HCS there was elevated P300 amplitudes in the target condition and
reduced P300 amplitudes in non-target condition. Thus it was possible to distinguish the SCZ-
OCD patients from both the OCD and SCZ groups. These authors argue that using a neuro‐
physiological approach one can separate a distinct clinical entity of Schizo-OCD from OCD
and SCZ.
Overall, ERPs reflecting attention-influenced cognitive processes can be potential biomarkers
distinguishing OCD and SCZ. Increased P3a amplitude in OCD and decreased P3a amplitude
in SCZ, shorter P300 latencies in OCD and longer P300 latencies in SCZ may all be good
candidates for making such a distinction. In addition, the, P300 can be used as a potential
biomarker to distinguish Schizo-OCD subtype from both OCD and SCZ.
3.7. Action monitoring
Acton monitoring processes can be assessed by error related negativity (ERN, [292]) the
negative portion of an event related potential that occurs 50-100 ms after a subject gives an
incorrect response. The ERN is usually followed by a positive deflection or error positivity (PE,
[293], [294]) and occurs 200-500 ms after an incorrect response.
Action monitoring studied with event-related negativity (ERN) in OCD. Patients with OCD are
thought to monitor their actions excessively. Electrophysiological support for this notion
comes from ERN measurements. Several studies have looked for error-related deviations in
brain activity in subjects with OCD. Multiple studies have found greater ERN amplitude in
subjects with OCD compared with healthy controls [292, 295-299]. Interestingly, Santesso et
al., [300] expanded this finding to children. However, Nieuwenhuis et al. [301] did not find
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latency of P300 could correspond to the speed of cognitive processing or to that of stimulus
classification [263]. It is notable that the P300 latency is negatively correlated with mental
function in normal subjects, such that shorter latencies are related to superior cognitive
performance [264].
Attention studied with P300 in OCD. There are few studies regarding novelty detection reflected
in P3a response in patients with OCD. The only study we were able to find to date showed
increased in novelty P3a amplitude in OCD patients compared with HCS [265]. It was
interpreted by authors as “indicator of an enhanced cortical orienting response implicating
stronger involuntary shifts of attention.” Interestingly, the emotional context (neutral or
negative) of stimulus presentation did not have any influence on P3a generation. It is worth
mentioning here two other studies by Gohle, Juckel [266] and Mavrogiorgou, Juckel [267], who
separated P3a and P3b subcomponents from P300 response elicited during classical “odd-ball”
paradigm with one standard and one deviant stimuli in OCD patients. Study design did not
utilize novel distracting stimuli here to elicit novelty P3a response.
Reports about alteration in P300 response in OCD patients are variable. Reduced P300
amplitude was demonstrated by Beech, Ciesielski [268] as well as by Towey, Tenke [232] in
response to attended target stimuli. At the same time an increase in P300 amplitude was
reported by other research groups [266, 267]. Interestingly, Towey, Tenke [232] observed
differences in P300 amplitudes between two conditions – attended and unattended stimuli.
P300 amplitude for unattended non-target stimuli was increased; at the same time it was
decreased in response to attended targets. These authors speculated that these findings may
imply abnormal allocation of attentional resources from relevant information (decreased P300
amplitude to the attended target stimulus) to irrelevant details (increased P300 amplitude to
unattended non-target stimuli). Interestingly, the degree of P300 increase was shown to
separate future treatment responders from non-responders [195]. Unlike the variable findings
regarding P300 amplitude in OCD, the findings of changes in P300 latency are very consistent
among the research groups. All studies show reduced P300 component latency in the OCD
group when compared to HCS [195, 211, 267-270] (see also Table 2). This is very important
finding demonstrating cortical hyperarousal associated with active attention processes and
faster cognitive processes in OCD patients.
Attention studied with P300 in SCZ. Similar to MMN response, most of the published studies
demonstrate decrease in P3a amplitude in SCZ patients when compared with HCS [271-273].
Reduction in P3a amplitude is strongly associated with clinical symptomatology, such as
negative SCZ symptoms [272]. P3a reduction in SCZ is a well established phenomena and has
also been confirmed in nonhuman primate model [274]. Together with MMN response, P3a
changes are excellent proposals for biomarkers of SCZ [275, 276].
Patients with SCZ also show reduction of P300 amplitude, particularly in an auditory task
[277-279]. Roth and Cannon [280] were the first to report reduced P300 amplitude in SCZ. Since
that time, the reduction of P300 amplitude has been demonstrated in various experimental
paradigms in acute, remitted, medicated and medication-free patients [277, 281-284]. Patients
with SCZ also exhibit a delayed P300 latency [285, 286]. These effects are robust and inde‐
pendent of medication, gender, or clinical state at the time of testing. A positive correlation
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between the duration of schizophrenia illness and P300 latency was demonstrated [287]. A
parietal P300 amplitude reduction in SCZhas been linkedto poorer performance on neuropsy‐
chological tests of memory, whereas frontal P300 amplitude reduction has been linked to
impaired selective attention [288]. Notably, the relationship between neural P300 generator
and clinical symptomatology was observed. In this way, Kim, Shim [289] demonstrated that
the decreased P300 source activation in the middle temporal gyrus, posterior cingulate,
precuneus, and superior occipital gyrus negatively correlated with negative symptom scores.
Comparative OCD and SCZ studies investigating attention processes with P300. Several comparative
studies were conducted. Kim, Kang [290] compared P300 responses elicited by an auditory
“odd-ball” paradigm in OCD, SCZ and a group of HCS; these authors also correlated neuro‐
physiological results with neuropsychological scores. In this study, the P300 amplitude was
smaller in both OCD and SCZ groups when compared with HCS. However, the differences in
correlation between deficits in P300 generation and cognitive performance scores were
observed in OCD and SCZ. Whereas P300-related cognitive deficits in OCD patients were
localized and mostly related to controlled attention and self-guided behavior, the P300-
associated cognitive deficits in SCZ were generalized, implying wide-range impairment. A
more recent study by Pallanti, Castellini [291] explored not only differences in P300 responses
between OCD and SCZ groups, but it also looked at SCZ patients exhibiting OCD behavior
(Schizo-OCD patients). This group of patients demonstrated a distinct pattern of P300respons‐
es: Unlike OCD patients there was no differences in P300 responses between non-target and
target conditions; unlike HCS there was elevated P300 amplitudes in the target condition and
reduced P300 amplitudes in non-target condition. Thus it was possible to distinguish the SCZ-
OCD patients from both the OCD and SCZ groups. These authors argue that using a neuro‐
physiological approach one can separate a distinct clinical entity of Schizo-OCD from OCD
and SCZ.
Overall, ERPs reflecting attention-influenced cognitive processes can be potential biomarkers
distinguishing OCD and SCZ. Increased P3a amplitude in OCD and decreased P3a amplitude
in SCZ, shorter P300 latencies in OCD and longer P300 latencies in SCZ may all be good
candidates for making such a distinction. In addition, the, P300 can be used as a potential
biomarker to distinguish Schizo-OCD subtype from both OCD and SCZ.
3.7. Action monitoring
Acton monitoring processes can be assessed by error related negativity (ERN, [292]) the
negative portion of an event related potential that occurs 50-100 ms after a subject gives an
incorrect response. The ERN is usually followed by a positive deflection or error positivity (PE,
[293], [294]) and occurs 200-500 ms after an incorrect response.
Action monitoring studied with event-related negativity (ERN) in OCD. Patients with OCD are
thought to monitor their actions excessively. Electrophysiological support for this notion
comes from ERN measurements. Several studies have looked for error-related deviations in
brain activity in subjects with OCD. Multiple studies have found greater ERN amplitude in
subjects with OCD compared with healthy controls [292, 295-299]. Interestingly, Santesso et
al., [300] expanded this finding to children. However, Nieuwenhuis et al. [301] did not find
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enhanced error-related activity in patients with OCD nor did Grundler et al. [296] in a
population with subclinical obsessive compulsive symptoms using a probabilistic learning
task. Yet, Grundler et al. [296] did find larger ERNs when using a flanker task. This finding of
a differential task-dependent response was replicated by Endrass et al. [302].
Action monitoring studied with event-related negativity (ERN) in SCZ. In contradistinction to the
results observed in OCD patients, the amplitude of ERN component related to action moni‐
toring in SCZ patients is reduced [303-305]. This reduction was found to be associated with
negative symptom severity and poorer real-world functioning (indicated by unemployment
and re-hospitalization over 10 years of illness) in a study by Foti, Kotov [306]. Authors
hypothesized that their results may represent decreased motivation to pursue goal-directed
behavior, which is thought to underlie the exhibition of negative symptoms in SCZ.
Comparative studies on action monitoring with event-related negativity (ERN) between OCD and
SCZ. To our knowledge, no comparative OCD-SCZ studies assessing action monitoring
behavior with its neurophysiological analogue – ERN have been performed to date. From the
individual reports of ERP studies in these two patient groups, it is evident that there are major
differences in ERN generation. These differences includeincreased ERN amplitude in OCD
and decreased ERN response in SCZ. These differences in ERN may be helpful as further
biomarkers of disease.
In conclusion, there are obvious reasons to believe that neurophysiological markers distin‐
guishing OCD and SCZ can be found. The main candidates are P3a and P3b responses as well
as ERN. Additional studies are needed to determine whether there are changes in MMN in
OCD. Future studies are recommended to dissociate deficits at the early stages of auditory and
visual processes in OCD and SCZ. New studies evaluating entraining mechanisms with SSR
in OCD are warranted. A special emphasis should be placed on examining developmental
differences in the neurophysiological responses in OCD. The use of MEG is highly recom‐
mended in OCD group, as it can provide not only time-related information, but also localize
the activity of interest in the space domain.
Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
Brain stem function
Brain stem
function
BAEPs to clicks
50 OCD; 50 anxiety disorder;
25 HCS
/adults; mean 33 ± 8 yo/
wave I–V
wave III
interpeak L↑
A↓
Nolfe et al.
[171]
Early sensory processing (pre-attentive)
Early visual
processing
VEPs to flash
8 OCD; 8 HCS
/adults; mean a
ge 36.5 yo/
P130 -
Ciesielski et
al. [211]
Early, auditory,
visual and
AEPs to binaural clicks,
VEPs to checkerboard
flashes, SEPs
14 OCD; 14 neurotics; 14
HCS
/adults/
Comparison
with HCS:
A↑
A↓
A↓
Shagass et
al. [324]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
somatosensory
processing
Somatosensory
P60
Visual N75
Auditory P50
Auditory P85
L↑
Early
somatosensory
processing
SEPs
14 OCD; 28 neurotics; 99
HCS; 49 chronic SCZ; 27
“other” SCZ; 20 latent SCZ;
42 major depressive
/adults; 23-48 yo/
Comparison
with HCS:
N60
P90
N130
A↑
A↓
A↓
Shagass et
al. [325]
Early auditory and
visual sensory
processing
AEPs to tone bursts and
VEPs to flash
50 OCD; 40 HCS
/no age-related information
was provided by authors/
Auditory and
visual
P1
N1
P2
-
Khanna et
al. [326]
Early auditory and
visual sensory
processing
AEPs to binaural clicks
and VEPs to flash
15 OCD (unmedicated); 30
HCS
/adults; 35.6 ± 9.9/
Auditory N1
Auditory P2
Visual N1
Visual P2
L↓
L↓
-
-
Savage et
al. [210]
BAEPs to
50 OCD; 50 anxiety disorder;
25 HCS
/adults; mean 33 ± 8 yo/
wave I–V
wave III
Early auditory
sensory processing
AEFs to binaural clicks
10 OCD; 10 HCS /youth;
8-13 yo/
M70
M100
M150
-
L↑
-
Korostensk
aja et al.
[193]*
Brain activity synchronization with external events (pre-attentive)
Synchronation of
brain activity with
external periodic
sensory
stimulation
ASSR to repetitively
presented trains of
identical clicks
No studies reported to date in OCD patients; for comparison, see review
section of ASSR studies in schizophrenia
Change detection (automatic attention processes)
Automatic
response to a
change in external
stimuli
Auditory MMN response
to deviant tones
interspersed among
frequent tones. No task
execution required
Only limited number of studies performed - see comparative OCD/SCZ
section; for comparison, see also review section of MMN studies in
schizophrenia
Novelty detection (involuntary attention switch)
Processing of
novel
AEPs elicited in response
to auditory novelty “odd-
ball” task with irrelevant
20 OCD; 20 HCS
/adults; 32.8 ± 9.9 yo/
P3a A↑
Ischebeck
et al. [265]
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enhanced error-related activity in patients with OCD nor did Grundler et al. [296] in a
population with subclinical obsessive compulsive symptoms using a probabilistic learning
task. Yet, Grundler et al. [296] did find larger ERNs when using a flanker task. This finding of
a differential task-dependent response was replicated by Endrass et al. [302].
Action monitoring studied with event-related negativity (ERN) in SCZ. In contradistinction to the
results observed in OCD patients, the amplitude of ERN component related to action moni‐
toring in SCZ patients is reduced [303-305]. This reduction was found to be associated with
negative symptom severity and poorer real-world functioning (indicated by unemployment
and re-hospitalization over 10 years of illness) in a study by Foti, Kotov [306]. Authors
hypothesized that their results may represent decreased motivation to pursue goal-directed
behavior, which is thought to underlie the exhibition of negative symptoms in SCZ.
Comparative studies on action monitoring with event-related negativity (ERN) between OCD and
SCZ. To our knowledge, no comparative OCD-SCZ studies assessing action monitoring
behavior with its neurophysiological analogue – ERN have been performed to date. From the
individual reports of ERP studies in these two patient groups, it is evident that there are major
differences in ERN generation. These differences includeincreased ERN amplitude in OCD
and decreased ERN response in SCZ. These differences in ERN may be helpful as further
biomarkers of disease.
In conclusion, there are obvious reasons to believe that neurophysiological markers distin‐
guishing OCD and SCZ can be found. The main candidates are P3a and P3b responses as well
as ERN. Additional studies are needed to determine whether there are changes in MMN in
OCD. Future studies are recommended to dissociate deficits at the early stages of auditory and
visual processes in OCD and SCZ. New studies evaluating entraining mechanisms with SSR
in OCD are warranted. A special emphasis should be placed on examining developmental
differences in the neurophysiological responses in OCD. The use of MEG is highly recom‐
mended in OCD group, as it can provide not only time-related information, but also localize
the activity of interest in the space domain.
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interpeak L↑
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Early sensory processing (pre-attentive)
Early visual
processing
VEPs to flash
8 OCD; 8 HCS
/adults; mean a
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P130 -
Ciesielski et
al. [211]
Early, auditory,
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AEPs to binaural clicks,
VEPs to checkerboard
flashes, SEPs
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Comparison
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A↑
A↓
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
somatosensory
processing
Somatosensory
P60
Visual N75
Auditory P50
Auditory P85
L↑
Early
somatosensory
processing
SEPs
14 OCD; 28 neurotics; 99
HCS; 49 chronic SCZ; 27
“other” SCZ; 20 latent SCZ;
42 major depressive
/adults; 23-48 yo/
Comparison
with HCS:
N60
P90
N130
A↑
A↓
A↓
Shagass et
al. [325]
Early auditory and
visual sensory
processing
AEPs to tone bursts and
VEPs to flash
50 OCD; 40 HCS
/no age-related information
was provided by authors/
Auditory and
visual
P1
N1
P2
-
Khanna et
al. [326]
Early auditory and
visual sensory
processing
AEPs to binaural clicks
and VEPs to flash
15 OCD (unmedicated); 30
HCS
/adults; 35.6 ± 9.9/
Auditory N1
Auditory P2
Visual N1
Visual P2
L↓
L↓
-
-
Savage et
al. [210]
BAEPs to
50 OCD; 50 anxiety disorder;
25 HCS
/adults; mean 33 ± 8 yo/
wave I–V
wave III
Early auditory
sensory processing
AEFs to binaural clicks
10 OCD; 10 HCS /youth;
8-13 yo/
M70
M100
M150
-
L↑
-
Korostensk
aja et al.
[193]*
Brain activity synchronization with external events (pre-attentive)
Synchronation of
brain activity with
external periodic
sensory
stimulation
ASSR to repetitively
presented trains of
identical clicks
No studies reported to date in OCD patients; for comparison, see review
section of ASSR studies in schizophrenia
Change detection (automatic attention processes)
Automatic
response to a
change in external
stimuli
Auditory MMN response
to deviant tones
interspersed among
frequent tones. No task
execution required
Only limited number of studies performed - see comparative OCD/SCZ
section; for comparison, see also review section of MMN studies in
schizophrenia
Novelty detection (involuntary attention switch)
Processing of
novel
AEPs elicited in response
to auditory novelty “odd-
ball” task with irrelevant
20 OCD; 20 HCS
/adults; 32.8 ± 9.9 yo/
P3a A↑
Ischebeck
et al. [265]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
(unexpected)
stimuli
repeated frequent
sounds and rare novel
sounds interspersed
among them; the
paradigm was presented
during performance of
visual recognition task
Active attention processes
Selective
attention;
complex
processing of
visual information
VEPs elicited during
visuospatial task:
discrimination of two
similar shapes
8 OCD; 8 HCS
/adults; mean
age 36.5 yo/
N220
P340
A↓; L↓
Similar trend
as for N220,
however not
statistically
significant
Ciesielski et
al. [211]
Selective
attention;
complex
processing of
visual information
VEPs elicited during
visuospatial task of
increasing difficulty:
discrimination of two
similar shapes
8 OCD; 8 HCS
/adults;
average age 40 yo/
N220
P350
A ↓; L ↓
A ↓; L ↓
Effect was
stronger with
increasing
task
complexity
Beech et al.
[268]
Active attention
AEPs elicited during
auditory “odd-ball”
discrimination paradigm
of increasing difficulty
10 OCD (drug-free for two
weeks); 10 HCS
/adults; 18-55 yo/
N200
P300
A↑
L↓ during
difficult
discrimination
task
Towey et al.
[269]
Active attention
AEPs elicited during
auditory “odd-ball”
discrimination paradigm
of increasing difficulty
17 OCD (unmedicated); 16
HCS
/adults; 18-55 yo/
N200
P300
A↑
A over the left
hemisphere
"/> than over
the right
hemisphere
-
Towey et al.
[327]
Selective attention
AEPs elicited during
direct attention task
18 OCD (unmedicated); 15
HCS
/adults; mean
age 30.0 ± 9.1 yo/
MMN (N2a)
N200 (N2b)
P300 for
attended
targets
P300 for
unattended
non-targets
-
-
A↓
A↑
L↑, A↑
A↑
Towey et al.
[232]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
PN
SW for
unattended
non-targets
Active attention
and discrimination
of verbal stimuli
AEPs elicited to verbal
(disyllabic) auditory
stimuli (meaningful and
meaningless) presented
in an “oddball”
paradigm; subjects were
asked to keep a mental
count of target stimuli
13 OCD (unmedicated); 13
HCS
/adults; 21-56 yo/
N1
N2
P2
P3
L↑
A↓
L↑
L↓
A over the left
hemisphere <
than over the
right
hemisphere
Morault et
al. [195]
Active attention
and discrimination
of auditory stimuli
AEPs elicited during
auditory “odd-ball”
paradigm with two
frequency deviants;
subjects were asked to
keep a mental count of
target stimuli
18 OCD (unmedicated); 18
HCS
/adults; 19-59 yo/
N200
P300
SW
A↑
-
L↓
de Groot et
al. [329]
Active attention
and discrimination
of auditory stimuli
AEPs elicited during
auditory “odd-ball”
paradigm with two
frequency deviants;
subjects were asked to
keep a mental count of
target stimuli
23 OCD (unmedicated); 12
SP (unmedicated); 18 HCS
21 OCD (medication-free);
21 HCS
/ mixed: youth and adults;
16-50 yo/
N200
P300
L↓ than SP
and HC
A↑ than in HC
L↓ than SP
and HC
Miyata et al.
[270]
Active attention
AEPs elicited during
auditory “oddball”
paradigm; authors do
not specify details of the
task performed by the
subjects
30 OCD (medication-free for
2-4 weeks); 30 HCS
/mixed: youth and adults;
16-40 yo/
P200 in
response to
irrelevant
(frequent)
stimuli
N200
A↑
A↓
Okasha et
al. [330]
Active attention
AEPs elicited during
“oddball” paradigm with
frequent and deviant
(target) stimuli; subjects
had to press a button in
response to target stimuli
21 OCD (medication-free);
21 HCS
/ mixed: youth and adults;
17-27 yo/
P3a
P3b
(importantly,
separation
between P3a
and P3b was
performed with
-
A↑
L ↓ (in the
right
hemisphere)
Mavrogiorg
ou et al.
[267]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
(unexpected)
stimuli
repeated frequent
sounds and rare novel
sounds interspersed
among them; the
paradigm was presented
during performance of
visual recognition task
Active attention processes
Selective
attention;
complex
processing of
visual information
VEPs elicited during
visuospatial task:
discrimination of two
similar shapes
8 OCD; 8 HCS
/adults; mean
age 36.5 yo/
N220
P340
A↓; L↓
Similar trend
as for N220,
however not
statistically
significant
Ciesielski et
al. [211]
Selective
attention;
complex
processing of
visual information
VEPs elicited during
visuospatial task of
increasing difficulty:
discrimination of two
similar shapes
8 OCD; 8 HCS
/adults;
average age 40 yo/
N220
P350
A ↓; L ↓
A ↓; L ↓
Effect was
stronger with
increasing
task
complexity
Beech et al.
[268]
Active attention
AEPs elicited during
auditory “odd-ball”
discrimination paradigm
of increasing difficulty
10 OCD (drug-free for two
weeks); 10 HCS
/adults; 18-55 yo/
N200
P300
A↑
L↓ during
difficult
discrimination
task
Towey et al.
[269]
Active attention
AEPs elicited during
auditory “odd-ball”
discrimination paradigm
of increasing difficulty
17 OCD (unmedicated); 16
HCS
/adults; 18-55 yo/
N200
P300
A↑
A over the left
hemisphere
"/> than over
the right
hemisphere
-
Towey et al.
[327]
Selective attention
AEPs elicited during
direct attention task
18 OCD (unmedicated); 15
HCS
/adults; mean
age 30.0 ± 9.1 yo/
MMN (N2a)
N200 (N2b)
P300 for
attended
targets
P300 for
unattended
non-targets
-
-
A↓
A↑
L↑, A↑
A↑
Towey et al.
[232]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
PN
SW for
unattended
non-targets
Active attention
and discrimination
of verbal stimuli
AEPs elicited to verbal
(disyllabic) auditory
stimuli (meaningful and
meaningless) presented
in an “oddball”
paradigm; subjects were
asked to keep a mental
count of target stimuli
13 OCD (unmedicated); 13
HCS
/adults; 21-56 yo/
N1
N2
P2
P3
L↑
A↓
L↑
L↓
A over the left
hemisphere <
than over the
right
hemisphere
Morault et
al. [195]
Active attention
and discrimination
of auditory stimuli
AEPs elicited during
auditory “odd-ball”
paradigm with two
frequency deviants;
subjects were asked to
keep a mental count of
target stimuli
18 OCD (unmedicated); 18
HCS
/adults; 19-59 yo/
N200
P300
SW
A↑
-
L↓
de Groot et
al. [329]
Active attention
and discrimination
of auditory stimuli
AEPs elicited during
auditory “odd-ball”
paradigm with two
frequency deviants;
subjects were asked to
keep a mental count of
target stimuli
23 OCD (unmedicated); 12
SP (unmedicated); 18 HCS
21 OCD (medication-free);
21 HCS
/ mixed: youth and adults;
16-50 yo/
N200
P300
L↓ than SP
and HC
A↑ than in HC
L↓ than SP
and HC
Miyata et al.
[270]
Active attention
AEPs elicited during
auditory “oddball”
paradigm; authors do
not specify details of the
task performed by the
subjects
30 OCD (medication-free for
2-4 weeks); 30 HCS
/mixed: youth and adults;
16-40 yo/
P200 in
response to
irrelevant
(frequent)
stimuli
N200
A↑
A↓
Okasha et
al. [330]
Active attention
AEPs elicited during
“oddball” paradigm with
frequent and deviant
(target) stimuli; subjects
had to press a button in
response to target stimuli
21 OCD (medication-free);
21 HCS
/ mixed: youth and adults;
17-27 yo/
P3a
P3b
(importantly,
separation
between P3a
and P3b was
performed with
-
A↑
L ↓ (in the
right
hemisphere)
Mavrogiorg
ou et al.
[267]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
dipole
modeling)
Active attention
AEPs elicited during
“oddball” paradigm with
frequent and deviant
(target) stimuli; subjects
had to press a button in
response to target stimuli
63 OCD (acutely ill,
unmedicated); 63 HCS
/adults; mean age 33.71 ±
10.17 yo/
P3a
P3b
(separation
between P3a
and P3b was
performed with
dipole
modeling)
-
A↑
Gohle et al.
[266]
Learning and memory
Implicit memory;
word repetition
effect
Implicit memory (word
repetition) task; ERPs to
visually presented word/
non-word lexical decision
task; subjects were asked
to decide whether each
item was word or non-
word
12 OCD; 13 HCS
/adults; 19-29 yo/
Word repetition
effect at
300-500 ms
post-stimulus
Hemispheric
functional
asymmetry for
the new words
OCD: No
HCS: Yes
OCD: Right-
sided
asymmetry
HCS: Left-
sided
asymmetry
Kim et al.
[331].
Error-related behavior
Action monitoring
ERPs were elicited during
Stroop task, consisting of
three visually presented
words “red”, “green”,
and “blue”; subjects were
instructed
to press the right or left
mouse button in
response to the color of
the words
9 OCD; 9 HCS
/adults; 19-58 yo/
ERN A↑
Gehring et
al. [292]
Action monitoring
and target
detection
ERP responses elicited
during visual
presentation of letters ‘H’
and ‘O’; targets consisted
of large letters, non-
targets consisted
of small letters; subjects
were instructed to
press a button held in the
right hand whenever a
10 OCD; 10 HCS
/adults; 22-40 yo/
ERN
P3b
A↑, L↓
L↓
Johannes et
al. [298]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
target H appeared and to
press another button in
the left hand when a
target O appeared
Action monitoring
and error
detection
ERPs were elicited during
Stroop task, consisting of
three visually presented
words “red”, “green”,
and “blue”; subjects were
instructed
to press the right or left
mouse button in
response to the color of
the words
18 high-OCD; 17 low-OCD
Response-
locked ERN
A↑ in high-
OCD group
[332]
Action monitoring
ERPs were recorded in
probabilistic learning
task and were associated
with errors and negative
feedback
16 OCD; 16 HCS
/adults; 21-49 yo/
ERN -
Nieuwenhu
is et al.
[301]
Error monitoring
processes
ERPs were elicited during
combined a Go/NoGo
task with an Eriksen
flanker
paradigm
11 OCD; 11 HCS
ERN
“early” Pe
“late” Pe
A↑
-
-
Ruchsow et
al. [333]
Performance
monitoring
ERPs were elicited during
modified version of
flanker interference task
20 OCD; 20 HCS
/adults; 33.5 ± 8 yo/
ERN
CRN
Pe
A↑
A↑
-
Endrass et
al. [295]
Performance
monitoring before
and after
treatment
ERPs were elicited during
modified version of
Simon task
Before treatment:
18 OCD; 18 HCS
After treatment:
10 OCD; 13 HCS
/youth; 8 - 17 yo/
ERN
A↑ (the effect
remained
after
treatment)
Hajcak et al.
[297]
Performance
monitoring
ERPs were elicited during
modified version of
flanker interference task
22 OCD; 22 HCS
/adults; 31.2 ± 8.4 yo/
Standard
condition:
ERN
CRN
Pe
A↑
A↑
-
Endrass et
al. [302]
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
25 OCD, 27 GAD, 27 HCS
/adults; 32.5 ± 10.2 yo/
ERN
Ne of difference
waveform
amplitude at
A↑ in OCD
A↑ in OCD
subjects, but
not in GAD
Xiao et al.
[334]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
dipole
modeling)
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(target) stimuli; subjects
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performed with
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-
A↑
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non-word lexical decision
task; subjects were asked
to decide whether each
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word
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Word repetition
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300-500 ms
post-stimulus
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OCD: No
HCS: Yes
OCD: Right-
sided
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HCS: Left-
sided
asymmetry
Kim et al.
[331].
Error-related behavior
Action monitoring
ERPs were elicited during
Stroop task, consisting of
three visually presented
words “red”, “green”,
and “blue”; subjects were
instructed
to press the right or left
mouse button in
response to the color of
the words
9 OCD; 9 HCS
/adults; 19-58 yo/
ERN A↑
Gehring et
al. [292]
Action monitoring
and target
detection
ERP responses elicited
during visual
presentation of letters ‘H’
and ‘O’; targets consisted
of large letters, non-
targets consisted
of small letters; subjects
were instructed to
press a button held in the
right hand whenever a
10 OCD; 10 HCS
/adults; 22-40 yo/
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A↑, L↓
L↓
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
target H appeared and to
press another button in
the left hand when a
target O appeared
Action monitoring
and error
detection
ERPs were elicited during
Stroop task, consisting of
three visually presented
words “red”, “green”,
and “blue”; subjects were
instructed
to press the right or left
mouse button in
response to the color of
the words
18 high-OCD; 17 low-OCD
Response-
locked ERN
A↑ in high-
OCD group
[332]
Action monitoring
ERPs were recorded in
probabilistic learning
task and were associated
with errors and negative
feedback
16 OCD; 16 HCS
/adults; 21-49 yo/
ERN -
Nieuwenhu
is et al.
[301]
Error monitoring
processes
ERPs were elicited during
combined a Go/NoGo
task with an Eriksen
flanker
paradigm
11 OCD; 11 HCS
ERN
“early” Pe
“late” Pe
A↑
-
-
Ruchsow et
al. [333]
Performance
monitoring
ERPs were elicited during
modified version of
flanker interference task
20 OCD; 20 HCS
/adults; 33.5 ± 8 yo/
ERN
CRN
Pe
A↑
A↑
-
Endrass et
al. [295]
Performance
monitoring before
and after
treatment
ERPs were elicited during
modified version of
Simon task
Before treatment:
18 OCD; 18 HCS
After treatment:
10 OCD; 13 HCS
/youth; 8 - 17 yo/
ERN
A↑ (the effect
remained
after
treatment)
Hajcak et al.
[297]
Performance
monitoring
ERPs were elicited during
modified version of
flanker interference task
22 OCD; 22 HCS
/adults; 31.2 ± 8.4 yo/
Standard
condition:
ERN
CRN
Pe
A↑
A↑
-
Endrass et
al. [302]
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
25 OCD, 27 GAD, 27 HCS
/adults; 32.5 ± 10.2 yo/
ERN
Ne of difference
waveform
amplitude at
A↑ in OCD
A↑ in OCD
subjects, but
not in GAD
Xiao et al.
[334]
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
medial frontal
electrodes
Pe
(compared
with HCS)
-
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
44 OCD; 44 HCS
/youth; 10 - 19 yo/
ERN A↑
Hanna et al.
[335]
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
26 OCD; 13 non-OCD
anxiety disorder; 27 HCS
/youth; 8 - 16 yo/
ERN A↑
Carrasco et
al. [170]
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
40 OCD; 19 unaffected
siblings of OCD subjects; 40
HCS
/youth; 10 - 17 yo/
ERN
A↑ (in both
OCD patients
and their
siblings)
Carrasco et
al. [336]
A – amplitude; AEFs – auditory evoked fields; AEPs – auditory evoked potentials; ASSR – auditory steady-state evoked respons‐
es; BAEPs - Brainstem auditory evoked potentials; CNV – contingent negative variation; CRN – correct response negativity;
ERN/Ne – error-related negativity; ERP – event related potential; GAD - generalized anxiety disorder; HAMA - Hamilton Anxiety
Rating Scale; HAMD - Hamilton Depression Rating Scale; HCS – healthy comparison subjects; L – latency; MMN – mismatch neg‐
ativity; OCD – obsessive-compulsive disorder; Pe – error positivity; PN – processing negativity; SCZ – schizophrenia; SEPs - some‐
tosentory evoked potentials; SP - social phobia; SW – slow wave; T/C – test/conditioning ratio; VEPs – visual evoked potentials;
yo – years old; ↓ – decrease; ↑ increase; “- “ – no effect; * denotes MEG studies
Table 2. ERP/ERF studies in patients with OCD
4. Neurophysiological markers of treatment response
Neurophysiologically guided clinical decisions is an exciting direction for translational
research. We are close to clinically useful predictors of treatment response in both OCD and
SCZ. Finding such a biomarker or assessment battery has been a longstanding goal of clinicians
and scientists, as the current treatment approach is one of trial-and-error with respect to choice
of medication. Since both SCZ and OCD are chronic conditions, patients with life-long,
treatment-resistant disorders suffer from complications including medication side effects,
poor quality of life, depression, unemployment and stigma. Although the symptoms of OCD
typically begin in childhood [307], only about half of youths with OCD respond to the current
standard-of-care treatment consisting of a serotonergic medication and cognitive behavior
therapy (POTS, [308]).
As early as 1984, Insel, Mueller [309] attempted to find a biomarker to predict treatment
response. This group of investigators examined a number of tests, including sleep EEG, the
dexamethasone suppression test and platelet 3H-imipramine binding, but they were unsuc‐
cessful in finding a marker that predicted clinical response to clomipramine in patients with
OCD. More recently, a number of functional imaging studies in adults have described changes
functional changes in specific anatomical regions as a response to treatment. Nakao et al. [317]
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found that elevated activity in the OFC, dorsolateral PFC and anterior cingulate cortex
decreased with fluvoxamine or cognitive behavior therapy. Rauch et al. [318] reported that
lower pretreatment regional cerebral blood flow (rCBF) in the OFC and higher rCBF in the
posterior cingulate cortex were predictive of treatment response to fluvoxamine in adults with
contamination obsessions. Similarly, Saxena et al. [319] reported glucose metabolism de‐
creased in the right anterolateral OFC and right caudate as a result of 8-12 weeks of treatment
with paroxetine. Prior to treatment with clomipramine, Rubin et al. (1995) reported that there
was increased uptake of HMPAO in the OFC, posterofrontal cortex and dorsal parietal cortex
compared with healthy volunteers. Decreased uptake in these regions occurred following
treatment.
With regard to electrophysiological studies, a series of three papers by a single team of
investigators have identified two groups of patients with OCD; one group had elevated alpha
power at baseline and the other group had elevated theta power. These groups predict
treatment response: the majority of patients with excess alpha respond to paroxetine and the
majority of the patients with excess theta were non-responders. The excess alpha observed in
the resting state prior to treatment normalized with treatment [76-78]. Fontenelle et al. [95], on
the other hand, found yet another EEG band predictive of treatment response. These investi‐
gators obtained the pretreatment EEG in 17 drug-free patients with OCD and analysed the
EEG with low-resolution electromagnetic tomography. Subjects were then treated for 12 weeks
with antidepressants; 10 subjects responded and 7 were considered non-responders. There
was significantly lower beta band activity in the anterior cingulate and medial frontal gyrus
in the pretreatment EEG of responders. In a randomized double-blind study comparing sham
feedback with neurofeedback (NFB) for the treatment of OCD, a significant decrease in
compulsions was seen in the NFB group. Unlike the findings of Fontanelle, these authors noted
than an increase in delta, low alpha and low beta in the baseline EEG were predictive of worse
treatment outcome [320].
In an early study of treatment prediction for SCZ, Galderisi et al., (1994) examined baseline
QEEG characteristics and their changes following a single test dose of either haloperidol or
clopenthixol in 29 patients with SCZ. Those who responded to medication less slow activity
and more fast activity than nonresponders. However, the authors go on to note that there was
overlap in the baseline activity of responders and non-responders decreasing the utility of this
approach. Yet changes in alpha 1, observed 6 hours after the administration of a single test
dose of either haloperidol or clopenthixol, did succeed in discriminating between responders
and nonresponders. Antipsychotic medications currently used to treat SCZ symptoms In a
more recent study of 22 drug-naïve patients with SCZ treated with a variety of medications
including conventional dopamine-blocking neuroleptics, serotonin-dopamine antagonists,
anticholinergic agents, antihistaminergic agents or benzodiazepine derivatives, no spectral
changes were found when comparing EEGs pre and post-treatment. However, using a novel
approach for treatment response assessment, this study used an analysis of multiscale entropy
and found that subjects with SCZ had greater complexity for lower frequencies than HCS in
fronto-centro-temporal regions, but not in parieto-occipital regions. Following treatment, the
elevated complexity normalized in fronto-central regions but was not alleviated in temporal
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Studied
processes
ERP/ERF component (-
s) studied/paradigm
Study participants
/age of OCD patients/
Observed ERP changes Authors
medial frontal
electrodes
Pe
(compared
with HCS)
-
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
44 OCD; 44 HCS
/youth; 10 - 19 yo/
ERN A↑
Hanna et al.
[335]
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
26 OCD; 13 non-OCD
anxiety disorder; 27 HCS
/youth; 8 - 16 yo/
ERN A↑
Carrasco et
al. [170]
Performance
monitoring
ERPs was elicited during
modified Erikson flankers
task
40 OCD; 19 unaffected
siblings of OCD subjects; 40
HCS
/youth; 10 - 17 yo/
ERN
A↑ (in both
OCD patients
and their
siblings)
Carrasco et
al. [336]
A – amplitude; AEFs – auditory evoked fields; AEPs – auditory evoked potentials; ASSR – auditory steady-state evoked respons‐
es; BAEPs - Brainstem auditory evoked potentials; CNV – contingent negative variation; CRN – correct response negativity;
ERN/Ne – error-related negativity; ERP – event related potential; GAD - generalized anxiety disorder; HAMA - Hamilton Anxiety
Rating Scale; HAMD - Hamilton Depression Rating Scale; HCS – healthy comparison subjects; L – latency; MMN – mismatch neg‐
ativity; OCD – obsessive-compulsive disorder; Pe – error positivity; PN – processing negativity; SCZ – schizophrenia; SEPs - some‐
tosentory evoked potentials; SP - social phobia; SW – slow wave; T/C – test/conditioning ratio; VEPs – visual evoked potentials;
yo – years old; ↓ – decrease; ↑ increase; “- “ – no effect; * denotes MEG studies
Table 2. ERP/ERF studies in patients with OCD
4. Neurophysiological markers of treatment response
Neurophysiologically guided clinical decisions is an exciting direction for translational
research. We are close to clinically useful predictors of treatment response in both OCD and
SCZ. Finding such a biomarker or assessment battery has been a longstanding goal of clinicians
and scientists, as the current treatment approach is one of trial-and-error with respect to choice
of medication. Since both SCZ and OCD are chronic conditions, patients with life-long,
treatment-resistant disorders suffer from complications including medication side effects,
poor quality of life, depression, unemployment and stigma. Although the symptoms of OCD
typically begin in childhood [307], only about half of youths with OCD respond to the current
standard-of-care treatment consisting of a serotonergic medication and cognitive behavior
therapy (POTS, [308]).
As early as 1984, Insel, Mueller [309] attempted to find a biomarker to predict treatment
response. This group of investigators examined a number of tests, including sleep EEG, the
dexamethasone suppression test and platelet 3H-imipramine binding, but they were unsuc‐
cessful in finding a marker that predicted clinical response to clomipramine in patients with
OCD. More recently, a number of functional imaging studies in adults have described changes
functional changes in specific anatomical regions as a response to treatment. Nakao et al. [317]
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found that elevated activity in the OFC, dorsolateral PFC and anterior cingulate cortex
decreased with fluvoxamine or cognitive behavior therapy. Rauch et al. [318] reported that
lower pretreatment regional cerebral blood flow (rCBF) in the OFC and higher rCBF in the
posterior cingulate cortex were predictive of treatment response to fluvoxamine in adults with
contamination obsessions. Similarly, Saxena et al. [319] reported glucose metabolism de‐
creased in the right anterolateral OFC and right caudate as a result of 8-12 weeks of treatment
with paroxetine. Prior to treatment with clomipramine, Rubin et al. (1995) reported that there
was increased uptake of HMPAO in the OFC, posterofrontal cortex and dorsal parietal cortex
compared with healthy volunteers. Decreased uptake in these regions occurred following
treatment.
With regard to electrophysiological studies, a series of three papers by a single team of
investigators have identified two groups of patients with OCD; one group had elevated alpha
power at baseline and the other group had elevated theta power. These groups predict
treatment response: the majority of patients with excess alpha respond to paroxetine and the
majority of the patients with excess theta were non-responders. The excess alpha observed in
the resting state prior to treatment normalized with treatment [76-78]. Fontenelle et al. [95], on
the other hand, found yet another EEG band predictive of treatment response. These investi‐
gators obtained the pretreatment EEG in 17 drug-free patients with OCD and analysed the
EEG with low-resolution electromagnetic tomography. Subjects were then treated for 12 weeks
with antidepressants; 10 subjects responded and 7 were considered non-responders. There
was significantly lower beta band activity in the anterior cingulate and medial frontal gyrus
in the pretreatment EEG of responders. In a randomized double-blind study comparing sham
feedback with neurofeedback (NFB) for the treatment of OCD, a significant decrease in
compulsions was seen in the NFB group. Unlike the findings of Fontanelle, these authors noted
than an increase in delta, low alpha and low beta in the baseline EEG were predictive of worse
treatment outcome [320].
In an early study of treatment prediction for SCZ, Galderisi et al., (1994) examined baseline
QEEG characteristics and their changes following a single test dose of either haloperidol or
clopenthixol in 29 patients with SCZ. Those who responded to medication less slow activity
and more fast activity than nonresponders. However, the authors go on to note that there was
overlap in the baseline activity of responders and non-responders decreasing the utility of this
approach. Yet changes in alpha 1, observed 6 hours after the administration of a single test
dose of either haloperidol or clopenthixol, did succeed in discriminating between responders
and nonresponders. Antipsychotic medications currently used to treat SCZ symptoms In a
more recent study of 22 drug-naïve patients with SCZ treated with a variety of medications
including conventional dopamine-blocking neuroleptics, serotonin-dopamine antagonists,
anticholinergic agents, antihistaminergic agents or benzodiazepine derivatives, no spectral
changes were found when comparing EEGs pre and post-treatment. However, using a novel
approach for treatment response assessment, this study used an analysis of multiscale entropy
and found that subjects with SCZ had greater complexity for lower frequencies than HCS in
fronto-centro-temporal regions, but not in parieto-occipital regions. Following treatment, the
elevated complexity normalized in fronto-central regions but was not alleviated in temporal
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regions [315]. Based on these studies, one wonders whether pretreatment alpha power does
not predict response to dopamine antagonists, but what about medications that target the
glutamatergic system which can also alleviate psychotic symptoms in SCZ [316]? Clinical trials
for such compounds may consider changes in alpha EEG activity as a biomarker of treatment
response or an alternate approach to response prediction.
For patients with SCZ, Khodayari-Rostamabad et al. [310] successfully used an alternative
analytic approach – that of machine learning-- to extract features in the pre-treatment EEG to
predict clinical response to clozapine. As such novel analytic approaches gain popularity in
neurophysiological research, there is hope that these will have translational value for treatment
prediction in the future. One such illustrative example is the machine learning approach to
develop computational models based on the patients’ MMNm and clinical data [311]. In the
field of epilepsy, investigators use machine learning to predict seizures outcome following
neurosurgery with 90% success rate [312] and to predict the likelihood of having a seizure from
EEG features [313]. New and important information about the effect of epilepsy on information
processing was reported by Ralescu, Lee [311] (Figure 3). The advantage of the computational
approach used by these authors is that it allows experimentation with various settings of the
parameters to generate possible scenarios for different models [314]. This computational
approach for psychophysiological data analysis may reveal individual patterns of activity
within the group. This innovative solution may have a strong potential to provide new insights
into predicting treatment response for other conditions using the neurophysiological param‐
eters of EEG/MEG or ERP/ERF responses in both OCD and SCZ.
Figure 3. Clustering the MMNm response data of the ten patients with epilepsy in a two dimensional space of princi‐
pal components. Patient P2 was farthest away from the rest of the data. Inspection of the P2 individual characteristics
revealed that her age at onset of epilepsy (0.5 years) was the earliest among the rest of the patients. Utilized approach
allowed differentiation of unique patients’ characteristics through the parameters of neurophysiological MMNm re‐
sponses.
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5. Future directions
On the basis of clinical history and mental status examination, the young adult with unwind‐
ing, stealing and contamination would be given the diagnosis of OCD. The authors are hopeful
that in the near future it will be possible to order an electrophysiological battery to confirm
the diagnosis in challenging cases and to guide individually tailored treatment.
The hope that a biomarker for psychiatric conditions will emerge is already becoming a reality
for some conditions. Basar’s [321] proposal that brain functions are a result of simultaneous
oscillations in various frequency bands has yielded fruit. Patients with ADHD can now be
diagnosed based on the ratio of theta to beta frequency bandwidths. Robinson [322] found an
inverse relationship between alpha and delta waves that correlated with personality type, with
lower magnitude in extraverted and neurotic subjects. Changes in the cross-frequency
coupling can be seen following treatment with psychotherapy [323]. Further examination of
the interactions between different frequency bandwidths for patients with schizophrenia and
OCD may be the logical next step.
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regions [315]. Based on these studies, one wonders whether pretreatment alpha power does
not predict response to dopamine antagonists, but what about medications that target the
glutamatergic system which can also alleviate psychotic symptoms in SCZ [316]? Clinical trials
for such compounds may consider changes in alpha EEG activity as a biomarker of treatment
response or an alternate approach to response prediction.
For patients with SCZ, Khodayari-Rostamabad et al. [310] successfully used an alternative
analytic approach – that of machine learning-- to extract features in the pre-treatment EEG to
predict clinical response to clozapine. As such novel analytic approaches gain popularity in
neurophysiological research, there is hope that these will have translational value for treatment
prediction in the future. One such illustrative example is the machine learning approach to
develop computational models based on the patients’ MMNm and clinical data [311]. In the
field of epilepsy, investigators use machine learning to predict seizures outcome following
neurosurgery with 90% success rate [312] and to predict the likelihood of having a seizure from
EEG features [313]. New and important information about the effect of epilepsy on information
processing was reported by Ralescu, Lee [311] (Figure 3). The advantage of the computational
approach used by these authors is that it allows experimentation with various settings of the
parameters to generate possible scenarios for different models [314]. This computational
approach for psychophysiological data analysis may reveal individual patterns of activity
within the group. This innovative solution may have a strong potential to provide new insights
into predicting treatment response for other conditions using the neurophysiological param‐
eters of EEG/MEG or ERP/ERF responses in both OCD and SCZ.
Figure 3. Clustering the MMNm response data of the ten patients with epilepsy in a two dimensional space of princi‐
pal components. Patient P2 was farthest away from the rest of the data. Inspection of the P2 individual characteristics
revealed that her age at onset of epilepsy (0.5 years) was the earliest among the rest of the patients. Utilized approach
allowed differentiation of unique patients’ characteristics through the parameters of neurophysiological MMNm re‐
sponses.
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5. Future directions
On the basis of clinical history and mental status examination, the young adult with unwind‐
ing, stealing and contamination would be given the diagnosis of OCD. The authors are hopeful
that in the near future it will be possible to order an electrophysiological battery to confirm
the diagnosis in challenging cases and to guide individually tailored treatment.
The hope that a biomarker for psychiatric conditions will emerge is already becoming a reality
for some conditions. Basar’s [321] proposal that brain functions are a result of simultaneous
oscillations in various frequency bands has yielded fruit. Patients with ADHD can now be
diagnosed based on the ratio of theta to beta frequency bandwidths. Robinson [322] found an
inverse relationship between alpha and delta waves that correlated with personality type, with
lower magnitude in extraverted and neurotic subjects. Changes in the cross-frequency
coupling can be seen following treatment with psychotherapy [323]. Further examination of
the interactions between different frequency bandwidths for patients with schizophrenia and
OCD may be the logical next step.
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1. Introduction
Obsessive-Compulsive Disorder (OCD) consists of recurrent and persistent thoughts
(obsessions), accompanied by the development of ritual and/or repetitive behaviors (com‐
pulsions). It has been widely suggested that these symptoms might be linked to different types
of cognitive and cerebral impairments. More precisely, it has been shown that OCD patients
present specific memory difficulties that could be related to a Cortico-Striato-Thalamo-Cortical
(CSTC) loop dysfunction. Some research has further explained these memory problems as a
result of poor confidence, along with affected emotional evaluation.
Numerous studies have undertaken the task to examine which specific aspect of memory
processing might be affected in OCD patients. For instance, the California Verbal Learning
Test (CVLT) was employed to assess verbal memory. Overall, findings have been mixed with
poorer encoding, but intact delayed recall, impaired encoding and long delay recall, or
completely intact encoding, recall and recognition memory. In contrast, there is a stronger
support for the presence of a visual memory deficit in OCD. Several studies have reported
impaired recall on the Rey Complex Figure Test (RCFT), as well as recall on other tests of non
verbal memory.
In parallel, a general questioning regarding a possible relationship between emotion process‐
ing and OCD symptoms remains unresolved. From a psychological measurement standpoint,
obsessive and compulsive symptom expressions could also be modulated by internal media‐
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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1. Introduction
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(obsessions), accompanied by the development of ritual and/or repetitive behaviors (com‐
pulsions). It has been widely suggested that these symptoms might be linked to different types
of cognitive and cerebral impairments. More precisely, it has been shown that OCD patients
present specific memory difficulties that could be related to a Cortico-Striato-Thalamo-Cortical
(CSTC) loop dysfunction. Some research has further explained these memory problems as a
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Numerous studies have undertaken the task to examine which specific aspect of memory
processing might be affected in OCD patients. For instance, the California Verbal Learning
Test (CVLT) was employed to assess verbal memory. Overall, findings have been mixed with
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completely intact encoding, recall and recognition memory. In contrast, there is a stronger
support for the presence of a visual memory deficit in OCD. Several studies have reported
impaired recall on the Rey Complex Figure Test (RCFT), as well as recall on other tests of non
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In parallel, a general questioning regarding a possible relationship between emotion process‐
ing and OCD symptoms remains unresolved. From a psychological measurement standpoint,
obsessive and compulsive symptom expressions could also be modulated by internal media‐
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
ting factors like the emotional context, including the type of material presented, its emotional
valence and its complexity. These examples of internal factors could likely influence perform‐
ance behavior including the degree of avoidance, hesitation and difficulties in recall and
memory. Thus, a potential candidate explanation for OCD patients’ altered neuropsycholog‐
ical performances, may lie in emotionality and emotional stressors. More precisely, stimuli
eliciting anxious over-concern, strong emotionality such as those perceived as threatening,
may activate a differential performance. Some investigations have focused their attention on
the relationship between emotion and cognition in order to explain and find what triggers
OCD behaviors. For instance, OCD patients attended to negative words longer than controls
in a modified Stroop test using neutral and emotional threatening word sets. It was proposed
that OCD patients have a propensity to encode negative words. In the same line, another
research group found that OCD patients exhibited deficits in the ability to forget negative
material compared to controls. Concurrently, others found that OCD washers showed longer
latency responses to contamination words than non-washers, but that in general, OCD
participants showed a longer latency to threat words. Thereby, these findings suggest that a
threat-related hypothesis might explain OCD’s maladaptive behaviors rather than an anxious
concern and emotionality hypothesis.
In addition, other studies have indicated that the apparent memory-deficit in OCD might be
modulated by the emotional valence of the presented stimulus. assessed memory in people
with OCD with fear for contamination and compared their memory capacities to healthy
controls. They mainly found that the OCD group had better memory skills for contaminated
objects than for clean ones. Furthermore, neuropsychological tests scores indicated that this
bias was not the result of differences in general memory ability. However, another investiga‐
tion showed that physiological emotional reactions to stimuli were appropriate in OCD, but
that patients' facial expressions indicated more attempts to suppress emotion and fear. In other
words, the OCD group reacted to their emotionality more censoriously. In certain context,
superior memory performances can be found with OCD checkers but they were more dissat‐
isfied with the vividness of their recall, than were the controls. This might constitute an
important clue underlying OCD’s difficulties in memory confidence. Additionally, recent
research suggests that there is a positive memory bias for threatening information in compul‐
sive cleaners. However, it was proposed that the relationship between OCD and memory is
likely to be more complex when the compulsive behavior is checking in a context of high
responsibility. explored this relationship in a clinical sample of compulsive checkers and found
a positive memory bias for threat-relevant information. In this laboratory setting, when the
responsibility was artificially inflated, they observed that this positive memory bias was
concurrently amplified. As expected, under conditions of no responsibility, no memory bias
was detectable. However, responsibility appeared to have had a greater impact on confidence
in memory than on memory itself in OCD.
In sum, the memory deficit seems to be mediated by emotionality, the degree of investment
in motivations and by the responsibility to threat-relevant stimuli. However, the link between
memory and emotional dimensions were not investigated yet in the context of cognitive
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electrophysiology and Event-Related brain potentials (ERP), which might bring some essential
insights regarding cognitive processes.
2. Event-related brain potentials in obsessive-compulsive disorder
The ERP technique represents the stimulus-locked average of the raw electroencephalographic
(EEG) signals. A core feature of the ERP approach is its sensitivity to covert information
processing, which may not be fully assessed with behavioral measures. By giving a particular
instruction during recordings, such as categorizing a stimulus by a motor response, various
ERP components are obtained. These are related to different levels of cognitive processes as
well as early sensory processing. Early ERP components (P100, N100, N200) are predominantly
related to basic cognitive functions such as selective attention and mismatch detection, whereas
the middle and late components (P300) vary with higher order information processing, such
as stimulus evaluation and working memory storage.
Several ERP studies hypothesized over-focused attention in OCD, as manifested by shorter
latency P300, particularly when task difficulty was increased. It has also been reported that
during attention tasks, OCD was associated with larger processing negativity over the frontal
area and a smaller P300 to attended target-stimuli, while the N200 was intact. Similar findings,
specific to OCD patients, were reported with a visual Oddball task showing reduced P300
amplitude to target-stimuli particularly in the anterior region. Furthermore, specifically to
OCD, while the P300 component appeared earlier, both N100 and P200 components oppositely
showed a delayed latency. Together, these ERP findings suggest that in OCD, there is a
misallocation of cognitive resources, particularly regarding memory updating and stimulus
evaluation timing. However, no experiment was designed to assess episodic memory, in the
context of emotional modulation.
3. Goal and hypotheses
Neuropsychological studies of OCD have most often reported minimal or no significant
correlations between OCD symptom severity and cognitive functioning in general. Concur‐
rently, some have effectively observed relationships, but more specific to certain memory or
executive function tests. We propose that the discrepancy in past results could reside in part
in the sub-optimal selection of OCD patients without taking into account the severity and the
comorbid symptoms such as depression and anxiety. Thus, the current project mainly aimed
to investigate the impact of OCD symptom severity and comorbidity on emotional memory
and ERPs. Since the emotional influence on memory for OCD patients has never been explored
with electrophysiological measures, our results might bring a more precise understanding of
the phenomenon, especially regarding the temporal resolution of these memory stages. The
use of pictures instead of words and separating the two groups by their symptom intensity
constitute original ways to analyze memory processes in OCD. We also intend to assess
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(EEG) signals. A core feature of the ERP approach is its sensitivity to covert information
processing, which may not be fully assessed with behavioral measures. By giving a particular
instruction during recordings, such as categorizing a stimulus by a motor response, various
ERP components are obtained. These are related to different levels of cognitive processes as
well as early sensory processing. Early ERP components (P100, N100, N200) are predominantly
related to basic cognitive functions such as selective attention and mismatch detection, whereas
the middle and late components (P300) vary with higher order information processing, such
as stimulus evaluation and working memory storage.
Several ERP studies hypothesized over-focused attention in OCD, as manifested by shorter
latency P300, particularly when task difficulty was increased. It has also been reported that
during attention tasks, OCD was associated with larger processing negativity over the frontal
area and a smaller P300 to attended target-stimuli, while the N200 was intact. Similar findings,
specific to OCD patients, were reported with a visual Oddball task showing reduced P300
amplitude to target-stimuli particularly in the anterior region. Furthermore, specifically to
OCD, while the P300 component appeared earlier, both N100 and P200 components oppositely
showed a delayed latency. Together, these ERP findings suggest that in OCD, there is a
misallocation of cognitive resources, particularly regarding memory updating and stimulus
evaluation timing. However, no experiment was designed to assess episodic memory, in the
context of emotional modulation.
3. Goal and hypotheses
Neuropsychological studies of OCD have most often reported minimal or no significant
correlations between OCD symptom severity and cognitive functioning in general. Concur‐
rently, some have effectively observed relationships, but more specific to certain memory or
executive function tests. We propose that the discrepancy in past results could reside in part
in the sub-optimal selection of OCD patients without taking into account the severity and the
comorbid symptoms such as depression and anxiety. Thus, the current project mainly aimed
to investigate the impact of OCD symptom severity and comorbidity on emotional memory
and ERPs. Since the emotional influence on memory for OCD patients has never been explored
with electrophysiological measures, our results might bring a more precise understanding of
the phenomenon, especially regarding the temporal resolution of these memory stages. The
use of pictures instead of words and separating the two groups by their symptom intensity
constitute original ways to analyze memory processes in OCD. We also intend to assess
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subjective memory confidence concurrently. Based on earlier studies of OCD participants, we
predicted that emotions will impact on memory. The classical episodic memory (EM) effect
will be less important in both patient groups than for the control group. In addition, severe
OCD patients will show the most important impairments.
4. Methodology
4.1. Participants
Two OCD groups were separated based on their symptom severity (median split at 29) with
the Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Goodman, Price, Rasmussen, Mazure,
Delgado, et al., 1989). Fourteen extreme OCD (OCD+) were compared to 15 less symptomatic
OCD (OCD-), matched to 15 controls on age, sex, laterality, mother tongue and education (see
table 1).
OCD +
(N=14)
OCD -
(N=15)
CTRL
(N=15)
sig
Age (Years) 38 (10) 39 (10) 35 (10) ns
Sex (F/M) 9/5 8/8 10/5 ns
Laterality (L/R/A) 1/9/2 0/11/0 0/15/0 ns
Mother tongue (French/English/Other) 10/1/0 10/3/0 14/0/1 ns
Schooling (Years) 14 14 18 ns
Note. n: non significant OCD+: Obsessive-Compulsive highly symptomatic; OCD-: Obsessive-Compulsive low sympto‐
matic; CTRL: non psychiatric control group.
Table 1. Mean and standard deviations (in parentheses) of demographic data
4.2. Clinical assessment
All groups completed the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI),
the Y-BOCS and the Padua Inventory for OCD symptoms. The OC symptoms severity was
evaluated with the self-rated Y-BOCS for all groups, while both self and clinician-rated Y-
BOCS was administered in both OCD group. With our sample of OCD, the reliability between
self and clinician-rated global scores were good (α = 0.71) with no statistical differences
between both evaluations (p= .11). Only the self-rated Y-BOCS will be reported in the current
study. Other studies confirm the validity and reliability of the scales (internal consistency =
0.91-0.94, r = 0.90). The self-rated Padua inventory was also administered to all groups and
constitute a 60-item inventory of obsessions and compulsions. The total scale (α = 0.95) and
the subscales (α = 0.75-0.91) are also reliable. The BAI was also administered and consist in a
21-item anxiety symptom checklist rating symptom intensity for the last week on a 0–3 scale
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(α = 0.91). To assess the presence of depression, the BDI was used, which consist in a 21-item
questionnaire relative to depression (α = 0.91).
Our groups were significantly different on the Y-BOCS global score [F(2,42) = 496.99, p < 0.001]
and the Padua inventory ([F(2,42) = 11.18, p < 0.001]. A post hoc Tukey revealed that the OCD
+ groups were different from the OCD- (p= .001) and the controls (p= .001). But OCD+ and
OCD- were not statistically different on the Padua inventory global scale and three subscales
(checking, precision and rumination). There was also significant differences on anxiety [F(2,42)
= 5.16, p < 0.01] and depression [F(2,42) = 14.58, p < 0.001], revealing that both OCD groups
were significantly different from the controls on these assessments (Table 2). Given the fact
that significant scores were found in anxiety and depression, we will use these traits as
covariates in the statistical analysis involving ERPs in order to partial out the effect of these
comorbid variables (see statistical analysis).
OCD +
(N=14)
OCD -
(N=15)
CTRL
(N=15)
Clinical scales A B C ANOVA Tukey
Y-BOCS global scale 33 (3) 24 (4) 0.60 (1) *** A > B > C
Obsessions 16 (2) 11 (4) 0.20 (1) *** A > B > C
Compulsions 17 (2) 13 (3) 0.40 (1) *** A > B > C
Padua Inventory 85 (60) 65 (28) 20 (13) *** A >C B > C
Checking 19 (13) 14 (8) 3 (3) *** A > C B > C
Precision 10 (7) 6 (4) 1 (1) *** A > C B > C
Rumination 32 (22) 27 (11) 7 (6) *** A > C B > C
Washing 15 (16) 15 (9) 7 (5) ns …
Beck Anxiety 17 (17) 14 (10) 4 (3) *** A > C B > C
Beck Depression 22 (16) 17 (6) 3 (3) *** A > C B > C
Note. ***: p < 0.001 Y-BOCS: Yale-Brown Obsessive-Compulsive Scale. OCD+: Obsessive-Compulsive high symptomatic;
OCD-: Obsessive-Compulsive low symptomatic; CTRL: non psychiatric control group. ns: non significant.
Table 2. Add a space or tabulation before Checking, Precision, Rumination and Washing. They are subscales of the
Padua Inventory.
4.3. Stimuli selection
The emotional materials were constituted by photographic images from the International
Affective Picture Systems, a standardized collection of images gathered from a wide variety
of emotional and semantic categories. A total of 150 photographic images were chosen and
classified into three groups, based on the arousal and valence estimation from the IAPS
normalization (50 unpleasants, 50 neutrals and 50 pleasants). The stimuli for the study phase
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the Y-BOCS and the Padua Inventory for OCD symptoms. The OC symptoms severity was
evaluated with the self-rated Y-BOCS for all groups, while both self and clinician-rated Y-
BOCS was administered in both OCD group. With our sample of OCD, the reliability between
self and clinician-rated global scores were good (α = 0.71) with no statistical differences
between both evaluations (p= .11). Only the self-rated Y-BOCS will be reported in the current
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(α = 0.91). To assess the presence of depression, the BDI was used, which consist in a 21-item
questionnaire relative to depression (α = 0.91).
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(checking, precision and rumination). There was also significant differences on anxiety [F(2,42)
= 5.16, p < 0.01] and depression [F(2,42) = 14.58, p < 0.001], revealing that both OCD groups
were significantly different from the controls on these assessments (Table 2). Given the fact
that significant scores were found in anxiety and depression, we will use these traits as
covariates in the statistical analysis involving ERPs in order to partial out the effect of these
comorbid variables (see statistical analysis).
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Y-BOCS global scale 33 (3) 24 (4) 0.60 (1) *** A > B > C
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Padua Inventory 85 (60) 65 (28) 20 (13) *** A >C B > C
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Beck Anxiety 17 (17) 14 (10) 4 (3) *** A > C B > C
Beck Depression 22 (16) 17 (6) 3 (3) *** A > C B > C
Note. ***: p < 0.001 Y-BOCS: Yale-Brown Obsessive-Compulsive Scale. OCD+: Obsessive-Compulsive high symptomatic;
OCD-: Obsessive-Compulsive low symptomatic; CTRL: non psychiatric control group. ns: non significant.
Table 2. Add a space or tabulation before Checking, Precision, Rumination and Washing. They are subscales of the
Padua Inventory.
4.3. Stimuli selection
The emotional materials were constituted by photographic images from the International
Affective Picture Systems, a standardized collection of images gathered from a wide variety
of emotional and semantic categories. A total of 150 photographic images were chosen and
classified into three groups, based on the arousal and valence estimation from the IAPS
normalization (50 unpleasants, 50 neutrals and 50 pleasants). The stimuli for the study phase
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included a total of 75 images. For the test phase, the list included the 75 images of the study
phase (old), plus 75 images that had not been presented (new) before. The selected images
were classified into three basic categories based on the IAPS female ratings of valence [un‐
pleasant = 1-3; neutral = 4-6; pleasant = 7-9]. These 150 images [25 trials by 2 response types
(old/new) by 3 valence categories (pleasant/unpleasant/neutral)] were presented in different
orders to counterbalance potential effects due to sequence. In addition, for half of participants,
the old/new order of presentation was inverted. There were no significant differences between
old and new categories across valence or arousal values (all p’s > .36). In each emotional
category, the images contained the same basic attributes (scenes including humans, animals,
inanimate objects or landscapes) across old and new category in order to preserve coherence
across recall conditions.
The images were presented one at a time on a 17'' SVGA monitor (Viewsonic), for a fixed
duration of 4000 ms, at a distance of 90 cm calculated from the nose to the center of the computer
screen with a 5 degrees angle. They were presented at a resolution of 640 x 480 pixels in 256
colors. The inter-trial interval (ITI) was fixed at 2000 ms during which a red and white
checkerboard image appeared (IAPS #7182). This red and white checkerboard image informed
the participant to fixate their gaze on a point between picture presentations and reduce the eye
movements. This procedure also helped to reduce the after image effect, which occurred
during presentation of a blank background in our previous pilots.
4.4. Experimental procedure
The experimental session began with a study phase during which the participants were
instructed first to fix their gaze on a red and white checkerboard screen while waiting for the
next images to appear. At that point, participants were told that a series of images would be
presented and that they should attend to each picture the entire time it appeared on the screen
without giving any response. A short retention interval of 10 minutes was allowed between
the study and the test phase. In the test phase, images were projected for the same duration
and ITI as for the study phase. The participants were instructed to detect the images that had
been already presented (old) during the study phase by a button press and also to identify the
images that had never been present (new) during the study phase by pressing another button.
The reaction times were obtained with a three-button device placed in front of the subject.
They were instructed to emphasize both speed and accuracy in their responses. The emotional
evaluation based on the Self Assessment Manikin (SAM) was administered after the ERP
experimentation and the participants rated, by a paper and pencil response, each of the 150
images presented in a booklet. Previous brain imaging studies using emotional photographic
images have shown that task instructions, prompting preparation for the processing of the
evocative images, are susceptible to affect neural activity. Thus, for both study and test phases,
participants were not informed about the emotional value of the images beforehand in order
to minimize emotional expectancy. The emotional evaluation of images was done post-test in
order to keep the emotional nature of the task implicit during the experimentation.
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4.5. EEG recordings and ERP extraction
The EEG was recorded from 28 tin electrodes mounted in an elastic nylon cap (Electro-Cap
International Inc) only during recall (test phase). The scalp electrodes were placed according
to the guidelines for standard electrode position by the at F3, FT7, FC3, T3, C3, F4, FC4, FT8,
C4, T4, TP7, CP3, T5, P3, O1, CP4, TP8, P4, T6, O2. All electrodes were referenced to linked
mastoids and their impedances were kept below 5 KΩ. The Electro-oculograms (EOG) was
recorded using four 9-mm tin external bi-polar electrodes for horizontal and vertical move‐
ments. For the horizontal EOG, electrodes were placed at the outer canthus of each eye and
for the vertical EOG at infra- and supra-orbital points at the left eye, aligned with the pupil
looking straight. A bioelectric analog amplifier model ISS3-32BA (SAI-InstEP) amplified
electrical signals (EOG gain = ±10000 and EEG gain = ±20000) with a band-pass between .01
and 30 Hz. The EEG was recorded continuously at a sampling rate of 250 Hz and averaged
offline in a time-window beginning at 100 ms before and until 1900 ms after picture onset. The
EOG artifact contained in the EEG were corrected with a dynamic multiple regression in the
frequency domain. The regressions were applied using the horizontal and the vertical EOG
activity subsequently. After EOG corrections, all remaining epochs with a voltage exceeding
±100 uV and clippings due to saturation or blocking of the amplifiers were eliminated
automatically during the averaging procedure. On average, 2.5 trials per condition were
rejected, after EOG corrections, because of the remaining artifacts (range = 0-5 trials). An
analysis of variance (ANOVA), applied to the number of artefact rejected, failed to show any
significant effect across response type and emotional valence conditions (all p’s over .30). A
second ANOVA applied on the two EOGs separately also failed to reach any statistical
significance according to response type or valence (all p’s > .10). A minimum amount of 16
trials free of both errors (false alarms and misses) and artifacts were included in the ERP
averaging, which is comparable to the criteria used in similar ERP experiments. All ERP data
were extracted for two time-windows (300-500ms and 500-1000ms). These two windows
allowed us to study the EM effect, which usually appear between 300 and 800 ms after the
stimulus presentation. The EM effect was first depicted by as a representation of recollection
processes associated with medial temporal lobe structures. Our experimental hypotheses were
tested using the mean amplitudes of the ERP detected within the temporal windows as defined
in previous recognition memory research.
4.6. Statistical analysis
Several ANOVAs were performed on age, education and non-verbal intelligence (Raven
matrices), as well as for BDI, BAI, Padua and Y-BOCS scores. Gender was analyzed using the
Kruskall-Wallis, non-parametric test.
EM effect amplitude was analyzed separately using multivariate repeated-measures analyses
of variance (MANOVA-RM). Subsequently, a separate multivariate analysis of covariance
(MANCOVA) was applied on ERP amplitude data considering BDI and BAI as covariates. The
analysis comprised a between-groups factor including three levels (OCD+, OCD- and control
groups), and the following within-groups factors: Memory, with two levels (old, new);
Emotion, with three levels (positive, neutral, negative); Hemisphere, with two levels (left,
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included a total of 75 images. For the test phase, the list included the 75 images of the study
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inanimate objects or landscapes) across old and new category in order to preserve coherence
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The images were presented one at a time on a 17'' SVGA monitor (Viewsonic), for a fixed
duration of 4000 ms, at a distance of 90 cm calculated from the nose to the center of the computer
screen with a 5 degrees angle. They were presented at a resolution of 640 x 480 pixels in 256
colors. The inter-trial interval (ITI) was fixed at 2000 ms during which a red and white
checkerboard image appeared (IAPS #7182). This red and white checkerboard image informed
the participant to fixate their gaze on a point between picture presentations and reduce the eye
movements. This procedure also helped to reduce the after image effect, which occurred
during presentation of a blank background in our previous pilots.
4.4. Experimental procedure
The experimental session began with a study phase during which the participants were
instructed first to fix their gaze on a red and white checkerboard screen while waiting for the
next images to appear. At that point, participants were told that a series of images would be
presented and that they should attend to each picture the entire time it appeared on the screen
without giving any response. A short retention interval of 10 minutes was allowed between
the study and the test phase. In the test phase, images were projected for the same duration
and ITI as for the study phase. The participants were instructed to detect the images that had
been already presented (old) during the study phase by a button press and also to identify the
images that had never been present (new) during the study phase by pressing another button.
The reaction times were obtained with a three-button device placed in front of the subject.
They were instructed to emphasize both speed and accuracy in their responses. The emotional
evaluation based on the Self Assessment Manikin (SAM) was administered after the ERP
experimentation and the participants rated, by a paper and pencil response, each of the 150
images presented in a booklet. Previous brain imaging studies using emotional photographic
images have shown that task instructions, prompting preparation for the processing of the
evocative images, are susceptible to affect neural activity. Thus, for both study and test phases,
participants were not informed about the emotional value of the images beforehand in order
to minimize emotional expectancy. The emotional evaluation of images was done post-test in
order to keep the emotional nature of the task implicit during the experimentation.
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4.5. EEG recordings and ERP extraction
The EEG was recorded from 28 tin electrodes mounted in an elastic nylon cap (Electro-Cap
International Inc) only during recall (test phase). The scalp electrodes were placed according
to the guidelines for standard electrode position by the at F3, FT7, FC3, T3, C3, F4, FC4, FT8,
C4, T4, TP7, CP3, T5, P3, O1, CP4, TP8, P4, T6, O2. All electrodes were referenced to linked
mastoids and their impedances were kept below 5 KΩ. The Electro-oculograms (EOG) was
recorded using four 9-mm tin external bi-polar electrodes for horizontal and vertical move‐
ments. For the horizontal EOG, electrodes were placed at the outer canthus of each eye and
for the vertical EOG at infra- and supra-orbital points at the left eye, aligned with the pupil
looking straight. A bioelectric analog amplifier model ISS3-32BA (SAI-InstEP) amplified
electrical signals (EOG gain = ±10000 and EEG gain = ±20000) with a band-pass between .01
and 30 Hz. The EEG was recorded continuously at a sampling rate of 250 Hz and averaged
offline in a time-window beginning at 100 ms before and until 1900 ms after picture onset. The
EOG artifact contained in the EEG were corrected with a dynamic multiple regression in the
frequency domain. The regressions were applied using the horizontal and the vertical EOG
activity subsequently. After EOG corrections, all remaining epochs with a voltage exceeding
±100 uV and clippings due to saturation or blocking of the amplifiers were eliminated
automatically during the averaging procedure. On average, 2.5 trials per condition were
rejected, after EOG corrections, because of the remaining artifacts (range = 0-5 trials). An
analysis of variance (ANOVA), applied to the number of artefact rejected, failed to show any
significant effect across response type and emotional valence conditions (all p’s over .30). A
second ANOVA applied on the two EOGs separately also failed to reach any statistical
significance according to response type or valence (all p’s > .10). A minimum amount of 16
trials free of both errors (false alarms and misses) and artifacts were included in the ERP
averaging, which is comparable to the criteria used in similar ERP experiments. All ERP data
were extracted for two time-windows (300-500ms and 500-1000ms). These two windows
allowed us to study the EM effect, which usually appear between 300 and 800 ms after the
stimulus presentation. The EM effect was first depicted by as a representation of recollection
processes associated with medial temporal lobe structures. Our experimental hypotheses were
tested using the mean amplitudes of the ERP detected within the temporal windows as defined
in previous recognition memory research.
4.6. Statistical analysis
Several ANOVAs were performed on age, education and non-verbal intelligence (Raven
matrices), as well as for BDI, BAI, Padua and Y-BOCS scores. Gender was analyzed using the
Kruskall-Wallis, non-parametric test.
EM effect amplitude was analyzed separately using multivariate repeated-measures analyses
of variance (MANOVA-RM). Subsequently, a separate multivariate analysis of covariance
(MANCOVA) was applied on ERP amplitude data considering BDI and BAI as covariates. The
analysis comprised a between-groups factor including three levels (OCD+, OCD- and control
groups), and the following within-groups factors: Memory, with two levels (old, new);
Emotion, with three levels (positive, neutral, negative); Hemisphere, with two levels (left,
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right); Region, with two levels (anterior, posterior) and Electrodes, with the five remaining
levels. The electrodes were divided in four quadrants as left anterior (F3, FT7, FC3, T3 and C3),
left posterior (TP7, CP3, T5, P3 and O1), right anterior (F4, FC4, FT8, C4 and T4) and right
posterior (CP4, TP8, P4, T6 and O2).
5. Results
5.1. Subjective evaluation of emotional images
Activation and valence evaluation: On one hand, a non-significant memory factor indicated that
memory showed no impact on the subjective evaluation of activation. On the other hand, the
emotional valence influenced the subjective evaluation of activation [F(2,38) = 151.17, p < 0.001].
Thus, the subjective evaluation of activation was higher for positive (6.79/9) and negative
(5.61/9) emotional valence stimuli than for neutral ones (3.82/9). Furthermore, we found a
significant memory by emotion interaction [F(2,38) = 25.50, p < 0.001], indicating that the
emotional valence effect was more important for the previously seen images. However, there
was no group effect since participants from both OCD groups (OCD+ and OCD-) gave a
subjective evaluation of activation that was equivalent to the control participants.
Dominance evaluation: The level of subjective confidence in participants’ respective responses
was also affected by the emotional valence of stimuli [F(2,38) = 7.24, p < 0.005]. We effectively
observed that the dominance level was significantly higher for responses to positive images
(7.93/9) compared to negative (7.53/9) and neutral ones (7.51/9). Additionally, a significant
interaction between memory and emotions [F(2,38) = 7.55, p < 0.005] indicated that the
subjective dominance level was greater only for responses to old positive images. Regarding
the comparison group, there was a trend suggesting a lower subjective confidence level for
both OCD groups when compared to the control group [F(2,39) = 2.96, p = 0.06].
5.2. Performance and reaction times
Reaction times: New images elicited a delayed reaction time (1329 ms) in comparison to old
ones (1205 ms) [Memory: F(1,42) 26.45, p < 0.001]. Likewise, reaction times to negative images
(1307 ms) were significantly delayed when compared to positive (1249 ms) and neutral (1247
ms) ones [Emotion: F (2,41) = 16.65: p < 0.001]. As exposed before, we noticed differences
between response times to old and new images. Thus, a significant memory by emotion
interaction [F (2,41) = 6.72: p < 0.005] showed that these old-new differences were larger when
a response was required for stimuli of negative emotional valence (158 ms) compare to positive
(137 ms) and neutral (75 ms) ones (see Figure 1). Additionally, we have noticed that both OCD
groups showed delayed reaction times than controls to the negative condition [Group by
emotion: F(2,42) = 3.84, p < 0.05].
Analysis of correct responses (hits): The novelty aspect affected the amount of correct responses
as indicated by a significantly greater amount of hits for new images than for old ones
[Memory: F(1,42) = 19.67, p < 0.001]. As well, emotions also showed an impact on performances
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[Emotion: F(1,42) = 19.67, p < 0.001], since negative images (24) elicited more hits than the neutral
(23) and the positive (22) ones. Similarly, the emotional valence of images has also showed an
impact on memory performances since a memory by emotion interaction was significant
[F(2,41) = 27.99, p < 0.001] only in positive and neutral conditions. As for the reaction times
analyses, a significant group by emotion interaction [F(4,84) = 3.34, p < 0.05] was found. This
indicates that negative images evoked better performances for the control and OCD- groups,
as represented by a higher number of hits.
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Figure 1. Illustration of the group by emotion interaction on the reaction times (RT) in function of the three emotional
conditions for the three groups. The RTs were delayed more dramatically in the unpleasant condition for both OCD
groups compared to the control group.
5.3. Electrophysiological data
300 ms to 500 ms post-stimulus window: The topographic distribution of ERPs revealed greater
amplitudes in the posterior comparatively to the anterior area [F (1,42) = 49.28: p < 0.001]. As
well, emotional valence impacted electrophysiological data as shown by more salient ERPs in
response to positive and negative images than those for the neutral ones [Emotion: F (2,41) =
16.95: p < 0.001]. Similarly, memory also influenced 300-500 ms brain activity as suggested by
significantly larger ERPs for old images than for new ones [F (1,42) = 30.34: p < 0.001], thus
attesting for the early EM effect. Additionally, a complex interaction between memory,
emotion and regions reached significance [F (2,41) = 3.57: p < 0.05]. Accordingly, specifically
over the anterior region, the EM effect was more important to positive and neutral emotions
than to negative ones. Furthermore, no effect of memory or emotions was evident over the
posterior region and importantly, no group difference was found for this time-window.
500 ms to 1000 ms post-stimulus window: The emotion factor remained significant in our second
time-window [F (2,41) = 16.31: p < 0.001]. The ERPs to positive and negative images were
significantly larger compared to those in response to neutral ones. Additionally, a complex
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right); Region, with two levels (anterior, posterior) and Electrodes, with the five remaining
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left posterior (TP7, CP3, T5, P3 and O1), right anterior (F4, FC4, FT8, C4 and T4) and right
posterior (CP4, TP8, P4, T6 and O2).
5. Results
5.1. Subjective evaluation of emotional images
Activation and valence evaluation: On one hand, a non-significant memory factor indicated that
memory showed no impact on the subjective evaluation of activation. On the other hand, the
emotional valence influenced the subjective evaluation of activation [F(2,38) = 151.17, p < 0.001].
Thus, the subjective evaluation of activation was higher for positive (6.79/9) and negative
(5.61/9) emotional valence stimuli than for neutral ones (3.82/9). Furthermore, we found a
significant memory by emotion interaction [F(2,38) = 25.50, p < 0.001], indicating that the
emotional valence effect was more important for the previously seen images. However, there
was no group effect since participants from both OCD groups (OCD+ and OCD-) gave a
subjective evaluation of activation that was equivalent to the control participants.
Dominance evaluation: The level of subjective confidence in participants’ respective responses
was also affected by the emotional valence of stimuli [F(2,38) = 7.24, p < 0.005]. We effectively
observed that the dominance level was significantly higher for responses to positive images
(7.93/9) compared to negative (7.53/9) and neutral ones (7.51/9). Additionally, a significant
interaction between memory and emotions [F(2,38) = 7.55, p < 0.005] indicated that the
subjective dominance level was greater only for responses to old positive images. Regarding
the comparison group, there was a trend suggesting a lower subjective confidence level for
both OCD groups when compared to the control group [F(2,39) = 2.96, p = 0.06].
5.2. Performance and reaction times
Reaction times: New images elicited a delayed reaction time (1329 ms) in comparison to old
ones (1205 ms) [Memory: F(1,42) 26.45, p < 0.001]. Likewise, reaction times to negative images
(1307 ms) were significantly delayed when compared to positive (1249 ms) and neutral (1247
ms) ones [Emotion: F (2,41) = 16.65: p < 0.001]. As exposed before, we noticed differences
between response times to old and new images. Thus, a significant memory by emotion
interaction [F (2,41) = 6.72: p < 0.005] showed that these old-new differences were larger when
a response was required for stimuli of negative emotional valence (158 ms) compare to positive
(137 ms) and neutral (75 ms) ones (see Figure 1). Additionally, we have noticed that both OCD
groups showed delayed reaction times than controls to the negative condition [Group by
emotion: F(2,42) = 3.84, p < 0.05].
Analysis of correct responses (hits): The novelty aspect affected the amount of correct responses
as indicated by a significantly greater amount of hits for new images than for old ones
[Memory: F(1,42) = 19.67, p < 0.001]. As well, emotions also showed an impact on performances
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[Emotion: F(1,42) = 19.67, p < 0.001], since negative images (24) elicited more hits than the neutral
(23) and the positive (22) ones. Similarly, the emotional valence of images has also showed an
impact on memory performances since a memory by emotion interaction was significant
[F(2,41) = 27.99, p < 0.001] only in positive and neutral conditions. As for the reaction times
analyses, a significant group by emotion interaction [F(4,84) = 3.34, p < 0.05] was found. This
indicates that negative images evoked better performances for the control and OCD- groups,
as represented by a higher number of hits.
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Figure 1. Illustration of the group by emotion interaction on the reaction times (RT) in function of the three emotional
conditions for the three groups. The RTs were delayed more dramatically in the unpleasant condition for both OCD
groups compared to the control group.
5.3. Electrophysiological data
300 ms to 500 ms post-stimulus window: The topographic distribution of ERPs revealed greater
amplitudes in the posterior comparatively to the anterior area [F (1,42) = 49.28: p < 0.001]. As
well, emotional valence impacted electrophysiological data as shown by more salient ERPs in
response to positive and negative images than those for the neutral ones [Emotion: F (2,41) =
16.95: p < 0.001]. Similarly, memory also influenced 300-500 ms brain activity as suggested by
significantly larger ERPs for old images than for new ones [F (1,42) = 30.34: p < 0.001], thus
attesting for the early EM effect. Additionally, a complex interaction between memory,
emotion and regions reached significance [F (2,41) = 3.57: p < 0.05]. Accordingly, specifically
over the anterior region, the EM effect was more important to positive and neutral emotions
than to negative ones. Furthermore, no effect of memory or emotions was evident over the
posterior region and importantly, no group difference was found for this time-window.
500 ms to 1000 ms post-stimulus window: The emotion factor remained significant in our second
time-window [F (2,41) = 16.31: p < 0.001]. The ERPs to positive and negative images were
significantly larger compared to those in response to neutral ones. Additionally, a complex
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interaction between memory, emotion and hemispheres was present [F (2,41) = 4.14: p < 0.05].
When taking into account the memory factor, ERPs in response to neutral images were larger
in the left hemisphere comparatively to the right hemisphere. Hemispheric lateralization of
the memory effect as observed in the left hemisphere was also noted for the negative images
(without being as important as for neutral and positive images). Similarly to the first time-
window, the ERPs scalp distribution revealed larger amplitudes in the posterior region
comparatively to the anterior area [F (1,42) = 13.38: p = 0.001]. A memory by region interaction
[F (1,40) = 7.87: p < 0.01] indicated that the amplitudes differences between old and new images
were greater in the posterior region than in the anterior area. Additionally, OCD+ participants
showed reduced amplitudes in comparison to controls and OCD- groups particularly in the
posterior region, as suggested by a significant region and group interaction [F (2,42) = 5.49: p
< 0.010]. Moreover, the group by memory interaction remained significant after covarying for
anxiety scores [F (2,40) = 3.78: p < 0, 05].
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Figure 2. Illustration of the group by memory interaction with the LPC amplitude in function of old-new memory con‐
dition for the three groups.
The EM effect reflected by the difference between old and new stimuli was significantly smaller
for OCD- and OCD+ respectively than for the control group, as shown in Figure 2. Also, a four-
way complex interaction between groups, memory, emotions and regions has been noticed
[F(2,40) = 3.57, p < 0.05].
6. Discussion
Globally, analyses suggested that old pictures triggered faster reaction times and that OCD
groups were characterized by delayed reaction times and less correct responses comparatively
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to healthy participants. These observations are consistent with current and past research
investigating anxious and depressive patients who showed similar phenomena. Additionally,
the pictures’ emotional valence influenced all participants’ episodic memory processing. As
well, the EM effect was smaller for all OCD patients, and even more particularly for the most
severely affected group. The severity of OCD symptoms seems to affect brain activity related
to memory processing and this could be, at least in part, explained by a dysfunction in the
CSTC. Moreover, emotional pictures elicited a reduced anterior EM effect among severe OCD
patients. Additionally, the insertion of depressive or anxious symptoms as covariables did not
influence the results, suggesting that the presence of significant comorbid symptoms were not
related to the altered emotional memory effect observed in OCD patients.
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Illustration of the stimulus-locked ERP amplitudes to old (solid lines) and new 
(dotted lines) images for all groups in neutral, negative and positive valence conditions. The 
left column represent ERPs of the left posterior parietal region and the right column refer to 
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reduced old-new effect compared to the OCD- and to the controls.
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interaction between memory, emotion and hemispheres was present [F (2,41) = 4.14: p < 0.05].
When taking into account the memory factor, ERPs in response to neutral images were larger
in the left hemisphere comparatively to the right hemisphere. Hemispheric lateralization of
the memory effect as observed in the left hemisphere was also noted for the negative images
(without being as important as for neutral and positive images). Similarly to the first time-
window, the ERPs scalp distribution revealed larger amplitudes in the posterior region
comparatively to the anterior area [F (1,42) = 13.38: p = 0.001]. A memory by region interaction
[F (1,40) = 7.87: p < 0.01] indicated that the amplitudes differences between old and new images
were greater in the posterior region than in the anterior area. Additionally, OCD+ participants
showed reduced amplitudes in comparison to controls and OCD- groups particularly in the
posterior region, as suggested by a significant region and group interaction [F (2,42) = 5.49: p
< 0.010]. Moreover, the group by memory interaction remained significant after covarying for
anxiety scores [F (2,40) = 3.78: p < 0, 05].
-0,4
0
0,4
0,8
1,2
1,6
LP
C
 A
m
pl
itu
de
 (µ
V
)
(5
00
-1
00
0 
m
s)
Old New Old-new
difference
+OCD
-OCD
Control
Conditions 
Figure 2. Illustration of the group by memory interaction with the LPC amplitude in function of old-new memory con‐
dition for the three groups.
The EM effect reflected by the difference between old and new stimuli was significantly smaller
for OCD- and OCD+ respectively than for the control group, as shown in Figure 2. Also, a four-
way complex interaction between groups, memory, emotions and regions has been noticed
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to healthy participants. These observations are consistent with current and past research
investigating anxious and depressive patients who showed similar phenomena. Additionally,
the pictures’ emotional valence influenced all participants’ episodic memory processing. As
well, the EM effect was smaller for all OCD patients, and even more particularly for the most
severely affected group. The severity of OCD symptoms seems to affect brain activity related
to memory processing and this could be, at least in part, explained by a dysfunction in the
CSTC. Moreover, emotional pictures elicited a reduced anterior EM effect among severe OCD
patients. Additionally, the insertion of depressive or anxious symptoms as covariables did not
influence the results, suggesting that the presence of significant comorbid symptoms were not
related to the altered emotional memory effect observed in OCD patients.
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6.1. Emotional memory performances and behavior
In general, performances and response times were delayed and the number of correct re‐
sponses was higher for new images. Similarly, it has been shown that new words elicit delayed
reaction times than old ones. Likewise, in a study investigating episodic memory accounting
for emotional factors of Gilles de la Tourette syndrome and OCD (SGT-OCD) patients, also
found that old words, that were presented only once, elicited shorter reaction times. Con‐
versely, found that depressive patients presented delayed reaction times for old words. Unlike,
we found that the emotional valence did in fact, influenced reaction times. Indeed, our results
showed that overall, negative images were those that elicited the fastest reaction times.
Additionally, participants were faster to detect old negative and positive images compara‐
tively to new positive and negative images. Using words rather than photographs, also
reported the same findings in depressive patients.
Analogously, the amount of correct responses was also influenced by the emotional valence
of images, especially for newly presented neutral and positive ones. This suggests that
emotional valence influences performance and modulates memory processes. Additionally,
we observed a trend toward longer reaction times for OCD patients when compared to
controls. Consistently, observed the same phenomenon in different OCD patients. Likewise,
when they compared moderately symptomatic OCD patients to controls, they showed
significantly delayed reaction times. These results coincide with those found by during an
implicit memory task that was part of an experiment assessing OCD patients’ memory using
words. It is interesting to note that the OCD patients included in that study were comparable
to our less symptomatic patients (OCD-) and that similar results were found (i.e. patients and
controls showed delayed reaction times for old words. Moreover, we also found that, for
images of the same emotional category, OCD+ participants showed a delayed response when
compared to controls. Additionally, our more symptomatic OCD patients tended to be less
confident in their responses to negative images compared to controls. These group difference
could be explained by a different recall strategy aiming to compensate the difficulties experi‐
enced by more severe OCD symptoms. From past results, we also know that checker OCD
patients have a poorer perception of their memory capacity and that they lack confidence in
their recognition capabilities.
6.2. The influence of OCD symptoms on episodic memory and ERPs
Between 300 and 500 ms post-stimulus, old images elicited larger ERP amplitude than new
images. Our results strongly resemble those of, which demonstrated that ERPs were more
positive for repeated words (i.e. old words). This old/new effect has been shown to be reflected
by episodic memory and is sensitive to conscious recollection. In our second time-window
(500-1000 ms post-stimulus), we also found that OCD+ participants showed significantly
smaller ERPs for old images. Moreover, this result remained significant even after covarying
for anxiety level.
Conversely, Kim et al. (2006) found no difference between their OCD patients and controls for
the EM effect with words. However, their OCD patients were moderately symptomatic (Y-
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BOCS = 25), and resembled more to our OCD- patients (Y-BOCS = 24) than our OCD+ patients
(Y-BOCS = 34+). In fact, our OCD- group revealed no significant differences compared to the
control group regarding the magnitude of the EM effect. These results suggest that only highly
symptomatic OCD patients may recollect information differently. Indeed, it has been found
that people suffering from OCD may feel the need to adopt a sequential rather than a com‐
prehensive approach to recognition and organization when performing even a simple memory
task. A possible explanation regarding the results discrepancies between different studies may
lie in the severity of OCD symptoms.
Another interesting finding is that ERPs remained more important in the posterior region
compared to the anterior area. This could indicate the presence of a late positive component
(LPC) associated with episodic memory. The EM effect is associated with the conscious
recollection processes that occur primarily in the left parietal scalp region, normally between
400 and 800 ms. Interestingly, we observed, comparatively to OCD- and controls, that highly
symptomatic OCD+ patients showed smaller EM effects, particularly in the posterior region.
Likewise, performed a similar study, comparing severe and moderate OCD patients to control
participants. They studied the EM effect after presenting new and old words, while recording
ERP signals. Although our OCD+ group (mean Y-BOCS = 33) was more symptomatic than
their severe group (mean Y-BOCS = 27), they also observed a diminution of the late EM effect
(450-650 ms). This reduction was specific to the severe OCD group compared to moderate OCD
and controls and was also more prominent in the parieto-temporal region. This could indicate
that severe OCD symptoms impact on processes mediated through the right prefrontal cortical
regions, which are hypothesized to be involved in memory inhibition mechanisms.
6.3. The influence of OCD on episodic memory and the influence of emotions on ERPs
With our participants, we noted that positive and negative images evoked the largest ERPs.
As well, numerous researchers have also reported that they observed increased ERPs’
amplitudes when presenting stimuli with an emotional component. Moreover, added that
emotions might modulate recognition processes. Thus, it is possible that ERPs reflect, in part,
the activity of the anterior cingulate cortex, which has connections with cortico-frontal regions
and limbic system. Additionally, found a decrease of the EM effect when they presented words
with positive and negative connotations to SGT-OCD patients. In parallel, for our first-time
window (300-500 ms post-stimulus), neutral images triggered larger EM effects and positive
ones elicited even larger ERPs. Analogously, reported similar conclusions following their SGT-
OCD study, where ERPs were larger particularly in the frontal and central regions.
Regarding our second time-window, the memory effect was linked to larger ERPs in the left
hemisphere particularly for neutral and negative images. This result seems consistent with
other findings with verbal stimuli. Recognition information that has no emotional component
might be related to more limited cerebral regions while information with emotional factors
might be related to other structures. found a smaller EM effect for positive images for SGT-
OCD patients comparatively to control participants. While covarying for anxiety levels, we
have observed the same phenomenon more particularly over the posterior region for OCD+
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6.1. Emotional memory performances and behavior
In general, performances and response times were delayed and the number of correct re‐
sponses was higher for new images. Similarly, it has been shown that new words elicit delayed
reaction times than old ones. Likewise, in a study investigating episodic memory accounting
for emotional factors of Gilles de la Tourette syndrome and OCD (SGT-OCD) patients, also
found that old words, that were presented only once, elicited shorter reaction times. Con‐
versely, found that depressive patients presented delayed reaction times for old words. Unlike,
we found that the emotional valence did in fact, influenced reaction times. Indeed, our results
showed that overall, negative images were those that elicited the fastest reaction times.
Additionally, participants were faster to detect old negative and positive images compara‐
tively to new positive and negative images. Using words rather than photographs, also
reported the same findings in depressive patients.
Analogously, the amount of correct responses was also influenced by the emotional valence
of images, especially for newly presented neutral and positive ones. This suggests that
emotional valence influences performance and modulates memory processes. Additionally,
we observed a trend toward longer reaction times for OCD patients when compared to
controls. Consistently, observed the same phenomenon in different OCD patients. Likewise,
when they compared moderately symptomatic OCD patients to controls, they showed
significantly delayed reaction times. These results coincide with those found by during an
implicit memory task that was part of an experiment assessing OCD patients’ memory using
words. It is interesting to note that the OCD patients included in that study were comparable
to our less symptomatic patients (OCD-) and that similar results were found (i.e. patients and
controls showed delayed reaction times for old words. Moreover, we also found that, for
images of the same emotional category, OCD+ participants showed a delayed response when
compared to controls. Additionally, our more symptomatic OCD patients tended to be less
confident in their responses to negative images compared to controls. These group difference
could be explained by a different recall strategy aiming to compensate the difficulties experi‐
enced by more severe OCD symptoms. From past results, we also know that checker OCD
patients have a poorer perception of their memory capacity and that they lack confidence in
their recognition capabilities.
6.2. The influence of OCD symptoms on episodic memory and ERPs
Between 300 and 500 ms post-stimulus, old images elicited larger ERP amplitude than new
images. Our results strongly resemble those of, which demonstrated that ERPs were more
positive for repeated words (i.e. old words). This old/new effect has been shown to be reflected
by episodic memory and is sensitive to conscious recollection. In our second time-window
(500-1000 ms post-stimulus), we also found that OCD+ participants showed significantly
smaller ERPs for old images. Moreover, this result remained significant even after covarying
for anxiety level.
Conversely, Kim et al. (2006) found no difference between their OCD patients and controls for
the EM effect with words. However, their OCD patients were moderately symptomatic (Y-
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BOCS = 25), and resembled more to our OCD- patients (Y-BOCS = 24) than our OCD+ patients
(Y-BOCS = 34+). In fact, our OCD- group revealed no significant differences compared to the
control group regarding the magnitude of the EM effect. These results suggest that only highly
symptomatic OCD patients may recollect information differently. Indeed, it has been found
that people suffering from OCD may feel the need to adopt a sequential rather than a com‐
prehensive approach to recognition and organization when performing even a simple memory
task. A possible explanation regarding the results discrepancies between different studies may
lie in the severity of OCD symptoms.
Another interesting finding is that ERPs remained more important in the posterior region
compared to the anterior area. This could indicate the presence of a late positive component
(LPC) associated with episodic memory. The EM effect is associated with the conscious
recollection processes that occur primarily in the left parietal scalp region, normally between
400 and 800 ms. Interestingly, we observed, comparatively to OCD- and controls, that highly
symptomatic OCD+ patients showed smaller EM effects, particularly in the posterior region.
Likewise, performed a similar study, comparing severe and moderate OCD patients to control
participants. They studied the EM effect after presenting new and old words, while recording
ERP signals. Although our OCD+ group (mean Y-BOCS = 33) was more symptomatic than
their severe group (mean Y-BOCS = 27), they also observed a diminution of the late EM effect
(450-650 ms). This reduction was specific to the severe OCD group compared to moderate OCD
and controls and was also more prominent in the parieto-temporal region. This could indicate
that severe OCD symptoms impact on processes mediated through the right prefrontal cortical
regions, which are hypothesized to be involved in memory inhibition mechanisms.
6.3. The influence of OCD on episodic memory and the influence of emotions on ERPs
With our participants, we noted that positive and negative images evoked the largest ERPs.
As well, numerous researchers have also reported that they observed increased ERPs’
amplitudes when presenting stimuli with an emotional component. Moreover, added that
emotions might modulate recognition processes. Thus, it is possible that ERPs reflect, in part,
the activity of the anterior cingulate cortex, which has connections with cortico-frontal regions
and limbic system. Additionally, found a decrease of the EM effect when they presented words
with positive and negative connotations to SGT-OCD patients. In parallel, for our first-time
window (300-500 ms post-stimulus), neutral images triggered larger EM effects and positive
ones elicited even larger ERPs. Analogously, reported similar conclusions following their SGT-
OCD study, where ERPs were larger particularly in the frontal and central regions.
Regarding our second time-window, the memory effect was linked to larger ERPs in the left
hemisphere particularly for neutral and negative images. This result seems consistent with
other findings with verbal stimuli. Recognition information that has no emotional component
might be related to more limited cerebral regions while information with emotional factors
might be related to other structures. found a smaller EM effect for positive images for SGT-
OCD patients comparatively to control participants. While covarying for anxiety levels, we
have observed the same phenomenon more particularly over the posterior region for OCD+
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and controls. Our results lead us to the same hypothesis articulated by: patients showed
diminished capacities for conscious recollection than healthy controls, especially in an
emotionally charged context.
7. Conclusion
Our findings highlighted the influence of severe OCD symptoms on processes mediated
through the right prefrontal cortical regions, which are hypothesized to be involved in memory
inhibition mechanisms. Indeed, it has been found that people suffering from OCD may feel
the need to adopt a sequential rather than a comprehensive approach to recognition and
organization when performing even a simple memory task. Anomaly in certainty or memory
inhibition mechanisms could influence information processing and working memory updat‐
ing processes, as reflected by an anterior P300 amplitude attenuation. Thus, our findings
support the importance of selecting more symptomatic participants in order to study differ‐
ences in emotional memory processes. This might explain why a relatively important part of
the literature often failed to notice any significant difference between OCD and control
participants.
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and controls. Our results lead us to the same hypothesis articulated by: patients showed
diminished capacities for conscious recollection than healthy controls, especially in an
emotionally charged context.
7. Conclusion
Our findings highlighted the influence of severe OCD symptoms on processes mediated
through the right prefrontal cortical regions, which are hypothesized to be involved in memory
inhibition mechanisms. Indeed, it has been found that people suffering from OCD may feel
the need to adopt a sequential rather than a comprehensive approach to recognition and
organization when performing even a simple memory task. Anomaly in certainty or memory
inhibition mechanisms could influence information processing and working memory updat‐
ing processes, as reflected by an anterior P300 amplitude attenuation. Thus, our findings
support the importance of selecting more symptomatic participants in order to study differ‐
ences in emotional memory processes. This might explain why a relatively important part of
the literature often failed to notice any significant difference between OCD and control
participants.
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1. Introduction
From its very beginning, behavior-cognitive therapy has been applied in the treatment of
obsessive-compulsive disorder (OCD), particularly using the exposure with response pre‐
vention strategy.
This treatment has different components: one of them is the exposure to the situation that
usually causes the compulsive behavior without completing the compulsive acts. The other
is cognitive exposure to the secondary anxiety caused by the avoiding compulsory activity,
with the confirmation that the feared situation doesn’t come.
Cognitive Behavior Therapy (CBT) is as efficient as pharmacotherapy in the treatment of
OCD and the effects last at least the same time. Some studies have found that the efficacy of
the combination of CBT and medication is higher than that of each one separately. But the
studies vary regarding the number of patients who achieved remission. Rodrigues et al
[2011] revised published studies with CBT and pharmacotherapy and they found than the
percentages of remission varied from 64% to 23%. But all the studies revised in their system‐
atic review suggested the efficacy of CBT as a next-step strategy for treating patients who do
not remit with pharmacological therapy only [1].
Almost 60% of patients with OCD do not respond adequately to medications and are con‐
sidered to be refractory to pharmacotherapy [2]. Relapse rates are still high among OCD pa‐
tients undergoing pharmacotherapy, from 24% to 89%, in part because of differences in
study designs and definitions of relapse. CBT provides promise for OCD patients, with ef‐
fectiveness rates ranging from 60% to 85%. Relapse rates three months after discontinuation
of intensive CBT are up to 50%.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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Desinsitization, hought detention, flooding, implosion therapy, and aversive conditioning
have been used in the treatment of OCD; all of them are based on the collaboration of the
patient and the need of tolerating anxiety related to obsessive thoughts, avoiding acting the
compulsions.
Following psychoanalytic view, OCD is related to aggressive impulses; so accepting them
through introspective or cognitive therapy can produce positive results. Constructive psy‐
chotherapy can help some patients with good cognitive capacity. Cognitive component of
therapy probably works emphasizing the creation of new representations and behaviors
more than correcting distorted cognitions.
In some cases group therapy is useful; it has been proved in children and adolescent pa‐
tients, populations that usually have problems to accept they are different to their peers.
Group therapy enhances treatment adherence and facilitates the use of humor in therapy,
particularly relevant for OCD patients because they live in a fearful and pessimistic world,
and reveal a significant lower level of positive emotions, even compared with depressive
population.
During cognitive therapy obsessions and compulsions are defined and relabeled as OCD
symptoms, different from ordinary thoughts. Patients are encouraged to distance them‐
selves from these obsessions and view these thoughts as strange to them. The exposure has
to be planned, with a previous exposure hierarchy. Refocusing is a way of increasing toler‐
ance for response prevention; refocusing on an alternative behavior facilitates response pre‐
vention and thought detention.
CBT procedures involve the selection and creation of alternative representations to restore
more positive mood states. New directions in CBT try to modify a person’s relationship to
his/her negative thoughts rather than directly to challenge the content of the thoughts.
Mindfulness-based cognitive therapy is based on the application of Buddhist meditation
techniques and it is beginning to be used in OCD as a complementary technique in treat‐
ment.
2. Obsessive-Compulsive Disorder — A brief explanation from cognitive
approach
Obsessive-compulsive disorder (OCD) is considered a multifactorial disorder that can sig‐
nificantly impair functionality and quality of life [3]. Though obsessive thoughts are com‐
mon in general population, in OCD the amount of time dedicated to them impairs the
execution of normal functioning.
Patients with OCD selectively attend to fearful signs, but they generally present difficulties
to inhibit irrelevant information as well. OCD is characterized for the preconscious deficit in
the ability to process irrelevant information which is essential to symptoms formation and
maintenance [4].
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Compulsions can involve washing, ordering, cleaning, checking, seeking reassurance, repet‐
itive actions as rituals, or mental compulsions, and their objective uses to be preventing
some danger to oneself or to the loved ones, or avoiding anxiety provoked by the obses‐
sions. Obsessions are found to be differentiated into five factors: contamination/cleaning,
symmetry/ordering, aggressive/checking, pure obsessions, and hoarding [5]. Checking repe‐
titions could be an altered function of memory of emotional events, a disability to distin‐
guish what is the imaginary part of events or a deficient record without alterations of recent
memory [4]. Repetitive checking behaviors are considered an example of the lack of certain‐
ty over the realization or not of an action. The patients cannot distinguish between “have
done it” or “have imagined doing it”. This uncertainty could lead to obsessive doubts that
provoked repetitive checking of doors, gas key, or others [4].
Classically OCD patients are classified as “washers” or “checkers”, but classified with five
factors seems to be more explanatory. Cognitive vulnerability dimensions may vary accord‐
ing to symptom subtype: harming-related fears due to the spread of contamination patients
have higher scores in responsibility/thread estimation when compared with patients with
pure contamination symptoms [5]. Inflated responsibility beliefs are related to harming/
doubting/checking obsessive compulsive symptoms. Responsibility appraisals are less rele‐
vant for washers than for checkers or patients with aggressive/harming obsessions. Patients
with contamination obsessive compulsive symptoms demonstrate cognitive bias to themati‐
cally related symptom stimuli, but patients with harming obsessions do not evidence greater
cognitive bias to responsibility words than contamination patients [5]. Contamination pa‐
tients have poorer response to cognitive therapy than checkers, which has to be kept in
mind when a treatment is planned.
Memories do not preserve a literal representation of the world [6], and memory retrieval is
constructive. In OCD it is frequent to observe illusory memories about previous danger that
have been avoided thanks to rituals. Long-term memories are influenced by the emotion ex‐
perienced during learning [7]. Mood-dependent memory is the enhance recollection of infor‐
mation previously recorded in a specific mood state. In patients with OCD, neutral
information about cleanliness, sexuality, or order, is invested with a strong emotional corre‐
late and becomes a fixed and obsessive idea. The internal representation of previously expe‐
rienced emotional stimulus may elicit a transient emotional state [7]. This mechanism
impairs the efficacy of cognitive therapy, because if the therapeutic work is to reconsolidate
a new memory trace, an emotional stimulus is needed. Cognitive-behavior therapy acts on
the premise that emotional memories are modified upon retrieval. In narrative approach,
the retrieval is used, but the objective is not to reduce anxiety thanks to be exposed to the
memory in a safe environment. The final objective is to re-explain the past experiences with
a new look.
People with OCD tend to present deficit in tasks which imply cognitive bias and distortions,
and they can be more sensitive in front of stimuli related to their fears [8], though contradic‐
tory data are found. Affective images are more capable to provoke cognitive bias than neu‐
tral ones. People with subclinical obsessive-compulsive symptoms evaluate neutral images
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less amiable than control people do, and all type of images as less controllable. OCD people
need to feel control over every aspect of their lives.
Obsessions are caused by catastrophic misinterpretations of the significance of one’s
thoughts or impulses, similar to normal negative intrusions but more severe, frequent and
upsetting [9]. There are two stages in the model: first an intrusion and then the misinterpre‐
tation of it. The OCD problems surge with the combination of perceived high responsibility
and expectation of a future catastrophe. Some authors view responsibility as central in OCD,
but others suppose it’s secondary to other processes.
The feared scenario appears more easily in OCD imagination than non-feared scenarios. The
repetition and “practice” of the same obsession results in the relevant simulation becoming
more coherent and elaborated and reinforced through ritualizing, fixing the symptomatolo‐
gy [10].
Thinking errors that lead to obsessions can be derived from “fusions”, as moral thought-ac‐
tion fusion (thinking of an action is as bad as doing it), thought-event fusion (thinking about
an event provokes it), thought-thought fusion (thinking about having a thought is the same
that having it) [9].
Criticism was defined as “a negative reinforcement which produces feelings of failure and
has been identified as a poor way to encourage better performance” (Neapolitan, cited in 3).
Among the difficulties in definition, criticism can mean different things for different people,
from “an act of analysis” to having quite negative connotations. Self-criticism has been in‐
vestigated in relation to mental health, and depends on feedback from others and internal
thoughts.
Central to the cognitive model of OCD is the role of responsibility. The distress experienced
in OCD has relation with the cognition of the self-responsibility about causing danger to
oneself or the others. People with OCD need feeling control over external circumstances,
managing them through rituals and compulsions.
Beliefs related to inflated responsibility have been proposed as one of six cognitive variables
that play a role in OCD (Obsessive Compulsive Cognitions Working Group). The other five
ones are: overimportance of thoughts (Thought Action Fusion), excessive concern about the
importance of controlling one’s thoughts, overestimation of threat, intolerance of uncertain‐
ty, and perfectionism [3].
The cognitive model of OCD emphasizes the role of early experiences that could predispose
an individual to develop an OCD. Rituals and compulsive behaviors can appear as a way to
avoid external criticism, and gain paternal approval. So, OCD could be the result of social
training. The parenting style in families with OCD people uses to be overprotective and crit‐
ical what could increase the need of control and responsibility. The experiences of recurrent
criticism may increase the “subjective cost of being responsible”. Harm eventually is descri‐
bed by OCD patients as excessive parental criticism. Overprotective parents may result in
fearful children. If overcritical style is added, the result could be children who attempt to
control and do everything right and avoid errors, resulting in checking behaviors. OCD pa‐
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rents’ relationships frequently are characterized by perfectionism, high level of criticism and
risk-aversion. It is frequent to observe familiar antecedents of compulsive behaviors or ob‐
sessive thoughts in OCD. Though it may be related to genetic factors, cognitive and behavio‐
ral styles are usually learned at home.
Perfectionism and responsibility functions are to maintain a sense of self-worth, maintaining
approval from others, specifically to gain approval from hypercritical parents. Individuals
with OCD may feel unsure about their self-worth due to receiving contradictory messages
from a dominant parent during childhood. Dysfunctional responsibility and responsibility
beliefs were related to an ambivalent sense of self. The cognitive model of OCD proposes
that an individual fears harm coming to self or being responsible and blamed for causing
harm. Compulsive behaviors may emerge as a way to regain a positive self-image or to re‐
tain social approval.
Responsibility in OCD uses to be high, and they are told frequently “you will be to blame if
anything happens”. When responsibility decreases, also anticipated criticism does.
Compulsive behaviors increase when an expectation of failure is present as well. There is a
relationship between criticism and checking behaviours. These are preventive, though the
cleaning ones are restorative. Through interactions with parents children learn to regulate
themselves, so excessive criticism for mistakes or punishment for irresponsibility incites a
concern with safety and responsibility.
3. Cognitive behavior therapy
CBT procedures involve the selection and creation of alternative representations to modify
irrational ways of thinking and dysfunctional ways of behaving [11]. Desensitization and ex‐
posure have been largely used in the treatment of OCD patients. CBT has become the psy‐
chological treatment of choice for OCD, reducing symptoms to a level similar to that seen
with pharmacotherapy, with clinical improvement maintained during follow-up [12]. In
many studies CBT associated to medication management has demonstrated to be superior to
the two strategies separately, even in pediatric age [13], though it seems to be more efficient
the addition to CBT to people with a partial response to medication.
An obsession is both meaningful and irrational, part of the self and yet alien and intrusive
[9]. For this reason, obsessions are a problem for cognitive approaches.
But CBT does not always lead to clinical improvement. Sometimes even secondary effects
can appear during CBT, as nausea and abdominal discomfort, which are related to the anxi‐
ety provoked by the exposition and response prevention along the treatment [12]. New di‐
rections in cognitive approach attempt to change the persons’ relationships with their
thoughts, not to directly intervene over the thought content. The cognitive models usually
assume that previous adversity provokes vulnerability in the form of negative representa‐
tions of the self and the world (negative schemas). Selves can be based on wishes or aspira‐
tions, and in OCD, as in other anxiety disorders, symptoms are associated with a perceived
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less amiable than control people do, and all type of images as less controllable. OCD people
need to feel control over every aspect of their lives.
Obsessions are caused by catastrophic misinterpretations of the significance of one’s
thoughts or impulses, similar to normal negative intrusions but more severe, frequent and
upsetting [9]. There are two stages in the model: first an intrusion and then the misinterpre‐
tation of it. The OCD problems surge with the combination of perceived high responsibility
and expectation of a future catastrophe. Some authors view responsibility as central in OCD,
but others suppose it’s secondary to other processes.
The feared scenario appears more easily in OCD imagination than non-feared scenarios. The
repetition and “practice” of the same obsession results in the relevant simulation becoming
more coherent and elaborated and reinforced through ritualizing, fixing the symptomatolo‐
gy [10].
Thinking errors that lead to obsessions can be derived from “fusions”, as moral thought-ac‐
tion fusion (thinking of an action is as bad as doing it), thought-event fusion (thinking about
an event provokes it), thought-thought fusion (thinking about having a thought is the same
that having it) [9].
Criticism was defined as “a negative reinforcement which produces feelings of failure and
has been identified as a poor way to encourage better performance” (Neapolitan, cited in 3).
Among the difficulties in definition, criticism can mean different things for different people,
from “an act of analysis” to having quite negative connotations. Self-criticism has been in‐
vestigated in relation to mental health, and depends on feedback from others and internal
thoughts.
Central to the cognitive model of OCD is the role of responsibility. The distress experienced
in OCD has relation with the cognition of the self-responsibility about causing danger to
oneself or the others. People with OCD need feeling control over external circumstances,
managing them through rituals and compulsions.
Beliefs related to inflated responsibility have been proposed as one of six cognitive variables
that play a role in OCD (Obsessive Compulsive Cognitions Working Group). The other five
ones are: overimportance of thoughts (Thought Action Fusion), excessive concern about the
importance of controlling one’s thoughts, overestimation of threat, intolerance of uncertain‐
ty, and perfectionism [3].
The cognitive model of OCD emphasizes the role of early experiences that could predispose
an individual to develop an OCD. Rituals and compulsive behaviors can appear as a way to
avoid external criticism, and gain paternal approval. So, OCD could be the result of social
training. The parenting style in families with OCD people uses to be overprotective and crit‐
ical what could increase the need of control and responsibility. The experiences of recurrent
criticism may increase the “subjective cost of being responsible”. Harm eventually is descri‐
bed by OCD patients as excessive parental criticism. Overprotective parents may result in
fearful children. If overcritical style is added, the result could be children who attempt to
control and do everything right and avoid errors, resulting in checking behaviors. OCD pa‐
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rents’ relationships frequently are characterized by perfectionism, high level of criticism and
risk-aversion. It is frequent to observe familiar antecedents of compulsive behaviors or ob‐
sessive thoughts in OCD. Though it may be related to genetic factors, cognitive and behavio‐
ral styles are usually learned at home.
Perfectionism and responsibility functions are to maintain a sense of self-worth, maintaining
approval from others, specifically to gain approval from hypercritical parents. Individuals
with OCD may feel unsure about their self-worth due to receiving contradictory messages
from a dominant parent during childhood. Dysfunctional responsibility and responsibility
beliefs were related to an ambivalent sense of self. The cognitive model of OCD proposes
that an individual fears harm coming to self or being responsible and blamed for causing
harm. Compulsive behaviors may emerge as a way to regain a positive self-image or to re‐
tain social approval.
Responsibility in OCD uses to be high, and they are told frequently “you will be to blame if
anything happens”. When responsibility decreases, also anticipated criticism does.
Compulsive behaviors increase when an expectation of failure is present as well. There is a
relationship between criticism and checking behaviours. These are preventive, though the
cleaning ones are restorative. Through interactions with parents children learn to regulate
themselves, so excessive criticism for mistakes or punishment for irresponsibility incites a
concern with safety and responsibility.
3. Cognitive behavior therapy
CBT procedures involve the selection and creation of alternative representations to modify
irrational ways of thinking and dysfunctional ways of behaving [11]. Desensitization and ex‐
posure have been largely used in the treatment of OCD patients. CBT has become the psy‐
chological treatment of choice for OCD, reducing symptoms to a level similar to that seen
with pharmacotherapy, with clinical improvement maintained during follow-up [12]. In
many studies CBT associated to medication management has demonstrated to be superior to
the two strategies separately, even in pediatric age [13], though it seems to be more efficient
the addition to CBT to people with a partial response to medication.
An obsession is both meaningful and irrational, part of the self and yet alien and intrusive
[9]. For this reason, obsessions are a problem for cognitive approaches.
But CBT does not always lead to clinical improvement. Sometimes even secondary effects
can appear during CBT, as nausea and abdominal discomfort, which are related to the anxi‐
ety provoked by the exposition and response prevention along the treatment [12]. New di‐
rections in cognitive approach attempt to change the persons’ relationships with their
thoughts, not to directly intervene over the thought content. The cognitive models usually
assume that previous adversity provokes vulnerability in the form of negative representa‐
tions of the self and the world (negative schemas). Selves can be based on wishes or aspira‐
tions, and in OCD, as in other anxiety disorders, symptoms are associated with a perceived
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failure to be the person oneself thinks he or she ought to be. Also, anxiety can be related to
feeling too close to a feared or undesired self, and striving to avoid experiencing it [11], par‐
ticularly relevant to OCD. Learning is a constructive process, constantly producing new rep‐
resentations which can collaborate or compete with the preexisting memories to control
behavior, so the construction of new representations can be more efficient in the correction
of distortions.
In OCD treatment can be focused in reduction of anxiety level, understanding OCD as an
anxiety disorder; focused in response prevention, trying to reduce compulsions; focused in
exposure to images, objects or situations that provoke obsessions; focused, finally, in chang‐
ing old habits by new habits [14]. It is important to integrate symptomatology with patient’s
story: how the disorder appears, which factors are maintaining it, what kind of coping strat‐
egies the patient is using to fight with the obsessions and compulsions.
Third wave of CBT includes new themes: metacognition, cognitive fusion, emotions, accept‐
ance, mindfulness, dialectics, spirituality, and therapeutic relationship [15]. Change in meta‐
cognitions is effective in treatment of OCD. Metacognition is the aspect of cognition that
controls mental processes and thinking. To this model, the cognitive attentional syndrome, a
psychopatological state consisting of repetitive cognitive processes such as worrying, rumi‐
nation, dysfunctional threat monitoring, and dysfunctional cognitive and behavioral coping
are at the core of depressive and anxiety disorders [15].
OCD patients reveal a significant lower proportion of positive emotions in dreams than oth‐
er people, and their dreams tend to be shorter, less complex and less emotional. These char‐
acteristics are not modified after CBT treatment, except the trend to show less negative
emotions during dreams. Exposure does not seem to have traumatizing effect [16].
In patients with anxiety there is a preferential encoding of information that is consistent
with the treat-related concerns [5]. The objective of cognitive therapy is to correct dysfunc‐
tional beliefs and information processes biases.
4. Treatment of OCD from a cognitive constructive perspective
Usually cognitive behavioral treatment of OCD is directed to develop a less threatening ex‐
planation of world and to prevent compulsive responses to obsessive thoughts in order to
neutralizing those behaviors.
During cognitive behavioural treatment some patients present an impairment of depressive
symptoms, specifically during exposure, but This group presents a higher level of improve‐
ment after treatment. It must be due to the integration of new knowledge and experiences,
which initially could lead to a bigger “chaos” [17]. Changes are associated to system destabi‐
lization, old patterns are less viable, and new patterns emerge, what provokes fluctuations.
Beliefs and behaviors are supposed to be related one to each other in OCD, and this relation
can be bidirectional. During treatment, changes in beliefs can be followed by changes in con‐
ducts, but also changes in beliefs can be preceded by the behavioral changes [17].
Obsessive-Compulsive Disorder - The Old and the New Problems124
Higher levels of predicted criticism are related to poorer treatment outcome, because nega‐
tive feedback is found to be less effective if the individual feels he has no influence over his
performance.
Attributional style involves communicating a causal belief about an event, and high levels of
relatives’ hostility is related to high levels of responsibility attributions. Cognitive treatment
of OCD tries to develop a less threatening explanation for the world. From a constructive
perspective, it’s important to develop a less dangerous perceived world, in which personal
control does not determine all the life circumstances.
Memory distortions may reflect the influence of adaptative processes that are beneficial for
cognitive functions, but also result in memory errors [18]. These distortions are based on the
operation of a schema that is useful to organize and interpret information. Episodic memory
supports the construction of future events by extracting and recombining stored information
into a simulation of a novel event. Brain activity is highly similar during remembering the
past and imagining the future [18]. This similarity could explain the link between thought
and act that is observed in some patients with OCD.
The elevated expressed emotions act as stressors for OCD patients and enhance symptoma‐
tology, so an objective of the treatment must be coping with those and / or family therapy to
reduce them.
Neutralizing behaviors such as compulsions have as an objective to prevent some danger
that would produce blame from significant ones. The OCD behaviors are maintained to
avoid criticism but are converted to stereotypical behaviors that no longer function in terms
of the original reasons. And OCD behavior itself provokes further criticism and acts as a
stressor to maintain behaviors.
When criticism is a focus in OCD treatment, Some previous questions must be answered:
who delivers criticism, how, where it is delivered, how does the recipient perceive the feed‐
back, if it is followed by punishment, and if it is overlapped with blame. The therapy focus
could be accepting or managing actual criticism when it is accurate and directed toward ap‐
propriate targets. If patient is in an unsupportive environment, therapeutic work must in‐
volve family or significant others who are the source of criticism [3].
Other cognitive mechanisms implicated in OCD are heightened responsibility, thought-ac‐
tion fusion (TAF), self-doubt, overimportance of thoughts, cognitive control, perfectionism,
overestimation of threat, and intolerance of uncertainty [10]. Obsessions are viewed as inter‐
ferences about reality, arrived at on the basis of an inductive narrative: the realty is per‐
ceived initially adaptively, but as a result of reasoning errors, that vision derives in
obsessional interferences: he or she is influenced by self-generated narratives that lead them
to doubt their perception of external experience in favor of a hypothetical, internally gener‐
ated version. These errors produce inferential confusion when a remote possibility is con‐
flated with a fictional narrative, so the previously imagined becomes a real possibility. Then
the individual acts as if this imagined supposition is potentially real and is drive to try to
modify it, albeit unsuccessfully [10].
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acteristics are not modified after CBT treatment, except the trend to show less negative
emotions during dreams. Exposure does not seem to have traumatizing effect [16].
In patients with anxiety there is a preferential encoding of information that is consistent
with the treat-related concerns [5]. The objective of cognitive therapy is to correct dysfunc‐
tional beliefs and information processes biases.
4. Treatment of OCD from a cognitive constructive perspective
Usually cognitive behavioral treatment of OCD is directed to develop a less threatening ex‐
planation of world and to prevent compulsive responses to obsessive thoughts in order to
neutralizing those behaviors.
During cognitive behavioural treatment some patients present an impairment of depressive
symptoms, specifically during exposure, but This group presents a higher level of improve‐
ment after treatment. It must be due to the integration of new knowledge and experiences,
which initially could lead to a bigger “chaos” [17]. Changes are associated to system destabi‐
lization, old patterns are less viable, and new patterns emerge, what provokes fluctuations.
Beliefs and behaviors are supposed to be related one to each other in OCD, and this relation
can be bidirectional. During treatment, changes in beliefs can be followed by changes in con‐
ducts, but also changes in beliefs can be preceded by the behavioral changes [17].
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Attributional style involves communicating a causal belief about an event, and high levels of
relatives’ hostility is related to high levels of responsibility attributions. Cognitive treatment
of OCD tries to develop a less threatening explanation for the world. From a constructive
perspective, it’s important to develop a less dangerous perceived world, in which personal
control does not determine all the life circumstances.
Memory distortions may reflect the influence of adaptative processes that are beneficial for
cognitive functions, but also result in memory errors [18]. These distortions are based on the
operation of a schema that is useful to organize and interpret information. Episodic memory
supports the construction of future events by extracting and recombining stored information
into a simulation of a novel event. Brain activity is highly similar during remembering the
past and imagining the future [18]. This similarity could explain the link between thought
and act that is observed in some patients with OCD.
The elevated expressed emotions act as stressors for OCD patients and enhance symptoma‐
tology, so an objective of the treatment must be coping with those and / or family therapy to
reduce them.
Neutralizing behaviors such as compulsions have as an objective to prevent some danger
that would produce blame from significant ones. The OCD behaviors are maintained to
avoid criticism but are converted to stereotypical behaviors that no longer function in terms
of the original reasons. And OCD behavior itself provokes further criticism and acts as a
stressor to maintain behaviors.
When criticism is a focus in OCD treatment, Some previous questions must be answered:
who delivers criticism, how, where it is delivered, how does the recipient perceive the feed‐
back, if it is followed by punishment, and if it is overlapped with blame. The therapy focus
could be accepting or managing actual criticism when it is accurate and directed toward ap‐
propriate targets. If patient is in an unsupportive environment, therapeutic work must in‐
volve family or significant others who are the source of criticism [3].
Other cognitive mechanisms implicated in OCD are heightened responsibility, thought-ac‐
tion fusion (TAF), self-doubt, overimportance of thoughts, cognitive control, perfectionism,
overestimation of threat, and intolerance of uncertainty [10]. Obsessions are viewed as inter‐
ferences about reality, arrived at on the basis of an inductive narrative: the realty is per‐
ceived initially adaptively, but as a result of reasoning errors, that vision derives in
obsessional interferences: he or she is influenced by self-generated narratives that lead them
to doubt their perception of external experience in favor of a hypothetical, internally gener‐
ated version. These errors produce inferential confusion when a remote possibility is con‐
flated with a fictional narrative, so the previously imagined becomes a real possibility. Then
the individual acts as if this imagined supposition is potentially real and is drive to try to
modify it, albeit unsuccessfully [10].
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OCD is related to “inflated responsibility”, because responsibility is extended beyond its
“normal” range [9]. A person with OCD acts “as if” personally responsible of the object of
him or her obsession. They do not believe to have acted the obsession, but they feel as if it
has happened. Some styles of information processing do not lend themselves to rational re‐
vision of beliefs, but the integration of these aspects of experience when integrating alterna‐
tive narratives to the OCD narrative may change cognition in the process of therapy.
Imagination has a core role in OCD, as is demonstrated by the efficacy of imaginary expo‐
sure with response prevention. Imagining a future event increases the subjective likelihood
that the event is going to occur, being more important when the event is ease to be thought.
The concerns of OCD people are almost always about imagined events that have never oc‐
curred before, at least to them [10].
Treatment uses to be similar in children and adults, due to clinical similitude [19], but in
younger there’s more evidence in behavior psychotherapy and pharmacological than in a
cognitive approach. In the cognitive therapy one of the components is relabeling obsessions
as symptoms, not ordinary thoughts. Patients are encouraged to distance themselves from
obsessions and view them as bizarre messages. Refocusing on an alternative behavior is im‐
portant, too, as a way to tolerate response prevention. Group treatment for OCD can be use‐
ful due to the sense of “being in it together”, that reduces anxiety [19].
Treatment of dysfunctional schemas is useful too in OCD, assuming these are in the origin
of negative intrusions and its misinterpretations. Sometimes OCD is the result of the inabili‐
ty to cope with early experiences as abuse and emotional rejection. The assumption of a uni‐
tary and rational self underlies in cognitive view, though it has no restraining influence on
the practice of cognitive therapy [9].
Narrative approach does not treat cognitions as stand-alone thought units, compared with
veridical perception nor reduce them to schemas, but narrative theory considers thoughts in
the experience and adaptative context of the person [9]. The narrative engages the person in
his/her own problem and positions on it, so obsessions fit into a complete scene.
First stage in narrative therapy is to elicit narratives, asking people to present the problem in
their own words, so it is easier to understand the relations among obsessional thoughts, per‐
sonal relationships, beliefs... obsessions are not isolated items, empty of content. Thinking
emerges as a part of a script, so responsibility can be origin of obsessions from “me” or from
“others”, as a way to understand oneself or something that affects relationships with other
people through the possible errors.
In dialogical approach, the inner world is studied in the form of interpersonal relationships:
the concept of one self is expanded to a multiplicity of relatively autonomous “I” positions,
each one with one voice. The voices of separate selves are validated socially, are heard, si‐
lenced or modified through dialogue [9]. Obsessions have an alien nature, that could be un‐
derstood as a thought or behavior designed as “not me”, belonging to the unfamiliar self,
revealed when people do not understand their own reactions. A dialogical approach sees
the issue of designating and obsessional thought, image, or impulse as consistent or incon‐
sistent with the “self” in a contextual and dialogical manner [9]. Some patients report that
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they feel like another person when they are performing an obsessional ritual, they feel that
the ritual is stronger than themselves. Self-generated narratives can modify confidence in al‐
ternative possibilities as well as actual perceptions.
The dialogical approach to obsessions interprets the specificity of obsessions in terms of an
unresolved dialogue [9], that can be completed, rephrased or answered to move it to resolu‐
tion. Many times the second voice is not present, so people with OCD are not able to answer
it. But sometimes OCD people explain their obsessions as “voices”, different from the reason
voice. In any case, obsessional neutralizing behavior would be dictated by the power of nar‐
rative, exposing and identifying with the person the processes by which narratives are con‐
structed.
With the schema theory, OCD emerges when a conflict appears between contradictory sche‐
mas. Development of a unitary self is not possible in presence of incompatible attachment
schemas. An excessive sense of personal vulnerability threatens identity. But OCD patients
can have a high functioning in many contexts, with the problem centered in a specific situa‐
tion, where the obsession emerges.
Many obsessions are consistent with the two-stage model of intrusions, in the way “If I
think about it, I will become very anxious”, but some times there is a common framework,
as to feel one is a sinner if a blasphemous thought (intrusion) appears. The themes of all ob‐
sessions fall into three categories, following Rachman (cited in 9]: aggression, sexuality and
blasphemy. Intrusive thoughts become more frequent, persistent and unpleasant when the
threat is bigger. It is not clear if the theme of an obsession is related to developmental expe‐
riences and prior beliefs. However, from narrative framework it is possible to link it to earli‐
er development, so the content of the obsession can be traced to children-parents` previous
experiences. The final aim of the treatment is to generate alternative accounts of the OCD
experience which would modify the meaning of thoughts and behavior.
Viewing over-responsibility, exaggerated danger, improbable consequences and magical
thinking within a narrative context helps to understand the development of them and ex‐
plain the individual response pattern [9]. The therapy tries to empower the patient to modi‐
fy his or her own obsessional narrative, not to ignore it or fight with it.
5. Obsessive-Compulsive Spectrum Disorders (OCSD)
Some disorders present clinical similarities with OCD, with the urge to execute a behavior
though it is unwanted or lived as desadaptative followed by relief when it is done or anxiety
if it could be done. These disorders are conceptualized as Obsessive-Compulsive Spectrum
Disorders (OCSD). Some authors understand these as an addictive behavior. These disor‐
ders at the compulsive end respond better to SSRIs and those at the impulsive end (dysmor‐
phic disorder, hypochondriasis, onychophagia, and psychogenic excoriation) appear to
benefit from a wider range of thymoleptics [20]. But also all of them respond, at least partial‐
ly, to CBT. Among Obsessive Compulsive Spectrum Disorders are described the following:
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Treatment uses to be similar in children and adults, due to clinical similitude [19], but in
younger there’s more evidence in behavior psychotherapy and pharmacological than in a
cognitive approach. In the cognitive therapy one of the components is relabeling obsessions
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portant, too, as a way to tolerate response prevention. Group treatment for OCD can be use‐
ful due to the sense of “being in it together”, that reduces anxiety [19].
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ty to cope with early experiences as abuse and emotional rejection. The assumption of a uni‐
tary and rational self underlies in cognitive view, though it has no restraining influence on
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Narrative approach does not treat cognitions as stand-alone thought units, compared with
veridical perception nor reduce them to schemas, but narrative theory considers thoughts in
the experience and adaptative context of the person [9]. The narrative engages the person in
his/her own problem and positions on it, so obsessions fit into a complete scene.
First stage in narrative therapy is to elicit narratives, asking people to present the problem in
their own words, so it is easier to understand the relations among obsessional thoughts, per‐
sonal relationships, beliefs... obsessions are not isolated items, empty of content. Thinking
emerges as a part of a script, so responsibility can be origin of obsessions from “me” or from
“others”, as a way to understand oneself or something that affects relationships with other
people through the possible errors.
In dialogical approach, the inner world is studied in the form of interpersonal relationships:
the concept of one self is expanded to a multiplicity of relatively autonomous “I” positions,
each one with one voice. The voices of separate selves are validated socially, are heard, si‐
lenced or modified through dialogue [9]. Obsessions have an alien nature, that could be un‐
derstood as a thought or behavior designed as “not me”, belonging to the unfamiliar self,
revealed when people do not understand their own reactions. A dialogical approach sees
the issue of designating and obsessional thought, image, or impulse as consistent or incon‐
sistent with the “self” in a contextual and dialogical manner [9]. Some patients report that
Obsessive-Compulsive Disorder - The Old and the New Problems126
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tion. Many times the second voice is not present, so people with OCD are not able to answer
it. But sometimes OCD people explain their obsessions as “voices”, different from the reason
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rative, exposing and identifying with the person the processes by which narratives are con‐
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schemas. An excessive sense of personal vulnerability threatens identity. But OCD patients
can have a high functioning in many contexts, with the problem centered in a specific situa‐
tion, where the obsession emerges.
Many obsessions are consistent with the two-stage model of intrusions, in the way “If I
think about it, I will become very anxious”, but some times there is a common framework,
as to feel one is a sinner if a blasphemous thought (intrusion) appears. The themes of all ob‐
sessions fall into three categories, following Rachman (cited in 9]: aggression, sexuality and
blasphemy. Intrusive thoughts become more frequent, persistent and unpleasant when the
threat is bigger. It is not clear if the theme of an obsession is related to developmental expe‐
riences and prior beliefs. However, from narrative framework it is possible to link it to earli‐
er development, so the content of the obsession can be traced to children-parents` previous
experiences. The final aim of the treatment is to generate alternative accounts of the OCD
experience which would modify the meaning of thoughts and behavior.
Viewing over-responsibility, exaggerated danger, improbable consequences and magical
thinking within a narrative context helps to understand the development of them and ex‐
plain the individual response pattern [9]. The therapy tries to empower the patient to modi‐
fy his or her own obsessional narrative, not to ignore it or fight with it.
5. Obsessive-Compulsive Spectrum Disorders (OCSD)
Some disorders present clinical similarities with OCD, with the urge to execute a behavior
though it is unwanted or lived as desadaptative followed by relief when it is done or anxiety
if it could be done. These disorders are conceptualized as Obsessive-Compulsive Spectrum
Disorders (OCSD). Some authors understand these as an addictive behavior. These disor‐
ders at the compulsive end respond better to SSRIs and those at the impulsive end (dysmor‐
phic disorder, hypochondriasis, onychophagia, and psychogenic excoriation) appear to
benefit from a wider range of thymoleptics [20]. But also all of them respond, at least partial‐
ly, to CBT. Among Obsessive Compulsive Spectrum Disorders are described the following:
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• Body Dysmorphic Disorder: associated to preoccupation with an imagined or overempha‐
sized defect in appearance appear repetitive and often ritualistic behaviours (such as
mirrorchecking and request for reassurance). Exposure to social situations avoiding
camouflage, resist to compulsive behaviors and cognitive restructuring have shown to be
beneficial. CBT plus psychopharmacologic treatment with Serotonin Reuptake Inhibitors
(SRI) have demonstrated the higher response.
• Hypochondriasis: is the persistent fear or belief that one has a serious illness based of one’s
misinterpretation of body signs, which leads to hypervigilance. Treatment is based in
restructuring faulty assumptions about physical symptoms and modifying maladaptative
patterns of behavior that maintain symptomatology. Individual psychotherapy focusing on
illness and symptom perception can be useful, too.
• Trichotillomania: recurrent pulling of one’s hair with noticeable hair loss. There is an
increased stress immediately before the behavior with posterior relief. Habit reversal
therapy (selfmonitoring, competing response, thought stopping) is the more efficient CBT,
also associated to acceptance and commitment therapy.
• Pathological gambling: uncontrollable urge or impulse to gamble that progressively
increases in intensity until generating social and / or economic difficulties. Imaginary
desensitization is more efficient than aversion relief or other behavioral treatments.
• Compulsive buying: implies shopping preoccupations or behaviors. The possible benefit of
cognitive restructuring techniques to enable patients to develop more appropriated
responses to their impulses has been suggested as efficient.
• Kleptomania: is characterized by the recurrent failure to resist impulse to steal items that
are not needed for personal use or for its monetary value. Patients experience increased
sense of tension prior to the act and a sense of pleasure, relief, or gratification when
committing theft. There are no studies published about CBT in kleptomania.
• Onychophagia and psychogenic excoriation: chronic nail biting and compulsive skin
picking are considered impulse control disorders, because the self-injurious behaviors are
habitual, ritualistic, tension-reducing, and ego-dystonic. Competing response therapy is
significantly superior to aversion therapy, and aversion therapy is superior to self-moni‐
toring alone.
6. Conclusions
OCD is a chronic, severe, and sometimes incapacitating disorder which needs to be treated
in a multifactorial way. Psychopharmacological treatment has demonstrated its utility in
this illness, but the best results are obtained when it is associated to psychotherapy. This ef‐
ficacy is more evident in patients who are resistant to pharmacotherapy alone.
One of the most proved therapies is cognitive behavioral therapy. CBT has many strategies
to treat OCD. The most used strategies are exposure with response prevention, but these are
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not applicable in all the patients, because they can provoke an increase of anxiety which
could be unbearable.
We propose in this revision to work with a narrative approach, putting the disorder in the
frame of the patients’ lives, understanding how and when it has emerged, trying to find the
sense of it, to give a new look to the disorder and constructing a new way to cope with the
irrational or overemphasized ideas.
There are not many evidences of constructive or narrative approach in treatment of OCD,
but we think constructivism has an important role in OCD treatment. Understanding the be‐
ginning of the disorder and the role of it into patients’ lives improve the way the patients
can face the symptomatology. This perspective helps the patients to re-explain the symp‐
toms as a way to cope with a fearsome world which could be adaptative in a moment but
these symptoms have lost their coping function when they have transformed themselves in
a rigid way.
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• Body Dysmorphic Disorder: associated to preoccupation with an imagined or overempha‐
sized defect in appearance appear repetitive and often ritualistic behaviours (such as
mirrorchecking and request for reassurance). Exposure to social situations avoiding
camouflage, resist to compulsive behaviors and cognitive restructuring have shown to be
beneficial. CBT plus psychopharmacologic treatment with Serotonin Reuptake Inhibitors
(SRI) have demonstrated the higher response.
• Hypochondriasis: is the persistent fear or belief that one has a serious illness based of one’s
misinterpretation of body signs, which leads to hypervigilance. Treatment is based in
restructuring faulty assumptions about physical symptoms and modifying maladaptative
patterns of behavior that maintain symptomatology. Individual psychotherapy focusing on
illness and symptom perception can be useful, too.
• Trichotillomania: recurrent pulling of one’s hair with noticeable hair loss. There is an
increased stress immediately before the behavior with posterior relief. Habit reversal
therapy (selfmonitoring, competing response, thought stopping) is the more efficient CBT,
also associated to acceptance and commitment therapy.
• Pathological gambling: uncontrollable urge or impulse to gamble that progressively
increases in intensity until generating social and / or economic difficulties. Imaginary
desensitization is more efficient than aversion relief or other behavioral treatments.
• Compulsive buying: implies shopping preoccupations or behaviors. The possible benefit of
cognitive restructuring techniques to enable patients to develop more appropriated
responses to their impulses has been suggested as efficient.
• Kleptomania: is characterized by the recurrent failure to resist impulse to steal items that
are not needed for personal use or for its monetary value. Patients experience increased
sense of tension prior to the act and a sense of pleasure, relief, or gratification when
committing theft. There are no studies published about CBT in kleptomania.
• Onychophagia and psychogenic excoriation: chronic nail biting and compulsive skin
picking are considered impulse control disorders, because the self-injurious behaviors are
habitual, ritualistic, tension-reducing, and ego-dystonic. Competing response therapy is
significantly superior to aversion therapy, and aversion therapy is superior to self-moni‐
toring alone.
6. Conclusions
OCD is a chronic, severe, and sometimes incapacitating disorder which needs to be treated
in a multifactorial way. Psychopharmacological treatment has demonstrated its utility in
this illness, but the best results are obtained when it is associated to psychotherapy. This ef‐
ficacy is more evident in patients who are resistant to pharmacotherapy alone.
One of the most proved therapies is cognitive behavioral therapy. CBT has many strategies
to treat OCD. The most used strategies are exposure with response prevention, but these are
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1. Introduction
Obsessive Compulsive Disorder (OCD) is a neuropsychiatric condition characterized by
obsessions (defined as recurrent and persistent thoughts, impulses or images that are intrusive
and inappropriate and cause marked distress) and compulsions (repetitive behaviors or
mental acts driven by obsessions to reduce distress or prevent dreaded events [1]. OCD is the
fourth most prevalent psychiatric disorder and was considered as one of the most debilitating
disorders with a prevalence rate of 2.5 % in an individuals’ lifetime [2, 3]. OCD is widespread
among both adults and children [4]. OCD is considered a relatively common occurrence in
childhood and adolescence where prevalence rates are between 1 to 3.6% [5-7]. As it is the case
with other mood and anxiety disorders, females tend to be at a higher risk of developing OCD
compared to males [8]. About one third to one half of adult OCD cases has its origins in
childhood or adolescence [9, 10]. However, a recent meta-analysis found that pregnant women
and post partum women have higher prevalence rates of OCD compared to the general
population, with postpartum women at a much greater risk compared to the general female
population [11]. Research has found that early onset is associated with males while late onset
is associated with females [10].
It is worthwhile to mention that the new DSM- 5 released in May, 2013 has a number of changes
to OCD and related disorders such as hoarding disorder and Body Dismorphic Disorder
(BDD). OCD is no longer an anxiety disorder, rather is has its own chapter in the DSM-5. The
chapter includes other disorders, in addition to obsessive-compulsive disorder, such as Body
Dysmorphic Disorder and trichotillomania (hair-pulling disorder), as well as two new
disorders: hoarding disorder and excoriation (skin-picking) disorder [12].
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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The presence of co-morbidities is common in people with OCD. For example, some of the most
common disorders associated with OCD are depression [13-15], anxiety [16-19], alcohol or
substance misuse [20-22], BDD [23], or eating disorders [24]. People with OCD have a tendency
for impulsive behavior (may include symptoms of childhood conduct disorder). They also
show higher rates of suicidal attempts [25]. OCD is often considered a chronic condition and
it significantly impairs various spheres of a person’s life including social, emotional and
somatic [25].
1.1. Etiology
The etiology of OCD is multifaceted. OCD is etiologically and phenomenologically heteroge‐
neous [26]. For individuals with OCD, it has been indicated that there are abnormalities in the
neurotransmitter; serotonin, which plays an important role in carrying nerve impulses from
neurons to the receptor cells via the brain. The normal functioning of serotonin is impaired in
patients with OCD as a result of blocked or impaired receptor sites in the brain [27]. Neuro‐
logical aberrations could be associated with genetic mutations, while environmental factors
can play a role in the expression of OCD symptoms [27]. The use of Clomipramine or Selective
Serotonin Reuptake Inhibitors (SSRIs) has shown promising results in reducing symptoms of
individuals with OCD [4, 28]. This indicates the involvement of the brain in the etiology of
OCD [27, 28].
Although the same diagnostic criteria are used to diagnose OCD, its expression varies from
person to person (i.e. onset, severity, obsessions and compulsions) [29]. Symptom dimensions
are heritable in OCD [30]. It is imperative to pinpoint that the onset of OCD is linked to the
interaction between both genetic and environmental correlates. This does not necessarily
indicate that negative life events cause OCD, rather a number of studies have found that for
people with biological or psychological vulnerability, negative events may trigger the onset
of OCD [31, 32].
The identification of susceptible genes involved in the onset of OCD is challenging given the
heterogeneity of the disorder. The use of symptom-based rather than disorder-based construct
has reduced the heterogeneity of OCD [3]. vanGrootheest (2008) conducted a twin-study to
explore the OC symptom dimension heritability [33]. The vanGrootheest study is pioneering
in the field because it utilized population-based rather than OCD - sample of twin pairs. It
identified rumination, contamination and checking; three OC symptom dimensions which
shared discrepancy with OC behavior that was explained by both genetic (36%) and environ‐
mental factors (64%). However, certain genes influenced the contamination dimension and
therefore, that dimension was independent. The use of family pedigrees is yet another
approach to determine the heritability of the OCD trait [34]. In pedigree analysis, a high genetic
loading was associated with symmetry and ordering symptoms. More interestingly, for
symmetry, hoarding and contamination symptoms, correlations among independent sibling
pairs were found [35, 36]. According to the OCD Collaborative Genetics Study, sibling-sibling
association was associated with four factors; hoarding and taboo thoughts being the most
prevalent [37, 38]. In families with a multigenerational history of OCD and hoarding, OC
symptoms were found to have a higher rate of heritability compared to hoarding [39].
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1.2. Symptoms and its Sub-types
Obsessive-Compulsive symptomatology is generally measured using the Yale-Brown Obses‐
sive Compulsive Scale (Y-BOCS), which includes an assessment of the severity of the disorder
and a checklist (YBOCS-CL) of the OC symptoms [40, 41]. This scale consists of 45 obsessions
and 29 compulsions within 15 predefined symptom categories [40, 41]. A recent meta-analysis
identified five OC symptom dimensions or factors: (i) symmetry and repeating; (ii) aggressive,
sexual and religious obsessions; (iii) contamination and cleaning, (iv) aggressive obsessions
and checking; and (v) somatic obsessions [42].
1.3. Diagnosis
According to the DSM-IV criteria, the symptoms of OCD should not be due to a general medical
disease, chemical substance, or drug overdose [1]. OC symptoms are associated with several
neurological lesions of the cortico-striatal-thalamic-corticol circuits resulting from the admin‐
istration of drugs such as methylphenidate or cocaine (dopamine agonists) or after strepto‐
coccal infection [4]. Clinically speaking, OCD symptoms are associated with marked anguish
and dysfunction. Subclinical OC symptoms are common and are noted during the path of
normal development [4]. However, OCD can negatively affect a person’s quality of life [43-45].
In some cases, diagnosis becomes unclear, when the symptoms are perplexed with those of
Obsessive-Compulsive Personality Disorder [42]. Although, OCD symptoms vary from
symptoms observed in other anxiety and mood disorders, they are an intrinsic component of
other disorders such as autism and frontal lobe lesions [46]. Inappropriate diagnosis, under
diagnosis and incompetent treatment are linked to tremendous direct and indirect costs [4].
2. Brief historical overview
Since the 4th century BC, OCD has been elucidated as “melancholia”, a unique disease with
certain mental and physical symptoms. These symptoms are attributed to the imbalance in the
bodily fluids; blood, black bile, yellow bile, and phlegm [47]. Hippocrates defined all fears and
depressions if lasting for a long time as symptoms of melancholia [47].
In the early Middle Ages in Europe, blasphemous, sexual or obsessive perceptions were
attributed to satanic possession, which was believed to lead to compulsive behaviors [48].
Priests treated patients by expelling spirits from their bodies. However, in the 17th century, the
concept of “religious melancholy” came to be known as the cause of several mental disorders
including those with OCD-like symptoms [49].
Sigmund Freud, an Austrian psychiatrist, suggested that OC behavior is associated with
unconscious conflicts [47, 50]. Freud’s analytical conceptualization of “obsessive neurosis” was
based on the idea that people develop OCD as a result of the difficulties in the anal psycho‐
sexual stage of development. Freud utilized psychoanalysis to treat OCD. There is no current
evidence - based research that supports the use of traditional psychodynamic psychotherapy
in the treatment of OCD [51]. This, in turn, gave rise to the behavioral mode of psychotherapy.
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Several cognitive behavioral theories have been developed to understand and target symp‐
toms’ progression and maintenance in people with OCD. The following sections will discuss
the various cognitive behavioral theories.
2.1. Mowrer’s two stage theory
Also known as the two-factor theory, Hobart Mowrer proposed a strictly behavioral drive-
based theory in 1947 to explain avoidance in entirely behavioral terms [52]. Mowrer’s theory
merged the learning principles of classical and operant conditioning and explains fear
acquisition and the vicious cycle of rituals. Based on classical conditioning, phobias are the
result of an association between a neutral stimulus (conditioned stimulus; CS) and feared
stimulus (unconditioned stimulus; UCS) [53]. Mowrer's theory supports the concept that a CS
provokes fear when it is recurrently presented with an UCS. The neutral stimulus is any mental
event and/or physical object while the avoidance of the stimulus reduces anxiety [53]. People
with OCD react to the neutral stimulus with the same fear level associated with the unpleasant
event. Furthermore, it is through the generalization process that fear and avoidance can extend
to other places or situations, which remind the individual of the trauma, triggering the same
fear response. The persistence of behavioral avoidance leads to further distress. The theory
also explains how rituals are maintained. Dollard and Miller (1950) further adopted Mowrer’s
theory to explain the progress and maintenance of fear/anxiety and avoidance in OCD [54].
In a series of experiments, Rachman and colleagues showed that obsessions increase obses‐
sional distress while compulsions reduce distress levels [55, 56]. It was this concept that defined
a functional relationship between obsessions and compulsions, defining OCD in DSM-III and
its successors [1]. Recently, many studies explored the relationship between OCD and other
anxiety disorders, and reconsidered the validity of the diagnostic classification of OCD [26,
57]. The core psychopathology of OCD is grounded on “preoccupation” and “repetitive
behaviors”, a result of cognitive and motor failure, which overlap with obsessive-compulsive
and related disorders (OCRDs), recently included in DSM-5 and ICD-11 [58].
Further, Roper et al. (1973) noted that obsessions and compulsions were maintained to
overcome associated anxiety. In addition, results showed that the urge to perform a particular
activity disappeared within a 15-180 minute period if the patient did not engage in the activity
[56]. The repetition of the exercises reduced the anxiety and urges to carry out these activities;
the phenomenon being defined as “habituation” and formed the basis of EX/RP therapy. In
1970s, clinical trials added more support to the efficacy of exposure and ritual prevention (EX/
RP) therapy in reducing OC symptoms, thus becoming one of the first choices for the treatment
of OCD [59, 60].
2.1.1. EX/RP Therapy — Efficacy and limitations
In more than 70% of the cases, individuals treated with OCD responded to EX/RP therapy
more efficiently compared to individuals who were on SSRIs [61]. However, the model has
some limitations. About 20- 30% of individuals with OCD drop-out or refuse treatment. This
is evident in cases with severe OCD or low insight level [62]. In addition, EX/RP had little or
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no benefit in helping people with pure obsessions. Furthermore, the model did not explain
why OCD sufferers become distressed by aggressive or sexual thoughts, without having
witnessed or committed such acts [63].
Cognitive theory and therapy was developed as a result of the limitations of the behavioral
and ERP theories and therapies. Cognitive techniques focus on distorted thoughts and
dysfunctional beliefs along with highlighting the role of cognitions in the origin and mainte‐
nance of symptoms [64]. The addition of cognitive techniques to ERP has been effective in the
treatment of patients who presented with pure obsessions or obsessive ruminations [60]. Also,
it led to the development of the “cognitive behavioral theories”, which is now considered as
the gold standard treatment for OCD [65].
2.2. Cognitive theories
Several cognitive theories emerged to understand the development and maintenance of OCD
symptoms. According to Rachman and de Silva (1978), obsessions of a disturbing nature are
a normal occurrence in people with and without OCD [66]. However, individuals with no OCD
do not give importance to such thoughts and they, as a result, disappear easily, although they
can play a critical role in transforming normal unpleasant thoughts into obsessions [66]. This
section will focus primarily on two theories: Foa and Kozak’s, and Salkovskis’ theory.
2.2.1. Foa and Kozak’s theory
According to Foa and Kozak, OCD is distinguished by two erroneous cognitions: (i) individ‐
uals with OCD have a cognitive vulnerability for the overestimation of the probability of
danger in safe situations; (ii) they exaggerate the severity of the consequences of negative
events [67].
2.2.2. Salkovskis theory
Salkovskis proposed an improved cognitive model in which responsibility was considered a
critical issue for the onset of obsessions [68, 69]. He proposed five basic assumptions that are
characteristic of individuals with OCD: (i) Thoughts and actions are the same; (ii) causing harm
is the same as not preventing harm; (iii) despite difficult events, personal liability for harm
continues; (iv) not engaging in harm related rituals is the same as having the intention to harm;
(v) controlling one’s thoughts is a personal obligation. Salkovskis’s theory proposes that
patients’ catastrophic appraisals of obsessions lead to an increased sense of responsibility [70].
Such responsibility beliefs tend to cause increased anxiety and end with compulsions to exert
control over obsessions [70]. Obsessions tend to persist as long as the distorted and blasphe‐
mous beliefs persist, and decline when such thoughts are enfeebled.
Rachman (2002) proposed a counterpart to this theory to explain the origins of compulsions
[71]. According to Rachman (2002), scrutiny of rituals occurs as inflated thoughts of respon‐
sibility lead to compulsions aimed at reducing any possible damage. Scrutiny, as a result, leads
to continuous scrutiny to eliminate doubt and possible risk [71].
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activity disappeared within a 15-180 minute period if the patient did not engage in the activity
[56]. The repetition of the exercises reduced the anxiety and urges to carry out these activities;
the phenomenon being defined as “habituation” and formed the basis of EX/RP therapy. In
1970s, clinical trials added more support to the efficacy of exposure and ritual prevention (EX/
RP) therapy in reducing OC symptoms, thus becoming one of the first choices for the treatment
of OCD [59, 60].
2.1.1. EX/RP Therapy — Efficacy and limitations
In more than 70% of the cases, individuals treated with OCD responded to EX/RP therapy
more efficiently compared to individuals who were on SSRIs [61]. However, the model has
some limitations. About 20- 30% of individuals with OCD drop-out or refuse treatment. This
is evident in cases with severe OCD or low insight level [62]. In addition, EX/RP had little or
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no benefit in helping people with pure obsessions. Furthermore, the model did not explain
why OCD sufferers become distressed by aggressive or sexual thoughts, without having
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nance of symptoms [64]. The addition of cognitive techniques to ERP has been effective in the
treatment of patients who presented with pure obsessions or obsessive ruminations [60]. Also,
it led to the development of the “cognitive behavioral theories”, which is now considered as
the gold standard treatment for OCD [65].
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symptoms. According to Rachman and de Silva (1978), obsessions of a disturbing nature are
a normal occurrence in people with and without OCD [66]. However, individuals with no OCD
do not give importance to such thoughts and they, as a result, disappear easily, although they
can play a critical role in transforming normal unpleasant thoughts into obsessions [66]. This
section will focus primarily on two theories: Foa and Kozak’s, and Salkovskis’ theory.
2.2.1. Foa and Kozak’s theory
According to Foa and Kozak, OCD is distinguished by two erroneous cognitions: (i) individ‐
uals with OCD have a cognitive vulnerability for the overestimation of the probability of
danger in safe situations; (ii) they exaggerate the severity of the consequences of negative
events [67].
2.2.2. Salkovskis theory
Salkovskis proposed an improved cognitive model in which responsibility was considered a
critical issue for the onset of obsessions [68, 69]. He proposed five basic assumptions that are
characteristic of individuals with OCD: (i) Thoughts and actions are the same; (ii) causing harm
is the same as not preventing harm; (iii) despite difficult events, personal liability for harm
continues; (iv) not engaging in harm related rituals is the same as having the intention to harm;
(v) controlling one’s thoughts is a personal obligation. Salkovskis’s theory proposes that
patients’ catastrophic appraisals of obsessions lead to an increased sense of responsibility [70].
Such responsibility beliefs tend to cause increased anxiety and end with compulsions to exert
control over obsessions [70]. Obsessions tend to persist as long as the distorted and blasphe‐
mous beliefs persist, and decline when such thoughts are enfeebled.
Rachman (2002) proposed a counterpart to this theory to explain the origins of compulsions
[71]. According to Rachman (2002), scrutiny of rituals occurs as inflated thoughts of respon‐
sibility lead to compulsions aimed at reducing any possible damage. Scrutiny, as a result, leads
to continuous scrutiny to eliminate doubt and possible risk [71].
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However, several theorists suggested that 6 other belief domains could be associated with the
origin and maintenance of OCD symptoms, including (i) inflated responsibility [68]; (ii) over-
importance of thoughts [72]; (iii) extreme concern about the importance of controlling one’s
thought [73, 74]; (iv) overestimation of risk [75]; (v) intolerance of uncertainty [75]; and (vi)
perfectionism [76].
Freeston et. al (1996) indicated various common features in patients who benefited from
cognitive interventions and they include: (i) placing high value over the incidence of obses‐
sions; (ii) believing that obsessions determine the patient’s real character; (iii) equating
thoughts and actions; and (iv) believing that the presence of a thought increase the possibility
of its occurrence. Several cognitive techniques were added to ERP therapy, leading to the
adoption of “Cognitive Behavioral Therapy (CBT)” [77].
Cognitive Therapy: Efficacy and Limitations: Cognitive therapy is efficient in the treatment of
patients  with predominant  obsessions,  and those with obsessions and compulsions [72].
Cognitive therapy can benefit patients with poor insight or those with dysfunctional beliefs,
suggesting  the  use  of  cognitive  therapy  prior  to  EX/RP  therapy  to  reduce  anxiety  and
improve adherence to EX/RP exercises. Cognitive therapy has not shown to be effective in
patients who significantly display obsessions of sexual, aggressive or destructive content.
However,  the  use  of  cognitive  therapy  alone  has  not  been  established,  giving  rise  to
cognitive behavior therapy [73].
3. Cognitive Behavioral Therapy (CBT)
The CBT model for the treatment of OCD is brief and structured, and it aims to help patients
cope with OCD symptoms. This is typically done through the utilization of behavioral as well
as cognitive strategies. Some of these strategies involve exposure to fearful stimuli, response
prevention, challenging dysfunctional erroneous beliefs, psycho-education, and home
exercises such as symptom monitoring and exposure exercises [79].
When OCD symptoms are mild and are not associated with any co-morbidity, CBT is usually
brief lasting between 13-20 sessions [80]. Initially, CBT is held on a weekly basis, or twice a
week until some improvements are observed. As the condition improves, sessions are spaced.
Behavioral exposure techniques help to achieve habituation to fear while cognitive techniques
target dysfunctional beliefs, especially for patients with a preponderance for obsessions [47].
The following sections will describe the process of CBT, which include patient assessment
followed by psycho-education, ERP and cognitive exercises, discharge and relapse prevention.
3.1. Patient assessment
A detailed psychiatric and psychological assessment is solicited from patients to rule out
differential diagnosis and any associated disorders [81]. In some cases, specific brain imaging
examinations may be included to rule out organic causes. The Yale-Brown Obsessive Com‐
pulsive Scale (Y-BOCS) can be utilized to acquire a comprehensive overview of the OCD
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symptoms. The effectiveness of CBT is reduced when OCD is accompanied by other co-morbid
conditions such as severe anxiety or depression, psychosis and addiction [82].
3.2. Initiation of CBT
Psychoeducation: Once OCD diagnosis has been confirmed, the therapist utilizes psycho-
education mini lessons to educate the patient about the nature of OCD, the CBT model of
treatment, vicious maintenance cycles and the role of avoidance and fear in maintaining the
disorder. In addition, patients will be educated about helpful and unhelpful coping strategies,
escape and avoidance, exposure therapy, the development of fear hierarchy and principles of
exposure. Given the crucial role of homework, patients and their families are introduced to
the role of homework within the therapy framework [83]. Engaging family members in this
stage is crucial, given the challenge family members face in changing their daily routines and
responding to questions with reassurances to accommodate the patient [84].
Motivation: Despite the growing body of research supporting the use of EX/RP in the treatment
of OCD, it is estimated that about 25% of patients with OCD refuse EX/RP [85]. This refusal
may be associated with the increased exposure to anxiety, which is an intrinsic part of the
treatment [86]. Lack or low level of motivation is especially problematic for pediatric patients
with OCD, and is associated with negative therapeutic outcomes. Therefore, interweaving
motivational interviewing techniques within the therapy framework helps patients decrease
their ambivalence about treatment. A recent study found that using the motivational inter‐
viewing within therapy sessions proved helpful in facilitating speedy improvement and
minimizing the burden for families [87].
3.2.1. Elaboration of list of hierarchy
The initial task in CBT is to work with patients to create a list of anxiety provoking situations
that targets main OCD symptoms. The Y-BOCS-CL is frequently used by clinicians to create
a comprehensive list. Anxiety provoking situations will be ranked by patient according to
the level of anxiety it creates starting from 1 (mild anxiety) to 4 (high level of anxiety). To
increase the patient’s self-efficacy, exposure exercises start with the least anxiety provok‐
ing situation [88].
Assessment measures: To monitor the progress of patients throughout the therapeutic process,
it is crucial to utilize assessment measures at various points during treatment. One of the
widely used sensitive scales is the Yale-Brown Scale, which is a valid and reliable instrument
for assessing the severity of obsessive-compulsive disorder [40, 41]. The Yale-Brown Scale is
composed of 10 questions; 5 to assess obsessions and 5 to assess compulsions. The scale assesses
severity from (0- no symptom, to 4 –severe symptoms). A maximum of 40 points can be
obtained for patients with severe symptoms [40, 41]. Another sensitive tool is the revised
version of the Obsessive Compulsive Inventory. Its usefulness has been proven as a diagnostic
tool for screening patients with OCD [89].
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as cognitive strategies. Some of these strategies involve exposure to fearful stimuli, response
prevention, challenging dysfunctional erroneous beliefs, psycho-education, and home
exercises such as symptom monitoring and exposure exercises [79].
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week until some improvements are observed. As the condition improves, sessions are spaced.
Behavioral exposure techniques help to achieve habituation to fear while cognitive techniques
target dysfunctional beliefs, especially for patients with a preponderance for obsessions [47].
The following sections will describe the process of CBT, which include patient assessment
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symptoms. The effectiveness of CBT is reduced when OCD is accompanied by other co-morbid
conditions such as severe anxiety or depression, psychosis and addiction [82].
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treatment, vicious maintenance cycles and the role of avoidance and fear in maintaining the
disorder. In addition, patients will be educated about helpful and unhelpful coping strategies,
escape and avoidance, exposure therapy, the development of fear hierarchy and principles of
exposure. Given the crucial role of homework, patients and their families are introduced to
the role of homework within the therapy framework [83]. Engaging family members in this
stage is crucial, given the challenge family members face in changing their daily routines and
responding to questions with reassurances to accommodate the patient [84].
Motivation: Despite the growing body of research supporting the use of EX/RP in the treatment
of OCD, it is estimated that about 25% of patients with OCD refuse EX/RP [85]. This refusal
may be associated with the increased exposure to anxiety, which is an intrinsic part of the
treatment [86]. Lack or low level of motivation is especially problematic for pediatric patients
with OCD, and is associated with negative therapeutic outcomes. Therefore, interweaving
motivational interviewing techniques within the therapy framework helps patients decrease
their ambivalence about treatment. A recent study found that using the motivational inter‐
viewing within therapy sessions proved helpful in facilitating speedy improvement and
minimizing the burden for families [87].
3.2.1. Elaboration of list of hierarchy
The initial task in CBT is to work with patients to create a list of anxiety provoking situations
that targets main OCD symptoms. The Y-BOCS-CL is frequently used by clinicians to create
a comprehensive list. Anxiety provoking situations will be ranked by patient according to
the level of anxiety it creates starting from 1 (mild anxiety) to 4 (high level of anxiety). To
increase the patient’s self-efficacy, exposure exercises start with the least anxiety provok‐
ing situation [88].
Assessment measures: To monitor the progress of patients throughout the therapeutic process,
it is crucial to utilize assessment measures at various points during treatment. One of the
widely used sensitive scales is the Yale-Brown Scale, which is a valid and reliable instrument
for assessing the severity of obsessive-compulsive disorder [40, 41]. The Yale-Brown Scale is
composed of 10 questions; 5 to assess obsessions and 5 to assess compulsions. The scale assesses
severity from (0- no symptom, to 4 –severe symptoms). A maximum of 40 points can be
obtained for patients with severe symptoms [40, 41]. Another sensitive tool is the revised
version of the Obsessive Compulsive Inventory. Its usefulness has been proven as a diagnostic
tool for screening patients with OCD [89].
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3.2.2. Exposure and response prevention exercises (EX/RP)
In Vivo exposure (involves the direct confrontation with the fearful stimulus) is the most
common form of exposure. Utilizing the already developed hierarchy list, the patient along
with the therapist initiate therapy by choosing a situation that evokes a medium level of
anxiety. Therapy sessions are focused on generalizing and extending gains to other situations
through designing homework exercises. It is crucial to discuss with the patient that while
confronting anxiety may increase anxiety, over time, anxiety will dissipates. Response
prevention increases anxiety level, but it gradually declines. That is why response prevention
reduces the need to engage in compulsions [61]. The main effect of EX/RP exercises is the
instant increase of anxiety in the session, which reaches its peak during the first exercise and
decreases or even disappears during the next 15-180 minutes [90].
3.3. Cognitive exercises
The initiation of cognitive exercises occurs when the patient have mastered EX/RP exercises
and is content with identifying OC symptoms. The patient should be able to make a distinction
between obsessions and normal thoughts. In these exercises, various parameters including
unpleasant thoughts, their background and emotive, physiological and behavioral concerns
are documented. Patients are taught the classifications of these beliefs based on their domains.
Cognitive techniques include the recognition and documentation of unpleasant thoughts;
Socratic questioning; downward arrow; and pie of responsibility [69].
3.4. Ending CBT and relapse prevention
Once OCD symptoms have significantly improved, spacing sessions are proposed and CBT is
ceased. Given that OCD is a chronic disorder with high relapse rates [91], both therapists and
patients work to prevent relapse through creating relapse prevention plans. Booster sessions
help in monitoring the maintenance of therapeutic gains [92].
4. Cognitive behavioral psychotherapy adaptation for children and
adolescents with obsessive compulsive disorder
Childhood OCD is linked with severe commotion in social and academic functioning, co-
morbid emotional and behavioral complications and family difficulties [93]. Cognitive-
Behavioral Therapy (CBT), especially exposure and response prevention (ERP) is the pivotal
therapy used for OCD in adults [94]. Exposure encompasses useful confrontation of objects or
situations that trigger obsessions; response prevention includes refraining from activities that
reduce anxiety generated by obsessions [93]. Initially, ERP was considered more helpful for
adults compared to children and adolescents.
However, since the mid-1990s, research proved ERP to be viable, safe and effective for both
children and adults [95]. However, not many children and adolescents receive CBT for various
factors, one being lack of trained clinicians. Interestingly, clinicians find the research-driven-
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treatment methodology not practical [93]. Furthermore, even though OCD in children is more
prevalent, variations in dimensions between adults and children (age, maturity, language
development..etc) obfuscate the application of CBT for children. Children are not able to
recognize or label their obsessions or fear responses. In certain cases, a child’s responses tend
to mislead adults into believing that the child’s behavior is willful [96]. One of the challenges
facing the child therapist is children’s lack of understanding of OCD symptoms. High anxiety
levels during ERP makes children resistant to engage in therapy. EX/RP homework exercises
are challenging to children given the aversion towards homework. This in turn makes parental
supervision crucial for a successful treatment [93]. Criticism and conflicts within the family
negatively affect therapy [97]. Dropout rates are associated with the rigidity in applying
treatment protocols, suggesting the need to assess developmental issues, and consequently
adopting treatment plans tailored to meet each child’s needs [93].
Recently, CBT protocols have been developed for children. These protocols typically include
psycho-education  in  age-appropriate  language,  and  cognitive  strategies  to  cope  with
anxiety, and the use of reinforcement contingent strategies within the family environment
[98].  Parents’  active involvement in the child’s  treatment  increases the effectiveness and
long-term  gains  from  the  treatment  [99].  A  sensitive  protocol  for  CBT  in  children  was
recently developed and is considered a flexible and practical guide for clinicians; RIDE Up
and Down the Worry Hill [100, 101].
4.1. RIDE up and down the worry hill
The abbreviation RIDE and the metaphor of riding a bicycle Up and Down the Worry Hill
were designed to describe basic CBT principles in a child-friendly manner [100, 102].
The “Worry Hill” explains the relationship between exposure and habituation. It explains the
gradual increase in anxiety levels as a result of exposure to the fearful stimuli. Anxiety levels
continue to increase as exposure to fear continues. The fear will reach the top peak in the Worry
Hill. This is when autonomic habituation starts and anxiety declines. However, if the child
surrenders to or escapes fear, habituation is interrupted and obsessions are strengthened [102].
The four-step RIDE acronym (Rename, Insist, Defy, Enjoy) comprises the steps that either the
child or adolescent should take to complete the Worry Hill [100, 102]. The RIDE was developed
to streamline EX/RP for children and adolescents and raise persistence of anxiety until
habituation occurs. RIDE includes cognitive (externalizing, distancing) and behavioral
(Controlling obsessions, exposure and self-reinforcement) techniques. Coaching is provided
in each of the four steps followed by therapist modeling, behavioral rehearsal, repeated
practice and reinforcement, until the individual has grasped each step [102]. The following
section will discuss each of the four steps.
4.1.1. R: Rename the thought (That’s OCD talking, not me!!)
This is the first step and comprises recognition of OCD thoughts as separate and different from
the child’s rational self [101, 102]. The method of externalizing OCD has been employed by
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with the therapist initiate therapy by choosing a situation that evokes a medium level of
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are documented. Patients are taught the classifications of these beliefs based on their domains.
Cognitive techniques include the recognition and documentation of unpleasant thoughts;
Socratic questioning; downward arrow; and pie of responsibility [69].
3.4. Ending CBT and relapse prevention
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ceased. Given that OCD is a chronic disorder with high relapse rates [91], both therapists and
patients work to prevent relapse through creating relapse prevention plans. Booster sessions
help in monitoring the maintenance of therapeutic gains [92].
4. Cognitive behavioral psychotherapy adaptation for children and
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Childhood OCD is linked with severe commotion in social and academic functioning, co-
morbid emotional and behavioral complications and family difficulties [93]. Cognitive-
Behavioral Therapy (CBT), especially exposure and response prevention (ERP) is the pivotal
therapy used for OCD in adults [94]. Exposure encompasses useful confrontation of objects or
situations that trigger obsessions; response prevention includes refraining from activities that
reduce anxiety generated by obsessions [93]. Initially, ERP was considered more helpful for
adults compared to children and adolescents.
However, since the mid-1990s, research proved ERP to be viable, safe and effective for both
children and adults [95]. However, not many children and adolescents receive CBT for various
factors, one being lack of trained clinicians. Interestingly, clinicians find the research-driven-
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treatment methodology not practical [93]. Furthermore, even though OCD in children is more
prevalent, variations in dimensions between adults and children (age, maturity, language
development..etc) obfuscate the application of CBT for children. Children are not able to
recognize or label their obsessions or fear responses. In certain cases, a child’s responses tend
to mislead adults into believing that the child’s behavior is willful [96]. One of the challenges
facing the child therapist is children’s lack of understanding of OCD symptoms. High anxiety
levels during ERP makes children resistant to engage in therapy. EX/RP homework exercises
are challenging to children given the aversion towards homework. This in turn makes parental
supervision crucial for a successful treatment [93]. Criticism and conflicts within the family
negatively affect therapy [97]. Dropout rates are associated with the rigidity in applying
treatment protocols, suggesting the need to assess developmental issues, and consequently
adopting treatment plans tailored to meet each child’s needs [93].
Recently, CBT protocols have been developed for children. These protocols typically include
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[98].  Parents’  active involvement in the child’s  treatment  increases the effectiveness and
long-term  gains  from  the  treatment  [99].  A  sensitive  protocol  for  CBT  in  children  was
recently developed and is considered a flexible and practical guide for clinicians; RIDE Up
and Down the Worry Hill [100, 101].
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The abbreviation RIDE and the metaphor of riding a bicycle Up and Down the Worry Hill
were designed to describe basic CBT principles in a child-friendly manner [100, 102].
The “Worry Hill” explains the relationship between exposure and habituation. It explains the
gradual increase in anxiety levels as a result of exposure to the fearful stimuli. Anxiety levels
continue to increase as exposure to fear continues. The fear will reach the top peak in the Worry
Hill. This is when autonomic habituation starts and anxiety declines. However, if the child
surrenders to or escapes fear, habituation is interrupted and obsessions are strengthened [102].
The four-step RIDE acronym (Rename, Insist, Defy, Enjoy) comprises the steps that either the
child or adolescent should take to complete the Worry Hill [100, 102]. The RIDE was developed
to streamline EX/RP for children and adolescents and raise persistence of anxiety until
habituation occurs. RIDE includes cognitive (externalizing, distancing) and behavioral
(Controlling obsessions, exposure and self-reinforcement) techniques. Coaching is provided
in each of the four steps followed by therapist modeling, behavioral rehearsal, repeated
practice and reinforcement, until the individual has grasped each step [102]. The following
section will discuss each of the four steps.
4.1.1. R: Rename the thought (That’s OCD talking, not me!!)
This is the first step and comprises recognition of OCD thoughts as separate and different from
the child’s rational self [101, 102]. The method of externalizing OCD has been employed by
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Schwartz (1996) [103] with adults and March at el (1994) [98] with children and has been found
to be effective.
4.1.2. I: Insist that YOU are in charge (I’m in charge. I choose NOT to believe OCD!)
The second step allows the child to use the power of choice [101, 102]. Insisting that oneself is
in charge helps build self-confidence and strength needed to embark on exposure.
4.1.3. D: Defy OCD-Do the OPPOSITE of what it wants (I will RIDE up the worry hill and stick it
out until i can coast down)
This step involves ERP, specifically a change in behavior [101, 102]. Response prevention
involves exposure to the obsession and associated fear response without engaging in compul‐
sions. This escalates anxiety till it reaches the peak, and once habituation is set, the anxiety
starts to decline. With continuous practice, anxiety habituates at a faster rate.
4.1.4. E: ENJOY your success — Reward yourself (I did it! I BEAT OCD! I can do it again)
This is the final step and lets the child review his/her success and take due credit for effort [101,
102].
The Worry Hill represents a universal metaphor as children, adolescents and even adults can
relate to the conception of riding a bicycle up a hill and makes it easier to understand the
principle behind CBT. The implementation of CBT in both children and adolescents occurs in
four sequential phases, which will be discussed in the following section.
4.2. Implementation of CBT in children and adolescents
The four phases are focused on specific goals and aims to develop various skills in every phase.
The severity of the disorder determines the number of psychotherapy sessions. In some cases,
a total of 6 sessions are required, whereas in others, an average of 10-20 sessions is required.
4.2.1. Phase 1 — Biophyschosocial assessment and treatment plan
This phase lays the foundation for effective treatment and takes from one to three sessions,
each session equaling 50-minutes. This assessment is designed to be culturally sensitive and
comprehensive to include an appreciation of OCD symptoms in a holistic manner. This
involves joint efforts amongst the therapist, parent, child and other concerned personnel. The
aim is to develop an individualized child-centered treatment plan. The use of clinical inter‐
views, self-report inventories and behavioral observations are important at this stage [101].
4.2.2. Phase 2 — Building treatment readiness
This phase emphasizes planned and active preparation for treatment. Although a critical
phase, it  tends to be ignored, leading to frequent treatment failures. This phase requires
one to three sessions and includes stabilization of any family crisis and the use of effec‐
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tive  communication skills  to  increase  awareness  about  treatment  and builds  therapeutic
rapport [101].
4.2.3. Phase 3 — The RIDE up and down the worry hill
This phase comprises of 4 to 15 sessions and consists of separate as well as joint sessions with
both child and parents. It is during this stage that the child participates in EX/RP [101].
4.2.4. Phase 4 — After the RIDE
As the final step of the treatment, it is initiated when the child and parents have mastered the
RIDE and the RALLY effectively, respectively as well as when there is a decline in the OCD
symptoms [101].
5. Efficacy studies of the cognitive behavioral psychotherapy and
pharmacology for OCD
In a systematic review, Foa and Kozak (1996) found that about 83% of patients with OCD
included in trials (n=330), showed a minimum of 30% improvement in their symptoms
compared to pre-treatment measures. These trials utilized exposure and response prevention
techniques [104].
When exploring long-term outcomes of patients with OCD who utilized CBT, a review of
17 studies indicated that about 76% of patients continue to show improvements in their
OCD symptoms at an average of about two years post treatment [104]. In addition, CBT
was shown its effectiveness not only in the treatment of OCD but also other mental health
disorders such as depression and generalized anxiety disorder as evidenced by a review of
16 meta-analyses [105].
On the other hand, Gava et.al (2007) conducted a systematic review of eight randomized trials
comparing the therapeutic outcomes of patients receiving a form of cognitive behavioral
therapy versus patients who were treated as usual [106]. Treatment as usual included no
treatment, waiting list or usual care. Results from 214 patients indicated that cognitive-
behvaioral therapy is associated with more significant decline in OCD symptoms compared
to treatment as usual [106]. Amelioration of 50-70 % of OCD symptoms were noted for patients
with OCD involved in the above mentioned trials. Therapeutic outcomes did not differ among
the variations of cognitive behavioral therapy. In addition, results showed no difference in the
clinical outcomes for patients with OCD who were assigned to individual or group psycho‐
therapy sessions.
Various randomized clinical studies were conducted to control for confounding variables
such  as  the  presence  of  co-morbid  disorders,  OCD  severity,  age,  just  to  name  a  few.
However, Franklin et al. (2000) compared the results of 4 randomized controlled trials (EX/
RP) with treatment outcomes for 110 clinical adult patients receiving the same treatment
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modality on a paid outpatient service [107]. Results showed that clinical patients showed
significant  improvement  in  their  OCD  symptoms  that  were  comparable  to  patients  in
randomized trials [107].
Many factors have been identified to help reach favorable clinical outcomes [108]. In session
(in vivo exposure) have been found to be associated with better clinical outcomes compared
to exposure techniques done by patient alone at home [108]. Tremendous reductions in
symptoms is associated with complete response prevention, as opposed to partial response
prevention [108].
CBT is indicated for patients with OCD with various levels of symptom severity. It is worth‐
while to mention some of the considerations when evaluating a patient’s suitability for this
treatment modality which include
1. An understanding of the treatment module and rationale, given that the implementation
of CBT requires a good grasp of main concepts that are practiced by the patient as
homework. Therefore, the utilization of CBT with people who are cognitively challenged
may be difficult.
2. Low insight level for the OCD symptoms poses a challenge for patients and therapists.
Low insight is associated with reduced engagement in exposure techniques, thus render‐
ing the use of cognitive techniques essential to increase insight levels for patients [109].
In addition, individuals with predominantly hoarding symptoms have showed lower
responses to CBT [104].
3. Patient’s preference: CBT is preferred by patients with no co-morbid conditions, mild to
moderate OC symptoms, or those with a preference for psychotherapy over medications
[110]. Furthermore, CBT is the preferred choice for pregnant women [110]. CBT is highly
effective for patients who did not or partially respond to treatment with psychotropic
medications [111, 112]. However, in some cases both medications and CBT are preferred
[113]. However, some cases warrant the use of medications such as the presence of severe
OCD symptoms, low psychological insight, and co-morbidities [113]. Respecting the
patient’s choice of his/her preferred treatment modality, after discussing the pros and cons
of each, is pivotal and is linked to increased adherence to treatment [114].
4. The presence of co morbid conditions such as depression and anxiety along with OCD
reduces the efficacy of CBT techniques [108].
5. Negative emotional involvement by family members was found to be associated with
higher treatment dropout rates. Hostility was a consistent factor associated with early
dropout rates and negative treatment outcome [115].
Other Psychotherapy Modalities: Among all psychosocial interventions and techniques,
exposure and response prevention, has led to better clinical outcomes for patients with OCD
[116]. Given the absence of randomized clinical trials to investigate the effectiveness of other
psychotherapeutic modalities in psychotherapy [106], CBT is considered as the gold standard
for the treatment of OCD.
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6. Psychotropic medications or CBT?
The utilization of CBT is associated with better clinical outcomes compared to the use of
Serotonin Reuptake Inhibitors. Although Clomipramine (CMI) was considered as the first line
drug therapy associated with significant improvements in OCD symptoms, [117], the random‐
ized trial conducted by Foa et al. (2005) showed that clinical outcomes did not differ for the
two control groups (EX/RP alone, and EX/RP plus Clomipramine) [61]. In addition, research
has indicated that D-cycloserine has shown to produce favourable clinical outcomes when
augmented with CBT [118]. Specifically, D-cycloserine helped to reduce response times after
exposure exercises [119].
7. Conclusion
Over the last 40 years, EX/RP has been recommended as first choice treatment for OCD, with
CBT as an alternate. More work is needed to enhance CBT programs and make it sensitive to
the population needs. Future studies need to explore the treatment responses for specific sub-
types of OCD patients such as “washers” and “checkers”. Such understanding will help in
designing sensitive treatment plans for the various sub-types of OCD. Also, future studies
need to incorporate patients’ populations with co-morbid conditions as they tend to be
excluded from such studies, thus making it difficult to know the efficacy level for CBT in this
patient population.
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1. Introduction
Obsessive-compulsive disorder (OCD) is a chronic condition represented by a diverse group
of symptoms that include intrusive thoughts, rituals, preoccupations, and compulsions. These
recurrent obsessions or compulsions cause severe distress to the person. The obsessions or
compulsions are time-consuming and interfere significantly with the person's normal routine,
occupational functioning, usual social activities, or relationships [1].
In the 10th revision of International Statistical Classification of Diseases and Related Health
Problems (ICD-10), OCD is diagnosed when either obsessions or compulsions (or both) are
present for a period of at least 2 weeks, acknowledged as excessive or unreasonable and are
repetitive and unpleasant. The patient tries to resist them and acknowledges that they are
originating in the mind and are not imposed by outside persons or influences as well as the
obsessive thought or the compulsive act is not experienced as pleasurable. [2] Recently
American Psychiatric Association's (APA) Diagnostic and Statistical Manual of Mental
Disorders, DSM-5 separated it from anxiety disorder group and reclassified it with disorders
like Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania, and excoriation
disorder [3].
A few decades ago OCD had been regarded as a psychiatric condition that was mostly
treatment-refractory [4]. Modern pharmacotherapy for OCD began with the observation that
colmipramine but not other TCAs, relieved OC symptoms. This led to hypothesis that
serotonin might be involved in pathophysiology of OCD5. Also numerous investigations
showing the therapeutic action of different selective serotonin reuptake inhibitors (SSRIs) in
OCD, and by additional findings, such as the provocation of OCD symptoms by the seroto‐
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Chapter 7
Treatment-Resistant Obsessive-Compulsive Disorder
(OCD) – Current Understanding
Mushtaq A. Margoob, Rajesh Chandel,
Huda Mushtaq and Dhuha Mushtaq
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/57232
1. Introduction
Obsessive-compulsive disorder (OCD) is a chronic condition represented by a diverse group
of symptoms that include intrusive thoughts, rituals, preoccupations, and compulsions. These
recurrent obsessions or compulsions cause severe distress to the person. The obsessions or
compulsions are time-consuming and interfere significantly with the person's normal routine,
occupational functioning, usual social activities, or relationships [1].
In the 10th revision of International Statistical Classification of Diseases and Related Health
Problems (ICD-10), OCD is diagnosed when either obsessions or compulsions (or both) are
present for a period of at least 2 weeks, acknowledged as excessive or unreasonable and are
repetitive and unpleasant. The patient tries to resist them and acknowledges that they are
originating in the mind and are not imposed by outside persons or influences as well as the
obsessive thought or the compulsive act is not experienced as pleasurable. [2] Recently
American Psychiatric Association's (APA) Diagnostic and Statistical Manual of Mental
Disorders, DSM-5 separated it from anxiety disorder group and reclassified it with disorders
like Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania, and excoriation
disorder [3].
A few decades ago OCD had been regarded as a psychiatric condition that was mostly
treatment-refractory [4]. Modern pharmacotherapy for OCD began with the observation that
colmipramine but not other TCAs, relieved OC symptoms. This led to hypothesis that
serotonin might be involved in pathophysiology of OCD5. Also numerous investigations
showing the therapeutic action of different selective serotonin reuptake inhibitors (SSRIs) in
OCD, and by additional findings, such as the provocation of OCD symptoms by the seroto‐
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
nergic agent m-chlorophenylpiperazine the role of serotonergic system in OCD was further
made strong. Not only is serotonin uptake blockade an apparent prerequisite for clinical
improvement, but there is a correlation between the magnitude of clinical response and the
reduction in various serotonin markers during treatment with these drugs [6]. There is
substantial evidence that suggests OCD patients may benefit from addition of antipsychotics
to their ongoing SSRI treatment, suggesting that dopamine also might play a role in the
pathophysiology of OCD [7]. Latest neuroimaging techniques have shown various structural
and volumetric abnormalities in prefrontal and basal ganglia region in patients suffering from
OCD. In prefrontal cortex there may be dopaminergic hyperfunction and in basal ganglia there
may be hypofunction of serotonergic system. This dysfunction of the 'cortico-striato-thalamic'
loops is strongly linked to the symptoms of OCD, where the dopamine has an inhibitory effect
on GABA neurons. The ascending serotonergic projections from the raphe nuclei restrain and
control the function of these loops. Thus, when serotonergic hypofunction is present, the
predominantly dopaminergic loops became overactive, which has been confirmed by neuro‐
imaging techniques and by neurocognitive tests as well. This could be the reason for the fact
that SSRIs have limited success in the treatment of OCD symptoms [8]. The role of glutamate,
which is the primary excitatory neurotransmitter, is being increasingly investigated in the
pathophisiology of OCD [9]. Glutamate is major excitatory neurotransmitter in the cortico-
striatal-pallido-thalamocortical circuits and is also known to interact extensively with seroto‐
nin and dopamine [10]. Moore et al. (1998) reported striking changes in caudate glutamatergic
concentrations (Glx)-a marker for combined glutamate and glutamine, resonance on proton
magnetic resonance spectroscopy (1H-MRS) in a paediatric OCD patient following treatment
with Paroxetine [11]. Rosenberg et al. (2000) studied 11 psychotropic drug-naïve children with
OCD, with single-voxel 1H-MRS examinations and demonstrated that caudate Glx concen‐
trations were significantly greater in the patients compared to healthy controls [12]. They also
found that the caudate Glx levels in patients decreased significantly following 12-weeks
treatment with Paroxetine to levels comparable to that of controls and the decrease was
associated with decrease in symptom severity of the OCD patients, while there was no
difference in Glx levels in the occipital cortex between the two groups. Whiteside et al. (2006)
have demonstrated that within the right orbitofrontal white matter, relative levels of Glx and
N-acetylaspartate were increased in adult patients with OCD compared with healthy controls
and greater levels of Glx/Creatine were associated with more severe OCD symptoms. [13]
Evidences from genetic studies are also suggesting the role of glutamate in pathophsiology of
OCD. Investigators have reported statistically significant association between OCD and a locus
on chromosome 9p24 that codes for a high-affinity neuronal/epithelial excitatory amino acid
transporter (EAAC-1), also known as SLC1A1 (Solute carrier family 1, member 1) [14, 15]. It is
hypothesized that in the brain this transporter is crucial in terminating the action of the
excitatory neurotransmitter glutamate and in maintaining extracellular glutamate concentra‐
tions within a normal range [16].Researchers have examined the role of the opioid system and
neuropeptides like oxytocin and vasopressin in OCD although the evidence has been equivocal
[17, 18, 19].
About 40-60% of obsessive compulsive disorder (OCD) sufferers do not respond to appropriate
courses of treatment with serotonin reuptake inhibitors (SRI) and even to combination of
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medicines [20]. Those OCD patients who do not achieve a satisfactory response after an
adequate trial of first line therapies are described as treatment resistant. The satisfactory
response is usually defined by a reduction in the Yale-Brown Obsessive Compulsive scale score
≥35% or ≥25% with respect to baseline [21].
The first selective serotonin reuptake inhibitor (SSRI), fluoxetine, was introduced in 1987. This
was followed by other SSRI’s i.e.fluvoxamine, paroxetine, sertraline, citalopram and escitalo‐
pram. The SSRIs are each structurally and chemically distinct. Escitalopram, an isomer of
citalopram, is the only exception. This molecular diversity explains why individual responses
to, and tolerability of, SSRIs are so varied. Fluoxetine has the longest half-life: 4 to 6 days. The
half-life of sertraline is 26 hours, 35 hours for citalopram, 27 to 32 hours for escitalopram, 21
hours for paroxetine, and 15 hours for fluvoxamine. Sertraline, fluoxetine, and paroxetine
being the most highly bound and escitalopram being the least bound. All SSRIs are metabolized
in the liver by the cytochrome P450 enzymes. The most important drug-drug interactions
involving the SSRIs occur as a result of the SSRIs inhibiting the metabolism of a co administered
medication [1]. Citalopram and escitalopram are the most selective inhibitors of serotonin
reuptake, with very little inhibition of norepinephrine or dopamine reuptake and very low
affinities for histamine H1, GABA or benzodiazepine receptors. The other SSRIs have a similar
profile, except that fluoxetine weakly inhibits norepinephrine reuptake and binds to 5-HT2C
receptors; sertraline weakly inhibits norepinephrine and dopamine reuptake; and paroxetine
has significant anticholinergic activity at higher dosages and binds to nitric oxide synthase [1].
According to a large number of published randomized controlled trials (RCTs), meta-analyses,
current expert guidelines, and consensus statements, SSRIs and clomipramine are recom‐
mended as first-line agents for drug treatment of OCD [22, 23, 24, 25]. Guidelines of the World
Federation of Societies of Biological Psychiatry (WFSBP) for the pharmacological treatment of
OCD grant the highest category of evidence (“A”, ie, full evidence from several RCTs) for the
SSRIs escitalopram, fluvoxamine, fluoxetine, paroxetine, and sertraline, as well as for the TCA
clomipramine. Since clomipramine is less well tolerated than the SSRIs, it was given a
recommendation grade of 2 (moderate risk benefit ratio), while the SSRIs received the highest
recommendation grade 1 (good risk: benefit ratio). For citalopram a recommendation grade
of 3 (limited evidence from controlled studies) was given as only one positive double-blind,
placebo-controlled study was published. According to WFSBP guidelines usually lower
response rates are achieved in OCD in comparison with other anxiety disorders, and that
sometimes only partial remission is achieved and higher doses are required for these drugs in
OCD than for other anxiety disorders. In a systematic review of all long-term, placebo-
controlled trials with SSRIs in OCD, the likelihood of relapse during 24 to 52 weeks of treatment
was significantly lower on an SSRI than with placebo [26].
According to the British National Institute for Health and Clinical Excellence (NICE) and the
Royal College of Psychiatrists guidelines, the initial pharmacological treatment in adults with
OCD should be one of the following SSRIs: fluoxetine, fluvoxamine, paroxetine, sertraline, or
citalopram [27]. A Cochrane review of placebo-controlled SSRI trials in OCD, comprising 17
studies with 3097 participants showed efficacy for all SSRIs (citalopram, fluoxetine, fluvoxa‐
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of 3 (limited evidence from controlled studies) was given as only one positive double-blind,
placebo-controlled study was published. According to WFSBP guidelines usually lower
response rates are achieved in OCD in comparison with other anxiety disorders, and that
sometimes only partial remission is achieved and higher doses are required for these drugs in
OCD than for other anxiety disorders. In a systematic review of all long-term, placebo-
controlled trials with SSRIs in OCD, the likelihood of relapse during 24 to 52 weeks of treatment
was significantly lower on an SSRI than with placebo [26].
According to the British National Institute for Health and Clinical Excellence (NICE) and the
Royal College of Psychiatrists guidelines, the initial pharmacological treatment in adults with
OCD should be one of the following SSRIs: fluoxetine, fluvoxamine, paroxetine, sertraline, or
citalopram [27]. A Cochrane review of placebo-controlled SSRI trials in OCD, comprising 17
studies with 3097 participants showed efficacy for all SSRIs (citalopram, fluoxetine, fluvoxa‐
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mine, paroxetine, and sertraline) but no statistical differences in short-term therapeutic action
among the individual SSRIs [28].
2. Treatment of OCD patients refractory to serotonergic antidepressants
Although SSRIs and clomipramine have proven efficacy in OCD, about 40% to 60% of pa‐
tients show no or just partial symptom improvement to a treatment with a first-line drug [29].
The large fraction of patients without substantial response to standard treatment experiences
significant morbidity [30]. Response is typically operationalized as a decline in symptoms, as
measured by a 30–35% reduction in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [31,
32] or a decline in symptoms below a threshold of 16 (i.e., the boundary between mild and
moderate OCD symptoms). So those patients who are “treatment responsive” as per operation‐
alized criterion may continue to have levels of symptoms in the mild-moderate range and spend
hours daily preoccupied with their obsessions and compulsions. We need novel treatment
modalities for these partially responsive as well as treatment resistant patients with OCD.
High-dose treatment with serotonergic drugs is one of the available strategy which should be
considered first. Greater improvement with higher vs lower doses of SSRI was reported using
250 to400 mg/d vs 200 mg/d of sertraline [33]and with escitalopram after an increase of dose
from 20 up to 50 mg/d [34]. In a Open-label study of high (30 mg) and moderate (20 mg) dose
escitalopram for the treatment of obsessive-compulsive disorder by Dougherty et al found that
the 30 mg (vs. 20 mg) dose of escitalopram may provide a superior reduction in OCD symptoms
for those sufferers with comorbid depression and/or anxiety [35].
Studies with tricyclic antidepressants, which act on both serotonin and norepinephrine,
suggested that blockade of serotonin reuptake was required for antiobsessional effect [36]. In
a meta-analysis of studies by Geller et al., including over 1000 adolescents with OCD clomipr‐
amine was shown to have greater efficacy compared with fluoxetine, fluvoxamine, paroxetine,
and sertraline [37]. Clomipramine, which retains some norepinephrine reuptake inhibitory
(NRI) effect relative to the SSRIs and its metabolite desmethylclomipramine has significant
NRI activity, appears to be more effective than the more selective agents in meta analyses,
though not in head-to-head comparisons leads to the hypothesis that dual-acting agent might
be more effective in treatment- resistant patients [38]. An open-label trial of venlafaxine, which
is a dual acting agent, both in treatment- naive and treatment-resistant OCD, suggested
superior efficacy to SSRIs [39], In a head-to-head comparison between venlafaxine and
clomipramine suggested comparable efficacy to clomipramine. [40]
Another strategy is to use other agents that target the serotonin system in a different way.
Mirtazapine, a 5HT2A agonist, can accelerate the effect of paroxetine on OCD symptoms [41].
But the long-term benefit of mirtazepine and citalopram augumentation over citalopram alone
is unclear [42]. Mirtazapine has also been shown to be efficacious as monotherapy in OCD
patients in an open trial [43].
Intravenous clomipramine [44, 45] and intravenous citalopram [46] have been shown to lead
to a substantial improvement in symptoms in some treatment-resistant patients.
Obsessive-Compulsive Disorder - The Old and the New Problems160
3. Augmentation with other drugs
A number of different agents are being used as augmentation strategies for standard SRI
therapy in treatment- refractory OCD, with variable success. Agents with modes of action
beyond the serotonin system have shown the capacity to significantly improve symptoms in
patients with limited response to SRI therapy alone [47].
Tourette’s syndrome is highly comorbid with Obsessive-compulsive disorder in the pediatric
population [48]. Overlapping pathological changes in the basal ganglia are implicated in the
two disorders [49, 50]. As we see both typical and atypical antipsychotics have positive effects
in Tourette’s syndrometrials of dopamine antagonists, augmentation therapy in OCD might
be worth considering [51, 52].
The combination of the antipsychotics risperidone, haloperidol, olanzapine, or quetiapine with
an SSRI was shown to be more effective than SSRI monotherapy in treatment-resistant cases
and is recommended (grade 3, ie, limited evidence from controlled studies) by the WFSBP
guidelines [25]. Antipsychotics should be added after at least 3 months of maximally tolerated
therapy of an SSRI. Response usually commences within one month duration as seen in most
of the studies and about one third of treatment-refractory OCD patients show a clinically
meaningful improvement. Superior effects of quetiapine versus ziprasidone as an adjunct to
SSRI were found in treatment-resistant OCD patients in a retrospective study [53]. A single-
blind study comparing risperidone versus olanzapine augmentation of SSRIs showed positive
responses without differences between the two treatment groups [54]. In a 12-week, open-
label, trial of aripiprazole, significant improvement of OCD symptoms was demonstrated [55].
In a small, open-label study suggest that aripiprazole as monotherapy was helpful for treating
OCD [56].Augmentation of paroxetine with perospirone resulted in improvement in a case
report [57].
A smaller number of studies have examined the utility of augmentation therapy with opioid
agents. Morphine given once weekly has shown efficacy in treatment-resistant obsessive-
compulsive disorder in a single doubleblind study, and administration of the opioid agonist
tramadol hydrochloride has also been shown to diminish OCD symptoms [58, 59, 60].The
mechanism of this interesting effect is unknown, but one of the proposed mechanism being
opioids inhibiting glutamate release in cortex through disinhibition of serotonergic neurons.
Other augmentation agents include clonazepam, inositol, clonidine, monoamine oxidase
inhibitors, and antiandrogens [61].
Positive results have been reported with longterm augmentation with citalopram (up to 60
mg/d) in 20 treatment-resistent OCD patients on clomipramine [62].
Riluzole is an antiglutamatergic agent that is approved by the Food and Drug Administration
for neuroprotection in amyotrophic lateral sclerosis (ALS) [63]. Various proposed mechanisms
of action of riluzole are inhibition of sodium currents in glutamatergic axon terminals, reducing
neurotransmitter release [64]; reduction of P/Qtype calcium currents in the axon terminals,
with a similar effect on glutamate release [65]; extension of the open time of Kv1.4 potassium
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mine, paroxetine, and sertraline) but no statistical differences in short-term therapeutic action
among the individual SSRIs [28].
2. Treatment of OCD patients refractory to serotonergic antidepressants
Although SSRIs and clomipramine have proven efficacy in OCD, about 40% to 60% of pa‐
tients show no or just partial symptom improvement to a treatment with a first-line drug [29].
The large fraction of patients without substantial response to standard treatment experiences
significant morbidity [30]. Response is typically operationalized as a decline in symptoms, as
measured by a 30–35% reduction in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [31,
32] or a decline in symptoms below a threshold of 16 (i.e., the boundary between mild and
moderate OCD symptoms). So those patients who are “treatment responsive” as per operation‐
alized criterion may continue to have levels of symptoms in the mild-moderate range and spend
hours daily preoccupied with their obsessions and compulsions. We need novel treatment
modalities for these partially responsive as well as treatment resistant patients with OCD.
High-dose treatment with serotonergic drugs is one of the available strategy which should be
considered first. Greater improvement with higher vs lower doses of SSRI was reported using
250 to400 mg/d vs 200 mg/d of sertraline [33]and with escitalopram after an increase of dose
from 20 up to 50 mg/d [34]. In a Open-label study of high (30 mg) and moderate (20 mg) dose
escitalopram for the treatment of obsessive-compulsive disorder by Dougherty et al found that
the 30 mg (vs. 20 mg) dose of escitalopram may provide a superior reduction in OCD symptoms
for those sufferers with comorbid depression and/or anxiety [35].
Studies with tricyclic antidepressants, which act on both serotonin and norepinephrine,
suggested that blockade of serotonin reuptake was required for antiobsessional effect [36]. In
a meta-analysis of studies by Geller et al., including over 1000 adolescents with OCD clomipr‐
amine was shown to have greater efficacy compared with fluoxetine, fluvoxamine, paroxetine,
and sertraline [37]. Clomipramine, which retains some norepinephrine reuptake inhibitory
(NRI) effect relative to the SSRIs and its metabolite desmethylclomipramine has significant
NRI activity, appears to be more effective than the more selective agents in meta analyses,
though not in head-to-head comparisons leads to the hypothesis that dual-acting agent might
be more effective in treatment- resistant patients [38]. An open-label trial of venlafaxine, which
is a dual acting agent, both in treatment- naive and treatment-resistant OCD, suggested
superior efficacy to SSRIs [39], In a head-to-head comparison between venlafaxine and
clomipramine suggested comparable efficacy to clomipramine. [40]
Another strategy is to use other agents that target the serotonin system in a different way.
Mirtazapine, a 5HT2A agonist, can accelerate the effect of paroxetine on OCD symptoms [41].
But the long-term benefit of mirtazepine and citalopram augumentation over citalopram alone
is unclear [42]. Mirtazapine has also been shown to be efficacious as monotherapy in OCD
patients in an open trial [43].
Intravenous clomipramine [44, 45] and intravenous citalopram [46] have been shown to lead
to a substantial improvement in symptoms in some treatment-resistant patients.
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3. Augmentation with other drugs
A number of different agents are being used as augmentation strategies for standard SRI
therapy in treatment- refractory OCD, with variable success. Agents with modes of action
beyond the serotonin system have shown the capacity to significantly improve symptoms in
patients with limited response to SRI therapy alone [47].
Tourette’s syndrome is highly comorbid with Obsessive-compulsive disorder in the pediatric
population [48]. Overlapping pathological changes in the basal ganglia are implicated in the
two disorders [49, 50]. As we see both typical and atypical antipsychotics have positive effects
in Tourette’s syndrometrials of dopamine antagonists, augmentation therapy in OCD might
be worth considering [51, 52].
The combination of the antipsychotics risperidone, haloperidol, olanzapine, or quetiapine with
an SSRI was shown to be more effective than SSRI monotherapy in treatment-resistant cases
and is recommended (grade 3, ie, limited evidence from controlled studies) by the WFSBP
guidelines [25]. Antipsychotics should be added after at least 3 months of maximally tolerated
therapy of an SSRI. Response usually commences within one month duration as seen in most
of the studies and about one third of treatment-refractory OCD patients show a clinically
meaningful improvement. Superior effects of quetiapine versus ziprasidone as an adjunct to
SSRI were found in treatment-resistant OCD patients in a retrospective study [53]. A single-
blind study comparing risperidone versus olanzapine augmentation of SSRIs showed positive
responses without differences between the two treatment groups [54]. In a 12-week, open-
label, trial of aripiprazole, significant improvement of OCD symptoms was demonstrated [55].
In a small, open-label study suggest that aripiprazole as monotherapy was helpful for treating
OCD [56].Augmentation of paroxetine with perospirone resulted in improvement in a case
report [57].
A smaller number of studies have examined the utility of augmentation therapy with opioid
agents. Morphine given once weekly has shown efficacy in treatment-resistant obsessive-
compulsive disorder in a single doubleblind study, and administration of the opioid agonist
tramadol hydrochloride has also been shown to diminish OCD symptoms [58, 59, 60].The
mechanism of this interesting effect is unknown, but one of the proposed mechanism being
opioids inhibiting glutamate release in cortex through disinhibition of serotonergic neurons.
Other augmentation agents include clonazepam, inositol, clonidine, monoamine oxidase
inhibitors, and antiandrogens [61].
Positive results have been reported with longterm augmentation with citalopram (up to 60
mg/d) in 20 treatment-resistent OCD patients on clomipramine [62].
Riluzole is an antiglutamatergic agent that is approved by the Food and Drug Administration
for neuroprotection in amyotrophic lateral sclerosis (ALS) [63]. Various proposed mechanisms
of action of riluzole are inhibition of sodium currents in glutamatergic axon terminals, reducing
neurotransmitter release [64]; reduction of P/Qtype calcium currents in the axon terminals,
with a similar effect on glutamate release [65]; extension of the open time of Kv1.4 potassium
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channels [66]; and increased astrocytic uptake of glutamate [67]. A case report and an open
label study suggest augmentation with the antiglutamatergic agent riluzole in SRI-resistant
OCD patients has significant efficacy [68, 69].
The amino acid N-acetylcysteine (NAC) is widely used for its antioxidant properties and as
an antidote for acetaminophen toxicity. Preclinical studies suggest that NAC also modulates
CNS glutamate. NAC is converted to cystine, a substrate for the glutamate/ cystine antiporter
located on glial cells. The uptake of cystine by glia causes glial release of glutamate into the
extrasynaptic space, where it appears to stimulate inhibitory metabotropic glutamate receptors
on glutamatergic nerve terminals and thereby reduces the synaptic release of glutamate
[70].There is evidence for benefit of NAC augmentation to SSRI’s in treating SRI-refractory
OCD in two preliminary case reports [71, 72].
In an open-label augmentation trial with memantine, an N-methyl-Daspartate (NMDA)
glutamate receptor antagonist, improvement of symptoms was seen in about half of the
patients, who had failed to respond to treatment with an SSRI for at least 3 months [73]. Feusner
et al in 2009 in an open label trial, compared the differential efficacy of memantine for
obsessive-compulsive disorder vs. generalized anxiety disorder. Ten OCD and 7 GAD subjects
received 12 weeks of open-label memantine 10 mg twice daily, as either monotherapy or
augmentation of their existing medication. Primary outcome measures were the Yale-Brown
Obsessive Compulsive Scale ( YBOCS) for the OCD group, the Hamilton Anxiety Rating Scale
(HARS) for the GAD group, and the Clinical Global Impression-Improvement Scale (CGII) for
both groups. The results suggest that memantine may have preferential efficacy in the
treatment of OCD versus GAD. But further larger placebo controlled studies are required
[74].A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive
Disorder provides preliminary supportive evidence for the effectiveness of memantine as a
glutamatergic augmenting agent in severe OCD [75].
Adjunctive glycine (an NMDA glutamate receptor agonist) was also tested in a small double-
blind placebo-controlled trial and approached efficacy for treatment of OCD symptoms but
with high dropout rates [76].
Amantadine (another NMDA antagonist) could be a useful drug for the treatment of OCD
according to preclinical findings [77].
Augmentation of SSRI’s with topiramate, in treatment-resistant OCD patients may be benefi‐
cial [78, 79]. Double-blind studies with topiramate are being conducted [80].
Pregabalin, which can indirectly inhibit glutamate release via blockade of calcium channels,
beneficial effects on OCD symptoms in combination with serotonergic antidepressants have
been reported in case reports [81, 82].A double-blind placebo-controlled study with pregablin
in SSRI-refractory OCD is being conducted [83].
D-cycloserine (a glutamatergic partial N-methyl-d-aspartate (NMDA) agonist) augmentation
of psychotherapy with exposure and response prevention in OCD has so far been investigated
in three randomized, double-blind, placebo-controlled studies. Significantly greater decreases
in obsession-related distress after four exposure sessions under D-cycloserine (125 mg, given
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2 hours before each session) were reported, however, after additional sessions, the placebo
group tended to catch up [84]. In another study, OCD patients were reported to be significantly
more improved under D-cycloserine at mid-treatment (ten behavior therapy sessions in total,
dose of 100 mg 1 hour before each session), but not at later time points, and the D-cycloserine
group’s depressive symptoms were significantly more improved at posttreatment [85].
In a randomized, double-blinded, placebo-controlled augmentation trial examining CBT + D
cycloserine versus CBT + Placebo with 30 youth (aged 8–17) with a primary diagnosis of OCD
received seven exposure and response prevention sessions paired with DCS or placebo taken
1 hour before sessions. Compared with the CBT + Placebo group, youth in the CBT + D
cycloserine arm showed small-to-moderate treatment effects. These results provide initial
support for a more extensive study of D Cycloserine augmentation of CBT among youth with
OCD [86].
It has been reported that canna-binoids inhibit glutamate release in the CNS. As discussed
above glutamate is implicated in pathophisiology of OCD. Addition-ally, cannabinoid type 1
(CB1) receptors are distributed abun-dantly in the striatum, a brain region frequently associ‐
ated with OCD [87, 88].
Two case reports showed Improvement in Refractory Obsessive Compulsive Disorder With
cannabinoid Dronabinol [89].
4. Augmentation with or switch to cognitive-behavioral psychotherapy
In a RCT, patients who were put on adequate dosages of SSRI for at least 12 weeks, and in
those who continued to have clinically significant symptoms, the augmentative effect of
exposure and ritual prevention versus stress management training was compared; Group with
exposure and response prevention had significant decrease of symptom severity of at least
25% by the end of 8 weeks [90].In a controlled open trial, patients with a history of an inade‐
quate response to multiple SSRI medications in adequate doses were treated with 15 sessions
of outpatient CBT. OCD symptoms decreased significantly and gains were maintained over 6
months [91]. A meta-analysis of psychotherapy and pharmacotherapy for OCD found highest
effect sizes for combined treatment [92].
5. Invasive treatment options
5.1. Psychosurgery
Treatment resistant obsessive-compulsive disorder is one of the few diagnoses in modern
psychiatry for which invasive neurosurgical procedures are part of the established treatment
options. All ablative neurosurgical techniques target the CSTC circuits that are believed to be
hyperactive in OCD. Anterior cingulotomy involves a lesion targeting the anterior cingulated
cortex and cingulum. Anterior capsulotomy targets the subcaudate white matter, interrupting
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channels [66]; and increased astrocytic uptake of glutamate [67]. A case report and an open
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The amino acid N-acetylcysteine (NAC) is widely used for its antioxidant properties and as
an antidote for acetaminophen toxicity. Preclinical studies suggest that NAC also modulates
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located on glial cells. The uptake of cystine by glia causes glial release of glutamate into the
extrasynaptic space, where it appears to stimulate inhibitory metabotropic glutamate receptors
on glutamatergic nerve terminals and thereby reduces the synaptic release of glutamate
[70].There is evidence for benefit of NAC augmentation to SSRI’s in treating SRI-refractory
OCD in two preliminary case reports [71, 72].
In an open-label augmentation trial with memantine, an N-methyl-Daspartate (NMDA)
glutamate receptor antagonist, improvement of symptoms was seen in about half of the
patients, who had failed to respond to treatment with an SSRI for at least 3 months [73]. Feusner
et al in 2009 in an open label trial, compared the differential efficacy of memantine for
obsessive-compulsive disorder vs. generalized anxiety disorder. Ten OCD and 7 GAD subjects
received 12 weeks of open-label memantine 10 mg twice daily, as either monotherapy or
augmentation of their existing medication. Primary outcome measures were the Yale-Brown
Obsessive Compulsive Scale ( YBOCS) for the OCD group, the Hamilton Anxiety Rating Scale
(HARS) for the GAD group, and the Clinical Global Impression-Improvement Scale (CGII) for
both groups. The results suggest that memantine may have preferential efficacy in the
treatment of OCD versus GAD. But further larger placebo controlled studies are required
[74].A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive
Disorder provides preliminary supportive evidence for the effectiveness of memantine as a
glutamatergic augmenting agent in severe OCD [75].
Adjunctive glycine (an NMDA glutamate receptor agonist) was also tested in a small double-
blind placebo-controlled trial and approached efficacy for treatment of OCD symptoms but
with high dropout rates [76].
Amantadine (another NMDA antagonist) could be a useful drug for the treatment of OCD
according to preclinical findings [77].
Augmentation of SSRI’s with topiramate, in treatment-resistant OCD patients may be benefi‐
cial [78, 79]. Double-blind studies with topiramate are being conducted [80].
Pregabalin, which can indirectly inhibit glutamate release via blockade of calcium channels,
beneficial effects on OCD symptoms in combination with serotonergic antidepressants have
been reported in case reports [81, 82].A double-blind placebo-controlled study with pregablin
in SSRI-refractory OCD is being conducted [83].
D-cycloserine (a glutamatergic partial N-methyl-d-aspartate (NMDA) agonist) augmentation
of psychotherapy with exposure and response prevention in OCD has so far been investigated
in three randomized, double-blind, placebo-controlled studies. Significantly greater decreases
in obsession-related distress after four exposure sessions under D-cycloserine (125 mg, given
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more improved under D-cycloserine at mid-treatment (ten behavior therapy sessions in total,
dose of 100 mg 1 hour before each session), but not at later time points, and the D-cycloserine
group’s depressive symptoms were significantly more improved at posttreatment [85].
In a randomized, double-blinded, placebo-controlled augmentation trial examining CBT + D
cycloserine versus CBT + Placebo with 30 youth (aged 8–17) with a primary diagnosis of OCD
received seven exposure and response prevention sessions paired with DCS or placebo taken
1 hour before sessions. Compared with the CBT + Placebo group, youth in the CBT + D
cycloserine arm showed small-to-moderate treatment effects. These results provide initial
support for a more extensive study of D Cycloserine augmentation of CBT among youth with
OCD [86].
It has been reported that canna-binoids inhibit glutamate release in the CNS. As discussed
above glutamate is implicated in pathophisiology of OCD. Addition-ally, cannabinoid type 1
(CB1) receptors are distributed abun-dantly in the striatum, a brain region frequently associ‐
ated with OCD [87, 88].
Two case reports showed Improvement in Refractory Obsessive Compulsive Disorder With
cannabinoid Dronabinol [89].
4. Augmentation with or switch to cognitive-behavioral psychotherapy
In a RCT, patients who were put on adequate dosages of SSRI for at least 12 weeks, and in
those who continued to have clinically significant symptoms, the augmentative effect of
exposure and ritual prevention versus stress management training was compared; Group with
exposure and response prevention had significant decrease of symptom severity of at least
25% by the end of 8 weeks [90].In a controlled open trial, patients with a history of an inade‐
quate response to multiple SSRI medications in adequate doses were treated with 15 sessions
of outpatient CBT. OCD symptoms decreased significantly and gains were maintained over 6
months [91]. A meta-analysis of psychotherapy and pharmacotherapy for OCD found highest
effect sizes for combined treatment [92].
5. Invasive treatment options
5.1. Psychosurgery
Treatment resistant obsessive-compulsive disorder is one of the few diagnoses in modern
psychiatry for which invasive neurosurgical procedures are part of the established treatment
options. All ablative neurosurgical techniques target the CSTC circuits that are believed to be
hyperactive in OCD. Anterior cingulotomy involves a lesion targeting the anterior cingulated
cortex and cingulum. Anterior capsulotomy targets the subcaudate white matter, interrupting
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frontothalamic fibers. Limbic leucotomy combines these two, lesioning both cingulum and
subcaudate white matter [93].
5.2. Deep brain stimulation
Several small-scale controlled and open studies have suggested that deep brain stimulation
(DBS) of the internal capsule and/or the adjacent ventral striatal region may be of benefit to
severely affected OCD patients who have exhausted conventional therapies [94, 95, 96, 97, 98,
99, 100, 101].
Benjamin et al in 2006 found promising long-term effects of DBS in highly treatment-resistant
OCD [102].
5.3. Electroconvulsive therapy (ECT)
Maletzky and colleagues in a retrospective study of 32 patients with treatmentresistant OCD
who received ECT between 1979 and 1991 (19 non-depressed and 13 depressed; 14 were
primarily checkers, 13 primarily cleaners, 4 did both). They were treated with bilateral
frontotemporal ECT and were evaluated 2 days prior to the start of treatment and at 5 days, 6
months, and 12 months after treatment. Five days after treatment, there were highly significant
differences between the pre- and post-scores (paired t-tests; P<.001). At 6-months posttreat‐
ment, the differences were still significant. In this study, ECT had an anti-obsessional effect
and the improvements occurred equally frequently and to an equal extent in depressed and
non-depressed groups [103]. In addition, several single-case reports provided further evidence
of the possible efficacy of ECT in treatment-resistant OCD. However, the unblinded design of
these reports, the frequent comorbidity with other Axis I psychopathology (schizophrenia,
depression, and Tourette’s syndrome), and the different parameters of ECT used limit the
confidence that can be placed in the findings [104, 105, [106, 107, 108].
5.4. Repetitive transcranial magnetic stimulation (rTMS)
Greenberg and colleagues randomized 12 patients with OCD into a singleblind trial. Patients
were treated with 1 session of active right-side, active left-side, or sham (occipital position)
TMS. Based on previous reports of prefrontal hypermetabolism or hyperperfusion in patients
with OCD,44 Greenberg and colleagues believed that the application of a highfrequency rTMS
to prefrontal cortex would have transiently interrupted OCD symptoms. The main finding
was that right prefrontal rTMS had modest acute effects on compulsions whereas effects of left
lateral prefrontal and occipital stimulation were transient and nonsignificant. Obsessions
appeared unaffected by rTMS. Treatment was well-tolerated, with two patients reporting mild
headache after stimulation [109]. Sachdev and colleagues randomized 12 treatment-resistant
OCD patients to a 10-session, single-blind, 2-week trial of active right-side or left-side TMS.
Ten subjects were taking medication (benzodiazepines, antidepressants, or antippsychotics)
and had been maintained on a constant dose for 8 weeks prior to and during the period of the
study. Evaluations after 2 weeks of stimulation and 1 month after the completion of the
treatment showed significant reduction in obsessions and compulsions in both groups with
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no significant difference between right and left stimulation on the overall Y-BOCS score. The
authors suggested that rTMS may be beneficial in the acute treatment of treatment resistant
OCD with an equal proportion of patients benefiting from right- and left-sided stimulation
[110]. In an open-label trial,10 patients with a history of several medication trial failures were
treated for 2 weeks with low-frequency TMS. The supplementary motor area (SMA) was
chosen as the site of stimulation with the coil placed along the sagittal midline in order to
stimulate the SMA bilaterally and simultaneously. The sample had a significant general clinical
improvement on the Clinical Global Impression Scale at the end of the first and second week
of treatment, and maintained that benefit at 1 month and 3 month follow-up [111]. Chiara
Ruffini and colleagues took twenty-three consecutively admitted right-handed inpatients with
DSM-IV-TR–diagnosed drug-resistant OCD and gave rTMS to the left OFC parallel (active: n
= 16) or perpendicular (sham: n = 7) to the scalp. The patients' OCD symptoms, mood, and
anxiety were rated at baseline, at the end of treatment, and once every 2 weeks for 3 months
after treatment. Considering changes in Yale-Brown Obsessive Compulsive Scale (YBOCS)
scores with 2-way analysis of variance for repeated measures for a total of 8 observations
(before rTMS, after treatment, and every 2 weeks for 12 weeks' follow-up), and found signif‐
icant reduction of YBOCS scores comparing active versus sham treatment for 10 weeks after
the end of rTMS (P <.02), with loss of significance after 12 weeks (P <.06). They concluded Low-
frequency rTMS of the left OFC produced significant but time-limited improvement in OCD
patients compared to sham treatment [112]. In a Randomized sham-controlled trial of repeti‐
tive transcranial magnetic stimulation in treatment-resistant obsessive–compulsive disorder
Antonio Mantovani et al found the response rate was 67% (6/9) with active and 22% (2/9) with
sham rTMS after 4 wk and patients receiving active rTMS showed on average a 25% reduction
in the YBOCS compared to a 12% reduction in those receiving sham. In those who received 8-
wk active rTMS, OCD symptoms improved from 28.2±5.8 to 14.5±3.6 [113].
Albert et al(2013) have most recently extensively reviewed available data on treatment resistant
OCD and attempted to build a treatment algorithm for those patients who fail to respond to a
first SSRI trial [114].
As WHO considers OCD to be fourth major mental illness with significant morbidity we need
more effective treatment options. Though a lot of research is available regarding evidence
based treatment approaches in treatment refractory OCD, a lot of clinical mysteries are still
present and further research need to be done. Most of the research available today is prelimi‐
nary short duration studies with small sample size and we need long term clinical trials to
further validate the hypothesis formed from these preliminary studies.
Serotonin related gene polymorphism is a field which might help in the prediction of response
to serotonergic drugs. Denys et al found that response in venlafaxine-treated OCD patients is
associated with the S/L genotype of the 5-HTTLPR polymorphism and in paroxetine-treated
OCD patients with the G/G genotype of the 5-HT2A polymorphism [115].
Functional imaging techniques for glucose metabolism might also predict treatment response
in patients with OCD. Saxena et al suggested that elevated activity (cerebral glucose metabo‐
lism) in the right caudate may be a marker of responsiveness to antiobsessional treatment [116].
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frontothalamic fibers. Limbic leucotomy combines these two, lesioning both cingulum and
subcaudate white matter [93].
5.2. Deep brain stimulation
Several small-scale controlled and open studies have suggested that deep brain stimulation
(DBS) of the internal capsule and/or the adjacent ventral striatal region may be of benefit to
severely affected OCD patients who have exhausted conventional therapies [94, 95, 96, 97, 98,
99, 100, 101].
Benjamin et al in 2006 found promising long-term effects of DBS in highly treatment-resistant
OCD [102].
5.3. Electroconvulsive therapy (ECT)
Maletzky and colleagues in a retrospective study of 32 patients with treatmentresistant OCD
who received ECT between 1979 and 1991 (19 non-depressed and 13 depressed; 14 were
primarily checkers, 13 primarily cleaners, 4 did both). They were treated with bilateral
frontotemporal ECT and were evaluated 2 days prior to the start of treatment and at 5 days, 6
months, and 12 months after treatment. Five days after treatment, there were highly significant
differences between the pre- and post-scores (paired t-tests; P<.001). At 6-months posttreat‐
ment, the differences were still significant. In this study, ECT had an anti-obsessional effect
and the improvements occurred equally frequently and to an equal extent in depressed and
non-depressed groups [103]. In addition, several single-case reports provided further evidence
of the possible efficacy of ECT in treatment-resistant OCD. However, the unblinded design of
these reports, the frequent comorbidity with other Axis I psychopathology (schizophrenia,
depression, and Tourette’s syndrome), and the different parameters of ECT used limit the
confidence that can be placed in the findings [104, 105, [106, 107, 108].
5.4. Repetitive transcranial magnetic stimulation (rTMS)
Greenberg and colleagues randomized 12 patients with OCD into a singleblind trial. Patients
were treated with 1 session of active right-side, active left-side, or sham (occipital position)
TMS. Based on previous reports of prefrontal hypermetabolism or hyperperfusion in patients
with OCD,44 Greenberg and colleagues believed that the application of a highfrequency rTMS
to prefrontal cortex would have transiently interrupted OCD symptoms. The main finding
was that right prefrontal rTMS had modest acute effects on compulsions whereas effects of left
lateral prefrontal and occipital stimulation were transient and nonsignificant. Obsessions
appeared unaffected by rTMS. Treatment was well-tolerated, with two patients reporting mild
headache after stimulation [109]. Sachdev and colleagues randomized 12 treatment-resistant
OCD patients to a 10-session, single-blind, 2-week trial of active right-side or left-side TMS.
Ten subjects were taking medication (benzodiazepines, antidepressants, or antippsychotics)
and had been maintained on a constant dose for 8 weeks prior to and during the period of the
study. Evaluations after 2 weeks of stimulation and 1 month after the completion of the
treatment showed significant reduction in obsessions and compulsions in both groups with
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no significant difference between right and left stimulation on the overall Y-BOCS score. The
authors suggested that rTMS may be beneficial in the acute treatment of treatment resistant
OCD with an equal proportion of patients benefiting from right- and left-sided stimulation
[110]. In an open-label trial,10 patients with a history of several medication trial failures were
treated for 2 weeks with low-frequency TMS. The supplementary motor area (SMA) was
chosen as the site of stimulation with the coil placed along the sagittal midline in order to
stimulate the SMA bilaterally and simultaneously. The sample had a significant general clinical
improvement on the Clinical Global Impression Scale at the end of the first and second week
of treatment, and maintained that benefit at 1 month and 3 month follow-up [111]. Chiara
Ruffini and colleagues took twenty-three consecutively admitted right-handed inpatients with
DSM-IV-TR–diagnosed drug-resistant OCD and gave rTMS to the left OFC parallel (active: n
= 16) or perpendicular (sham: n = 7) to the scalp. The patients' OCD symptoms, mood, and
anxiety were rated at baseline, at the end of treatment, and once every 2 weeks for 3 months
after treatment. Considering changes in Yale-Brown Obsessive Compulsive Scale (YBOCS)
scores with 2-way analysis of variance for repeated measures for a total of 8 observations
(before rTMS, after treatment, and every 2 weeks for 12 weeks' follow-up), and found signif‐
icant reduction of YBOCS scores comparing active versus sham treatment for 10 weeks after
the end of rTMS (P <.02), with loss of significance after 12 weeks (P <.06). They concluded Low-
frequency rTMS of the left OFC produced significant but time-limited improvement in OCD
patients compared to sham treatment [112]. In a Randomized sham-controlled trial of repeti‐
tive transcranial magnetic stimulation in treatment-resistant obsessive–compulsive disorder
Antonio Mantovani et al found the response rate was 67% (6/9) with active and 22% (2/9) with
sham rTMS after 4 wk and patients receiving active rTMS showed on average a 25% reduction
in the YBOCS compared to a 12% reduction in those receiving sham. In those who received 8-
wk active rTMS, OCD symptoms improved from 28.2±5.8 to 14.5±3.6 [113].
Albert et al(2013) have most recently extensively reviewed available data on treatment resistant
OCD and attempted to build a treatment algorithm for those patients who fail to respond to a
first SSRI trial [114].
As WHO considers OCD to be fourth major mental illness with significant morbidity we need
more effective treatment options. Though a lot of research is available regarding evidence
based treatment approaches in treatment refractory OCD, a lot of clinical mysteries are still
present and further research need to be done. Most of the research available today is prelimi‐
nary short duration studies with small sample size and we need long term clinical trials to
further validate the hypothesis formed from these preliminary studies.
Serotonin related gene polymorphism is a field which might help in the prediction of response
to serotonergic drugs. Denys et al found that response in venlafaxine-treated OCD patients is
associated with the S/L genotype of the 5-HTTLPR polymorphism and in paroxetine-treated
OCD patients with the G/G genotype of the 5-HT2A polymorphism [115].
Functional imaging techniques for glucose metabolism might also predict treatment response
in patients with OCD. Saxena et al suggested that elevated activity (cerebral glucose metabo‐
lism) in the right caudate may be a marker of responsiveness to antiobsessional treatment [116].
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Metabotropic glutamate receptor anatagonists, are being developed by pharmaceutical
industry which might be of help in treatment resistant OCD patients [117, 118, 119].
Some of this exciting research may soon get translated into relevant clinical treatment options
for the patients suffering from continued agonizing symptoms of OCD.
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1. Introduction
Psychiatric co-morbidities in forms of affective and anxiety disorders are believed to be the
most frequent complications of epilepsy. It concerns mostly the patients with localization
related forms, and temporal lobe epilepsy [TLE], in particular. Perini et al. have shown that
patients with TLE have higher rates of affective and personality disorders compared to persons
with juvenile myoclonic epilepsy [1]. Despite their frequent prevalence that achieves about
8%-50% among patients with epilepsy [2-6] the data on the risk factors for the development of
psychiatric co-morbidities in TLE remain obscure and rather controversial. That also concerns
obsessive-compulsive disorder (OCD), which is regarded as one of co-morbid psychopatho‐
logical complications in TLE [7].
According to Bear and Fedio data [8] focus laterality in TLE determines the kind of interictal
psychopathology, and in patients with right-sided TLE such symptoms as sadness, elation and
obsessional thinking can origin, while in the left-sided TLE paranoia, anger, dependence and
negative self-image may appear.
Nevertheless, these results have been lately criticized since some subsequent studies couldn’t
replicate these data [9,10]. It implies that data on foci lateralization themselves couldn’t explain
the origin of some psychopathological signs and obsessional thinking in particular in all cases
of TLE. Obviously some other neurobiological factors and personality traits should also be
taken into account in order to predict the probable OCD development in TLE. Moreover,
whether the seizure semiotics has influence upon its development or not remains unknown
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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although in 19-th century have been reported that obsessions were frequently accompanied
by a family history of epilepsy [11, 12].
Among neurobiological factors the data on motor lateralization can be important for prediction
of psychopathological comorbidity i.e. OCD. Along with neurobiological signs the personality
structure variables also may be important for this reason.
Thus, focus lateralization in TLE is thought not to be enough to predict the probability of
psychopathology development in patients with epilepsy, and other factors, such as motor
lateralization and premorbid personality features also should be taken into account. In one of
our previous study we have shown that Alexithymia exerts maximal effect on psychopatho‐
logical variables, i.e. Depression in SCL-90, and maximal values of SCL-90 constructs were
observed in cases with combination Alexithymia and left-handedness and Alexithymia and
right-sided seizure focus [13]. Here should be stressed that Alexithymia itself represents only
a part of complicated psychopathological structure of so-called premorbid personality, and
other personality factors may be also important for the development of psychopathological
disorders in patients with TLE. Any possible relationships between personality, neurobiolog‐
ical variables and OCD in epilepsy have not been properly studied.
Premorbid personality features to date have been fairly studied in terms of risk for psychiatric
pathology in numerous studies. It concerned mainly the role of premorbid personality
structure in affective disorders, schizophrenia, and organic disorders, although the strictly
definite and universal findings have not been obtained yet. Thus, Tellenbach introduced
concept of “Typus melancholicus” (TM) which is still regarded as premorbid personality
features constellation for unipolar (recurrent) depression development [14-16]. Such approach
has been mainly used in Germany and Japan and obtained in this context data are rather
controversial, and complicated. Thus, if some authors agree in unison on the significant role
of TM in depression development [14-17] other authors are careful and could find, that only
between 30 and 70 % of depressed patients have a typical TM structure [18, 19].
Thus, Furukawa et al.[19] used a special scales for assessment of TM features in 140 psychiatric
patients and couldn‘t find any statistically significant discrepancies with normal control
subjects except that among the recurrent depression patients the TM score was lower than in
control group. Unfortunately the similar study has not been performed in epilepsy patients
yet, and whether the premorbid personality has influence on the development of psychopa‐
thology remains unknown.
To date the several personality traits are thought to be significant for the development of
psychiatric disorders at all, and some tests have been elaborated in this context to detect such
personality predisposition to depression in particular. One of such questionnaire widely
known as Munich Personality Test (MPT) has been developed by von Zerssen et al using factor
analysis in 1988 [20]. Detailed description of MPT is given in Materials and Methods section.
Although such multidimensional approach has been widely used in psychiatry, data on its use
in patients with epilepsy are practically absent. Since such neuropsychological variables as
focus laterality (FL) and motor lateralization (ML) are important for development of psychi‐
atric disorders in patients with TLE [13], suggestion could be made that premorbid personality
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features in patients with TLE might be significant for the development of comorbid psycho‐
pathology, and OCD in particular, if take into account their interaction between each other.
The principal aim of the current study was to find any possible relationships between
personality features and OCD development in patients with different neurobiological patterns
i.e. in persons with different combination of FL and ML. The corner stone of the current study
was hypothesis, that the different combinations of FL and ML are thought to be a neurobio‐
logical basis for relationship between premorbid personality features, on the one hand, and
obsessive-compulsive symptoms, on the other hand in patients with TLE.
2. Material and methods
The study has been carried out on 103 patients with epilepsy. Among all studied patients were
33 men and 70 women. The diagnosis of symptomatic epilepsy was set in 40 patients, the
diagnosis of cryptogenic form –in 54 patients, and the diagnosis of idiopathic temporal lobe
epilepsy-in 9 patients. The focus laterality was detected strictly by visual EEG-method, and
data on ictal semiotics have not been taken into account. The left-sided foci were detected in
48 patients (12 men and 36 women), the right-sided foci – in 55 patients (22 men and 33 women).
All patients were evaluated by psychiatrists in order to set a psychiatric diagnosis. ICD-10
criteria were used for these purposes. In line with these criteria the diagnosis of OCD was set
in 19 patients. For the assessment of severity of OCD symptoms the correspond construct of
SCL-90 scale was used and filled in by physicians. The mean value of obsessive-compulsive
construct in OCD patients reached 20,16+-4,13, while in patients without OCD – only 6,31+-3,
72 points.
For assessment of the premorbid personality features the MPT has been used [20]. The MPT
represents a self-rating questionnaire, and includes 51 questions depicting the different
personality traits. The patients have filled in all rating scales themselves, and after that the
obtained raw data have been transformed into six constructs in line with specific structure of
scales. These constructs include Extraversion, Neuroticism, Rigidity, Frustration Tolerance,
Tendencies to Isolation and Esoteric Tendency. The last two constructs form Schizoidia scale
[20]. The other two control scales of MPT (Orientation towards Social Norms and Motivation)
were not included in the final analysis.
Extraversion and Neuroticism constructs are derived from Eysenck and Eysenck concepts [21].
Rigidity is quite similar to construct of Typus melancholicus proposed by Tellenbach [14-17],
while Tendency to Isolation and Esoteric Tendency are based on Kretschmer’s classical study
on relationships between constitution and personality [22]. Frustration tolerance refers to
resiliency or stress coping strategy.
Along with MPT the Toronto Alexithymia Scale (TAS-26) [23, 24] was explored for assessment
of alexithymia. This scale consists of 26 items, and each item can be scored in points from 1 to
5. The global alexithymia score in TAS-26 may be expressed from 26 to 130 points. All patients
whose global TAS-26 score exceeds 74 points were regarded as alexithymic persons. The mean
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average of TAS-26 score in nonalexithymic group (N=78) was 58,5+-11,5, and in alexithymic
group (N=22) was 80,0+-4,8 points.
Assessment of psychopathological status of patients has been performed by use Symptom
Check List-90 (SCL-90). This questionnaire represents a self-rated scale that has 9 psychiatric
symptom groups, consisting of 90 items with a range of five degree severity (0,1,2,3,4). The
evaluated psychiatric constructs include somatization, obsessive-compulsive symptoms,
interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideations,
and psychoticism [25, 26].
For the assessment of handedness Annet’s scale was used [27]. Persons whose global score on
that scale was lower than-5 points were regarded as left-handers, whilst persons with global
score exceeded+5 points-as right-handers. Among all studied patients 73 persons were
considered as right-handers (Mean+-Std. Dev.:+19,2+-6,0) in Annet’s score and 31 persons as
left-handers (Mean+-Std. Dev:-11,2+-10,9).
For analysis purposes al patients were divided into groups in relation to combination of focus
lateralization and motor asymmetry (handedness). In line with this rule the next four groups
were defined: Left focus/Left-handedness (13 patients), Left focus/Right-handedness (33
patients), Right focus/Left-handedness (17 patients) and Right focus/Right-handedness (36
patients).
3. Statistics
All data were statistically processed by Statistica program (9-th version) on personal computer.
On the first step the possible relationship between focus laterality and OCD development was
assessed. In addition the mean values of seizure frequency of different semiotics in patients
with OCD and in persons without OCD have been calculated. On the next step the mean values
of premorbid personality traits, including MPT-constructs and TAS-26 have been calculated,
while on the third stage the multiple regression analysis has been performed for OCD construct
(SCL-90). Here OCD construct was dependent variable, while the premorbid personality
features (TAS-26 χand MPT constructs) were used as independent variables. On the final stage
the values of variances obtained in result of regression analysis were compared between
different groups of patients, and the maximal variances were regarded as more robust criteria
for prediction of OCD [28].
4. Results
The main results are listed in the next several tables. In Table 1 the mean values of seizure
frequency are presented. As can be seen no statistically significant discrepancies between
groups with and without OCD are obtained. In other words, the seizure semiotics doesn’t
determine the OCD development. Noteworthy, the statistically significant relationship
between focus laterality and OCD also has not been revealed (χ2=2,25, p=0,13), that implies
the lack of influence of focus laterality upon OCD development in patients with epilepsy.
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Type of seizure
Patients with
OCD (n=19)
Patients without
OCD (n=84)
Discrepancy
Primary GTCS 0,05+-0,23 0, 27+-0,76 n.s.
Simple partial
seizures
25, 68+-69,48 49,23+-136,3 n.s.
Sensory simple partial seizures 5,21+-10,11 37,58+-120,67 n.s.
Motor simple
partial seizures
20,68+-70,3 14, 10+-74,63 n.s.
Complex
partial seizures
31,47+-71,44 21,36+-57,71 n.s.
Secondary GTCS 6,89+-13,69 7,20+-12,57 n.s.
Notes: GTCS – Generalized tonic-clonic seizures
Table 1. Mean frequency (per year) of different semiotics seizures in patients with OCD and without OCD in epilepsy
The premorbid personality structure data, quite the contrary, have revealed their role in the
origin of OCD, as can be seen from Table 2. As can be seen from table the OCD patients
compared with patients without OCD symptoms as a whole, were characterized by less degree
of Extraversion and Frustration Tolerance than patients in whom OCD symptoms didn’t
develop. On the other hand, OCD patients in premorbid personality structure had higher
values of Neuroticism, Esoteric Tendencies and Schizoidia in comparison with patients
without OCD. The values of Alexithymia, Rigidity and Tendencies to Isolation couldn’t
discriminate two compared groups of patients.
Personality construct
Patients with
OCD (n=19)
Patients without
OCD (n=84)
Discrepancy
Extraversion
(MPT)
11,74+-5,61 16,38+-5,64 p=0,0016
Neuroticism
(MPT)
18,26+-3,69 12,37+-5,44 p=0,000012
Frustration
Tolerance (MPT)
5,58+-2,85 8,19+-3,98 p=0,0081
Rigidity (MPT) 12,53+-3,91 13,00+-4,56 n.s.
Tendency to
Isolation (MPT)
5,37+-2,65 4,67+-2,50 n.s.
Esoteric Tendencies (MPT) 3,37+-2,29 2,27+-2,08 p=0,044
Schizoidia (MPT) 8,89+-3,59 6,93+-3,72 p=0,039
Alexithymia (TAS-26) 68,94+-13,69 62,35+-13,66 n.s.
Table 2. Mean values of different Munich Personality Test constructs and alexithymia in patients with OCD and
without OCD in epilepsy
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5,37+-2,65 4,67+-2,50 n.s.
Esoteric Tendencies (MPT) 3,37+-2,29 2,27+-2,08 p=0,044
Schizoidia (MPT) 8,89+-3,59 6,93+-3,72 p=0,039
Alexithymia (TAS-26) 68,94+-13,69 62,35+-13,66 n.s.
Table 2. Mean values of different Munich Personality Test constructs and alexithymia in patients with OCD and
without OCD in epilepsy
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Based on these obtained data preliminary conclusion can be made that interaction of multi‐
farious personality factors seems to be significant for the OCD origin. In order to reveal such
interaction the multiple regression analysis (forward model) has been performed in different
groups of patients formed on the basis of different combinations motor lateralization and focus
laterality. In other words, this analysis has been performed for prediction of OCD level based
on premorbid personality variables.
Main results of that analysis are listed in the Table 3.
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(N=99)
- -0,24 0,48 - - - - - 0,49
RH
(n=69)
- -0,25 0,55 - - -0,25 - - 0,56
LH
(n=30)
0,51 - - - - - - - 0,50
RF
(n=53)
- -0,23 0,62 - - -0,35 - - 0,69
LF
(n=46)
- - - - - - - - 0,35
RHRF
(n=36)
- -0,35 0,67 - - -0,27 - - 0,74
RHLF
(n=33)
-0,41 - 0,41 -0,37 - - - - 0,51
LHRF
(n=17)
0,53 - 0,38 - - - - - 0,60
LHLF
(n=13)
0,145 -0,64 - - 0,168 0,983 0,79 -0,92 0,78
Notes: RH – right-handers; LH-lefthanders; RF-right focus patients; LF – left focus patients; RHRF-right-handers with right
focus; RHLF – right-handers with left focus; LHRF-lefthanders with right focus; LHLF-lefthanders with left focus; R2 –
explained variance.
Table 3. Multiple forward stepwise regression analysis for OCD disorder as dependent variable in different groups of
patients with epilepsy
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As can be seen from Tab 3 in the final predictive score of OCD the several personality variables
are important. These variables included mostly such features, as Alexithymia, Extraversion,
and Neuroticism. Noteworthy, Alexithymia has been included into regression equation with
positive loadings in left-handers and in group of left-handers with right focus activity. It
implies the alexithymia to be a risk factor for OCD development strictly in left-handed TLE
patients and particularly in left-handed persons with right focus activity. On the other hand,
Alexithymia has been included into regression equation with negative loading in group of
right-handed patients with left-sided focus epileptic activity. It implies that in such category
of patients Alexithymia reduces the final OCD score and by that exerts protective action against
its development.
Noteworthy, the Extraversion and Neuroticism scores both have been included into regression
within same several combination of handedness and focus laterality, although with opposite
loadings. Thus, Extroversion always had negative loading and by that reduced the final OCD
score. It concerned as all patients, as especially patients with right focus activity and the right-
handed patients and persons with combination of right-handedness and right focus activity.
In other words the high Extraversion exerts protective effect on OCD development, while low
level of Extraversion (Introversion) determines OCD and right-handed persons with right
focus activity are especially vulnerable to it.
Neuroticism, on the contrary had been included into final regression equation with positive
loadings and by that determined the OCD development in the same categories of patients. In
other words, Extroversion and Neuroticism have an opposite influence on OCD score, and
Neuroticism is thought to be a risk factor for OCD development.
On the final stage comparison of mutual variances between dependent and independent
variables in regression analysis has been performed (Tab 3). The comparison revealed that
maximal values of variances were observed in regression performed for group of patients with
right focus activity and especially for group of right-handers with right-sided focus (R2=0,74)
and for person with combination of left-handedness and left focus activity (R2=0,78).
Nevertheless, the role of maximal variance value in the last category of patients (left-handers
with left focus activity) shouldn’t not been exaggerated, since no statistically significant
loading for any personality construct has been observed.
Conversely, the minimal values of explained variances were obtained for whole group of
patients where handedness and focus laterality have not been taken into account
5. Discussion
The current study is rather the second one, in which the premorbid personality features were
evaluated as risk factors in combination with certain neurobiological variables in patients with
TLE. Earlier we have performed the similar work on relationships between premorbid
personality traits and development of depression and anxiety states in temporal lobe epilepsy
[29]. The principal limitations of the current study concern the small size of LHRF and LHLF
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Based on these obtained data preliminary conclusion can be made that interaction of multi‐
farious personality factors seems to be significant for the OCD origin. In order to reveal such
interaction the multiple regression analysis (forward model) has been performed in different
groups of patients formed on the basis of different combinations motor lateralization and focus
laterality. In other words, this analysis has been performed for prediction of OCD level based
on premorbid personality variables.
Main results of that analysis are listed in the Table 3.
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are important. These variables included mostly such features, as Alexithymia, Extraversion,
and Neuroticism. Noteworthy, Alexithymia has been included into regression equation with
positive loadings in left-handers and in group of left-handers with right focus activity. It
implies the alexithymia to be a risk factor for OCD development strictly in left-handed TLE
patients and particularly in left-handed persons with right focus activity. On the other hand,
Alexithymia has been included into regression equation with negative loading in group of
right-handed patients with left-sided focus epileptic activity. It implies that in such category
of patients Alexithymia reduces the final OCD score and by that exerts protective action against
its development.
Noteworthy, the Extraversion and Neuroticism scores both have been included into regression
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loadings. Thus, Extroversion always had negative loading and by that reduced the final OCD
score. It concerned as all patients, as especially patients with right focus activity and the right-
handed patients and persons with combination of right-handedness and right focus activity.
In other words the high Extraversion exerts protective effect on OCD development, while low
level of Extraversion (Introversion) determines OCD and right-handed persons with right
focus activity are especially vulnerable to it.
Neuroticism, on the contrary had been included into final regression equation with positive
loadings and by that determined the OCD development in the same categories of patients. In
other words, Extroversion and Neuroticism have an opposite influence on OCD score, and
Neuroticism is thought to be a risk factor for OCD development.
On the final stage comparison of mutual variances between dependent and independent
variables in regression analysis has been performed (Tab 3). The comparison revealed that
maximal values of variances were observed in regression performed for group of patients with
right focus activity and especially for group of right-handers with right-sided focus (R2=0,74)
and for person with combination of left-handedness and left focus activity (R2=0,78).
Nevertheless, the role of maximal variance value in the last category of patients (left-handers
with left focus activity) shouldn’t not been exaggerated, since no statistically significant
loading for any personality construct has been observed.
Conversely, the minimal values of explained variances were obtained for whole group of
patients where handedness and focus laterality have not been taken into account
5. Discussion
The current study is rather the second one, in which the premorbid personality features were
evaluated as risk factors in combination with certain neurobiological variables in patients with
TLE. Earlier we have performed the similar work on relationships between premorbid
personality traits and development of depression and anxiety states in temporal lobe epilepsy
[29]. The principal limitations of the current study concern the small size of LHRF and LHLF
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groups, that couldn’t reveal always statistically significant correlations and discrepancies
between compared groups. Nevertheless, obtained data have shown that based on certain so-
called premorbid variables rated subjectively by patients themselves the prediction of OCD in
TLE patients is quite possible.
Principally, the identification and diagnostics of OCD pathology have been performed by
psychiatrists using objective scales, and those physicians were blind to data on patient
personality traits. Such approach has been used in order to avoid any bias in the qualification
of patient personality structure.
Another reason for the criticism is statement that traits used in study depict not premorbid
period in TLE patients at all, but personality changed due epilepsy course itself. Here should
be stressed that similar approach has been already widely used in numerous studies on
different contingent of patients including organic brain disorders and their authors believe
that MPT constructs can assess strictly premorbid personality [15-18]. Moreover, personality
changes in TLE patients are characterized as a rule by other kind of features, and viscosity is
the prominent trait among them and it isn’t included into either construct of MPT. In this
context MPT doesn’t depict the structure of epileptic personality at all, although Rigidity
construct can be seen as similar but not identical to epileptic personality changes.
The principal results of present study have shown, that neither seizure semiotics, nor focus
lateralization (assessed separately from personality features) couldn’t discriminate epileptic
patients in terms of risk OCD development. However, such prediction becomes probable, if
take into account the personality traits.
The third reason for critic of current study may concern the fact that here has not been used
Yale-Brown scale. Here should be stressed that OCD construct included in SCL-90 question‐
naire describes thoroughly obsessive-compulsive symptoms and may be adequately enough
used for the assessment of such signs severity along with other psychopathological constructs
[25, 26].
The main results of the current study have shown that premorbid personality features have
multifactorial influence on OCD development in patients with TLE. Thus, obsessionality in
patients with TLE may evolve similarly from such different personality traits as alexithymia,
low extraversion score (introversion) and neuroticism and esoteric tendencies. Nonetheless,
the certain premorbid personality trait becomes relevant for OCD development strictly on
condition that some definite neurobiological variables, such as handedness, focus lateraliza‐
tion and their combination in TLE patients should also be taken into account. Moreover, the
certain interaction among concrete personality characteristics with definite neurobiological
variables indeed exists.
Thus, Alexithymia may become risk factor for OCD appearance strictly in left-handed patients
and in left-handed persons with right focus activity. Quite the contrary, Alexithymia may play
protective role against OCD development in right-handed patients with left focus activity. In
other words, quite mirror image role of Alexithymia for OCD origin in epilepsy depends on
interaction between handedness and focus lateralization.
Neuroticism and Extroversion, on the other hand, were risk factors for OCD in cases of right-
handed patients with right-focus activity, although Neuroticism had positive loading for OCD
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development in right-handed patients with the left focus activity too. Obviously, the right-
handedness seems to be more important for Neuroticism construct in terms of its role in OCD
triggering than focus laterality. It implies that Neuroticism as personality feature may be
maximally expressed in the right-handed, but not in the left-handed persons, i.e. seems to be
the prerogative of persons with normal motor lateralization.
Obtained results have confirmed data of our previous work, that Alexithymic and Neurotic
traits are thought to depict the different types of personality that rather exclude each other. In
this context the appearance of similar OCD disorders in TLE patients with such different
personality structures seems to be unexpected and rather contradictory and should be properly
explained. Unfortunately, only speculative explanation may be proposed in this context.
Obviously, the OCD and affective and anxiety disorders seem to be the adaptive forms of
reaction on environmental and internal factors, and could appear in evolution of animals and
Homo sapiens. As adaptive forms of behavior these disorders are required in persons with
different types of neurobiological mechanisms, including motor lateralization and focus
laterality in TLE.
Contrary to our initial expectations we couldn’t find any significant effect of construct
“Rigidity” on OCD in patients with TLE, although the repetition of obsessions seems to be an
attribute of rigidity. Principally, in our previous work we couldn’t find any relationship
between Rigidity and depression development in patients with epilepsy [29]. It implies that
“Status melancholicus” concept is not rather relevant enough for prediction of affective
disorders and OCD development, and mentioned psychiatric co-morbidity have different
personality predisposition traits that become trigger risk factors in TLE. Obviously, that
alexithymia, extraversion, neuroticism and esoteric tendencies are more relevant for depres‐
sion, anxiety and OCD in persons with TLE, than Rigidity.
Based on the data obtained in the current and previous work [29] conclusion can be made, that
premorbid personality profile of affective, anxiety disorders and OCD is quite similar and
includes high Neuroticism level and low Extraversion (high Introversion) level in the right-
handed patients with right focus activity. Besides, the high level of Alexithymia seems to be
Conditio sine qua non for the OCD and depression and anxiety in left-handed persons. Obviously
that Neuroticism combined with low level of Extraversion (Introversion), on one side, and
Alexithymia, on the other side, may cause the similar psychopathological disorders such as
OCD and depression and anxiety states in patients with different neurobiological predisposi‐
tion. It implies that Neuroticism, Extraversion and Alexithymia represent the universal
personality constructs for development as affective, as OCD. Further studies are required to
elucidate the pathogenic mechanisms of co-morbid psychopathology in person with epilepsy.
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low extraversion score (introversion) and neuroticism and esoteric tendencies. Nonetheless,
the certain premorbid personality trait becomes relevant for OCD development strictly on
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